Physical O
mapping O
220 O
kb O
centromeric O
of O
the O
human O
MHC O
and O
DNA O
sequence O
analysis O
of O
the O
43 O
- O
kb O
segment O
including O
the O
RING1 B
, O
HKE6 O
, O
and O
HKE4 O
genes O
. O

DNA O
elements O
recognizing O
NF B
- I
Y I
and O
Sp1 B
regulate O
the O
human O
multidrug O
- O
resistance O
gene O
promoter O
. O

As O
tat B
itself O
dramatically O
increases O
HIV O
- O
1 O
gene O
expression O
, O
it O
too O
is O
presumably O
regulated O
in O
the O
latent O
state O
, O
and O
may O
also O
be O
activated O
by O
mitogenic O
stimulation O
. O

To O
clarify O
the O
difference O
, O
both O
the O
Crk B
II I
and O
Crk O
II O
- O
23 O
, O
proteins O
were O
expressed O
in O
E O
. O
coli O
and O
examined O
their O
binding O
capacity O
in O
vitro O
. O

Transcription O
of O
FN O
promoter O
- O
chloramphenicol B
acetyltransferase I
fusion O
genes O
carrying O
the O
base O
substitution O
in O
one O
or O
more O
of O
these O
G O
- O
rich O
sequences O
both O
in O
vivo O
and O
in O
vitro O
revealed O
that O
the O
base O
substitution O
in O
any O
G O
- O
rich O
sequence O
results O
in O
reduction O
of O
promoter O
activity O
, O
although O
the O
downstream O
GC O
box O
( O
GCd O
) O
plays O
a O
primary O
role O
. O

A O
GT O
- O
rich O
sequence O
binding O
the O
transcription B
factor I
Sp1 I
is O
crucial O
for O
high O
expression O
of O
the O
human O
type O
VII O
collagen O
gene O
( O
COL7A1 O
) O
in O
fibroblasts O
and O
keratinocytes O
. O

It O
was O
found O
that O
Nopp140 B
binds O
primarily O
to O
the O
CK2 O
regulatory O
subunit O
, O
beta O
. O

Effects O
of O
long O
- O
term O
use O
of O
raloxifene O
, O
a O
selective O
estrogen B
receptor I
modulator O
, O
on O
thyroid O
function O
test O
profiles O
. O

Interestingly O
, O
basal O
MAPK B
, O
but O
not O
Raf B
- I
1 I
, O
activity O
was O
constitutively O
enhanced O
in O
Jak1 B
- O
deficient O
HeLa O
cells O
. O

Thus O
, O
primate O
vs O
. O
rodent O
promoter O
selectivity O
mediated O
by O
the O
TBP B
- O
TAFI O
complex O
is O
likely O
to O
be O
the O
result O
of O
cumulative O
subtle O
differences O
between O
individual O
subunits O
that O
lead O
to O
species O
- O
specific O
properties O
of O
RNA B
polymerase I
I I
transcription O
. O

The O
cDNA O
clones O
encode O
a O
polypeptide O
of O
657 O
amino O
acids O
with O
a O
bHLH O
( O
basic O
- O
helix O
- O
loop O
- O
helix O
) O
domain O
, O
characteristic O
of O
a O
large O
family O
of O
transcription O
factors O
, O
and O
a O
PAS B
( O
Per O
- O
Arnt B
- O
Sim B
) O
domain O
in O
the O
amino O
- O
terminal O
half O
region O
. O

Synergy O
between O
interferon B
- I
gamma I
and O
tumor B
necrosis I
factor I
- I
alpha I
in O
transcriptional O
activation O
is O
mediated O
by O
cooperation O
between O
signal O
transducer O
and O
activator O
of O
transcription O
1 O
and O
nuclear B
factor I
kappaB I
. O

Furthermore O
, O
ERK B
phosphorylation O
was O
substantially O
prolonged O
in O
LC O
/ O
BRY O
- O
treated O
cells O
compared O
to O
those O
exposed O
to O
BRY O
alone O
, O
and O
pretreatment O
with O
the O
highly O
specific O
MEK B
inhibitors O
, O
PD98059 O
, O
U0126 O
, O
and O
SL327 O
, O
opposed O
ERK B
activation O
while O
protecting O
cells O
from O
LC O
/ O
BRY O
- O
induced O
lethality O
. O

The O
levels O
of O
soluble O
L B
- I
selectin I
and O
ICAM O
- O
1 O
in O
the O
serum O
were O
determined O
by O
the O
ELISA O
method O
. O

Glutathione B
reductase I
activities O
in O
liver O
, O
kidney O
, O
lung O
, O
and O
brain O
were O
not O
affected O
by O
diet O
. O

Soluble O
fibrin B
monomer O
complexes O
in O
thromboembolism O

Tbx6 B
maps O
to O
chromosome O
7 O
and O
does O
not O
appear O
to O
be O
linked O
to O
any O
known O
mutation O
. O

The O
encoded O
protein O
contains O
an O
amino O
terminal O
PDZ B
domain O
, O
followed O
by O
a O
predicted O
coiled O
- O
coil O
region O
, O
a O
PEST O
domain O
, O
and O
a O
carboxy O
- O
terminal O
SAM O
domain O
. O

Several O
studies O
have O
demonstrated O
that O
the O
corticotropin B
- I
releasing I
factor I
test O
( O
CRF B
) O
is O
useful O
for O
the O
aetiological O
diagnosis O
of O
Cushing O
' O
s O
syndrome O
: O
in O
Cushing O
' O
s O
disease O
, O
as O
opposed O
to O
ectopic O
ACTH B
secretion O
syndrome O
, O
the O
hypothalamus O
- O
pituitary O
- O
adrenal O
( O
HPA O
) O
axis O
can O
still O
be O
stimulated O
by O
CRF B
. O

The O
results O
of O
the O
transient O
- O
transfection O
assay O
showed O
that O
the O
Sp1 O
binding O
element O
located O
in O
the O
core O
region O
( O
positions O
- O
- O
64 O
to O
+ O
1 O
) O
of O
the O
alpha2 O
- O
integrin O
promoter O
plays O
an O
essential O
role O
in O
the O
alpha2 O
- O
integrin O
promoter O
activity O
and O
its O
downregulation O
by O
Erb B
- O
B2 O
. O

To O
test O
this O
hypothesis O
, O
we O
developed O
a O
system O
of O
transient O
transfection O
of O
rat O
adipocytes O
with O
constructs O
containing O
glyceraldehyde B
- I
3 I
- I
phosphate I
dehydrogenase I
( O
GAPDH B
) O
and O
fatty O
acid O
synthetase O
( O
FAS B
) O
promoters O
fused O
to O
gene O
reporter O
CAT O
. O

SHBG B
concentrations O
in O
women O
were O
also O
significantly O
higher O
at O
T O
- O
2 O
and O
T O
- O
3 O
when O
compared O
to O
T O
- O
1 O
values O
. O

Simvastatin O
decreased O
levels O
of O
total O
cholesterol O
by O
20 O
. O
8 O
% O
, O
LDL B
cholesterol I
by O
29 O
. O
7 O
% O
, O
triglycerides O
by O
13 O
. O
6 O
% O
, O
apolipoprotein O
B O
by O
22 O
. O
4 O
% O
, O
alpha O
- O
tocopherol O
by O
16 O
. O
2 O
% O
, O
beta O
- O
carotene O
by O
19 O
. O
5 O
% O
, O
and O
ubiquinol O
- O
10 O
by O
22 O
. O
0 O
% O
( O
P O
< O
. O
001 O
for O
all O
) O
and O
increased O
levels O
of O
HDL B
cholesterol I
by O
7 O
. O
0 O
% O
( O
P O
< O
. O
001 O
) O
and O
serum B
insulin I
by O
13 O

The O
more O
severe O
the O
CRF O
, O
the O
more O
likely O
that O
total O
HDL B
and O
HDL2 B
cholesterol I
will O
be O
low O
. O

They O
are O
growth O
- O
inhibited O
by O
TGF B
- I
beta1 I
. O

This O
is O
consistent O
with O
the O
need O
for O
a O
nuclear O
retinoid O
receptor O
function O
in O
RA O
- O
induced O
ERK2 B
activation O
. O

In O
the O
virus O
- O
infected O
cells O
, O
translation O
of O
the O
M1 O
protein O
was O
reduced O
to O
10 O
to O
20 O
% O
of O
that O
of O
the O
wild O
- O
type O
virus O
; O
however O
, O
the O
translation O
of O
neither O
the O
nucleoprotein O
nor O
NS1 B
was O
significantly O
interfered O
with O
, O
indicating O
the O
important O
role O
of O
NS1 B
in O
translational O
stimulation O
of O
the O
M1 O
protein O
. O

Interactions O
were O
also O
detected O
between O
full O
- O
length O
HSF1 B
and O
the O
small O
subunit O
( O
gamma O
) O
of O
TFIIA O
. O

We O
report O
that O
Nim1 O
possesses O
intrinsic O
serine O
- O
kinase O
, O
threonine O
- O
kinase O
and O
tyrosine B
- I
kinase I
activities O
. O

BACKGROUND O
- O
- O
Platelet B
activating I
factor I
( O
PAF B
) O
has O
been O
implicated O
in O
the O
pathogenesis O
of O
airway O
hyperresponsiveness O
in O
asthma O
. O

TFEC O
RNA O
is O
found O
in O
many O
tissues O
of O
adult O
rats O
, O
but O
the O
relative O
concentrations O
of O
TFEC B
and O
TFE3 O
RNAs O
vary O
considerably O
in O
these O
different O
tissues O
. O

Our O
results O
show O
that O
unlike O
the O
case O
for O
sos1 B
, O
sos2 O
gene O
function O
is O
dispensable O
for O
normal O
mouse O
development O
, O
growth O
, O
and O
fertility O
. O

The O
effect O
on O
FIV O
LTR O
promoter O
activity O
of O
progressively O
deleting O
these O
nuclear O
factor O
binding O
sites O
was O
examined O
by O
linking O
LTR O
deletion O
mutants O
to O
the O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
gene O
. O

A O
series O
of O
sequence O
fragments O
were O
placed O
5 O
' O
to O
the O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
reporter O
gene O
and O
ability O
to O
mediate O
transcription O
of O
CAT B
in O
response O
to O
IFN B
gamma I
or O
LPS O
treatment O
was O
studied O
following O
transient O
transfection O
in O
the O
macrophage O
- O
like O
cell O
line O
RAW O
264 O
. O
7 O
. O

Module O
2 O
of O
RifA O
lacks O
a O
beta O
- O
ketoacyl O
: O
acyl O
carrier O
protein O
reductase O
( O
KR B
) O
domain O
and O
the O
one O
in O
module O
3 O
has O
an O
apparently O
inactive O
NADPH O
binding O
motif O
, O
similar O
to O
one O
found O
in O
the O
Er O
PKS O
, O
while O
the O
other O
eight O
KR O
domains O
of O
the O
Rf O
PKS O
should O
be O
functional O
. O

In O
murine O
cells O
, O
FPGS B
expression O
is O
controlled O
by O
two O
promoters O
that O
, O
as O
we O
show O
here O
, O
vary O
substantially O
in O
their O
efficiency O
, O
at O
least O
in O
the O
context O
of O
a O
reporter O
gene O
assay O
. O

Should O
we O
use O
thiazide O
diuretics O
in O
hypertensive O
patients O
with O
non O
- O
insulin B
- O
dependent O
diabetes O
mellitus O
? O

The O
GST B
- O
CBL B
- O
LZIP O
fusion O
protein O
contains O
a O
binding O
site O
for O
the O
SH2 B
domain I
of O
the O
p85 B
subunit I
of O
phosphatidylinositol B
3 I
- I
kinase I
, O
which O
mapped O
to O
Tyr731 O
, O
which O
is O
present O
in O
the O
sequence O
YEAM O
. O

We O
now O
show O
that O
the O
FRAP B
Ser2035 O
- O
- O
> O
Ala O
mutant O
displays O
similar O
binding O
affinity O
when O
compared O
with O
the O
wild O
- O
type O
protein O
, O
whereas O
all O
other O
mutations O
at O
this O
site O
, O
including O
mimics O
of O
phosphoserine O
, O
abolish O
binding O
, O
presumably O
due O
to O
either O
unfavorable O
steric O
interactions O
or O
induced O
conformational O
changes O
. O

Titres O
of O
antistreptolysin B
O I
in O
mothers O
of O
children O
affected O
with O
Down O
' O
s O
syndrome O
. O

Defects O
in O
RT6 O
expression O
coincide O
with O
increased O
susceptibility O
in O
animal O
models O
for O
insulin B
- O
dependent O
diabetes O
mellitus O
and O
other O
autoimmune O
diseases O
. O

The O
unc O
- O
101 O
, O
sli B
- I
1 I
, O
and O
rok O
- O
1 O
genes O
encode O
a O
distinct O
set O
of O
negative O
regulators O
of O
vulval O
differentiation O
. O

Both O
sequence O
analysis O
and O
restriction O
fragment O
length O
polymorphism O
analysis O
revealed O
a O
high O
degree O
of O
sequence O
( O
97 O
% O
homology O
) O
and O
structural O
similarity O
among O
members O
of O
the O
ART O
- O
CH B
family O
, O
indicating O
their O
common O
origin O
and O
recent O
penetration O
into O
chicken O
DNA O
. O

In O
addition O
, O
wild O
- O
type O
and O
mutated O
DNA O
templates O
were O
used O
as O
probes O
in O
DNase B
I I
protection O
experiments O
to O
determine O
sites O
of O
protein O
- O
DNA O
interaction O
. O

Previous O
work O
has O
shown O
that O
glucose O
repression O
of O
PRB1 O
transcription O
is O
not O
mediated O
by O
HXK2 O
or O
by O
the O
SNF1 B
, O
SNF4 B
, O
and O
SNF6 O
genes O
( O
C O
. O

The O
pyridostigmine O
inhibited O
AChE B
recovered O
only O
in O
the O
100 O
mumol O
kg O
- O
1 O
kg O
oxime O
groups O
at O
the O
end O
of O
the O
experiment O
. O

Mutation O
of O
this O
threonine O
to O
isoleucine O
had O
no O
observable O
effect O
on O
either O
nuclear O
localization O
of O
E1 B
or O
DNA O
replication O
of O
the O
intact O
viral O
genome O
. O

Serum B
prolactin I
and O
oestradiol O
levels O
at O
different O
stages O
of O
puberty O
. O

The O
zinc O
finger O
protein O
A20 O
is O
a O
tumor B
necrosis I
factor I
( O
TNF B
) O
- O
and O
interleukin B
1 I
( O
IL B
- I
1 I
) O
- O
inducible O
protein O
that O
negatively O
regulates O
nuclear B
factor I
- I
kappa I
B I
( O
NF B
- I
kappaB I
) O
- O
dependent O
gene O
expression O
. O

At O
least O
one O
such O
complex O
is O
eliminated O
by O
preincubating O
the O
nuclear O
extract O
with O
an O
antibody O
with O
broad O
cross O
- O
reactivity O
with O
Ets B
- I
1 I
and O
Ets O
- O
2 O
proteins O
, O
thus O
confirming O
that O
an O
ETS O
transcription O
factor O
( O
s O
) O
recognizes O
the O
- O
12 O
motif O
. O

Mutant O
beta2 O
- O
adrenergic O
receptors O
with O
a O
Tyr O
- O
to O
- O
Phe O
substitution O
at O
Tyr O
- O
350 O
do O
not O
display O
agonist O
- O
induced O
desensitization O
, O
Src B
recruitment O
, O
or O
Src B
activation O
. O

Role O
of O
distinct O
mitogen B
- I
activated I
protein I
kinase I
pathways O
and O
cooperation O
between O
Ets B
- I
2 I
, O
ATF B
- I
2 I
, O
and O
Jun O
family O
members O
in O
human O
urokinase O
- O
type O
plasminogen O
activator O
gene O
induction O
by O
interleukin B
- I
1 I
and O
tetradecanoyl O
phorbol O
acetate O
. O

These O
data O
may O
indicate O
redundancy O
between O
members O
of O
the O
NGFI B
- I
B I
/ O
Nurr1 O
/ O
Nor1 O
subfamily O
and O
could O
explain O
why O
no O
phenotypic O
disturbances O
have O
yet O
been O
found O
in O
mice O
in O
which O
the O
NGFI O
- O
B O
gene O
has O
been O
inactivated O
. O

To O
directly O
address O
this O
issue O
, O
we O
used O
a O
tetracycline O
- O
regulated O
system O
in O
human O
U2OS O
osteosarcoma O
cells O
and O
thus O
found O
that O
BCL6 B
mediates O
growth O
suppression O
associated O
with O
impaired O
S O
phase O
progression O
and O
apoptosis O
. O

Stability O
of O
125 O
I O
- O
labeled O
insulin B
used O
in O
radioimmunoassay O
of O
insulin B
. O

Paclitaxel O
caused O
a O
rapid O
and O
transient O
increase O
in O
c B
- I
Jun I
NH2 I
- I
terminal I
kinase I
( O
JNK B
) O
activity O
, O
a O
proposed O
mediator O
of O
stress O
activation O
pathways O
. O

However O
, O
additional O
studies O
on O
cell O
lines O
and O
whole O
animals O
are O
required O
to O
understand O
GnRH B
signaling O
in O
the O
context O
of O
other O
hormones O
during O
the O
reproductive O
cycle O
of O
mouse O
and O
human O
. O

ATF6 B
, O
a O
basic O
- O
leucine O
zipper O
protein O
, O
was O
isolated O
by O
binding O
to O
SRF B
and O
in O
particular O
to O
its O
transcriptional O
activation O
domain O
. O

The O
largest O
one O
probably O
corresponds O
to O
the O
precursor O
form O
of O
PS2 B
in O
E O
. O
coli O
. O

VAV B
and O
SOCS1 O
form O
a O
protein O
complex O
through O
interactions O
between O
the O
VAV O
NH O
( O
2 O
) O
- O
terminal O
regulatory O
region O
and O
the O
SH2 B
domain I
of O
SOCS1 O
in O
a O
phosphotyrosine O
- O
independent O
manner O
. O

Furthermore O
, O
disruption O
of O
pcr1 B
reduced O
expression O
of O
fbp1 B
, O
a O
glucose O
- O
repressible O
gene O
negatively O
regulated O
by O
PKA B
. O

In O
solution O
, O
[ O
( O
125 O
) O
I O
] O
- O
labeled O
ankyrin B
was O
found O
by O
ND O
- O
PAGE3 O
to O
enhance O
the O
affinity O
of O
spectrin O
self O
- O
association O
by O
10 O
- O
fold O
. O

Flux O
of O
the O
paramyxovirus O
hemagglutinin B
- O
neuraminidase O
glycoprotein O
through O
the O
endoplasmic O
reticulum O
activates O
transcription O
of O
the O
GRP78 B
- O
BiP B
gene O
. O

The O
goals O
of O
these O
experiments O
were O
to O
determine O
whether O
lactational O
anestrus O
would O
be O
prolonged O
by O
a O
48 O
- O
h O
fast O
at O
days O
13 O
and O
14 O
postpartum O
( O
pp O
) O
and O
, O
if O
so O
, O
to O
determine O
whether O
this O
effect O
could O
be O
reversed O
by O
treatment O
with O
the O
Ob O
protein O
leptin B
. O

Complete O
activation O
of O
signal O
transducer O
and O
activator O
of O
transcription O
1 O
( O
STAT1 B
) O
requires O
phosphorylation O
at O
both O
Y701 O
and O
a O
conserved O
PMS O
( O
727 O
) O
P O
sequence O
. O

The O
Ras O
GTPase O
- O
activating O
- O
protein O
- O
related O
human O
protein O
IQGAP2 O
harbors O
a O
potential O
actin O
binding O
domain O
and O
interacts O
with O
calmodulin B
and O
Rho O
family O
GTPases O
. O

DNase B
I I
protection O
analysis O
as O
well O
as O
oligonucleotide O
competition O
experiments O
indicate O
that O
this O
binding O
is O
sequence O
specific O
. O

Plasmid O
pSP64E6E7 O
which O
contains O
the O
reading O
frames O
of O
both O
E6 B
and O
E7 B
was O
constructed O
in O
order O
to O
study O
the O
expression O
of O
both O
proteins O
in O
a O
coupled O
transcription O
/ O
rabbit O
reticulocyte O
translation O
system O
. O

Both O
viruses O
express O
the O
mil O
/ O
raf B
oncogene O
product O
as O
a O
gag O
- O
fusion O
polyprotein O
, O
while O
the O
myc B
oncogene O
of O
MH2 O
is O
expressed O
via O
a O
subgenomic O
mRNA O
. O

Recombinant O
protein O
encoded O
by O
ESX O
( O
for O
epithelial O
- O
restricted O
with O
serine O
box O
) O
exhibits O
Ets O
- O
like O
DNA O
binding O
specificity O
in O
electrophoretic O
mobility O
shift O
assays O
and O
, O
in O
transient O
transfection O
assays O
, O
transactivates O
Ets O
- O
responsive O
promoter O
elements O
including O
that O
found O
in O
the O
HER2 B
/ O
neu B
oncogene O
. O

Of O
921 O
specimens O
, O
95 O
yielded O
non O
- O
albicans O
species O
, O
mainly O
from O
patients O
with O
low O
CD4 B
lymphocyte O
counts O
and O
extensive O
previous O
azole O
exposure O
. O

These O
findings O
suggest O
that O
eIF5 B
- O
eIF2beta O
interaction O
plays O
an O
essential O
role O
in O
eIF5 B
function O
in O
eukaryotic O
cells O
. O

Cytokine O
- O
mediated O
I B
kappa I
B I
alpha I
reappearance O
was O
completely O
blocked O
by O
the O
protein O
synthesis O
inhibitor O
cycloheximide O
. O

Development O
of O
P O
carinii O
pneumonia O
was O
associated O
with O
the O
stage O
of O
Kaposi O
' O
s O
sarcoma O
, O
B O
subtype O
disease O
, O
and O
the O
presence O
of O
0 O
. O
20 O
X O
10 O
( O
9 O
) O
/ O
L O
( O
200 O
/ O
mm3 O
) O
or O
fewer O
CD4 B
cells O
at O
study O
entry O
. O

Genetic O
analysis O
places O
CWH43 O
upstream O
of O
the O
BCK2 B
branch O
of O
the O
PKC1 O
signalling O
pathway O
, O
since O
cwh43 O
mutations O
were O
synthetic O
lethal O
with O
pkc1 O
deletion O
, O
whereas O
the O
cwh43 O
defects O
could O
be O
rescued O
by O
overexpression O
of O
BCK2 B
and O
not O
by O
high O
- O
copy O
- O
number O
expression O
of O
genes O
encoding O
downstream O
proteins O
of O
the O
PKC1 O
pathway O
However O
, O
unlike O
BCK2 B
, O
whose O
disruption O
in O
a O
cln3 O
mutant O
resulted O
in O
growth O
arrest O
in O
G O
( O
1 O
) O
, O
no O
growth O
defect O
was O
observed O
in O
a O
double O
cwh43 O
cln3 O
mutants O
. O

Reversal O
of O
' O
refractory O
septic O
shock O
' O
by O
infusion O
of O
amrinone O
and O
angiotensin B
II I
in O
an O
anthracycline O
- O
treated O
patient O
. O

Negative O
modulation O
of O
alpha1 O
( O
I O
) O
procollagen O
gene O
expression O
in O
human O
skin O
fibroblasts O
: O
transcriptional O
inhibition O
by O
interferon B
- I
gamma I
. O

On O
the O
basis O
of O
this O
homology O
, O
we O
examined O
the O
potential O
role O
of O
c B
- I
Rel I
in O
controlling O
IL B
- I
2R I
alpha I
transcription O
. O

Expression O
of O
CBP B
/ O
p300 B
potentiated O
HS2 O
- O
mediated O
transactivation O
. O

We O
next O
developed O
a O
rapid O
purification O
method O
for O
bacterial O
recombinant O
MyoD O
- O
bHLH O
domain O
by O
affinity O
chromatography O
using O
a O
calmodulin B
- O
Sepharose O
column O
and O
investigated O
the O
phosphorylation O
of O
that O
peptide O
by O
PKC B
and O
its O
interactions O
with O
calmodulin B
and O
S100a O
. O

HL B
is O
hypothesized O
to O
directly O
couple O
HDL B
lipid O
metabolism O
to O
tissue O
/ O
cellular O
lipid O
metabolism O
. O

Epstein B
- I
Barr I
virus I
nuclear I
antigen I
2 I
exerts O
its O
transactivating O
function O
through O
interaction O
with O
recombination O
signal O
binding O
protein O
RBP O
- O
J O
kappa O
, O
the O
homologue O
of O
Drosophila O
Suppressor O
of O
Hairless O
. O

We O
constructed O
a O
stable O
, O
doubly O
transfected O
cell O
line O
( O
TIS O
- O
10 O
) O
carrying O
a O
chromosomally O
integrated O
ptetO7 O
- O
CMV O
- O
L O
reporter O
construct O
and O
expressing O
the O
TetR B
- O
KRAB B
protein O
. O

We O
suggest O
that O
electrical O
stimulation O
of O
the O
NTS O
in O
rats O
undergoing O
such O
surgical O
preparation O
to O
observe O
the O
pressor O
response O
and O
/ O
or O
increase O
in O
pVP O
, O
represents O
a O
rapid O
approach O
for O
screening O
the O
neurosecretory O
function O
of O
the O
central O
neural O
integration O
to O
release O
vasopressin B
. O

Together O
with O
previous O
work O
our O
results O
suggest O
that O
C B
/ I
EBP I
may O
be O
a O
general O
cooperation O
partner O
for O
v O
- O
Myb O
in O
myelomonocytic O
cells O
. O

Fig1p O
and O
Fig2p O
are O
likely O
to O
act O
at O
the O
cell O
surface O
as O
Fig1 O
: O
: O
beta B
- I
gal I
and O
Fig2 O
: O
: O
beta O
- O
gal O
fusion O
proteins O
localize O
to O
the O
periphery O
of O
mating O
cells O
. O

Our O
data O
suggest O
that O
association O
of O
TBP B
with O
the O
TATA O
box O
may O
be O
regulated O
, O
directly O
or O
indirectly O
, O
by O
a O
substrate O
of O
Snf1 B
. O

In O
the O
absence O
of O
Mg2 O
+ O
, O
the O
extent O
of O
destabilization O
of O
tRNAPhe B
is O
greater O
but O
appears O
to O
be O
confined O
to O
internal O
regions O
of O
the O
acceptor O
and O
T O
psi O
C O
helices O
, O
as O
evidenced O
by O
the O
selectively O
enhanced O
exchange O
rates O
for O
imino O
protons O
associated O
with O
these O
base O
pairs O
. O

Serum O
alpha O
- O
amylase O
, O
trypsin B
, O
trypsin O
inhibitor O
, O
lipase B
and O
total O
protease O
activity O
in O
the O
pancreatic O
tissue O
was O
studied O
as O
indicator O
of O
the O
treatment O
efficacy O
with O
5 O
- O
fluorouracil O
electro O
- O
cumulation O
. O

This O
effect O
is O
independent O
of O
the O
Gal4 B
protein I
, O
as O
it O
operates O
in O
a O
gal4 O
mutant O
background O
as O
well O
. O

Consistent O
with O
the O
large O
pocket O
of O
Rb B
binding O
to O
TAF B
( I
II I
) I
250 I
, O
the O
large O
pocket O
domains O
of O
both O
p107 B
and O
p130 B
are O
able O
to O
bind O
to O
TAF B
( I
II I
) I
250 I
in O
vivo O
. O

Activation O
of O
the O
receptor O
induces O
Ret B
phosphorylation O
that O
leads O
the O
survival O
- O
promoting O
effects O
. O

Critical O
review O
of O
tests O
for O
the O
HBs B
antigen I
in O
the O
detection O
of O
infectious O
blood O

DSS4 O
- O
1 O
is O
a O
dominant O
suppressor O
of O
sec4 B
- I
8 I
that O
encodes O
a O
nucleotide O
exchange O
protein O
that O
aids O
Sec4p O
function O
. O

The O
vaccine O
was O
highly O
immunogenic O
, O
since O
111 O
of O
113 O
patients O
( O
98 O
% O
) O
produced O
anti B
- I
HBs I
( O
10 O
mIU O
/ O
ml O
or O
more O
) O
. O

The O
interleukin O
- O
2 O
receptor O
alpha O
( O
IL B
- I
2R I
alpha I
) O
chain O
gene O
contains O
a O
sequence O
similar O
to O
the O
immunoglobulin O
( O
Ig O
) O
kappa O
( O
kappa O
) O
enhancer O
NF O
- O
kappa O
B O
binding O
site O
. O

Although O
mutant O
pex5delta O
cells O
expressing O
a O
yeast O
/ O
tobacco O
Pex5p O
chimaera O
failed O
to O
import O
a O
GFP B
- O
Eci1p O
reporter O
protein O
, O
they O
were O
able O
to O
grow O
on O
oleic O
acid O
. O

Consistent O
with O
this O
observation O
, O
introduction O
of O
Smad O
sites O
into O
a O
TGFbeta B
- O
insensitive O
LEF1 B
/ O
TCF B
target O
gene O
confers O
cooperative O
TGFbeta B
and O
Wnt B
responsiveness O
to O
the O
promoter O
. O

Serum B
IgM I
levels O
showed O
a O
highly O
significant O
increase O
in O
all O
types O
of O
brain O
tumour O
when O
compared O
to O
controls O
. O

NER O
was O
also O
measured O
by O
a O
plasmid O
host O
cell O
re O
- O
activation O
assay O
using O
a O
vector O
containing O
a O
luciferase B
reporter I
gene I
. O

PATIENTS O
: O
33 O
HIV O
- O
infected O
, O
zidovudine O
- O
experienced O
patients O
with O
serum O
HIV O
RNA O
levels O
of O
at O
least O
20 O
, O
000 O
copies O
/ O
mL O
and O
CD4 B
counts O
ranging O
from O
50 O
to O
400 O
cells O
/ O
mm3 O
. O

These O
data O
, O
taken O
together O
, O
suggest O
that O
CRF B
produces O
its O
behavioral O
activating O
and O
anxiogenic O
effects O
, O
at O
least O
in O
part O
, O
by O
increasing O
the O
activity O
of O
LC O
noradrenergic O
neurons O
. O

The O
sequence O
of O
Vac1p B
contains O
two O
putative O
zinc O
- O
binding O
RING O
motifs O
, O
a O
zinc O
finger O
motif O
, O
and O
a O
coiled O
- O
coil O
motif O
. O

Using O
green B
fluorescent I
protein I
fusions O
we O
demonstrate O
that O
the O
SYT O
, O
SSX O
and O
the O
SYT O
- O
SSX O
proteins O
are O
nuclear O
proteins O
. O

These O
data O
suggested O
that O
mutant O
PS1 O
may O
cause O
disease O
as O
a O
result O
of O
reduction O
in O
PS1 B
function O
. O

Mammalian O
ribonucleotide B
reductase I
shows O
S O
- O
phase O
specific O
expression O
and O
consists O
of O
two O
non O
- O
identical O
subunits O
, O
proteins O
R1 O
( O
large O
subunit O
) O
and O
R2 B
( O
small O
subunit O
) O
. O

Recombinant O
MsERK1 O
( O
rMsERK1 O
) O
, O
when O
overexpressed O
in O
Escherichia O
coli O
, O
is O
recognized O
by O
antibodies O
raised O
against O
MAP O
kinases O
from O
rat O
, O
Xenopus O
, O
and O
sea O
star O
and O
by O
anti B
- I
phosphotyrosine I
antibodies I
. O

The O
identification O
of O
SRP54sc O
and O
SRP54sp O
provides O
the O
first O
evidence O
for O
SRP B
related O
proteins O
in O
yeast O
. O

We O
previously O
demonstrated O
that O
AKT2 O
, O
a O
member O
of O
protein O
kinase O
B O
family O
, O
is O
activated O
by O
a O
number O
of O
growth O
factors O
via O
Ras B
and O
PI B
3 I
- I
kinase I
signaling O
pathways O
. O

Unlike O
CSK B
, O
the O
SH3 B
domain I
of O
HYL O
was O
unique O
since O
the O
ALYDY O
motif O
was O
absent O
. O

Its O
phosphorylation O
strongly O
potentiates O
its O
ability O
to O
activate O
transcription O
of O
the O
c B
- I
fos I
promoter I
through O
a O
ternary O
complex O
assembled O
on O
the O
c O
- O
fos O
serum O
response O
element O
. O

Fus3p O
and O
Kss1p O
together O
increase O
the O
expression O
of O
CLN3 B
and O
PCL2 O
genes O
that O
promote O
budding O
, O
and O
Kss1p O
inhibits O
the O
MAP B
kinase I
cascade O
. O

Consistent O
with O
our O
observation O
that O
AP B
- I
1 I
binding O
does O
not O
contribute O
to O
c B
- I
Jun I
coactivation O
is O
the O
observation O
that O
the O
activation O
of O
PU B
. I
1 I
by O
c B
- I
Jun I
is O
blocked O
by O
overexpression O
of O
c B
- I
Fos I
. O

Human O
epidermal O
growth O
factor O
( O
EGF B
) O
, O
a O
naturally O
occurring O
protein O
, O
has O
been O
implicated O
in O
the O
protection O
of O
gastrointestinal O
mucosal O
integrity O
. O

A O
minimal O
pheromone O
induction O
domain O
, O
delineated O
as O
residues O
301 O
to O
335 O
of O
Ste12p B
, O
is O
dependent O
on O
the O
pheromone O
mitogen B
- I
activated I
protein I
( I
MAP I
) I
kinase I
pathway O
for O
induction O
activity O
. O

In O
addition O
, O
both O
activated O
Ral O
- O
GDS O
- O
like O
factor O
and O
Raf B
stimulate O
cyclin O
D O
( O
1 O
) O
transcription O
and O
E2F B
activity O
and O
act O
in O
synergy O
with O
PI B
3 I
- I
kinase I
. O

From O
the O
present O
results O
a O
concept O
of O
hormone O
- O
dependent O
AR B
activation O
is O
proposed O
, O
which O
requires O
a O
functional O
, O
direct O
or O
indirect O
intramolecular O
interaction O
between O
the O
TAD O
and O
the O
LBD O
. O

Down O
- O
regulation O
of O
Id1 O
mRNA O
correlated O
with O
mitogenesis O
and O
occurred O
when O
quiescent O
cells O
were O
treated O
with O
growth O
factors O
that O
activate O
G B
protein I
- I
coupled I
receptors I
and O
receptor O
protein O
tyrosine O
kinases O
but O
not O
with O
a O
non O
- O
mitogenic O
cAMP O
analog O
. O

The O
electron O
spin O
resonance O
study O
also O
demonstrated O
that O
the O
formation O
of O
superoxide O
- O
DMPO O
spin O
adduct O
was O
strongly O
inhibited O
by O
a O
selective O
cyclooxygenase B
- I
2 I
inhibitor O
, O
etodolac O
, O
in O
a O
concentration O
- O
dependent O
manner O
. O

BK O
- O
induced O
translocation O
and O
overexpression O
of O
PKC O
isoforms O
as O
well O
as O
coexpression O
of O
inactive O
or O
constitutively O
active O
mutants O
of O
different O
PKC O
isozymes O
provided O
evidence O
for O
a O
role O
of O
the O
diacylglycerol O
- O
sensitive O
PKCs O
alpha O
and O
epsilon O
in O
BK O
signaling O
toward O
MAPK B
. O

A O
lead O
phthalocyanin O
method O
for O
the O
demonstration O
of O
acid B
hydrolases I
in O
plant O
and O
animal O
tissues O
. O

Here O
we O
describe O
the O
characterization O
of O
cDNAs O
encoding O
two O
unusual O
E2Fs O
, O
E2F O
- O
4 O
and O
E2F O
- O
5 O
, O
each O
identified O
by O
the O
ability O
of O
their O
gene O
product O
to O
interact O
with O
p130 B
in O
a O
yeast O
two O
- O
hybrid O
system O
. O

Interestingly O
, O
unlike O
PAK65 O
, O
HPK1 B
does O
not O
contain O
the O
small B
GTPase I
Rac1 B
/ O
Cdc42 B
- O
binding O
domain O
and O
does O
not O
bind O
to O
either O
Rac1 B
or O
Cdc42 B
, O
suggesting O
that O
HPK1 B
. O
activation O
is O
Rac1 B
/ O
Cdc42 B
- O
independent O
. O

Tumor B
necrosis I
factor I
levels O
were O
measured O
by O
enzyme O
- O
linked O
immunoabsorbent O
assay O
in O
plasma O
samples O
obtained O
from O
the O
hyperthermic O
isolated O
limb O
perfusion O
circuit O
and O
systemic O
circulation O
. O

However O
, O
only O
plasma B
fibrinogen I
concentrations O
showed O
statistically O
significant O
positive O
associations O
with O
IMT O
in O
both O
groups O
. O

All O
such O
polypeptides O
containing O
263 O
or O
more O
residues O
derived O
from O
the O
C O
- O
terminus O
of O
P130gag O
- O
fps B
( O
i O
. O
e O
. O
residues O
920 O
- O
1182 O
) O
were O
enzymatically O
active O
as O
tyrosine B
kinases I
. O

A O
structural O
model O
for O
Vpu B
is O
proposed O
in O
which O
the O
membrane O
anchor O
precedes O
a O
region O
comprising O
two O
amphipathic O
alpha O
- O
helices O
of O
opposed O
polarity O
, O
joined O
by O
a O
strongly O
acidic O
turn O
that O
protrudes O
into O
the O
cytoplasm O
and O
contains O
the O
CK O
- O
2 O
phosphorylation O
sites O
. O

Thus O
, O
CARP B
is O
a O
YB O
- O
1 O
associated O
factor O
and O
represents O
the O
first O
identified O
cardiac O
- O
restricted O
downstream O
regulatory O
gene O
in O
the O
homeobox O
gene O
Nkx2 B
- I
5 I
pathway O
and O
may O
serve O
as O
a O
negative O
regulator O
of O
HF O
- O
1 O
- O
dependent O
pathways O
for O
ventricular O
muscle O
gene O
expression O
. O

Each O
receptor O
must O
therefore O
engage O
a O
unique O
subset O
of O
the O
available O
signaling O
elements O
- O
- O
at O
least O
partly O
through O
the O
selection O
of O
proteins O
with O
src B
- I
homology I
2 I
domains I
( O
SH2 O
proteins O
) O
. O

Transforming B
growth I
factor I
- I
beta I
( O
TGF B
- I
beta I
) O
inhibits O
cell O
cycle O
progression O
, O
in O
part O
through O
up O
- O
regulation O
of O
gene O
expression O
of O
the O
p21 B
( O
WAF1 B
/ O
Cip1 B
) O
( O
p21 B
) O
cell O
cycle O
inhibitor O
. O

The O
results O
suggest O
that O
both O
superficial O
and O
deep O
cortical O
venous O
drainage O
of O
the O
cat O
kidney O
should O
be O
considered O
when O
measuring O
renal B
renin I
release O
. O

7 O
- O
Nitroindazole O
( O
7NI O
) O
, O
a O
relatively O
selective O
neuronal O
nitric B
oxide I
synthase I
( O
nNOS B
) O
inhibitor O
. O
was O
intraperitoneally O
administered O
to O
the O
guinea O
pigs O
30 O
minutes O
before O
the O
onset O
of O
local O
anoxia O
. O

An O
evaluation O
of O
a O
positive O
control O
for O
platelet O
neutralization O
procedure O
testing O
with O
seven O
commercial O
activated O
partial O
thromboplastin B
time O
reagents O
. O

Five O
girls O
with O
Turner O
' O
s O
syndrome O
aged O
12 O
to O
17 O
years O
showed O
LH B
values O
( O
5 O
. O
0 O
- O
14 O
. O
5 O
IU O
/ O
12 O
h O
) O
at O
the O
upper O
end O
of O
or O
slightly O
above O
the O
normal O
range O
and O
pathologically O
high O
values O
( O
22 O
. O
2 O
- O
43 O
. O
5 O
IU O
/ O
12 O
h O
) O
for O
FSH B
. O

In O
vitro O
death O
assays O
with O
transient O
overexpression O
of O
deletion O
constructs O
of O
both O
isoforms O
using O
beta B
- I
galactosidase I
as O
a O
reporter O
gene O
in O
MCF7 O
cells O
suggest O
the O
following O
: O
1 O
) O
the O
nucleotide O
binding O
domain O
may O
act O
as O
a O
negative O
regulator O
of O
the O
killing O
activity O
of O
DEFCAP O
; O
2 O
) O
the O
LRR O
/ O
CARD O
represents O
a O
putative O
constitutively O
active O
inducer O
of O
apoptosis O
; O
3 O
) O
the O
killing O
activity O
of O
LRR O
/ O
CARD O
is O
inhibitable O
by O
benzyloxycarbonyl O
- O
Val O
- O
Ala O
- O

The O
association O
of O
I O
- O
92 O
with O
p92 O
, O
p84 O
, O
p75 O
, O
p73 B
, O
p69 O
, O
and O
p57 O
was O
completely O
reversible O
after O
treatment O
with O
the O
detergent O
deoxycholate O
( O
DOC O
) O
. O

Hetero O
- O
oligomerization O
of O
Smad4 B
with O
the O
pathway O
- O
restricted O
SMAD O
proteins O
is O
essential O
for O
Smad4 B
- O
mediated O
transcription O
. O

After O
Northern O
blot O
hybridization O
, O
two O
Cx31 O
transcripts O
of O
2 O
. O
2 O
and O
1 O
. O
8 O
kb O
were O
detected O
in O
total O
RNA O
of O
the O
human O
keratinocyte O
cell O
line O
HaCaT O
and O
two O
transcripts O
of O
2 O
. O
2 O
and O
1 O
. O
9 O
kb O
in O
total O
RNA O
of O
E6 B
/ O
E7 B
transfected O
human O
keratinocytes O
( O
HEK O
cells O
) O
. O

In O
summary O
, O
FGFR3 B
signaling O
pathway O
utilizes O
two O
GRB2 O
- O
containing O
complexes O
; O
Shc B
. O
GRB2 B
. O
Sos B
and O
80K B
- I
H I
. O
pp66 O
. O
GRB2 B
. O
Sos B
; O
these O
two O
complexes O
may O
alternatively O
link O
FGFG3 O
to O
mitogen B
- I
activated I
protein I
kinase I
. O

Earlier O
published O
data O
, O
indicating O
Sp1 B
binding O
to O
the O
R1 O
alpha O
/ O
beta O
regions O
, O
could O
not O
be O
confirmed O
, O
suggesting O
that O
the O
R1 O
initiator O
element O
may O
function O
independent O
of O
Sp1 B
. O

Increased O
TRE O
DNA O
binding O
failed O
to O
lead O
to O
increased O
transactivation O
correlating O
with O
the O
inability O
of O
SB O
203580 O
to O
increase O
phosphorylation O
of O
these O
AP B
- I
1 I
proteins I
. O

However O
, O
and O
in O
contrast O
to O
other O
MMP O
genes O
, O
no O
significative O
synergistic O
effect O
on O
CAT B
activity O
between O
the O
AP B
- I
1 I
and O
PEA O
- O
3 O
elements O
found O
in O
the O
collagenase O
- O
3 O
gene O
promoter O
was O
found O
. O

To O
examine O
the O
effect O
of O
the O
cAMP O
signal O
transduction O
pathway O
on O
transcription O
of O
the O
gene O
encoding O
the O
catalytic O
subunit O
of O
glucose O
- O
6 O
- O
phosphatase O
( O
G6Pase O
) O
, O
G6Pase O
- O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
fusion O
genes O
were O
transiently O
transfected O
into O
either O
the O
liver O
- O
derived O
HepG2 O
or O
kidney O
- O
derived O
LLC O
- O
PK O
cell O
line O
. O

( O
We O
observed O
a O
ferritin B
value O
as O
high O
as O
47 O
mg O
/ O
L O
in O
one O
patient O
. O
) O
Results O
with O
all O
these O
kits O
did O
not O
inter O
- O
compare O
well O
for O
ferritin B
concentrations O
greater O
than O
300 O
micrograms O
/ O
L O
, O
a O
finding O
that O
casts O
further O
doubt O
on O
the O
controversial O
use O
of O
serum B
ferritin I
measurement O
in O
cases O
of O
iron O
overload O
. O

ER O
beta O
was O
less O
potent O
than O
ER O
alpha O
in O
activating O
E2 O
- O
stimulated O
ERELuc B
activity O
( O
4 O
- O
vs O
. O

Disruption O
of O
PML O
subnuclear O
domains O
by O
the O
acidic O
IE1 O
protein O
of O
human O
cytomegalovirus O
is O
mediated O
through O
interaction O
with O
PML B
and O
may O
modulate O
a O
RING O
finger O
- O
dependent O
cryptic O
transactivator O
function O
of O
PML B
. O

Furthermore O
, O
the O
GC O
- O
rich O
sequences O
could O
confer O
Sp1 B
- O
dependent O
transactivation O
to O
a O
heterologous O
prolactin O
minimal O
promoter O
. O

Twelve O
patients O
of O
leprosy O
with O
arthritis O
and O
161 O
patients O
without O
arthritis O
were O
studied O
for O
immunological O
parameters O
like O
immunoglobulins O
( O
IgG B
, O
IgM B
, O
IgA B
) O
, O
C O
- O
reactive O
proteins O
and O
rheumatoid B
factor I
. O

Several O
reports O
assert O
that O
prolactin B
affects O
the O
delta O
5 O
and O
delta O
4 O
pathways O
through O
its O
effect O
on O
the O
activity O
of O
3beta O
- O
hydroxysteroid O
dehydrogenase O
( O
3beta O
- O
OHSD O
) O
. O

Y1 O
, O
Y2 O
, O
and O
Y4 B
/ O
PP1 B
. O

Developmentally O
- O
regulated O
interaction O
of O
a O
transcription O
factor O
complex O
containing O
CDP B
/ O
cut B
with O
the O
early O
histone O
H3 O
gene O
promoter O
of O
the O
sea O
urchin O
Tetrapygus O
niger O
is O
associated O
with O
changes O
in O
chromatin O
structure O
and O
gene O
expression O
. O

The O
mRNA O
for O
this O
protein O
is O
expressed O
in O
the O
T O
- O
ALL O
cell O
line O
Jurkat O
and O
has O
been O
designated O
HUG1 B
, O
for O
HOX11 O
Upstream O
Gene O
. O

Its O
activity O
was O
twice O
that O
of O
a O
construct O
where O
the O
CAT B
gene I
was O
driven O
by O
the O
H O
- O
2Kb O
5 O
' O
enhancer O
region O
( O
H2TF1 B
/ O
KBF1 O
site O
) O
and O
comparable O
to O
that O
of O
pRSVCAT O
construct O
carrying O
the O
strong O
Rous O
sarcoma O
virus O
LTR O
enhancer O
. O

No O
promoter O
activity O
could O
be O
detected O
with O
various O
mouse O
Fli O
- O
1 O
promoter O
- O
CAT B
constructs O
containing O
600 O
bp O
of O
the O
5 O
' O
flanking O
region O
, O
the O
complete O
exon O
1 O
, O
the O
5 O
' O
end O
of O
intron O
1 O
and O
/ O
or O
retroviral O
LTR O
sequence O
. O

Cbl B
is O
a O
signaling O
molecule O
with O
multiple O
functional O
domains O
: O
an O
SH2 B
domain I
which O
binds O
phosphotyrosine O
residues O
, O
a O
RING O
finger O
domain O
which O
acts O
as O
a O
ubiquitin B
ligase I
, O
a O
proline O
- O
rich O
region O
which O
serves O
as O
a O
docking O
site O
for O
SH3 O
- O
containing O
proteins O
, O
phosphotyrosine O
residues O
which O
serve O
as O
docking O
sites O
for O
SH2 O
- O
containing O
proteins O
such O
a O
CrkL B
and O
the O
p85 B
subunit I
of O
PI B
3 I
- I
kinase I
, O
and O
a O
nuclear O
localization O
signal O
. O

Our O
data O
are O
in O
line O
with O
the O
hypothesis O
that O
E2F B
functions O
as O
a O
growth O
- O
and O
cell O
cycle O
regulated O
tethering O
factor O
between O
Sp1 B
and O
the O
basic O
transcription O
machinery O
. O

IRA2 B
, O
a O
second O
gene O
of O
Saccharomyces O
cerevisiae O
that O
encodes O
a O
protein O
with O
a O
domain O
homologous O
to O
mammalian O
ras O
GTPase O
- O
activating O
protein O
. O

Creatinine O
and O
creatine B
phosphokinase I
( O
CPK B
) O
. O

Herein O
, O
we O
report O
that O
CRE O
- O
decoy O
oligonucleotide O
treatment O
results O
in O
an O
increase O
in O
the O
p53 B
protein I
level O
in O
MCF O
- O
7 O
human O
breast O
cancer O
cells O
that O
express O
wild O
- O
type O
p53 B
. O

The O
selective O
5 B
- I
HT2 I
receptor I
blocker O
ketanserin O
was O
found O
to O
reduce O
maximal O
urethral O
pressures O
in O
healthy O
females O
by O
about O
40 O
% O
without O
reducing O
blood O
pressure O
. O

Protein B
kinase I
C I
transiently O
activated O
heteromeric O
N O
- O
methyl O
- O
D O
- O
aspartate O
receptor O
channels O
independent O
of O
the O
phosphorylatable O
C O
- O
terminal O
splice O
domain O
and O
of O
consensus O
phosphorylation O
sites O
. O

Highly O
significant O
similarities O
were O
detected O
between O
the O
N O
- O
terminal O
region O
of O
P30 B
and O
those O
of O
GENA O
[ O
the O
product O
of O
another O
unidentified O
gene O
( O
geneA O
) O
located O
upstream O
of O
the O
aceEF O
- O
lpd O
operon O
] O
, O
and O
GNTR O
( O
a O
putative O
transcriptional O
repressor O
of O
the O
gluconate O
operon O
of O
Bacillus O
subtilis O
) O
. O

Both O
claR O
and O
car B
are O
expressed O
as O
monocistronic O
transcripts O
; O
the O
level O
of O
transcript O
declined O
rapidly O
after O
48h O
in O
complex O
media O
, O
but O
low O
sustained O
levels O
of O
both O
transcripts O
were O
observed O
in O
defined O
GSPG O
medium O
until O
96h O
. O

claR O
and O
car B
were O
not O
significantly O
expressed O
in O
mutants O
disrupted O
in O
the O
ccaR O
gene O
, O
a O
regulatory O
gene O
that O
controls O
positively O
clavulanic O
acid O
and O
cephamycin O
biosynthesis O
. O

The O
hepatic O
isoform O
of O
6 O
- O
phosphofructo O
- O
2 O
- O
kinase O
/ O
fructose B
- I
2 I
, I
6 I
- I
bisphosphatase I
( O
PF2K O
/ O
Fru O
- O
2 O
, O
6 O
- O
BPase O
) O
is O
transcriptionally O
stimulated O
by O
glucocorticoids O
, O
whereas O
insulin B
blocks O
this O
stimulatory O
effect O
. O

Being O
implicated O
in O
insulin B
and O
GK O
gene O
regulations O
as O
a O
common O
transcription O
factor O
, O
IPF1 O
/ O
STF O
- O
1 O
/ O
PDX O
- O
1 O
is O
likely O
to O
play O
an O
essential O
role O
in O
maintaining O
normal O
beta O
- O
cell O
functions O
. O

Mouse O
embryo O
cells O
( O
C57BL O
/ O
6 O
, O
H O
- O
2b O
) O
transformed O
by O
the O
E1A B
and O
E1B B
genes O
of O
adenovirus O
type O
5 O
( O
Ad5E1 O
MEC O
) O
are O
highly O
immunogenic O
. O

To O
determine O
the O
transactivation O
potential O
of O
each O
of O
the O
four O
Ahr B
Sp1 B
sites I
, O
we O
fused O
the O
Ahr O
promoter O
to O
a O
luciferase B
( O
LUC B
) O
reporter O
gene O
and O
transfected O
the O
construct O
into O
the O
Drosophila O
cell O
line O
Schneider O
- O
2 O
, O
which O
contains O
no O
Sp1 B
or O
Sp1 O
- O
like O
factors O
. O

The O
impairment O
of O
the O
nocturnal O
secretion O
was O
related O
to O
the O
subjects O
' O
age O
and O
, O
for O
the O
GH B
secretory O
pattern O
only O
, O
also O
to O
the O
MMSE O
score O
. O

Thus O
, O
the O
antibody O
class O
switch O
appears O
to O
be O
directed O
by O
induction O
of O
accessibility O
, O
as O
assayed O
by O
transcription O
of O
germ O
line O
CH B
genes O
. O

Recombinant B
Human I
Erythropoietin I
and O
Platinum O
- O
Based O
Chemotherapy O
In O
Advanced O
Ovarian O
Cancer O

Some O
of O
these O
physiological O
responses O
are O
regulated O
via O
activation O
of O
transcription O
factors O
such O
as O
activator B
protein I
1 I
( O
AP B
- I
1 I
) O
. O

To O
test O
the O
role O
of O
myb O
family O
members O
in O
progression O
through O
the O
cell O
cycle O
, O
we O
comicroinjected O
c B
- I
myc I
and O
myb B
expression O
vectors O
into O
serum O
- O
deprived O
quiescent O
SMCs O
. O

A O
group O
of O
factors O
known O
as O
activating B
transcription I
factors I
( O
ATF B
) O
have O
been O
found O
to O
bind O
to O
the O
latter O
and O
related O
sequences O
found O
upstream O
of O
early O
adenovirus O
promoters O
induced O
by O
E1A B
, O
and O
these O
factors O
are O
highly O
homologous O
to O
the O
CREB B
protein I
. O

The O
vertebrate O
transcription O
factors O
TCF O
( O
T O
cell O
factor O
) O
and O
LEF B
( O
lymphocyte O
enhancer O
binding O
factor O
) O
interact O
with O
beta B
- I
catenin I
and O
are O
hypothesized O
to O
mediate O
Wingless B
/ O
Wnt B
signaling O
. O

Hypocalcemia O
is O
usually O
due O
to O
either O
a O
disturbance O
in O
the O
parathyroid B
hormone I
- O
adenylate B
cyclase I
system O
or O
a O
disturbance O
in O
vitamin O
D O
metabolism O
. O

In O
seven O
patients O
( O
7 O
. O
8 O
% O
) O
with O
new O
Q O
- O
waves O
and O
a O
pathologic O
CK B
- I
MB I
profile O
( O
group O
II O
) O
troponin B
T I
reached O
median O
levels O
of O
10 O
. O
47 O
micrograms O
/ O
l O
( O
quartile O
6 O
. O
34 O
- O
12 O
. O
50 O
micrograms O
/ O
l O
) O
( O
P O
< O
0 O
. O
001 O
I O
vs O
II O
) O
. O

The O
132 O
- O
bp O
PHO8p O
fragment O
, O
connected O
at O
position O
- O
281 O
of O
the O
5 O
' O
upstream O
region O
of O
a O
HIS5 O
' O
- O
' B
lacZ I
fused O
gene O
, O
could O
sense O
Pi O
signals O
in O
vivo O
, O
but O
a O
20 O
- O
bp O
synthetic O
oligonucleotide O
having O
the O
same O
sequence O
from O
- O
544 O
to O
- O
525 O
of O
the O
PHO8p O
DNA O
could O
not O
. O

Sequences O
within O
the O
UAS2 O
element O
of O
the O
ENO2 O
gene O
bound O
a O
second O
protein O
which O
corresponded O
to O
the O
ABFI B
( O
autonomously O
replicating O
sequence O
- O
binding O
factor O
) O
protein O
. O

The O
sequence O
of O
LZ321 O
matched O
that O
of O
RREB1 O
, O
a O
transcription O
factor O
that O
bound O
to O
a O
Ras O
responsive O
element O
( O
RRE B
) O
very O
different O
from O
the O
sequence O
with O
which O
we O
isolated O
LZ321 O
. O

This O
bud O
morphology O
results O
at O
least O
in O
part O
from O
a O
cell O
cycle O
delay O
imposed O
by O
the O
Cdc28p B
- O
inhibitory O
kinase O
Swe1p O
. O

In O
vitro O
, O
c B
- I
Src I
phosphorylated O
FAK O
Tyr O
- O
925 O
in O
a O
glutathione B
S I
- I
transferase I
- O
FAK B
C O
- O
terminal O
domain O
fusion O
protein O
, O
whereas O
FAK O
did O
not O
. O

METHODS O
AND O
RESULTS O
: O
The O
effect O
of O
prolonged O
nitrate O
therapy O
between O
2 O
days O
and O
6 O
weeks O
during O
healing O
after O
infarction O
on O
serial O
parameters O
of O
ventricular O
remodeling O
( O
scar O
expansion O
, O
scar O
thinning O
, O
ventricular O
dilation O
, O
and O
hypertrophy O
) O
and O
function O
( O
asynergy O
or O
akinesis O
plus O
dyskinesis O
and O
ejection O
fraction O
) O
by O
serial O
two O
- O
dimensional O
echocardiography O
, O
hemodynamics O
, O
postmortem O
topography O
( O
computerized O
planimetry O
, O
geometric O
maps O
, O
and O
radiographs O
) O
, O
and O
collagen B
content O
( O
hydroxyproline O

Gel O
shift O
analysis O
of O
protein O
binding O
from O
nuclear O
extracts O
to O
these O
caveolin O
promoter O
DNA O
sequences O
, O
together O
with O
DNase B
I I
footprinting O
, O
confirmed O
nucleoprotein O
binding O
to O
the O
SRE O
- O
like O
elements O
as O
part O
of O
the O
transcriptional O
response O
to O
LDL O
- O
FC O
. O

The O
phP1 O
mutation O
was O
induced O
by O
insertion O
of O
a O
1 O
. O
2 O
- O
kb O
P B
element I
into O
the O
5 O
' O
transcribed O
nontranslated O
region O
of O
the O
proximal O
polyhomeotic O
gene O
. O

Initial O
computer O
based O
similarity O
searches O
identified O
human O
retinoblastoma O
binding O
protein O
1 O
( O
RBP O
- O
1 O
) O
, O
Drosophila O
melanogaster O
male O
specific O
lethal O
- O
3 O
( O
Msl O
- O
3 O
) O
, O
S O
. O
pombe O
altered O
polarity O
- O
13 O
( O
Alp13 O
) O
and O
S O
. O
cerevisiae O
Eaf3p O
, O
a O
component O
of O
the O
yeast O
NuA4 O
HAT B
complex O
( O
Galarneau O
et O
al O
. O
, O
2000 O
. O

Serum O
prolactin B
rapidly O
decreased O
after O
institution O
of O
treatment O
, O
with O
actual O
normalization O
( O
less O
than O
20 O
ng O
/ O
ml O
) O
by O
the O
3rd O
month O
. O

We O
report O
five O
of O
13 O
evaluable O
patients O
undergoing O
allogeneic O
sibling O
BM O
or O
PBSC O
transplantation O
for O
MM O
between O
1990 O
and O
1997 O
who O
met O
the O
criteria O
for O
adjuvant O
alpha B
- I
IFN I
therapy O
. O

The O
6 O
. O
5 O
- O
kb O
genomic O
fragment O
contains O
the O
complete O
coding O
region O
of O
MyoD B
, O
distributed O
over O
three O
exons O
, O
plus O
2 O
. O
3 O
kb O
of O
5 O
' O
- O
noncoding O
sequence O
and O
1 O
. O
4 O
kb O
of O
3 O
' O
- O
noncoding O
sequence O
. O

Molecular O
cloning O
of O
cDNAs O
encoding O
alpha O
- O
subunits O
of O
guanine O
nucleotide O
- O
binding O
regulatory O
proteins O
( O
G B
- I
proteins I
) O
has O
revealed O
the O
existence O
of O
nine O
species O
of O
alpha O
- O
subunits O
. O

Pros O
and O
cons O
of O
selective O
inhibition O
of O
cyclooxygenase B
- I
2 I
versus O
dual O
lipoxygenase O
/ O
cyclooxygenase B
inhibition O
: O
is O
two O
better O
than O
one O
? O

The O
other O
regions O
include O
potential O
binding O
sites O
for O
transcription O
factors O
ATF B
, O
NF1 B
, O
and O
a O
CCAAT O
- O
binding O
protein O
. O

TNF B
- I
alpha I
effect O
was O
eliminated O
by O
a O
2 O
- O
bp O
substitution O
mutation O
in O
the O
NF O
- O
kappa O
B1 O
binding O
half O
site O
of O
the O
NF O
- O
kappa O
B O
cis O
element O
. O

The O
M O
- O
phase O
induction O
activity O
of O
Cdc2 B
- O
Cdc13 B
is O
inhibited O
by O
Wee1 O
tyrosine O
kinase O
, O
which O
phosphorylates O
Cdc2 B
on O
tyrosine O
- O
15 O
. O

lacZ B
expression O
was O
first O
detected O
in O
the O
allantois O
at O
day O
7 O
. O
5 O
p O
. O
c O
. O
and O
in O
mesoderm O
and O
ectoderm O
at O
day O
8 O
. O
5 O
of O
gestation O
. O

Serum O
levels O
of O
angiotensin B
converting I
enzyme I
were O
well O
maintained O
. O

The O
UL3 O
ORF O
of O
204 O
amino O
acids O
shows O
significant O
homology O
to O
UL3 B
( O
nuclear O
phosphoprotein O
) O
of O
HSV O
- O
1 O
( O
62 O
% O
) O
and O
PRV O
( O
53 O
% O
) O
. O

The O
gp41 O
peptide O
( O
Glu O
- O
Leu O
- O
Asp O
- O
Lys O
- O
Trp O
- O
Ala O
) O
fused O
to O
the O
C O
- O
terminus O
of O
Sj O
GST O
forms O
a O
loop O
stabilized O
by O
symmetry O
- O
related O
GSTs B
. O

Comparison O
of O
bioreactive O
and O
immunoreactive O
gastrin B
. O

Also O
, O
PTx O
had O
no O
effect O
on O
shear O
- O
dependent O
activation O
of O
JNK B
. O

We O
analyzed O
the O
contribution O
of O
the O
three O
different O
types O
of O
UV O
- O
inducible O
mitogen B
- I
activated I
protein I
( I
MAP I
) I
kinases I
( O
ERK B
, O
JNK B
/ O
SAPK B
, O
and O
p38 B
) O
to O
the O
activation O
of O
the O
murine O
uPA O
promoter O
by O
UV O
. O

Cotransfection O
with O
C B
/ I
EBPbeta I
and O
GATA B
- I
1 I
expression O
vectors O
produced O
a O
5 O
- O
fold O
increase O
compared O
with O
cotransfection O
with O
the O
C B
/ I
EBPbeta I
or O
GATA B
- I
1 I
expression O
vectors O
individually O
. O

In O
contrast O
to O
the O
p16 B
- O
mediated O
G1 O
block O
, O
G1 O
arrest O
mediated O
by O
the O
cdk B
inhibitors O
p21Cip1 B
or O
p27Kip1 B
cannot O
be O
bypassed O
either O
by O
inactivation O
of O
pRb B
or O
overexpression O
of O
E2F O
family O
members O
. O

To O
investigate O
the O
role O
of O
bHLH B
proteins I
in O
MC3T3 O
- O
E1 O
osteoblasts O
, O
which O
undergo O
a O
developmental O
sequence O
in O
vitro O
, O
we O
analyzed O
the O
transcriptional O
control O
of O
osteocalcin O
gene O
expression O
by O
stable O
transfection O
of O
an O
osteocalcin O
promoter O
- O
luciferase B
chimeric O
gene O
( O
p637OC O
- O
luc O
) O
and O
assessed O
the O
role O
of O
E O
- O
box O
cis O
- O
acting O
elements O
in O
osteocalcin O
promoter O
by O
DNA O
binding O
assays O
. O

In O
this O
study O
, O
we O
show O
that O
HNF B
- I
4 I
, O
a O
member O
of O
the O
steroid O
hormone O
receptor O
superfamily O
, O
binds O
the O
AF O
- O
1 O
site O
on O
the O
apoB O
promoter O
and O
through O
it O
activates O
transcription O
in O
transient O
transfection O
assays O
in O
both O
liver O
and O
non O
- O
liver O
cell O
lines O
, O
HepG2 O
and O
HeLa O
, O
respectively O
. O

We O
have O
previously O
shown O
that O
the O
transcriptional O
activator O
CREM B
is O
highly O
expressed O
in O
postmeiotic O
cells O
. O

Our O
current O
study O
aims O
at O
clarifying O
the O
role O
of O
myristoylation O
in O
caveolar O
targeting O
using O
well O
- O
characterized O
acylation O
mutants O
of O
two O
model O
proteins O
, O
namely O
Gi1 O
alpha O
and O
c B
- I
Src I
. O

We O
infer O
that O
RecA B
- O
mediated O
cleavage O
of O
UmuD B
is O
another O
role O
for O
RecA B
in O
SOS O
mutagenesis O
, O
probably O
activating O
UmuD B
for O
its O
mutagenic O
function O
. O

The O
Rep B
proteins I
of O
adeno O
- O
associated O
virus O
type O
2 O
( O
AAV O
) O
are O
known O
to O
bind O
to O
Rep O
recognition O
sequences O
( O
RRSs O
) O
in O
the O
AAV O
inverted O
terminal O
repeats O
( O
ITRs O
) O
, O
the O
AAV O
p5 O
promoter O
, O
and O
the O
preferred O
AAV O
integration O
site O
in O
human O
chromosome O
19 O
, O
called O
AAVS1 O
. O

The O
analysis O
of O
the O
effects O
of O
eight O
signaling O
molecules O
in O
the O
TGFbeta B
, O
FGF B
, O
Hh B
, O
Wnt B
, O
and O
EGF O
families O
in O
tooth O
explant O
cultures O
revealed O
that O
the O
expression O
of O
edar O
was O
induced O
by O
activinbetaA O
, O
whereas O
Wnt6 O
induced O
ectodysplasin O
expression O
. O

In O
mouse O
, O
two O
high O
- O
affinity O
binding O
sites O
with O
an O
apparent O
dissociation O
constant O
( O
Kd O
) O
of O
50 O
to O
100 O
nM O
have O
been O
mapped O
in O
the O
5 O
' O
ETS B
upstream O
from O
the O
early O
pre O
- O
rRNA O
processing O
site O
. O

This O
deletion O
disrupts O
the O
PU B
. I
1 I
Ets B
domain I
. O

In O
turn O
, O
production O
of O
sufficient O
amounts O
of O
TraR B
apparently O
is O
sensitive O
to O
a O
cellular O
function O
requiring O
RNase O
D O
. O

Phytohemagglutinin B
( O
PHA B
) O
, O
the O
seed O
lectin O
of O
the O
common O
bean O
, O
accumulates O
in O
protein O
storage O
vacuoles O
of O
storage O
parenchyma O
cells O
in O
cotyledons O
. O

This O
dynamic O
nature O
may O
be O
relevant O
to O
the O
ability O
of O
E47 B
both O
to O
homodimerize O
and O
to O
heterodimerize O
with O
MyoD B
, O
Id B
, O
and O
Tal1 B
. O

Overexpression O
of O
p50 B
in O
transient O
cotransfection O
studies O
using O
the O
proximal O
CRP O
promoter O
( O
- O
125 O
/ O
+ O
9 O
) O
linked O
to O
a O
luciferase B
reporter I
caused O
a O
3 O
- O
fold O
increase O
of O
luciferase B
activity O
, O
while O
C B
/ I
EBPbeta I
overexpression O
caused O
an O
18 O
- O
fold O
increase O
; O
simultaneous O
overexpression O
of O
both O
transcription O
factors O
increased O
luciferase B
activity O
approximately O
600 O
- O
fold O
. O

Immunological O
studies O
also O
failed O
to O
demonstrate O
any O
significant O
change O
except O
for O
a O
significant O
increase O
of O
natural O
killer O
( O
NK O
) O
cell O
activity O
after O
IFN B
- I
gamma I
infusion O
. O

Rat O
cholesterol O
side O
- O
chain O
cleavage O
cytochrome O
P O
- O
450 O
( O
P B
- I
450scc I
) O
gene O
. O

Pig O
uPA O
promoter O
- O
CAT B
constructs O
were O
more O
active O
than O
mouse O
constructs O
in O
this O
assay O
. O

By O
computed O
homology O
search O
, O
we O
noticed O
significant O
similarities O
between O
US3 O
PK O
and O
p21 B
- I
activated I
kinase I
( O
PAK B
) O
, O
which O
is O
activated O
by O
the O
Cdc42 B
or O
Rac B
. O

These O
8 O
- O
oxoguanine O
DNA O
glycosylases O
, O
hOgg1 B
( O
human O
) O
and O
mOgg1 O
( O
murine O
) O
, O
are O
homologous O
to O
each O
other O
and O
to O
yeast O
Ogg1 O
. O

CONCLUSIONS O
: O
These O
results O
suggest O
that O
, O
by O
interacting O
with O
cellular O
transcription O
factors O
and O
cofactors O
, O
vIRF B
- I
2 I
may O
modulate O
the O
expression O
of O
the O
early O
inflammatory O
genes O
and O
potentially O
deregulate O
the O
immune O
system O
. O

We O
report O
that O
Gcn5 B
, O
a O
histone O
H3 O
acetylase O
, O
plays O
a O
central O
role O
in O
initiation O
of O
meiosis O
via O
effects O
on O
IME2 O
expression O
. O

The O
carboxy O
- O
proximal O
regions O
of O
the O
VP1 B
, O
which O
contain O
very O
low O
amino O
acid O
homology O
, O
displayed O
evidence O
of O
conservation O
in O
structural O
features O
such O
as O
a O
hydrophilic O
, O
highly O
basic O
domain O
. O

Interferon B
- I
alpha I
inducibility O
of O
IFI16 B
may O
be O
regulated O
by O
an O
interferon O
- O
alpha O
/ O
beta O
- O
stimulated O
response O
consensus O
element O
in O
the O
5 O
' O
UT O
exon O
, O
as O
a O
similar O
motif O
is O
conserved O
in O
the O
corresponding O
position O
in O
the O
related O
myeloid O
cell O
nuclear O
differentiation O
antigen O
gene O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

In O
the O
present O
study O
we O
use O
a O
tnaC B
- O
UGA O
- O
' B
lacZ I
construct O
lacking O
the O
tnaC B
- O
tnaA O
spacer O
region O
to O
analyze O
the O
effect O
of O
TnaC B
synthesis O
on O
the O
behavior O
of O
the O
ribosome O
that O
translates O
tnaC B
. O

Antisense O
oligonucleotides O
complementary O
to O
the O
5 O
' O
end O
of O
PKC O
- O
zeta O
mRNA O
sequences O
significantly O
reduced O
the O
collagen B
lattice O
- O
stimulated O
alpha2 O
and O
MMP O
- O
1 O
mRNA O
levels O
. O

Overexpression O
of O
a O
HIF B
- I
1alpha I
construct O
with O
deletions O
of O
the O
basic O
domain O
and O
carboxy O
terminus O
blocked O
reporter O
gene O
activation O
by O
endogenous O
HIF B
- I
1 I
in O
hypoxic O
cells O
. O

Residues O
crucial O
for O
Ras B
interaction O
with O
GDP O
- O
GTP O
exchangers O
. O

In O
serum O
- O
starved O
NIH O
3T3 O
cells O
, O
v O
- O
raf O
increased O
mdr1 B
promoter I
activity O
approximately O
10 O
- O
fold O
compared O
to O
a O
v O
- O
raf O
frame O
- O
shift O
control O
. O

It O
is O
also O
affected O
by O
the O
HAP2 O
/ O
3 O
/ O
4 O
transcription O
factor O
complex O
and O
by O
SNF1 B
and O
SSN6 O
. O

The O
effective O
use O
of O
superoxide B
dismutase I
from O
human O
erythrocytes O
in O
the O
late O
stages O
of O
experimental O
influenza O
infection O

Western O
immunoblot O
analysis O
detected O
p55gag O
and O
its O
cleavage O
products O
p39 O
and O
p27 B
in O
purified O
particles O
derived O
by O
expression O
of O
gag B
and O
gag B
- O
pol B
, O
respectively O
. O

3 O
- O
5 O
- O
fold O
increases O
in O
EGF B
receptor I
but O
not O
p185 O
( O
neu B
) O
tyrosine O
phosphorylation O
occur O
following O
Gi O
- O
coupled O
receptor O
stimulation O
. O

Next O
, O
to O
examine O
the O
regulation O
mechanism O
of O
CD44 O
/ O
ERM B
interaction O
in O
vivo O
, O
we O
reexamined O
the O
immunoprecipitated O
CD44 O
/ O
ERM B
complex O
from O
BHK O
cells O
and O
found O
that O
it O
contains O
Rho O
- O
GDP O
dissociation O
inhibitor O
( O
GDI O
) O
, O
a O
regulator O
of O
Rho O
GTPase O
. O

To O
determine O
cis O
- O
acting O
elements O
controlling O
the O
rat O
B O
- O
50 O
/ O
GAP B
- I
43 I
gene O
expression O
, O
the O
genomic O
DNA O
encoding O
exon O
1 O
and O
the O
5 O
' O
flanking O
sequence O
was O
isolated O
. O

TNF B
- I
alpha I
stimulated O
these O
changes O
in O
part O
by O
increasing O
transcription O
and O
stabilization O
of O
RNA O
for O
amphiregulin O
, O
an O
EGF B
receptor I
ligand O
, O
and O
amphiregulin O
directly O
increased O
HPV O
- O
16 O
E6 B
/ O
E7 B
and O
cyclin O
A O
RNAs O
. O

BAG O
- O
1 O
also O
prevented O
growth O
arrest O
following O
UV O
- O
irradiation O
- O
induced O
genotoxic O
injury O
without O
interfering O
with O
accumulation O
of O
p53 B
protein I
or O
p21 B
( O
waf O
- O
1 O
) O
expression O
. O

These O
larger O
sizes O
, O
however O
, O
are O
consistent O
with O
predictions O
from O
the O
DNA O
sequence O
of O
the O
pol B
gene I
. O

In O
addition O
, O
two O
cis O
- O
acting O
elements O
direct O
the O
first O
zygotic O
expression O
of O
Kr B
in O
a O
striped O
subpattern O
within O
the O
central O
region O
of O
the O
blastoderm O
embryo O
. O

P53 B
mutations I
also O
offer O
new O
approaches O
to O
the O
study O
of O
the O
origins O
of O
mutations O
in O
human O
cancer O
. O

Particle O
bombardment O
of O
barley O
aleurone O
with O
a O
B22EL8 O
promoter O
- O
GUS B
( O
beta B
- I
glucuronidase I
) O
construct O
demonstrates O
that O
the O
promoter O
( O
3 O
kb O
) O
is O
active O
in O
developing O
barley O
grains O
. O

Characterization O
of O
regions O
of O
fibronectin B
besides O
the O
arginine O
- O
glycine O
- O
aspartic O
acid O
sequence O
required O
for O
adhesive O
function O
of O
the O
cell O
- O
binding O
domain O
using O
site O
- O
directed O
mutagenesis O
. O

Elements O
regulating O
cell O
- O
and O
stage O
- O
specific O
expression O
of O
the O
C O
. O
elegans O
MyoD B
family O
homolog O
hlh O
- O
1 O
. O

An O
analysis O
of O
the O
c O
- O
kit O
5 O
' O
flanking O
region O
using O
the O
bacterial O
chloramphenicol O
acetyltransferase O
gene O
( O
CAT B
assay O
) O
in O
human O
erythroleukemia O
HEL O
cells O
, O
which O
express O
the O
endogenous O
c O
- O
kit O
mRNA O
at O
high O
levels O
, O
showed O
that O
a O
region O
from O
- O
180 O
to O
- O
22 O
is O
important O
for O
the O
expression O
of O
the O
c O
- O
kit O
gene O
. O

After O
5 O
days O
stimulation O
with O
G B
- I
CSF I
( O
10 O
micrograms O
/ O
kg O
) O
1l O
of O
blood O
was O
drawn O
, O
kept O
unprocessed O
for O
3 O
days O
and O
reinfused O
24 O
h O
after O
completion O
of O
chemotherapy O
. O

However O
, O
the O
relative O
substrate O
specificity O
of O
RSK3 B
differed O
from O
that O
reported O
for O
other O
isoforms O
. O

Our O
data O
indicate O
that O
the O
various O
subunits O
of O
the O
human O
P B
- I
TEFb I
complex O
may O
play O
distinct O
roles O
at O
multiple O
stages O
to O
mediate O
Tat B
activation O
of O
HIV O
- O
1 O
transcription O
elongation O
. O

Sox8 B
maps O
to O
the O
t O
complex O
on O
mouse O
chromosome O
17 O
and O
to O
human O
chromosome O
16p13 O
. O
3 O
, O
a O
region O
associated O
with O
the O
microphthalmia O
- O
cataract O
syndrome O
CATM O
and O
the O
alpha O
- O
thalassemia O
/ O
mental O
retardation O
syndrome O
ATR O
- O
16 O
. O

Mean O
CD4 B
percentages O
were O
lower O
postpartum O
( O
21 O
. O
9 O
+ O
/ O
- O
3 O
. O
4 O
) O
than O
prepartum O
( O
45 O
. O
1 O
+ O
/ O
- O
6 O
. O
7 O
) O
in O
all O
five O
patients O
studied O
, O
although O
proliferative O
responses O
to O
the O
mitogens O
phytohemagglutinin O
and O
pokeweed O
were O
unchanged O
during O
the O
study O
period O
. O

The O
results O
indicate O
that O
the O
RNA O
in O
T7 B
RNA I
polymerase I
is O
not O
free O
of O
steric O
interactions O
in O
the O
ternary O
complex O
and O
not O
available O
for O
structure O
formation O
until O
it O
is O
at O
least O
10 O
bases O
away O
from O
the O
site O
of O
polymerization O
. O

The O
STP1 O
locus O
is O
located O
on O
chromosome O
IV O
close O
to O
at O
least O
two O
other O
genes O
involved O
in O
RNA O
splicing O
: O
PRP3 O
and O
SPP41 B
. O

In O
vitro O
, O
SHIP B
catalyzes O
the O
conversion O
of O
the O
phosphoinositide B
3 I
- I
kinase I
( O
PI3K B
) O
product O
phosphatidylinositol O
3 O
, O
4 O
, O
5 O
- O
trisphosphate O
( O
PIP3 O
) O
into O
phosphatidylinositol O
3 O
, O
4 O
- O
bisphosphate O
. O

The O
two O
complexes O
were O
detected O
with O
a O
similar O
activation O
kinetics O
upon O
IL B
- I
4 I
stimulation O
. O

None O
of O
the O
10 O
sequences O
has O
hitherto O
been O
recognized O
as O
part O
of O
the O
p53 B
signaling O
pathway O
. O

Both O
residues O
are O
conserved O
in O
the O
three O
phosphorylated O
paralogs O
but O
are O
absent O
in O
the O
ones O
that O
were O
not O
substrates O
of O
RsbT O
: O
YetI O
and O
YezB O
, O
each O
of O
which O
bears O
only O
one O
of O
the O
conserved O
residues O
; O
and O
YtvA O
, O
which O
lacks O
both O
residues O
and O
instead O
possesses O
an O
N O
- O
terminal O
PAS B
domain O
. O

Consistently O
, O
we O
show O
that O
phosphorylation O
by O
protein B
kinase I
A I
inhibits O
Sfl1 O
DNA O
binding O
in O
vitro O
, O
and O
that O
a O
tpk2Delta O
mutation O
increases O
the O
levels O
of O
Sfl1 O
protein O
associated O
with O
specific O
promoter O
elements O
in O
vivo O
. O

Some O
CHOP B
- O
C B
/ I
EBP I
heterodimers O
apparently O
bind O
to O
alternative O
DNA O
sequence O
and O
thereby O
regulate O
the O
transcription O
of O
other O
genes O
. O

To O
identify O
and O
determine O
the O
function O
of O
Ino2p O
in O
yeast O
cells O
, O
we O
raised O
antibodies O
to O
a O
beta B
- I
galactosidase I
/ O
Ino2 B
fusion O
protein O
. O

The O
arrangement O
of O
amino O
acids O
in O
the O
helix O
1 O
and O
helix O
2 O
regions O
is O
quite O
similar O
to O
those O
of O
Mxi O
and O
Mad B
, O
but O
different O
from O
those O
of O
E2F B
- I
1 I
and O
DP B
- I
1 I
. O

Anovulatory O
cycles O
with O
an O
apparently O
normal O
level O
of O
blood O
prolactin B
. O

We O
further O
examined O
the O
interaction O
of O
JAK2 B
with O
the O
GHR O
cytoplasmic O
domain O
by O
two O
lines O
of O
investigation O
. O

These O
p21 B
- O
E2F B
complexes O
, O
while O
present O
in O
young O
G1 O
cells O
at O
very O
low O
levels O
, O
were O
elevated O
in O
senescent O
cells O
. O

The O
reconstituted O
RNA B
polymerases I
containing O
the O
mutant O
alpha O
subunits O
were O
examined O
for O
their O
response O
to O
transcription O
activation O
by O
cAMP B
- I
CRP I
and O
the O
rrnBP1 B
UP I
element I
. O

Our O
results O
indicate O
that O
GCN4 B
contains O
two O
activation O
domains O
of O
similar O
potency O
that O
can O
function O
independently O
to O
promote O
high O
- O
level O
transcription O
of O
the O
target O
genes O
HIS3 B
and O
HIS4 O
. O

Tax B
was O
demonstrated O
to O
interact O
directly O
with O
CREB1 O
but O
not O
with O
other O
bZIP B
proteins I
, O
including O
CREB2 O
and O
Jun B
. O

We O
also O
demonstrate O
that O
a O
p110RB1 B
mutant I
, O
which O
is O
refractory O
to O
cell O
cycle O
phosphorylation O
but O
intact O
in O
E1a O
/ O
large B
T I
antigen I
- O
binding O
properties O
, O
represses O
EIIaE B
with O
50 O
- O
to O
80 O
- O
fold O
greater O
efficiency O
than O
wild O
- O
type O
p110RB1 O
. O

The O
IGFBP B
- I
1 I
IRS B
and O
PEPCK B
IRS B
both O
bind O
the O
alpha O
and O
beta O
forms O
of O
hepatic O
nuclear O
factor O
3 O
( O
HNF B
- I
3 I
) O
, O
although O
the O
latter O
does O
so O
with O
a O
sixfold O
- O
lower O
relative O
affinity O
. O

Our O
aim O
was O
to O
check O
whether O
, O
during O
PG O
- O
DS O
administration O
, O
serum O
lipase B
activity O
changes O
simultaneously O
with O
serum O
amylase B
activity O
, O
and O
, O
if O
so O
, O
what O
the O
reason O
is O
for O
the O
detected O
change O
. O

The O
effect O
of O
the O
NMDA B
- I
receptor I
antagonist O
( O
+ O
/ O
- O
) O
- O
CPP O
on O
the O
conditioned O
- O
reflex O
activation O
of O
an O
operant O
reaction O
in O
the O
brain O
electrical O
self O
- O
stimulation O
test O
in O
rats O

Constructs O
containing O
fragments O
of O
the O
upstream O
region O
of O
the O
cytotactin B
gene I
fused O
to O
a O
promoterless O
gene O
for O
chloramphenicol B
acetyltransferase I
were O
transiently O
transfected O
into O
chicken O
embryo O
fibroblasts O
to O
define O
functional O
promoter O
sequences O
. O

We O
investigated O
the O
pattern O
of O
evolution O
of O
bronchial O
albumin B
, O
IgA B
, O
and O
IgG B
levels O
in O
ventilated O
ICU O
patients O
in O
relation O
to O
nosocomial O
pneumonia O
. O

There O
was O
no O
correlation O
between O
starting O
platelet O
- O
associated O
IgG B
levels O
or O
changes O
in O
platelet O
- O
associated O
IgG B
levels O
with O
therapy O
and O
the O
increment O
in O
the O
patient O
' O
s O
platelet O
count O
. O

In O
contrast O
translocation O
of O
G1 B
to O
the O
Golgi O
was O
not O
observed O
when O
G1 B
was O
coexpressed O
with O
NSm O
, O
although O
NSm O
itself O
was O
still O
detected O
in O
the O
Golgi O
. O

A O
400 O
- O
bp O
fragment O
( O
bp O
- O
339 O
through O
+ O
71 O
) O
of O
the O
CD22 O
promoter O
region O
was O
subcloned O
into O
a O
pGEM O
- O
chloramphenicol B
acetyltransferase I
vector O
and O
after O
transfection O
into O
B O
and O
T O
cells O
was O
found O
to O
be O
active O
in O
both O
B O
and O
T O
cells O
. O

RESULTS O
: O
There O
were O
no O
significant O
differences O
in O
the O
mean O
serum O
vitamin O
A O
, O
E O
concentrations O
and O
vitamin O
E O
/ O
cholesterol O
ratio O
between O
pregnant O
women O
with O
normal O
hemoglobin B
and O
hemoglobinopathies O
, O
while O
confounding O
variables O
that O
might O
affect O
serum O
vitamin O
levels O
i O
. O
e O
. O
maternal O
age O
, O
gravida O
, O
BMI O
, O
gestational O
age O
, O
hematocrit O
, O
hemoglobin B
, O
mean O
corpuscular O
hemoglobin B
concentration O
and O
blood O
group O
were O
not O
different O
. O

The O
gap B
protein O
knirps O
mediates O
both O
quenching O
and O
direct O
repression O
in O
the O
Drosophila O
embryo O
. O

Here O
we O
demonstrate O
that O
CD40 B
or O
IgM O
receptor O
stimulation O
of O
primary O
B O
cells O
results O
in O
transactivation O
of O
this O
enhancer O
. O

Both O
RNA14 B
and O
RNA15 O
wild O
- O
type O
genes O
, O
when O
cloned O
on O
a O
multicopy O
plasmid O
, O
are O
able O
to O
suppress O
the O
temperature O
- O
sensitive O
phenotype O
of O
strains O
bearing O
either O
the O
rna14 B
or O
the O
rna15 O
mutation O
, O
suggesting O
that O
the O
encoded O
proteins O
could O
interact O
with O
each O
other O
. O

Treatments O
were O
two O
adrenocorticotrophin O
( O
ACTH B
) O
preparations O
given O
intramuscularly O
at O
2 O
. O
2 O
U O
/ O
kg O
, O
one O
of O
the O
ACTH B
preparations O
given O
intramuscularly O
at O
1 O
U O
/ O
kg O
and O
a O
synthetic O
polypeptide O
with O
ACTH O
- O
like O
activity O
( O
tetracosactrin O
, O
cosyntropin O
) O
given O
intravenously O
at O
5 O
micrograms O
/ O
kg O
. O

Accordingly O
, O
infection O
of O
IFN B
- O
pretreated O
HeLa O
S3 O
cells O
with O
an O
E3L O
- O
deficient O
VV O
( O
VVDeltaE3L O
) O
resulted O
in O
increased O
phosphorylation O
levels O
of O
both O
PKR B
and O
eIF2alpha O
. O

The O
predicted O
amino O
- O
acid O
sequence O
includes O
an O
N O
- O
terminal O
signal O
sequence O
of O
27 O
amino O
acids O
, O
a O
27 O
amino O
- O
acid O
pro O
- O
region O
, O
a O
251 O
amino O
- O
acid O
catalytic O
domain O
typical O
of O
a O
serine B
protease I
with O
trypsin B
- O
like O
specificity O
, O
and O
a O
C O
- O
terminal O
hydrophobic O
extension O
which O
is O
predicted O
to O
function O
as O
a O
membrane O
anchor O
. O

To O
examine O
the O
biochemical O
mechanism O
of O
Tax1 B
transactivation O
, O
we O
have O
developed O
an O
in O
vitro O
transactivation O
assay O
in O
which O
wild O
- O
type O
Tax1 B
is O
able O
to O
specifically O
transactivate O
a O
polymerase O
II O
promoter O
through O
upstream O
Tax1 O
- O
responsive O
elements O
. O

Interestingly O
, O
PMA O
- O
, O
PDGF B
- O
, O
and O
serum O
- O
induced O
GHR O
proteolysis O
was O
associated O
with O
substantial O
decreases O
in O
GH B
- O
induced O
activation O
of O
Janus O
kinase O
- O
2 O
, O
which O
were O
also O
prevented O
by O
IC3 O
. O

Thus O
, O
IF O
- O
laser O
therapy O
has O
a O
certain O
antioxidative O
effect O
by O
increasing O
SOD B
activity O
in O
RA O
patients O
' O
blood O
cells O
and O
reducing O
the O
production O
of O
highly O
reactive O
oxygen O
and O
nitrogen O
forms O
. O

Reactive O
mesothelial O
cells O
, O
usually O
seen O
as O
exfoliated O
cells O
, O
were O
consistently O
strongly O
positive O
for O
alpha B
1 I
- I
antichymotrypsin I
and O
more O
variably O
for O
alpha B
1 I
- I
antitrypsin I
and O
lysozyme B
. O

In O
patients O
with O
active O
TB O
, O
cytokines O
that O
were O
elevated O
in O
serum O
were O
IFN B
- I
gamma I
, O
IL B
- I
6 I
and O
IL O
- O
10 O
. O

We O
show O
that O
Fos B
down O
regulates O
several O
immediate B
- I
early I
genes I
( O
c B
- I
fos I
, O
Egr B
- I
1 I
, O
and O
Egr B
- I
2 I
) O
after O
mitogenic O
stimulation O
. O

This O
study O
demonstrates O
a O
novel O
link O
between O
alterations O
in O
platelet B
- I
derived I
growth I
factor I
( O
PDGF B
) O
regulation O
of O
ornithine O
decarboxylase O
( O
ODC B
) O
expression O
during O
malignant O
conversion O
. O

The O
human O
IFI16 O
gene O
is O
a O
member O
of O
an O
interferon B
- O
inducible O
family O
of O
mouse O
and O
human O
genes O
closely O
linked O
on O
syntenic O
regions O
of O
chromosome O
1 O
. O

A O
third O
GEF B
, O
GRP3 O
( O
KIAA0846 O
) O
, O
activated O
both O
Ras B
and O
Rap1 B
and O
shared O
significant O
sequence O
homology O
with O
the O
calcium O
- O
and O
diacylglycerol O
- O
activated O
GEFs O
, O
GRP1 O
and O
GRP2 O
. O

A O
new O
simple O
identification O
of O
rheumatoid B
factor I
on O
nitrocellulose O
was O
developed O
that O
allows O
quantitative O
detection O
. O

Reversal O
of O
biliary O
sphincter O
spasm O
with O
low O
dose O
glucagon B
during O
operative O
cholangiography O
. O

Second O
, O
CGGA O
- O
containing O
sequences O
placed O
at O
- O
88 O
in O
the O
delta O
MTV O
- O
CAT O
reporter O
plasmid O
conferred O
insulin B
responsiveness O
to O
the O
mammary O
tumor O
virus O
promoter O
. O

In O
the O
absence O
of O
c B
- I
fos I
gene I
expression O
, O
c O
- O
Fos O
protein O
appears O
to O
be O
replaced O
by O
proteins O
of O
Fos B
family I
( O
Fra B
- I
1 I
) O
and O
ATF B
family I
( O
ATF B
- I
2 I
and O
ATFa O
) O
. O

Characterization O
of O
Chlamydomonas O
reinhardtii O
zygote O
- O
specific O
cDNAs O
that O
encode O
novel O
proteins O
containing O
ankyrin B
repeats O
and O
WW O
domains O
. O

Basic O
helix O
- O
loop O
- O
helix O
proteins O
can O
act O
at O
the O
E O
- O
box O
within O
the O
serum O
response O
element O
of O
the O
c B
- I
fos I
promoter I
to O
influence O
hormone O
- O
induced O
promoter O
activation O
in O
Sertoli O
cells O
. O

Using O
yeast O
two O
- O
hybrid O
screening O
, O
we O
isolated O
histone B
H3 I
as O
an O
interacting O
factor O
of O
CIA O
. O

After O
3 O
months O
of O
intervention O
, O
sustained O
physical O
training O
was O
associated O
with O
the O
decrease O
of O
FVII O
and O
PAI B
- I
1 I
levels O
. O

E1 B
recognition O
sequences O
in O
the O
bovine O
papillomavirus O
type O
1 O
origin O
of O
DNA O
replication O
: O
interaction O
between O
half O
sites O
of O
the O
inverted O
repeats O
. O

We O
found O
that O
secretion O
of O
chitinolytic O
enzymes O
by O
cultured O
L O
. O
major O
parasites O
is O
inhibited O
by O
blood O
or O
hemoglobin B
, O
and O
hence O
these O
enzymes O
are O
apparently O
absent O
from O
the O
blood O
- O
fed O
infected O
flies O
, O
where O
the O
cardiac O
valve O
appears O
undamaged O
. O

Patients O
in O
the O
mucinous O
cyst O
group O
had O
significantly O
lower O
CA B
125 I
cystic O
fluid O
levels O
compared O
with O
women O
with O
endometriomas O
and O
dermoids O
( O
P O
& O
lt O
; O
0 O
. O
05 O
) O
. O

SATB1 O
interacted O
with O
CDP B
through O
its O
DNA O
- O
binding O
domain O
, O
as O
demonstrated O
by O
glutathione B
S I
- I
transferase I
( O
GST B
) O
pull O
- O
down O
assays O
. O

Plasma B
prolactin I
concentrations O
in O
pinealectomized O
ewes O
receiving O
melatonin O
treatment O
and O
in O
pineal O
intact O
ewes O
maintained O
under O
a O
non O
- O
24 O
- O
hour O
photoperiod O
. O

The O
transcriptional O
start O
site O
, O
identified O
by O
primer O
extension O
and O
S1 B
nuclease I
assay O
, O
is O
34 O
nt O
upstream O
of O
the O
translation O
initiation O
codon O
. O

psrA O
mutants O
of O
both O
Pseudomonas O
species O
lost O
the O
ability O
to O
induce O
rpoS B
expression O
at O
stationary O
phase O
, O
but O
they O
retained O
the O
ability O
to O
produce O
quorum O
- O
sensing O
autoinducer O
molecules O
. O

The O
role O
of O
the O
putative O
C2 B
domain O
of O
Nedd4 B
has O
not O
been O
elucidated O
. O

However O
the O
precise O
function O
of O
DNA B
- I
PK I
in O
DNA O
double O
- O
strand O
break O
repair O
is O
not O
known O
. O

This O
new O
receptor O
, O
TOR O
( O
thymus O
orphan O
receptor O
) O
, O
is O
most O
closely O
related O
in O
both O
its O
DNA O
- O
binding O
domain O
and O
ligand O
- O
binding O
domain O
, O
90 O
% O
and O
53 O
% O
, O
respectively O
, O
to O
ROR O
alpha O
/ O
RZR O
alpha O
and O
clusters O
with O
these O
two O
receptors O
and O
RZR B
beta I
in O
a O
phylogenetic O
tree O
, O
when O
both O
the O
DNA O
- O
binding O
domain O
and O
the O
ligand O
- O
binding O
domain O
sequences O
of O
nuclear O
receptors O
are O
compared O
. O

In O
this O
report O
, O
we O
have O
examined O
whether O
PTP1B B
effects O
transformation O
induced O
by O
p210 B
bcr B
- O
abl B
. O

S1 B
nuclease I
analysis O
of O
the O
RNA O
from O
a O
number O
of O
QT6 O
- O
LD O
clones O
gave O
similar O
results O
, O
indicating O
that O
the O
LD O
population O
was O
composed O
of O
viruses O
with O
similar O
but O
not O
identical O
deletion O
endpoints O
. O

Association O
of O
Smads O
with O
lymphoid O
enhancer O
binding O
factor O
1 O
/ O
T O
cell O
- O
specific O
factor O
mediates O
cooperative O
signaling O
by O
the O
transforming B
growth I
factor I
- I
beta I
and O
wnt B
pathways O
. O

The O
three O
OAS O
genes O
are O
flanked O
by O
markers O
WI O
- O
10614 O
( O
cen O
) O
and O
D12S2293 O
( O
tel B
) O
and O
are O
contained O
within O
three O
sets O
of O
overlapping O
cosmid O
clones O
. O

22 O
. O
6 O
% O
of O
patients O
were O
found O
to O
be O
positive O
at O
histology O
in O
the O
corpus O
mucosa O
; O
all O
but O
one O
of O
these O
patients O
had O
elevated O
circulating O
IgG B
to O
H O
. O
pylori O
( O
Group O
C O
) O
. O

Rottlerin O
also O
inhibited O
the O
activation O
of O
MAP B
kinase I
kinase I
( O
MEK B
) O
in O
response O
to O
activated O
Raf B
, O
but O
had O
no O
effect O
upon O
c B
- I
Raf I
activity O
or O
ERK B
activation O
by O
activated O
MEK B
. O

The O
isolation O
of O
crt5 O
- O
262 O
, O
an O
additional O
cdc O
allele O
of O
POL1 B
/ O
CDC17 B
, O
suggests O
for O
the O
first O
time O
that O
directly O
blocking O
DNA O
replication O
can O
provide O
a O
signal O
to O
induce O
the O
DNA O
damage O
response O
. O

crt2 O
mutants O
show O
a O
defect O
in O
basal O
level O
expression O
of O
RNR1 O
- O
lacZ B
reporter O
constructs O
. O

We O
prospectively O
studied O
serum B
prolactin I
( O
PRL B
) O
elevation O
after O
different O
types O
of O
documented O
seizures O
in O
17 O
patients O
. O

A O
GTP O
/ O
GDP O
exchange O
assay O
was O
used O
to O
assess O
the O
potential O
role O
of O
Ras B
in O
the O
pathway O
leading O
to O
ERK B
phosphorylation O
; O
DADLE O
failed O
to O
stimulate O
GTP O
/ O
GDP O
exchange O
in O
comparison O
to O
PMA O
. O

Phenotypic O
analysis O
demonstrates O
that O
trio O
and O
Abl B
cooperate O
in O
regulating O
axon O
outgrowth O
in O
the O
embryonic O
central O
nervous O
system O
( O
CNS O
) O
. O

Free O
protein B
S I
deficiency O
in O
acute O
ischemic O
stroke O
. O

The O
NF B
- I
kappa I
B I
precursor O
p100 O
( O
lyt O
- O
10 O
, O
p97 B
, O
p98 O
) O
generates O
after O
proteolytic O
processing O
a O
52 O
kDa O
subunit O
, O
which O
can O
bind O
to O
kappa O
B O
- O
motifs O
. O

CONCLUSION O
: O
The O
biodistribution O
of O
111In O
IgG B
is O
similar O
to O
that O
of O
99mTc O
- O
HMPAO O
- O
labeled O
leukocytes O
. O

In O
a O
previous O
study O
of O
transforming B
growth I
factor I
- I
beta1 I
- O
mediated O
inhibition O
of O
the O
cyclin O
A O
promoter O
, O
we O
mapped O
the O
inhibitory O
effect O
to O
the O
ATF B
site I
; O
in O
the O
present O
study O
of O
IFN B
- I
gamma I
treatment O
, O
functional O
analysis O
by O
transient O
transfection O
showed O
that O
inhibition O
of O
the O
cyclin O
A O
promoter O
persisted O
despite O
mutation O
of O
the O
ATF B
, O
NF B
- I
Y I
, O
or O
CDE O
elements O
. O

Progressive O
immunodeficiency O
in O
a O
patient O
with O
IgA B
deficiency O

The O
N O
- O
terminal O
exon1 O
had O
no O
homology O
at O
the O
amino O
acid O
level O
with O
NGFI B
- I
B I
, O
the O
mammalian O
homologue O
. O

This O
paper O
describes O
a O
longitudinal O
study O
in O
which O
clinical O
parameters O
and O
aspartate B
aminotransferase I
( O
AST B
) O
in O
gingival O
crevicular O
fluid O
( O
GCF O
) O
were O
monitored O
bimonthly O
over O
a O
6 O
- O
12 O
months O
period O
in O
970 O
sites O
from O
7 O
treated O
periodontitis O
patients O
. O

We O
conclude O
from O
these O
observations O
that O
the O
cTnC O
3 O
' O
Ile O
element O
is O
a O
composite O
enhancer O
that O
functions O
through O
the O
combined O
interactions O
of O
at O
least O
five O
regulatory O
elements O
and O
their O
cognate O
binding O
factors O
: O
three O
or O
four O
E O
- O
boxes O
, O
a O
MEF B
- I
2 I
site I
, O
and O
a O
MEF O
- O
3 O
site O
. O

These O
data O
show O
that O
the O
processing O
of O
specific O
target O
transcripts O
, O
such O
as O
the O
P O
- O
element O
mRNA O
, O
is O
regulated O
by O
a O
functional O
PSI O
- O
U1 B
snRNP O
interaction O
in O
Drosophila O
. O

In O
four O
calves O
given O
Haemonchus O
contortus O
larvae O
, O
the O
serum B
pepsinogen I
concentration O
rose O
quickly O
to O
reach O
a O
mean O
of O
3 O
. O
5 O
iu O
tyrosine O
on O
day O
14 O
after O
infection O
. O

These O
results O
strongly O
suggest O
that O
HSV O
- O
1 O
infection O
inhibits O
host O
cell O
splicing O
through O
the O
action O
of O
ICP27 B
. O

Transformation O
of O
chicken O
embryo O
fibroblasts O
( O
CEF O
) O
with O
the O
Gag B
- O
Crk B
fusion O
protein O
results O
in O
the O
elevation O
of O
tyrosine O
phosphorylation O
on O
specific O
cellular O
proteins O
with O
molecular O
weights O
of O
130 O
, O
000 O
, O
110 O
, O
000 O
, O
and O
70 O
, O
000 O
( O
p130 B
, O
p110 B
, O
and O
p70 B
, O
respectively O
) O
, O
an O
event O
which O
has O
been O
correlated O
with O
cell O
transformation O
. O

Urease B
activity O
, O
judged O
as O
the O
amount O
of O
ammonia O
production O
from O
urea O
, O
could O
be O
measured O
at O
25 O
ng O
per O
tube O
( O
S O
/ O
N O
= O
1 O
. O
5 O
) O
with O
Jack B
bean I
meal I
urease I
. O

Here O
, O
we O
provide O
direct O
evidence O
that O
the O
meiotic O
defect O
caused O
by O
either O
unregulated O
cAPK B
activity O
or O
unregulated O
ran1 O
+ O
kinase O
activity O
is O
due O
to O
inability O
to O
induce O
transcription O
of O
the O
mei2 O
+ O
gene O
, O
which O
is O
required O
for O
meiotic O
initiation O
. O

In O
K562 O
cells O
, O
using O
the O
bicistronic O
vector O
, O
selection O
with O
colchicine O
led O
to O
at O
least O
20 O
- O
fold O
higher O
expression O
of O
the O
MDR1 O
gene O
product O
than O
did O
selection O
with O
G418 O
, O
suggesting O
that O
the O
stringent O
MDR1 B
selection O
system O
is O
very O
efficient O
for O
obtaining O
overexpression O
of O
foreign O
genes O
. O

We O
identify O
YY1 B
recognition O
sequences O
within O
the O
vitamin O
D O
response O
element O
( O
VDRE O
) O
of O
the O
osteocalcin O
gene O
that O
are O
critical O
for O
YY1 B
- O
dependent O
repression O
of O
vitamin O
D O
- O
enhanced O
promoter O
activity O
. O

Point O
mutations O
of O
Stat3 B
within O
the O
interacting O
domains O
blocked O
both O
physical O
interaction O
of O
Stat3 B
with O
c B
- I
Jun I
and O
their O
cooperation O
in O
IL B
- I
6 I
- O
induced O
transcription O
directed O
by O
the O
alpha O
( O
2 O
) O
- O
macroglobulin O
enhancer O
. O

The O
prgX O
gene O
is O
adjacent O
to O
prgQ B
which O
provides O
the O
promoter O
for O
prgB O
expression O
. O

Cellular O
lysates O
were O
analyzed O
for O
luciferase B
and O
beta B
- I
galactosidase I
activities O
. O

This O
mutant O
also O
functions O
in O
vivo O
as O
a O
trans O
- O
acting O
dominant O
negative O
regulator O
: O
the O
transcriptional O
inducibility O
of O
the O
HIV B
long I
terminal I
repeat I
( O
which O
contains O
two O
potential O
NF B
- I
kappa I
B I
binding I
sites I
) O
by O
phorbol O
ester O
( O
PMA O
) O
is O
inhibited O
when O
it O
is O
co O
- O
transfected O
into O
CD4 B
+ I
T O
cells O
with O
the O
delta O
SP O
mutant O
. O

During O
chronic O
treatment O
with O
salmon B
calcitonin I
, O
alkaline B
phosphatase I
activity O
and O
urinary O
hydroxyproline O
excretion O
decrease O
on O
an O
average O
of O
50 O
% O
in O
patients O
with O
Paget O
' O
s O
disease O
. O

Stress O
- O
induced O
suppression O
of O
the O
prolactin B
afternoon O
surge O
in O
ovariectomized O
, O
estrogen O
- O
treated O
rats O
and O
the O
nocturnal O
surge O
in O
pseudopregnant O
rats O
are O
accompanied O
by O
an O
increase O
in O
median O
eminence O
dihydroxyphenylacetic O
acid O
concentrations O
. O

Thus O
integration B
host I
factor I
is O
required O
for O
normal O
type O
1 O
fimbriae O
phase O
variation O
in O
E O
. O
coli O
. O

Insulin B
therapy O
has O
been O
expanded O
by O
development O
of O
human O
insulin O
and O
new O
modes O
of O
injection O
, O
including O
insulin B
pumps O
. O

We O
examined O
the O
mechanisms O
by O
which O
two O
different O
types O
of O
photonic O
radiation O
, O
short O
wavelength O
UV O
( O
UV O
- O
C O
) O
and O
gamma O
radiation O
, O
activate O
transcription O
factor O
NF B
- I
kappaB I
. O

However O
, O
coligation O
of O
Fc B
gamma I
RIIB1 I
with O
B O
cell O
Ag O
receptors O
( O
BCR B
) O
inhibits O
BCR B
- O
mediated O
signaling O
by O
a O
mechanism O
that O
may O
involve O
recruitment O
of O
phosphatases O
SHP O
- O
1 O
, O
SHP B
- I
2 I
, O
and O
the O
SH2 O
containing O
inositol O
5 O
' O
phosphatase O
( O
SHIP B
) O
to O
the O
phosphorylated O
Fc O
gamma O
RIIB1 O
immunoreceptor O
tyrosine O
- O
based O
inhibitory O
motif O
. O

We O
conclude O
that O
the O
BR O
- O
C O
early O
gene O
directly O
activates O
late B
gene I
transcription O
by O
interacting O
with O
late B
gene I
cis O
- O
acting O
regulatory O
elements O
and O
that O
this O
interaction O
is O
responsible O
for O
the O
temporal O
linkage O
of O
early O
and O
late O
ecdysone O
- O
induced O
gene O
expression O
. O

We O
have O
identified O
the O
gene O
encoding O
sigma O
E O
using O
a O
genetic O
screen O
designed O
to O
isolate O
trans O
- O
acting O
mutations O
that O
abolish O
expression O
from O
either O
htrA O
or O
rpoHP3 O
, O
two O
promoters O
recognized O
uniquely O
by O
sigma O
E O
- O
containing O
RNA B
polymerase I
. O

These O
patients O
developed O
severe O
diabetic O
symptoms O
including O
glucose O
intolerance O
, O
weight O
loss O
, O
impaired O
energy O
utilization O
, O
and O
nerve O
and O
brain O
disorders O
that O
were O
refractory O
to O
insulin B
. O

One O
promoter O
, O
p53P1 O
, O
is O
located O
100 O
- O
250 O
bp O
upstream O
of O
the O
218 O
- O
bp O
noncoding O
first O
exon O
; O
a O
second O
, O
stronger O
promoter O
, O
p53P2 B
, O
maps O
within O
the O
first O
intron O
. O

The O
corresponding O
tetrapeptide O
sequences O
SSPD O
and O
SATD O
for O
human O
and O
mouse O
PKC O
- O
epsilon O
, O
respectively O
, O
are O
unusual O
for O
caspase B
- I
3 I
. O

The O
lipopolysaccharide O
- O
binding O
protein O
is O
a O
secretory O
class O
1 O
acute O
- O
phase O
protein O
whose O
gene O
is O
transcriptionally O
activated O
by O
APRF O
/ O
STAT B
/ I
3 I
and O
other O
cytokine O
- O
inducible O
nuclear O
proteins O
. O

This O
region O
does O
not O
contain O
a O
consensus O
estrogen O
response O
element O
, O
and O
ER B
binding O
to O
this O
DNA O
sequence O
was O
not O
observed O
. O

The O
strangulated O
intestinal O
pathologies O
of O
horses O
are O
accompanied O
by O
a O
local O
activation O
of O
the O
neutrophils O
, O
that O
can O
be O
revealed O
by O
measuring O
the O
tissular O
enzymatic O
activity O
of O
the O
granulocytic O
enzyme O
myeloperoxidase B
( O
MPO B
) O
. O

The O
homeodomain B
transcription I
factor I
CDP B
/ O
cut B
interacts O
with O
the O
cell O
cycle O
regulatory O
element O
of O
histone O
H4 O
genes O
packaged O
into O
nucleosomes O
. O

Transient O
cotransfection O
analyses O
indicate O
that O
the O
cooperative O
association O
of O
NF B
- I
IL I
- I
6 I
and O
RelA B
with O
the O
IL B
- I
8 I
promoter I
results O
in O
synergistic O
transcriptional O
activation O
. O

Decreased O
plasma O
level O
of O
antithrombin B
III I
was O
assumed O
to O
be O
one O
of O
the O
major O
factors O
underlying O
hypercoagulable O
state O
in O
nephrotic O
syndrome O
. O

Cotransfection O
of O
pINV O
- O
2473 O
, O
a O
construct O
containing O
2473 O
base O
pairs O
of O
hINV O
upstream O
sequence O
linked O
to O
luciferase B
, O
with O
POU O
homeodomain O
transcription O
factors O
Oct1 B
, O
Oct2 B
, O
Brn4 O
, O
SCIP O
, O
Skn1a O
or O
Skn1i O
, O
results O
in O
a O
strong O
suppression O
of O
basal O
promoter O
activity O
. O

We O
have O
compared O
the O
ability O
of O
GST B
- O
Bem3 O
to O
serve O
as O
a O
GAP B
for O
Cdc42Hs B
relative O
to O
other O
members O
of O
the O
rho B
- O
GAP B
subfamily O
and O
found O
the O
following O
order O
of O
potency O
: O
human O
platelet O
Cdc42Hs O
GAP O
> O
p190 B
> O
Bem3 O
> O
break O
point O
cluster O
region O
protein O
, O
whereas O
p85 B
, O
like O
Bem2 O
, O
shows O
no O
GAP B
activity O
or O
any O
ability O
to O
bind O
to O
the O
GTP O
- O
bound O
form O
of O
Cdc42Hs B
. O

Ligand O
binding O
of O
multi O
- O
chain O
antigen O
receptors O
and O
hematopoietin O
/ O
cytokine O
receptors O
results O
in O
rapid O
activation O
of O
protein B
tyrosine I
kinase I
( O
PTK B
) O
- O
dependent O
signalling O
molecules O
such O
as O
phosphatidylinositol B
3 I
- I
kinase I
( O
PI B
3 I
- I
kinase I
) O
. O

Previous O
data O
suggested O
a O
subtle O
increase O
in O
serum O
P O
at O
the O
time O
of O
hCG B
injection O
without O
LH B
surge O
reduces O
the O
PR O
of O
women O
having O
oocyte O
retrievals O
for O
IVF O
; O
this O
study O
compared O
PRs O
of O
recipients O
in O
a O
shared O
oocyte O
program O
according O
to O
the O
donors O
' O
pre O
- O
hCG O
P O
level O
. O

The O
architecture O
of O
the O
hRap1 O
Myb B
domain I
is O
very O
close O
to O
that O
of O
each O
of O
the O
Myb B
domains I
from O
TRF1 O
, O
scRap1p O
and O
c B
- I
Myb I
. O

80 O
v B
- I
ets I
- O
encoded O
amino O
- O
acids O
located O
immediately O
after O
the O
v O
- O
myb O
/ O
v B
- I
ets I
junction O
are O
not O
found O
in O
P54 B
/ O
56c O
- O
ets O
, O
the O
translation O
product O
of O
the O
c O
- O
ets O
proto O
- O
oncogene O
, O
nor O
in O
a O
set O
of O
cellular O
proteins O
of O
64 O
, O
62 O
, O
and O
60 O
kDa O
related O
to O
but O
distinct O
from O
P54 B
/ O
56c O
- O
ets O
. O

Latex O
products O
( O
gloves O
, O
balloons O
, O
and O
condoms O
) O
directly O
bound O
IgE B
from O
all O
four O
patients O
. O

Previous O
studies O
have O
shown O
that O
TGFbeta1 B
expression O
is O
upregulated O
in O
mouse O
keratinocytes O
infected O
with O
a O
v O
- O
rasHa O
retrovirus O
, O
although O
the O
functional O
significance O
of O
this O
has O
not O
been O
clear O
. O

Using O
a O
GTP O
- O
dependent O
, O
brefeldin O
A O
- O
sensitive O
in O
vitro O
AP B
- I
1 I
binding O
assay O
, O
we O
have O
determined O
here O
the O
parameters O
of O
the O
AP B
- I
1 I
binding O
reaction O
. O

Plasma B
enteroglucagon I
was O
measured O
before O
and O
during O
three O
hours O
after O
a O
standard O
meal O
in O
21 O
untreated O
adult O
patients O
with O
suspected O
coeliac O
disease O
who O
all O
had O
villous O
atrophy O
of O
the O
small O
intestinal O
mucosa O
and O
malabsorption O
, O
and O
in O
nine O
control O
subjects O
. O

Regulation O
of O
the O
human O
stress O
response O
gene O
GADD153 O
expression O
: O
role O
of O
ETS1 B
and O
FLI O
- O
1 O
gene O
products O
. O

The O
PRP4 O
protein O
of O
Saccharomyces O
cerevisiae O
is O
an O
essential O
part O
of O
the O
U4 B
/ O
U6 B
snRNP O
, O
a O
component O
of O
the O
mRNA O
splicing O
apparatus O
. O

Serum O
PRL B
concentrations O
significantly O
increased O
after O
MCP O
administration O
in O
normal O
women O
, O
hyperprolactinemic O
patients O
with O
normal O
sella O
and O
patients O
with O
microadenoma O
, O
but O
not O
in O
macroadenoma O
patients O
with O
and O
without O
suprasellar O
expansion O
( O
SSE O
) O
. O

The O
coding O
region O
of O
nifA B
was O
determined O
using O
a O
translational O
lacZ O
fusion O
and O
by O
site O
- O
directed O
mutagenesis O
to O
identify O
which O
of O
four O
in O
frame O
AUG O
codons O
was O
used O
. O

Peptide O
competition O
studies O
have O
localized O
a O
cyclin O
A O
interaction O
site O
to O
a O
Lys381Lys382Leu383Met384Phe385 O
sequence O
within O
C O
- O
terminal O
negative O
regulatory O
domain O
of O
human B
p53 I
. O

Heterodimerization O
mutant O
RXR O
failed O
to O
alter O
GFP B
- O
VDR B
and O
nlsGFP O
- O
VDR B
distribution O
or O
activity O
. O

Purified O
phosphorylated O
PhoP B
( O
PhoPP O
) O
had O
a O
half O
- O
life O
of O
approximately O
2 O
. O
5 O
h O
, O
which O
was O
reduced O
to O
about O
15 O
min O
by O
addition O
of O
the O
same O
molar O
amount O
of O
* O
PhoR O
( O
the O
cytoplasmic O
region O
of O
PhoR O
) O
. O

This O
transformation O
suppression O
by O
Rb B
was O
further O
shown O
to O
be O
due O
to O
transcriptional O
repression O
of O
neu B
using O
Rb B
expressing O
effector O
plasmid O
and O
neu B
promoter O
- O
chloramphenicol B
acetyltransferase I
reporter O
gene O
. O

Biochemical O
studies O
and O
studies O
of O
cells O
expressing O
mutant O
IL O
- O
2 O
receptors O
indicate O
that O
IL B
- I
2 I
- O
induced O
tyrosine B
kinase I
activation O
initiates O
a O
complex O
signaling O
cascade O
. O

Cloning O
of O
the O
GATA B
- I
binding I
protein I
that O
regulates O
endothelin O
- O
1 O
gene O
expression O
in O
endothelial O
cells O
. O

The O
Synechococcus O
gene O
rps1 O
encoding O
S1 B
is O
located O
1 O
. O
1 O
kb O
downstream O
from O
psbB B
, O
which O
encodes O
the O
photosystem O
II O
P680 O
chlorophyll O
a O
apoprotein O
. O

The O
BHV O
- O
1 O
UL24 O
, O
UL25 O
, O
UL26 B
and O
UL26 O
. O
5 O
transcripts O
all O
terminated O
at O
a O
common O
3 O
' O
- O
polyadenylation O
site O
and O
varied O
significantly O
in O
their O
relative O
abundance O
. O

Electrophoretic O
mobility O
shift O
analysis O
of O
protein O
- O
DNA O
complexes O
formed O
with O
nuclear O
proteins O
isolated O
from O
I3C O
- O
treated O
and O
- O
untreated O
cells O
, O
in O
combination O
with O
supershift O
assays O
using O
Sp1 O
antibodies O
, O
demonstrated O
that O
the O
Sp1 B
- I
binding I
site I
in O
the O
CDK6 O
promoter O
forms O
a O
specific O
I3C O
- O
responsive O
DNA O
- O
protein O
complex O
that O
contains O
the O
Sp1 O
transcription O
factor O
. O

These O
results O
suggest O
that O
both O
the O
distinct O
DNA O
binding O
properties O
of O
PMLRAR O
homodimers O
and O
the O
sequestration O
of O
RXR B
by O
PMLRARs O
may O
contribute O
to O
the O
molecular O
mechanisms O
which O
underlie O
the O
pathogenesis O
of O
APL O
. O

Low O
- O
affinity O
E2 O
- O
binding O
site O
mediates O
downmodulation O
of O
E2 B
transactivation O
of O
the O
human O
papillomavirus O
type O
8 O
late O
promoter O
. O

Untransformed O
3T3 O
cells O
carry O
abundant O
1 O
. O
9 O
kb O
Hox O
1 O
. O
3 O
RNA O
, O
whereas O
the O
methylcholanthrene O
- O
transformed O
MB66 O
and O
LTK O
- O
cells O
or O
3T3 O
cells O
transformed O
by O
the O
oncogenes O
src B
, O
fos B
or O
SV40 B
T I
antigen I
express O
only O
low O
levels O
. O

Finally O
, O
synthetic O
peptides O
corresponding O
to O
the O
mutant O
proteins O
were O
assessed O
for O
the O
ability O
to O
act O
as O
substrates O
for O
PR B
. O

These O
results O
suggest O
that O
camptothecin O
resistance O
in O
CEM O
/ O
DOX O
cells O
is O
due O
to O
different O
mechanism O
( O
s O
) O
than O
topoisomerase B
- O
or O
P B
- I
glycoprotein I
- O
associated O
multidrug O
resistance O
. O

Four O
newborns O
in O
this O
group O
became O
HBsAg B
carriers O
. O

A O
5789 O
- O
nucleotide O
- O
long O
EcoRI O
fragment O
from O
the O
genome O
of O
Thermotoga O
maritima O
, O
identified O
by O
cross O
- O
hybridization O
to O
L11 B
, O
L1 B
, O
L10 O
, O
and O
L12 O
ribosomal O
protein O
gene O
sequences O
from O
Escherichia O
coli O
, O
was O
cloned O
and O
sequenced O
. O

The O
use O
of O
ALAD B
activity O
and O
EP O
as O
cumulative O
lead O
exposure O
indicators O
is O
suggested O
. O

Binding O
of O
C B
/ I
EBPs I
to O
all O
three O
spi O
2 O
. O
3 O
3 O
' O
UTR O
repressor O
sites O
, O
although O
rather O
weak O
, O
was O
confirmed O
by O
electrophoretic O
mobility O
shift O
assays O
that O
otherwise O
failed O
to O
reveal O
specific O
interactions O
with O
other O
liver O
nuclear O
proteins O
in O
vitro O
. O

Cell O
cycle O
regulatory O
components O
have O
been O
largely O
conserved O
in O
eukaryotes O
; O
however O
, O
orthologs O
of O
neither O
CAK1 B
nor O
csk1 O
have O
been O
identified O
in O
other O
species O
to O
date O
. O

Finally O
, O
in O
samples O
obtained O
from O
two O
patients O
with O
drug O
refractory O
ALL O
, O
BAC O
- O
derived O
probes O
applied O
to O
archived O
marrow O
cells O
demonstrated O
that O
a O
breakpoint O
occurred O
between O
MDR1 B
and O
sequences O
500 O
- O
1000 O
KB O
telomeric O
to O
MDR1 B
, O
consistent O
with O
a O
random O
chromosomal O
rearrangement O
. O

PC12 O
cultures O
that O
had O
been O
" O
primed O
" O
in O
this O
way O
showed O
an O
accelerated O
and O
augmented O
differentiation O
response O
to O
nerve B
growth I
factor I
. O

The O
median O
levels O
of O
t O
- O
PA O
Ag O
and O
PAI B
in O
plasma O
were O
respectively O
10 O
. O
7 O
ng O
/ O
ml O
( O
interquartile O
range O
8 O
. O
6 O
ng O
/ O
ml O
) O
and O
15 O
. O
7 O
IU O
/ O
ml O
( O
interquartile O
range O
12 O
. O
2 O
IU O
/ O
ml O
) O
. O

The O
leucine O
zipper O
region O
of O
ATF O
proteins O
is O
also O
similar O
to O
that O
of O
the O
AP B
- I
1 I
/ O
c B
- I
jun I
family O
of O
transcription O
factors O
, O
whose O
DNA O
- O
binding O
site O
differs O
from O
the O
ATF B
- O
binding O
site O
at O
a O
single O
position O
. O

Taken O
together O
, O
these O
results O
demonstrate O
that O
the O
BSMV O
coat O
protein O
is O
the O
sole O
translation O
product O
of O
the O
genomic O
RNA O
beta O
, O
whereas O
sgRNA O
beta O
1 O
serves O
as O
a O
messenger O
for O
translation O
of O
the O
beta O
b O
protein O
, O
and O
sgRNA O
beta O
2 O
functions O
as O
a O
messenger O
for O
translation O
of O
beta B
c I
and O
beta O
d O
and O
the O
newly O
discovered O
beta O
d O
' O
protein O
. O

When O
the O
measured O
beta B
- I
galactosidase I
activity O
in O
the O
pWP O
- O
transfected O
cells O
was O
normalized O
to O
the O
pCH110 O
- O
transfected O
cells O
( O
an O
appropriate O
control O
if O
the O
SV40 O
early O
region O
promoter O
functions O
constitutively O
in O
various O
cell O
lines O
) O
, O
the O
results O
suggested O
that O
the O
promoter O
region O
of O
the O
PLP B
gene I
contains O
the O
information O
necessary O
for O
initiation O
of O
transcription O
in O
a O
C6 O
cell O
- O
specific O
manner O
. O

The O
P O
- O
ITIM O
- O
compelled O
multi O
- O
phosphoprotein O
complex O
binds O
to O
and O
activates O
SHP B
- I
2 I
, O
which O
in O
turn O
dephosphorylates O
SHIP B
and O
Shc B
and O
probably O
other O
substrates O
. O

We O
now O
report O
that O
both O
HSCR O
mutations O
impair O
the O
fixation O
of O
Shc B
to O
RET B
and O
consequently O
prevent O
its O
phosphorylation O
. O

There O
is O
an O
overall O
functional O
similarity O
between O
IL B
- I
6 I
and O
c O
- O
fos O
promoters O
, O
since O
transfection O
of O
excess O
amounts O
of O
either O
promoter O
DNA O
into O
intact O
HeLa O
cells O
modulates O
the O
function O
of O
the O
heterologous O
promoter O
construct O
. O

Two O
SH2 B
domains I
of O
p120 B
Ras B
GTPase B
- I
activating I
protein I
bind O
synergistically O
to O
tyrosine O
phosphorylated O
p190 B
Rho O
GTPase B
- I
activating I
protein I
. O

p120 B
GTPase B
- I
activating I
protein I
( O
GAP B
) O
is O
a O
negative O
regulator O
of O
Ras B
that O
functions O
at O
a O
key O
relay O
point O
in O
signal O
transduction O
pathways O
that O
control O
cell O
proliferation O
. O

A O
homologue O
of O
the O
MAP O
/ O
ERK B
family O
of O
protein O
kinase O
genes O
is O
expressed O
in O
vegetative O
and O
in O
female O
reproductive O
organs O
of O
Petunia O
hybrida O
. O

ALT B
( O
alanine B
aminotransferase I
) O
and O
Hb B
( O
hemoglobin B
) O
appeared O
to O
be O
predictive O
for O
efficacy O
. O

Signal O
transduction O
in O
fibroblasts O
stably O
transformed O
by O
[ O
Val12 O
] O
Ras O
- O
- O
the O
activities O
of O
extracellular B
- I
signal I
- I
regulated I
kinase I
and O
Jun B
N I
- I
terminal I
kinase I
are O
only O
moderately O
increased O
, O
and O
the O
activity O
of O
the O
delta O
- O
inhibitor O
of O
c B
- I
Jun I
is O
not O
alleviated O
. O

This O
result O
suggests O
that O
the O
target O
protein O
specificity O
of O
E2s O
can O
be O
altered O
by O
the O
addition O
of O
appropriate O
C O
- O
terminal O
extensions O
, O
thus O
providing O
a O
way O
to O
modify O
the O
selectivity O
of O
the O
ubiquitin B
system O
. O

This O
study O
was O
undertaken O
to O
evaluate O
the O
physical O
and O
biological O
characteristics O
of O
nebulized O
interleukin B
2 I
liposomes O
. O

The O
atopic O
disposition O
, O
indicated O
by O
positive O
skin O
reactions O
and O
IgE B
antibody O
titers O
etc O
. O
, O
and O
the O
bronchial O
reactivity O
to O
inhaled O
acetylcholine O
were O
examined O
on O
the O
following O
three O
groups O
: O
( O
1 O
) O
20 O
young O
adults O
with O
a O
history O
of O
childhood O
asthma O
who O
have O
been O
symptom O
- O
free O
for O
more O
than O
4 O
yr O
; O
( O
2 O
) O
20 O
current O
asthmatics O
, O
and O
( O
3 O
) O
20 O
healthy O
young O
adults O
. O

We O
conclude O
that O
these O
cDNAs O
belong O
to O
a O
novel O
GST B
class O
hereby O
designated O
Kappa O
, O
with O
the O
rat O
GST O
subunit O
13 O
gene O
designated O
rGSTK1 O
and O
the O
human O
gene O
being O
called O
hGSTK1 O
. O

c B
- I
Jun I
repressed O
the O
CG O
alpha O
promoter O
through O
a O
canonical O
cAMP O
response O
element O
( O
CRE O
) O
that O
is O
known O
to O
bind O
c B
- I
Jun I
and O
other O
members O
of O
the O
B O
- O
Zip O
transcription O
factor O
family O
. O

Previous O
studies O
using O
partial O
sequences O
have O
suggested O
the O
potential O
of O
26S O
or O
large O
- O
subunit O
( O
LSU O
) O
rDNA O
for O
phylogeny O
retrieval O
at O
taxonomic O
levels O
comparable O
to O
those O
investigated O
with O
18S B
rDNA I
. O

The O
sensitivity O
of O
99mTc O
- O
IgG B
scintigraphy O
ranged O
between O
71 O
% O
and O
100 O
% O
. O

The O
cause O
for O
the O
increase O
in O
plasma B
ANP I
levels O
in O
the O
active O
phase O
remains O
to O
be O
determined O
. O

Similarly O
, O
an O
increase O
in O
CAT B
expression O
from O
the O
same O
construct O
( O
pBLCAT O
- O
ENDOA O
) O
was O
also O
observed O
in O
7AQS2 O
. O
1 O
cells O
. O

The O
contractile O
effects O
of O
oxytocin B
, O
prostaglandin O
F2 O
alpha O
and O
their O
combined O
use O
on O
human O
pregnant O
myometrium O
were O
studied O
in O
vitro O
. O

These O
involve O
( O
1 O
) O
subcloning O
a O
promoterless O
sucCD O
fragment O
downstream O
of O
the O
lac B
promoter I
in O
M13mp10 O
, O
and O
( O
2 O
) O
precise O
splicing O
of O
the O
suc O
coding O
regions O
with O
the O
efficient O
atpE O
ribosome O
- O
binding O
site O
and O
expression O
from O
the O
thermoinducible O
lambda O
promoters O
in O
the O
pJLA503 O
vector O
. O

These O
mutations O
prevent O
FKBP12 O
- O
rapamycin O
binding O
to O
TOR2 B
, O
as O
assayed O
with O
the O
two O
- O
hybrid O
system O
. O

Fas B
( O
APO O
- O
1 O
/ O
CD95 O
) O
, O
which O
is O
a O
member O
of O
the O
tumor O
necrosis O
factor O
receptor O
superfamily O
, O
is O
a O
cell O
surface O
receptor O
that O
induces O
apoptosis O
. O

Sequencing O
of O
this O
fragment O
showed O
that O
the O
MRP13 B
coding O
region O
specifies O
a O
324 O
- O
amino O
- O
acid O
basic O
protein O
with O
a O
calculated O
Mr O
of O
37 O
, O
366 O
. O

Viral O
complementary O
15 O
S O
mRNA O
that O
directs O
the O
synthesis O
of O
N O
protein O
and O
hybridizes O
to O
the O
predicted O
N B
gene I
DNA O
has O
been O
identified O
in O
infected O
cell O
extracts O
. O

Electrophoretic O
mobility O
shift O
assays O
and O
DNase B
I I
protection O
analyses O
revealed O
that O
FP O
I O
was O
bound O
by O
the O
transcription O
factor O
PU B
. I
1 I
/ O
Spi O
- O
1 O
. O

Retroviral O
vector O
producer O
cell O
populations O
and O
cell O
clones O
were O
established O
for O
each O
chLTR B
vector O
, O
and O
all O
were O
capable O
of O
yielding O
high O
vector O
titers O
( O
> O
10 O
( O
5 O
) O
G418R O
cfu O
/ O
ml O
on O
NIH O
- O
3T3 O
) O
. O

Increasing O
insulin B
sensitivity O
in O
type O
I O
diabetic O
patients O
should O
alert O
clinicians O
to O
the O
possibility O
of O
glucocorticoid O
deficiency O
. O

However O
, O
differential O
utilization O
of O
these O
determinants O
mediate O
RAR B
- O
RXR B
heterodimer O
binding O
to O
DR O
- O
2 O
and O
DR O
- O
5 O
RAREs O
. O

The O
addition O
of O
novel O
techniques O
, O
such O
as O
histopathologic O
ultrastaging O
, O
immunohistochemistry O
staining O
, O
and O
reverse B
transcriptase I
polymerase O
chain O
reaction O
assays O
, O
will O
help O
increase O
the O
accuracy O
and O
rate O
of O
detection O
of O
disease O
. O

NF B
- I
kappaB I
DNA O
- O
protein O
binding O
and O
ICAM B
- I
1 I
promoter I
activity O
were O
enhanced O
by O
IL B
- I
1beta I
and O
these O
effects O
were O
inhibited O
by O
tyrphostin O
23 O
, O
but O
not O
by O
PD O
98059 O
or O
SB O
203580 O
. O

The O
myb O
proto O
oncogene O
product O
( O
c B
- I
Myb I
) O
is O
a O
transcriptional O
regulator O
and O
its O
expression O
and O
function O
are O
tightly O
linked O
to O
the O
cellular O
entry O
into O
S O
phase O
and O
DNA O
synthesis O
. O

Both O
the O
p38 B
kinase I
inhibitor O
SB205380 O
( O
SB O
) O
and O
cotransfection O
of O
a O
dominant O
- O
negative O
mutant O
of O
p38 B
kinase I
reduced O
IL B
- I
1beta I
stimulation O
of O
the O
hBNP O
promoter O
. O

In O
addition O
, O
because O
SB203580 O
had O
no O
effect O
of O
TNF B
- O
or O
ceramide O
- O
induced O
apoptosis O
, O
our O
results O
strongly O
argue O
against O
a O
role O
for O
p38 B
MAPK I
in O
the O
induction O
of O
TNF B
- O
- O
or O
ceramide O
- O
induced O
apoptosis O
. O

Ptx1 B
belongs O
to O
an O
expanding O
family O
of O
bicoid O
- O
related O
vertebrate O
homeobox O
genes O
. O

Sequential O
immunoprecipitation O
showed O
all O
detectable O
p53 B
to O
be O
of O
the O
PAb246 O
+ O
class O
in O
each O
LPV O
- O
transformed O
cell O
line O
, O
suggesting O
that O
the O
stable O
p53 B
was O
indeed O
wild O
type O
. O

To O
better O
understand O
the O
relationship O
between O
expression O
of O
an O
oncogene O
and O
genetic O
instability O
, O
we O
have O
studied O
a O
cell O
line O
expressing O
an O
activated O
human O
Ha O
- O
ras O
under O
the O
control O
of O
bacterial O
lactose O
operon O
regulatory O
elements O
for O
changes O
in O
methotrexate O
resistance O
and O
dihydrofolate O
reductase O
( O
dhfr B
) O
gene O
amplification O
following O
mutant O
Ha O
- O
ras O
induction O
. O

Inspection O
of O
X O
. O
tropicalis O
, O
mouse O
and O
human O
U6 O
DNA O
upstream O
sequences O
revealed O
the O
presence O
of O
a O
TATA O
box O
as O
well O
as O
of O
the O
proximal O
and O
enhancer O
( O
octamer O
motif O
) O
elements O
contained O
in O
snRNA O
genes O
transcribed O
by O
RNA B
polymerase I
II I
. O

These O
data O
show O
that O
both O
Sp1 B
and O
Sp3 O
transcription O
factors O
upregulate O
HGF O
promoter O
activity O
by O
binding O
to O
the O
Sp1 B
binding I
site I
at O
position O
- O
318 O
to O
- O
303 O
bp O
in O
the O
HGF B
gene I
promoter I
. O

Mammalian O
homologues O
of O
the O
Polycomb O
- O
group O
gene O
Enhancer B
of I
zeste I
mediate O
gene O
silencing O
in O
Drosophila O
heterochromatin O
and O
at O
S O
. O
cerevisiae O
telomeres O
. O

The O
S3 O
protein O
also O
contains O
a O
DNA O
repair O
activity O
, O
efficiently O
processing O
8 O
- O
oxoguanine O
residues O
in O
DNA O
via O
an O
N B
- I
glycosylase I
/ O
apurinic O
- O
apyrimidinic O
( O
AP O
) O
lyase O
activity O
. O

We O
conclude O
, O
therefore O
, O
that O
in O
the O
absence O
of O
E1A B
, O
E4orf4 O
is O
sufficient O
by O
itself O
to O
trigger O
a O
p53 B
- O
independent O
apoptosis O
pathway O
that O
may O
operate O
independently O
of O
the O
known O
zVAD O
- O
inhibitable O
caspases B
, O
and O
that O
may O
involve O
an O
as O
yet O
uncharacterized O
mechanism O
. O

The O
expression O
of O
Scmh1 B
and O
rae28 O
/ O
mph1 O
is O
well O
correlated O
in O
most O
tissues O
of O
embryos O
. O

The O
nucleoporin O
98 O
gene O
( O
NUP98 B
) O
, O
which O
is O
rearranged O
in O
several O
acute O
myeloid O
leukemia O
translocations O
, O
is O
located O
within O
this O
region O
. O

A O
new O
direct O
hemagglutination O
test O
( O
HI O
- O
GONAVIS O
) O
for O
urinary O
LH B
was O
compared O
with O
the O
serum O
radioimmuno O
- O
assay O
of O
LH B
. O

Dmyd O
clone O
encodes O
a O
polypeptide O
of O
332 O
amino O
acids O
with O
82 O
% O
identity O
to O
MyoD B
in O
the O
41 O
amino O
acids O
of O
the O
putative O
helix O
- O
loop O
- O
helix O
region O
and O
100 O
% O
identity O
in O
the O
13 O
amino O
acids O
of O
the O
basic O
domain O
proposed O
to O
contain O
the O
essential O
recognition O
code O
for O
muscle O
- O
specific O
gene O
activation O
. O

Identification O
of O
an O
osteocalcin O
gene O
promoter O
sequence O
that O
binds O
AP1 B
. O

Expression O
of O
these O
chemokines O
is O
similar O
in O
that O
both O
require O
the O
NF O
- O
kappa O
B O
element O
and O
additional O
regions O
such O
as O
the O
CAAT O
/ O
enhancer O
binding O
protein O
( O
C B
/ I
EBP I
) O
element O
of O
the O
IL B
- I
8 I
promoter I
. O

Cells O
were O
co O
- O
infected O
simultaneously O
with O
IBV O
, O
the O
recombinant O
FPV O
( O
rFPV O
) O
containing O
the O
D O
- O
RNA O
sequence O
and O
a O
second O
rFPV O
expressing O
T7 B
RNA I
polymerase I
for O
the O
initial O
expression O
of O
the O
D O
- O
RNA O
transcript O
, O
subsequently O
rescued O
by O
helper O
IBV O
. O

The O
AP B
- I
1 I
recruited O
by O
ARF1 O
. O
GTP O
is O
released O
from O
the O
Golgi O
membrane O
by O
treatment O
with O
1 O
M O
Tris O
- O
HCl O
( O
pH O
7 O
) O
or O
upon O
reincubation O
at O
37 O
degreesC O
, O
whereas O
AP B
- I
1 I
recruited O
with O
GTPgammaS O
or O
by O
a O
constitutively O
active O
point O
mutant O
, O
ARF1 O
( O
Q71L O
) O
, O
remains O
membrane O
bound O
after O
either O
treatment O
. O

The O
pra2 O
gene O
encodes O
a O
pea O
( O
Pisum O
sativum O
) O
small O
GTPase O
belonging O
to O
the O
YPT B
/ O
rab O
family O
, O
and O
its O
expression O
is O
down O
- O
regulated O
by O
light O
, O
mediated O
by O
phytochrome B
. O

To O
explore O
further O
the O
role O
of O
the O
carboxyl O
- O
terminal O
domain O
in O
determining O
the O
cell O
cycle O
function O
of O
CDC34 B
, O
we O
constructed O
and O
characterized O
genes O
encoding O
chimeric O
E2s O
incorporating O
sequences O
from O
CDC34 B
and O
the O
related O
but O
functionally O
distinct O
E2 B
RAD6 B
( O
UBC2 B
) O
. O

MAPKK O
kinase O
/ O
MEKK O
phosphorylates O
and O
activates O
its O
downstream O
protein O
kinase O
, O
MAPK O
kinase O
/ O
MEK B
, O
which O
in O
turn O
activates O
MAPK B
. O

To O
investigate O
its O
transcription O
, O
1 O
. O
1 O
kilobases O
of O
the O
5 O
' O
- O
flanking O
sequence O
were O
fused O
to O
a O
luciferase B
reporter I
gene I
. O

In O
contrast O
, O
corticotropin B
releasing I
factor I
( O
CRF B
) O
, O
injected O
centrally O
produces O
a O
suppression O
of O
punished O
and O
non O
- O
punished O
responding O
in O
the O
conflict O
test O
consistent O
with O
its O
hypothesized O
role O
in O
mediating O
behavioral O
responses O
to O
stress O
. O

Temporal O
recruitment O
of O
the O
mSin3A O
- O
histone B
deacetylase I
corepressor O
complex O
to O
the O
ETS O
domain O
transcription O
factor O
Elk B
- I
1 I
. O

In O
addition O
, O
FOP O
- O
FGFR1 B
- O
expressing O
cells O
show O
constitutive O
phosphorylation O
of O
the O
positive O
regulator O
of O
translation O
p70S6 O
kinase O
; O
this O
phosphorylation O
is O
inhibited O
by O
PI3 O
- O
kinase O
and O
mTOR B
( O
mammalian O
target O
of O
rapamycin O
) O
inhibitors O
. O

The O
newly O
identified O
repressor O
element O
is O
a O
rare O
example O
of O
a O
naturally O
occurring O
perfect O
palindromic O
binding O
motif O
for O
the O
NF B
- I
kappa I
B I
/ O
Rel B
family O
of O
transcription O
factors O
. O

Tryptophan O
induction O
prevents O
Rho B
- O
dependent O
transcription O
termination O
in O
the O
leader O
region O
of O
the O
operon O
. O

The O
majority O
of O
putative O
TSC2 O
mutations O
were O
found O
in O
sporadic O
rather O
than O
TSC2 B
- O
linked O
families O
. O

PMA O
produced O
similar O
results O
, O
but O
the O
induction O
of O
the O
WT O
AP1 O
c B
- I
jun I
promoter O
- O
CAT O
plasmid O
was O
smaller O
. O

The O
determination O
of O
antithrombin B
III I
( O
AT B
III I
) O
and O
its O
clinical O
significance O

Glucose O
consumption O
of O
the O
human O
brain O
under O
the O
influence O
of O
intravenous O
infusions O
of O
glucose O
, O
glucagon B
and O
glucose O
- O
insulin O

These O
observations O
suggest O
that O
the O
AF O
- O
1 O
region O
of O
PPARalpha B
is O
partially O
silenced O
by O
corepressor O
proteins O
, O
which O
might O
interact O
in O
a O
phosphorylation O
- O
dependent O
manner O
. O

However O
, O
in O
a O
variation O
of O
this O
assay O
in O
which O
the O
protease O
is O
omitted O
, O
the O
mutant O
enzymes O
exhibited O
substantial O
levels O
of O
prolyl B
isomerase I
activity O
( O
5 O
- O
20 O
% O
of O
wild O
- O
type O
) O
, O
revealing O
that O
these O
mutations O
confer O
sensitivity O
to O
protease O
digestion O
and O
that O
the O
classic O
in O
vitro O
assay O
for O
prolyl B
isomerase I
activity O
may O
be O
misleading O
. O

Nucleotide O
sequence O
of O
the O
gag B
gene I
and O
gag B
- O
pol B
junction O
of O
feline O
leukemia O
virus O
. O

On O
the O
basis O
of O
the O
physical O
interactions O
between O
Sxl O
and O
Snf B
, O
we O
present O
a O
model O
for O
Sxl O
splicing O
regulation O
. O

We O
cloned O
the O
BamHI O
- O
F O
fragment O
from O
the O
left O
end O
of O
Ad4 O
in O
pUC13 O
- O
1 O
between O
the O
SalI B
and O
BamHI O
sites O
in O
order O
to O
carry O
out O
the O
structural O
analysis O
of O
the O
E1A O
region O
of O
Ad4 O
. O

In O
both O
RAW O
cells O
and O
the O
microglia O
cell O
line O
EOC20 O
, O
two O
IFN B
- I
gamma I
- O
activated O
transcription O
factors O
, O
STAT O
- O
1alpha O
and O
IRF B
- I
1 I
, O
bind O
the O
GAS B
and O
IRF O
elements O
, O
respectively O
. O

After O
inhibition O
of O
monoamine B
oxidase I
with O
pargyline O
( O
10 O
mg O
/ O
kg O
. O
i O
. O
v O
. O
) O
, O
the O
effects O
of O
tyramine O
( O
1000 O
micrograms O
) O
injected O
into O
the O
hepatic O
artery O
were O
potentiated O
. O

Helenalin O
triggers O
a O
CD95 O
death O
receptor O
- O
independent O
apoptosis O
that O
is O
not O
affected O
by O
overexpression O
of O
Bcl B
- I
x I
( I
L I
) I
or O
Bcl B
- I
2 I
. O

These O
results O
indicate O
that O
patients O
with O
SS O
and O
evidence O
of O
exercise O
- O
induced O
ST O
- O
segment O
depression O
may O
have O
decreased O
myocardial O
oxygen O
supply O
due O
to O
low O
hemoglobin B
levels O
and O
increased O
myocardial O
oxygen O
demand O
( O
elevated O
double O
products O
) O
when O
compared O
to O
subjects O
with O
SS O
who O
do O
not O
have O
exercise O
- O
induced O
ST O
- O
segment O
depression O
. O

Using O
this O
oligonucleotide O
as O
a O
probe O
, O
an O
8 O
- O
kilobase O
HindIII B
fragment O
of O
genomic O
DNA O
was O
isolated O
and O
subjected O
to O
Sanger O
dideoxy O
DNA O
sequencing O
. O

Wild O
type O
MEKK1 B
enhances O
promoter O
activity O
and O
the O
activity O
can O
be O
inhibited O
by O
dominant O
negative O
MEKK1 B
, O
MEK1 B
, O
MEK7 O
, O
MEK3 O
, O
p38 B
/ O
RK O
, O
and O
c B
- I
Jun I
. O

Using O
the O
conflict O
drinking O
test O
as O
a O
model O
, O
we O
studied O
in O
rats O
the O
effect O
of O
the O
nonselective O
beta B
- I
adrenoceptor I
blockers O
pindolol O
and O
cyanopindolol O
which O
bind O
to O
5 O
- O
HT1A O
and O
5 O
- O
HT1B O
receptors O
, O
and O
of O
the O
selective O
beta O
1 O
- O
and O
beta O
2 O
- O
adrenoceptor O
antagonists O
betaxolol O
and O
ICI O
118 O
, O
551 O
, O
respectively O
, O
which O
have O
a O
negligible O
affinity O
for O
5 O
- O
HT O
receptors O
. O

Although O
several O
other O
signal O
transduction O
molecules O
also O
contain O
tandemly O
occurring O
SH3 B
and O
SH2 B
domains I
, O
the O
function O
of O
these O
closely O
spaced O
domains O
is O
not O
well O
understood O
. O

But O
if O
one O
equalizes O
the O
upper O
limits O
of O
normal O
for O
both O
markers O
to O
a O
common O
95 O
% O
specificity O
, O
the O
tumour O
- O
indicating O
sensitivity O
of O
CA B
19 I
- I
9 I
clearly O
surpasses O
that O
of O
CA B
50 I
. O

Transfection O
of O
both O
Calu O
- O
6 O
and O
JEG O
- O
3 O
cells O
with O
a O
PKA B
expression O
vector O
resulted O
in O
a O
10 O
- O
fold O
induction O
of O
human O
renin O
transcriptional O
activity O
in O
constructs O
containing O
the O
native O
or O
consensus O
CRE O
and O
5 O
- O
fold O
activation O
in O
a O
construct O
containing O
a O
nonfunctional O
CRE O
. O

V O
- O
ErbB O
- O
mediated O
complex O
formation O
and O
transformation O
have O
been O
shown O
to O
occur O
independently O
of O
Ras B
activation O
. O

Postheparin O
lipoprotein B
lipase I
, O
measured O
using O
fat O
emulsion O
as O
substrate O
, O
also O
was O
significantly O
greater O
in O
female O
rats O
compared O
with O
males O
. O

Deletion O
analysis O
revealed O
that O
only O
the O
TM O
domain O
of O
E2 B
was O
required O
for O
Golgi O
targeting O
. O

In O
addition O
, O
putative O
binding O
sites O
for O
SH3 B
and O
SH2 B
domains I
are O
present O
in O
the O
amino O
- O
terminal O
half O
of O
the O
molecule O
. O

The O
MAP O
kinase O
kinase O
kinase O
MLK2 O
co O
- O
localizes O
with O
activated O
JNK B
along O
microtubules O
and O
associates O
with O
kinesin O
superfamily O
motor O
KIF3 O
. O

They O
are O
transduced O
through O
TM O
to O
the O
cytoplasmic O
portion O
( O
cytoloops O
and O
the O
C O
- O
terminal O
tail O
) O
of O
the O
receptor O
and O
then O
, O
transferred O
to O
cytoplasmic O
signaling O
molecules O
, O
such O
as O
G B
protein I
. O

Serum B
alkaline I
phosphatase I
and O
creatine B
kinase I
activities O
were O
significantly O
increased O
in O
the O
A O
praelongus O
- O
fed O
pigs O
and O
significantly O
decreased O
in O
Na2SeO4 O
- O
fed O
pigs O
. O

Although O
polyubiquitin O
chains O
linked O
through O
Lys O
( O
29 O
) O
of O
ubiquitin B
have O
been O
implicated O
in O
the O
targeting O
of O
certain O
substrates O
to O
proteasomes O
, O
the O
signaling O
properties O
of O
these O
chains O
are O
poorly O
understood O
. O

An O
in O
vitro O
Raf B
- I
1 I
kinase I
assay O
, O
however O
, O
failed O
to O
detect O
LPS O
- O
induced O
Raf B
- I
1 I
kinase I
activity O
in O
RAW O
264 O
. O
7 O
cells O
, O
suggesting O
that O
in O
RAW O
264 O
. O
7 O
cells O
, O
Raf B
- I
1 I
kinase I
is O
not O
an O
activating O
component O
of O
the O
LPS O
signaling O
pathway O
regulating O
MAPK B
activity O
or O
sIL O
- O
1Ra O
promoter O
activity O
. O

Phosphorylation O
of O
the O
ras B
GTPase B
- I
activating I
protein I
( O
GAP B
) O
by O
the O
p93c O
- O
fes O
protein B
- I
tyrosine I
kinase I
in O
vitro O
and O
formation O
of O
GAP B
- O
fes B
complexes O
via O
an O
SH2 B
domain O
- O
dependent O
mechanism O
. O

Two O
methods O
for O
the O
routine O
determination O
of O
blood O
hemoglobin B
oxygen O
affinity O
are O
described O
. O

RET B
/ O
PTC B
oncogenes O
, O
generated O
by O
chromosomal O
rearrangements O
in O
papillary O
thyroid O
carcinomas O
, O
are O
constitutively O
activated O
versions O
of O
proto O
- O
RET O
, O
a O
gene O
coding O
for O
a O
receptor O
- O
type O
tyrosine O
kinase O
( O
TK B
) O
whose O
ligand O
is O
still O
unknown O
. O

PCC O
6803 O
mutant O
impaired O
in O
cytochrome B
c I
maturation O
. O

In O
rats O
exposed O
to O
Cd O
for O
30 O
d O
, O
the O
levels O
of O
urinary O
excretion O
of O
cAMP O
after O
treatment O
with O
parathyroid B
hormone I
( O
PTH B
) O
, O
parathyroidectomy O
( O
PTX O
) O
, O
or O
1 O
alpha O
- O
hydroxycholecalciferol O
( O
1 O
alpha O
- O
OH O
- O
D3 O
) O
showed O
almost O
the O
same O
patterns O
as O
those O
of O
control O
rats O
: O
the O
response O
of O
urinary O
cAMP O
to O
treatment O
with O
PTH B
was O
not O
influenced O
by O
continuous O
oral O
administration O
of O
Cd O
. O

In O
the O
absence O
of O
shock O
, O
sepsis O
, O
or O
other O
identifiable O
causes O
of O
lactic O
acidosis O
, O
the O
severe O
anemia O
( O
hemoglobin B
1 O
. O
2 O
g O
/ O
dl O
) O
appeared O
to O
be O
the O
primary O
etiologic O
factor O
. O

Despite O
a O
lowering O
of O
her O
plasma O
ACTH B
concentration O
during O
therapy O
with O
valproic O
acid O
, O
the O
patient O
' O
s O
tumour O
showed O
no O
evidence O
of O
regression O
while O
she O
was O
taking O
the O
drug O
. O

Our O
studies O
suggest O
that O
the O
helicase B
assembly O
protein O
is O
responsible O
for O
loading O
T4 O
gene O
41 O
helicase O
specifically O
at O
replication O
forks O
, O
and O
that O
its O
binding O
sites O
for O
each O
arm O
must O
hold O
more O
than O
six O
, O
but O
not O
more O
than O
12 O
nucleotides O
. O

The O
human B
SHBG I
proximal I
promoter I
was O
analyzed O
by O
DNase B
I I
footprinting O
, O
and O
the O
functional O
significance O
of O
6 O
footprinted O
regions O
( O
FP1 O
- O
FP6 O
) O
within O
the O
proximal O
promoter O
was O
studied O
in O
human O
HepG2 O
hepatoblastoma O
cells O
. O

Tag B
expression O
induced O
apoptosis O
in O
mammary O
epithelial O
cells O
during O
late O
pregnancy O
. O

The O
factors O
defective O
in O
groups O
A O
( O
CIITA B
) O
, O
C O
( O
RFX5 B
) O
and O
D O
( O
RFXAP B
) O
have O
been O
identified O
. O

By O
deletion O
analysis O
, O
we O
identified O
the O
regions O
of O
c B
- I
Jun I
encoding O
transformation O
and O
transactivation O
functions O
. O

To O
test O
for O
progesterone B
receptor I
- O
mediated O
activation O
of O
transcription O
in O
yeast O
, O
reporter O
plasmids O
were O
constructed O
to O
transform O
yeast O
cells O
expressing O
PRB B
or O
C1C2 O
receptors O
. O

Fli B
- I
1 I
is O
a O
proto O
- O
oncogene O
which O
is O
rearranged O
in O
tumors O
induced O
by O
three O
different O
retroviruses O
, O
Cas O
- O
Br O
- O
E O
, O
F O
- O
MuLV O
, O
and O
10A1 O
. O

In O
src B
- O
transformed O
cells O
GAP B
forms O
heteromeric O
complexes O
, O
notably O
with O
a O
highly O
tyrosine O
phosphorylated O
62 O
- O
kDa O
protein O
( O
p62 O
) O
. O

PrRP B
rapidly O
and O
transiently O
activated O
extracellular B
signal I
- I
regulated I
protein I
kinase I
( O
ERK B
) O
in O
both O
types O
of O
cells O
. O

Cell O
- O
free O
extracts O
of O
E O
. O
coli O
( O
fpg O
mutY B
) O
harboring O
pYSB10 O
possess O
an O
enzymatic O
activity O
that O
cleaves O
a O
34 O
- O
mer O
oligonucleotide O
containing O
a O
single O
8 O
- O
oxoG O
opposite O
a O
cytosine O
( O
8 O
- O
OxoG O
/ O
C O
) O
. O

Long O
- O
range O
mapping O
by O
pulse O
- O
field O
gel O
electrophoresis O
indicated O
that O
the O
three O
mdr B
genes I
are O
closely O
linked O
on O
a O
genomic O
DNA O
segment O
of O
approximately O
625 O
kilobases O
. O

These O
sequences O
were O
further O
tested O
for O
the O
presence O
of O
an O
enhancer O
element O
, O
by O
their O
ability O
to O
activate O
a O
fusion O
reporter O
gene O
consisting O
of O
the O
CAT B
gene I
linked O
to O
the O
gamma O
- O
globin O
gene O
promoter O
, O
in O
erythroid O
( O
K562 O
) O
and O
non O
- O
erythroid O
( O
HeLa O
) O
cells O
. O

All O
patients O
received O
marrow O
from O
HLA B
- O
identical O
sibling O
donors O
, O
underwent O
similar O
myeloablative O
regimens O
, O
and O
had O
similar O
pretreatment O
characteristics O
. O

Soluble O
recombinant O
RI B
and O
soluble O
recombinant O
C O
alpha O
can O
associate O
in O
vitro O
and O
be O
activated O
by O
cyclic O
AMP O
. O

IRIS O
/ O
GAS B
DNA O
also O
formed O
a O
number O
of O
specific O
complexes O
with O
constitutively O
expressed O
factors O
, O
none O
of O
which O
were O
affected O
by O
the O
above O
Abs O
. O

Electrophoretic O
mobility O
- O
shift O
assays O
with O
nuclear O
extracts O
from O
COS O
- O
1 O
cells O
transfected O
with O
expression O
vectors O
for O
SMADs O
1 O
- O
5 O
indicate O
that O
SMAD3 B
forms O
a O
complex O
with O
a O
migration O
similar O
to O
that O
of O
the O
endogenous O
TGF O
- O
beta O
- O
specific O
complex O
observed O
in O
fibroblast O
extracts O
. O

The O
newly O
identified O
NF O
kappa O
B O
enhancer O
( O
TGGAAATTCC O
) O
is O
bound O
by O
a O
TNF B
alpha I
- O
induced O
nuclear O
protein O
and O
appears O
to O
be O
the O
key O
element O
in O
rapid O
transcription O
induction O
by O
TNF B
alpha I
( O
and O
TPA O
) O
, O
while O
transactivation O
of O
this O
element O
is O
repressed O
by O
the O
ligand O
- O
bound O
glucocorticoid B
receptor I
. O

Our O
results O
showed O
that O
the O
5 O
- O
hydroxytryptamine O
( O
5 O
- O
HT O
) O
content O
in O
platelets O
was O
: O
( O
1 O
) O
increased O
in O
the O
subgroup O
of O
anti O
- O
social O
alcoholics O
; O
( O
2 O
) O
transiently O
and O
differently O
altered O
in O
alcoholics O
compared O
to O
opiate O
addicts O
; O
and O
( O
3 O
) O
lowered O
in O
drinking O
alcoholics O
and O
normal O
in O
alcoholics O
who O
were O
drinking O
as O
well O
as O
smoking O
( O
that O
may O
occur O
via O
MAO B
- I
B I
inhibition O
by O
smoke O
) O
. O

In O
the O
second O
group O
, O
which O
consisted O
of O
babies O
of O
33 O
to O
36 O
weeks O
of O
gestational O
age O
, O
haptoglobin B
was O
detected O
in O
6 O
infants O
, O
with O
levels O
less O
than O
25 O
mg O
/ O
dl O
in O
3 O
. O

However O
, O
H19 B
and O
IGF2 B
lie O
within O
a O
larger O
imprinted O
domain O
, O
and O
the O
gene O
specificity O
of O
H19 B
epimutation O
has O
been O
a O
persistent O
question O
. O

As O
much O
thrombin B
was O
formed O
during O
cardiopulmonary O
bypass O
( O
measured O
by O
the O
prothrombin O
activation O
fragment O
F1 O
+ O
2 O
and O
thrombin B
- O
antithrombin B
complexes O
) O
as O
in O
normal O
patients O
, O
showing O
that O
factor B
XII I
was O
not O
necessary O
for O
thrombin B
generation O
. O

Treatment O
of O
chronic O
hepatitis O
B O
with O
interferon B
: O
experience O
in O
western O
countries O
. O

In O
vitro O
binding O
studies O
previously O
showed O
that O
NF B
- I
kappa I
B I
p50 B
homodimer O
binds O
the O
switch O
nuclear O
B O
- O
site O
protein O
( O
SNIP O
) O
of O
the O
S O
gamma O
3 O
tandem O
repeat O
. O

In O
this O
case O
myogenic O
factors O
are O
not O
initially O
expressed O
and O
these O
migratory O
cells O
are O
characterized O
by O
the O
expression O
of O
the O
paired B
- O
box O
gene O
Pax3 B
. O

It O
is O
concluded O
that O
the O
atherogenic O
process O
includes O
stimulation O
of O
collagen B
and O
elastin O
synthesis O
. O

These O
results O
indicate O
that O
( O
1 O
) O
RXR B
- O
TR B
heterodimers O
play O
a O
role O
in O
basal O
transactivation O
and O
T3 O
suppression O
of O
negatively O
regulated O
genes O
, O
and O
( O
2 O
) O
RXRs O
increase O
the O
dominant O
negative O
effect O
of O
some O
mutant O
TRs B
on O
specific O
negative O
TREs O
. O

Phenotypic O
responses O
of O
additional O
mutants O
, O
including O
exo1 O
, O
srs2 O
, O
rad5 B
, O
and O
rdh54 O
strains O
, O
suggest O
roles O
in O
recombinational O
repair O
, O
but O
not O
in O
NHEJ O
. O

In O
this O
work O
, O
we O
determined O
the O
sequences O
of O
eight O
VirF O
- O
binding O
sites O
from O
four O
different O
genes O
, O
by O
DNase B
I I
or O
hydroxyl O
radical O
footprinting O
. O

Rhinovirus O
2A O
protease O
and O
foot O
- O
and O
- O
mouth O
- O
disease O
virus O
L O
protease O
were O
used O
to O
analyze O
the O
association O
of O
eIF4G O
with O
eIF4A B
, O
eIF4E B
, O
and O
eIF3 B
. O

One O
hundred O
cDNA O
clones O
were O
sequenced O
and O
8 O
RTKs B
were O
identified O
, O
as O
well O
as O
12 O
non O
- O
RTKs B
and O
2 O
serine B
/ I
threonine I
kinases I
. O

Furthermore O
, O
it O
was O
found O
that O
the O
Shb B
- O
overexpressing O
cells O
extended O
neurites O
in O
response O
to O
epidermal B
growth I
factor I
. O

Levels O
of O
p53 B
were O
substantially O
increased O
by O
E1A B
expression O
during O
adenovirus O
infection O
. O

In O
cases O
of O
intracapsular O
prostatic O
cancer O
the O
level O
of O
prostatic B
acid I
phosphatase I
( O
PAP B
) O
measured O
by O
radioimmunoassay O
was O
1 O
. O
4 O
+ O
/ O
- O
0 O
. O
8 O
micrograms O
/ O
l O
. O

In O
EGF B
receptor I
- O
mediated O
signaling O
, O
the O
protein O
kinase O
PKB O
/ O
Akt B
and O
the O
mitogen O
- O
activated O
protein O
kinase O
c O
- O
Jun O
N O
- O
terminal O
kinase O
, O
but O
not O
extracellular O
signal O
- O
regulated O
kinase O
2 O
, O
function O
downstream O
of O
phosphatidylinositol B
3 I
- I
kinase I
( O
PI B
3 I
- I
kinase I
) O
. O

Immunoprecipitation O
of O
cell O
lysates O
with O
anti O
- O
phosphotyrosine O
and O
immunoblotting O
showed O
phosphorylated O
forms O
of O
the O
mitogenic O
pathway O
proteins O
Shc B
and O
MAPK B
in O
addition O
to O
p185 O
( O
neu B
) O
, O
suggesting O
that O
the O
Ras B
to O
MAPK B
mitogenic O
pathway O
is O
activated O
. O

We O
suggest O
that O
this O
effect O
of O
Myc B
is O
mediated O
by O
its O
action O
upstream O
of O
cyclin B
E I
- O
CDK2 B
, O
and O
occurs O
via O
the O
neutralization O
of O
p27 B
( O
Kip1 B
) O
family O
proteins O
, O
rather O
than O
induction O
of O
Cdc25A B
. O

These O
data O
suggest O
that O
certain O
of O
the O
nuclear O
protein O
import O
functions O
of O
NTF2 B
and O
Ran B
/ O
TC4 O
are O
closely O
linked O
and O
that O
NTF2 B
may O
serve O
to O
modulate O
a O
transport O
step O
involving O
Ran B
/ O
TC4 O
. O

Both O
oligonucleotide O
cross O
- O
competition O
and O
antibody O
supershift O
experiments O
established O
that O
the O
double O
- O
strand O
binding O
protein O
is O
equivalent O
to O
Sp1 B
. O

However O
, O
C B
/ I
EBP I
beta I
stimulated O
transcription O
primarily O
through O
the O
cAMP O
- O
responsive O
element O
( O
CRE O
) O
, O
which O
maps O
between O
positions O
- O
77 O
to O
- O
94 O
, O
but O
not O
at O
the O
more O
5 O
' O
- O
binding O
sites O
. O

Finally O
, O
antisense O
mediated O
reduction O
of O
Elk B
- I
1 I
in O
GH4 O
cells O
decreased O
insulin B
- O
increased O
prolactin O
gene O
expression O
and O
confirmed O
the O
requirement O
for O
Elk B
- I
1 I
for O
insulin B
- O
increased O
prolactin O
gene O
expression O
. O

The O
aromatic O
hydrocarbon O
receptor O
( O
AHR B
) O
is O
a O
ligand O
- O
activated O
transcription O
factor O
that O
regulates O
the O
expression O
of O
several O
drug O
- O
metabolizing O
enzymes O
and O
has O
been O
implicated O
in O
immunosuppression O
, O
teratogenesis O
, O
cell O
- O
specific O
hyperplasia O
, O
and O
certain O
types O
of O
malignancies O
and O
toxicities O
. O

To O
define O
the O
molecular O
mechanism O
regulating O
FGFR B
- I
1 I
gene I
expression O
in O
proliferating O
myoblasts O
and O
post O
- O
mitotic O
muscle O
fibers O
, O
we O
have O
isolated O
and O
partially O
characterized O
the O
avian O
FGFR B
- I
1 I
gene I
promoter O
. O

Moreover O
, O
FACT O
specifically O
interacts O
with O
nucleosomes O
and O
histone O
H2A B
/ O
H2B B
dimers O
, O
indicating O
that O
it O
may O
work O
by O
promoting O
nucleosome O
disassembly O
upon O
transcription O
. O

Mutation O
of O
the O
distal O
E2F B
binding I
site I
in O
the O
cdc25A O
promoter O
abolished O
E2 B
- O
induced O
repression O
, O
whereas O
mutation O
of O
the O
proximal O
E2F O
site O
or O
the O
E2 B
site I
had O
no O
effect O
. O

Plasmid O
pNK21 O
, O
in O
which O
2 O
. O
05 O
- O
kb O
sequence O
covering O
the O
region O
encoding O
the O
nitrilase O
was O
was O
placed O
under O
the O
control O
of O
the O
lac B
promoter I
, O
directed O
overproduction O
of O
enzymatically O
active O
nitrilase O
in O
response O
to O
addition O
of O
isopropyl O
beta O
- O
D O
- O
thiogalactopyranoside O
in O
Escherichia O
coli O
. O

These O
results O
demonstrate O
a O
specific O
association O
of O
SIV O
and O
HIV B
- I
2 I
nef I
, O
but O
not O
HIV B
- I
1 I
nef I
, O
with O
TCRzeta B
. O

Upon O
incubation O
of O
the O
most O
highly O
purified O
fractions O
with O
Mn O
- O
ATP O
or O
Mg O
- O
ATP O
, O
p40 B
was O
the O
only O
protein O
phosphorylated O
on O
tyrosine O
. O

Consistent O
with O
this O
hypothesis O
, O
alpha1 O
- O
PDX O
prevents O
cleavage O
of O
BMP B
- I
4 I
in O
an O
oocyte O
translation O
assay O
. O

A O
p53 O
cDNA O
deletion O
mutant O
( O
delta O
pro O
AE O
) O
, O
which O
lacks O
this O
entire O
proline O
- O
rich O
domain O
( O
deleted O
for O
amino O
acids O
62 O
- O
91 O
) O
, O
was O
created O
and O
characterized O
for O
a O
variety O
of O
p53 B
functions O
. O

Multiple O
aortic O
thrombi O
associated O
with O
protein B
C I
and O
S O
deficiency O
. O

We O
functionally O
characterised O
AtXPO1 O
by O
its O
interaction O
with O
NESs O
of O
animal O
and O
plant O
proteins O
, O
which O
is O
inhibited O
by O
the O
cytotoxin O
leptomycin O
B O
( O
LMB O
) O
, O
and O
also O
by O
its O
interaction O
with O
the O
small B
GTPase I
Ran1 O
in O
the O
yeast O
two O
- O
hybrid O
system O
. O

S1 B
nuclease I
protection O
mapping O
and O
primer O
extension O
analysis O
allowed O
us O
to O
propose O
that O
the O
A O
residue O
located O
19 O
bp O
upstream O
from O
the O
translation O
initiation O
codon O
is O
the O
site O
of O
transcription O
initiation O
. O

Various O
stimuli O
inactivate O
IkappaB B
alpha I
by O
triggering O
phosphorylation O
of O
the O
N O
- O
terminal O
residues O
Ser32 O
and O
Ser36 O
. O

In O
addition O
, O
the O
results O
suggest O
that O
N O
region O
diversity O
at O
V O
( O
D O
) O
J O
junctions O
within O
rearranged O
immunoglobulin B
and O
T O
cell O
receptor O
gene O
loci O
can O
only O
be O
introduced O
after O
the O
generation O
of O
RAG B
- O
catalyzed O
DNA O
double O
- O
strand O
breaks O
, O
i O
. O
e O
. O
during O
the O
DNA O
end O
joining O
phase O
of O
the O
V O
( O
D O
) O
J O
recombination O
reaction O
. O

Thus O
, O
Shp2 B
regulates O
phosphotyrosine O
- O
signalling O
events O
during O
the O
complex O
ectodermal O
- O
mesenchymal O
interactions O
that O
regulate O
mammalian O
budding O
morphogenesis O
. O

Coexpression O
of O
CREB B
- I
binding I
protein I
( O
CBP B
) O
/ O
p300 B
with O
TReP O
- O
132 O
has O
an O
additive O
effect O
on O
promoter O
activity O
, O
and O
the O
proteins O
were O
demonstrated O
to O
interact O
physically O
. O

Catalase B
plays O
a O
key O
role O
as O
an O
antioxidant O
, O
protecting O
aerobic O
organisms O
from O
the O
toxic O
effects O
of O
hydrogen O
peroxide O
, O
and O
in O
some O
cases O
has O
been O
postulated O
to O
be O
a O
virulence O
factor O
. O

Recent O
developments O
in O
the O
study O
of O
growth O
factors O
: O
GRF B
and O
somatomedins O
. O

CAT B
assays O
demonstrated O
that O
overexpression O
of O
RXRalpha B
conferred O
the O
best O
RA O
response O
, O
consistent O
with O
our O
previous O
observation O
that O
9 O
- O
cis O
- O
RA O
is O
more O
potent O
than O
all O
- O
trans O
- O
RA O
for O
inducing O
the O
expression O
of O
the O
AFP O
gene O
. O

Lag O
phases O
were O
14 O
. O
89 O
hours O
+ O
/ O
- O
0 O
. O
77 O
, O
13 O
. O
33 O
hours O
+ O
/ O
- O
0 O
. O
50 O
, O
20 O
. O
22 O
hours O
+ O
/ O
- O
0 O
. O
76 O
, O
and O
20 O
. O
00 O
hours O
+ O
/ O
- O
0 O
. O
79 O
, O
respectively O
, O
for O
endothelial O
cell O
- O
induced O
LDL B
oxidation O
. O

The O
HPV O
E1 B
and O
E2 B
proteins O
along O
with O
cellular O
factors O
, O
are O
required O
for O
replication O
of O
the O
viral O
genome O
. O

In O
ten O
other O
endotoxin O
- O
albumin B
- O
treated O
pigs O
PGE1 O
infusion O
( O
0 O
. O
25 O
micrograms O
X O
kg O
- O
1 O
X O
min O
- O
1 O
) O
was O
begun O
after O
established O
pulmonary O
and O
cardiovascular O
dysfunction O
, O
for O
closer O
mimicking O
of O
clinical O
use O
. O

It O
is O
postulated O
that O
the O
synthesis O
of O
the O
peptidoglycan O
layer O
was O
affected O
by O
the O
antimetabolites O
since O
the O
morphological O
effects O
were O
strikingly O
similar O
to O
those O
caused O
by O
treatment O
of O
E O
. O
cloacae O
with O
disodium O
edetate O
plus O
lysozyme B
. O

One O
cytoplasmic O
target O
which O
reflects O
the O
functional O
state O
of O
the O
plastids O
is O
protein B
kinase I
C I
. O

These O
three O
chromosomes O
share O
the O
transferrin O
gene O
( O
TF B
) O
, O
the O
myosin O
light O
polypeptide O
3 O
gene O
( O
MYL3 O
) O
, O
and O
the O
acylpeptide O
hydrolase O
gene O
( O
APEH O
) O
. O

The O
human O
BRCA1 O
promoter O
also O
contains O
a O
conserved O
E2F O
site O
and O
is O
similarly O
regulated O
by O
E2F1 B
and O
Rb B
. O

In O
vitro O
, O
cytokine O
- O
or O
hypoxia O
- O
induced O
up O
- O
regulation O
of O
Fas B
expression O
is O
associated O
with O
RTC O
apoptosis O
. O

The O
site O
of O
acetylation O
of O
Tat B
was O
mapped O
to O
the O
double O
- O
lysine O
motif O
in O
a O
highly O
conserved O
region O
, O
( O
49 O
) O
RKKRRQ O
( O
54 O
) O
, O
of O
the O
basic O
RNA O
- O
binding O
motif O
of O
Tat B
. O

It O
is O
dangerous O
to O
label O
such O
conditions O
as O
' O
inappropriate O
' O
secretion O
of O
ADH B
since O
the O
maintenance O
of O
circulating O
volume O
is O
at O
least O
as O
important O
a O
physiological O
requirement O
as O
the O
defence O
of O
tonicity O
. O

This O
C O
- O
terminal O
domain O
contains O
several O
YxxI O
/ O
L O
motifs O
reminiscent O
of O
LMP2A B
and O
a O
putative O
TRAF O
binding O
site O
as O
in O
LMP1 B
. O

This O
mutation O
was O
associated O
with O
reduced O
or O
absent O
expression O
of O
TGF O
- O
beta O
RI O
protein O
and O
p53 B
protein I
in O
tumor O
tissues O
. O

Optimized O
USF B
and O
MYC B
DNA O
- O
binding O
sites O
, O
which O
differ O
in O
the O
nucleotides O
bordering O
the O
hexanucleotide O
box O
displace O
the O
E O
- O
C4 O
factor O
in O
competition O
assays O
but O
with O
lesser O
efficiency O
than O
the O
E O
- O
C4 O
site O
itself O
. O

A O
surge O
in O
the O
rate O
of O
ascorbyl O
radical O
production O
, O
directly O
correlated O
with O
oxyradical O
stress O
and O
an O
abrupt O
fall O
in O
superoxide B
dismutase I
activity O
in O
the O
granuloma O
, O
indicates O
' O
switching O
on O
' O
of O
a O
free O
radical O
- O
dependent O
machinery O
for O
the O
formation O
of O
granuloma O
after O
vasectomy O
. O

Vorozole O
( O
Rivizor O
) O
is O
a O
potent O
and O
stereospecific O
inhibitor O
of O
aromatase B
having O
shown O
promising O
endocrine O
effects O
in O
phase O
I O
studies O
. O

These O
findings O
suggest O
that O
T3R B
can O
repress O
or O
activate O
transcription O
while O
tethered O
to O
the O
LBD O
of O
GAL4 B
- O
RXR B
and O
that O
heterodimerization O
can O
occur O
in O
vivo O
without O
stabilization O
by O
hormone O
response O
elements O
. O

Most O
interestingly O
, O
although O
the O
effector O
plasmid O
containing O
the O
ICP27 O
gene O
had O
little O
effect O
on O
its O
own O
, O
two O
different O
and O
marked O
effects O
depending O
on O
the O
target O
were O
observed O
when O
ICP27 B
was O
combined O
with O
ICP4 B
or O
ICP0 B
or O
both O
. O

TOM1 O
encodes O
a O
member O
of O
the O
hect O
- O
domain O
- O
containing O
E3 B
ubiquitin O
- O
protein O
ligase O
family O
that O
is O
required O
for O
growth O
at O
elevated O
temperatures O
. O

We O
suggest O
that O
the O
induction O
of O
IFNA O
promoter O
region O
requires O
cooperation O
between O
alpha O
F1 O
binding O
proteins O
and O
IRF B
- I
1 I
. O

The O
gene O
atp6 O
, O
encoding O
subunit O
6 O
of O
the O
mitochondrial O
F0 O
- O
ATPase B
complex O
, O
has O
been O
characterized O
from O
both O
the O
normal O
( O
fertile O
) O
and O
Ogura O
( O
male O
- O
sterile O
) O
radish O
cytoplasms O
in O
order O
to O
determine O
if O
previously O
identified O
atp6 B
transcriptional O
differences O
could O
play O
a O
role O
in O
cytoplasmic O
male O
sterility O
. O

The O
gag B
- O
myc B
proteins O
encoded O
by O
these O
variants O
efficiently O
localized O
to O
the O
cell O
nucleus O
. O

UPR O
elements O
present O
in O
other O
ER O
chaperone O
genes O
, O
such O
as O
yeast O
KAR2 O
( O
BiP B
) O
, O
mammalian O
GRP78 O
( O
BiP B
) O
, O
and O
GRP94 O
, O
function O
in O
an O
analogous O
manner O
to O
that O
in O
FKB2 O
. O

These O
data O
also O
suggest O
the O
existence O
of O
a O
mechanism O
by O
which O
regulatory O
subunits O
modulate O
the O
PI B
3 I
- I
kinase I
- O
mediated O
signals O
, O
independent O
of O
the O
kinase O
activity O
, O
possibly O
through O
subcellular O
localization O
of O
the O
catalytic O
subunit O
or O
interaction O
with O
additional O
signaling O
molecules O
. O

Plasmid O
subclones O
of O
the O
hr1a O
- O
containing O
AcMNPV O
HindIII B
- O
N O
fragment O
were O
examined O
for O
their O
ability O
to O
replicate O
in O
virus O
- O
infected O
( O
Spodoptera O
frugiperda O
) O
Sf9 O
cells O
, O
and O
to O
stimulate O
transcription O
when O
linked O
in O
cis O
with O
a O
39K O
gene O
promoter O
- O
beta O
- O
glucuronidase O
fusion O
and O
cotransfected O
into O
cells O
along O
with O
a O
plasmid O
( O
ple O
- O
1 O
) O
containing O
the O
gene O
encoding O
the O
trans O
- O
acting O
factor O
IE O
- O
1 O
. O

In O
normal O
B O
cells O
stimulated O
by O
LPS O
or O
IL B
- I
4 I
, O
new O
complexes O
appear O
that O
bind O
to O
C B
/ I
EBP I
and O
NF O
- O
IL O
- O
4 O
elements O
, O
respectively O
, O
located O
within O
the O
- O
125 O
/ O
- O
101 O
region O
. O

The O
adeno O
- O
associated O
virus O
type O
2 O
( O
AAV O
- O
2 O
) O
Rep78 B
/ O
Rep68 B
regulatory O
proteins O
are O
pleiotropic O
effectors O
of O
viral O
and O
cellular O
DNA O
replication O
, O
of O
cellular O
transformation O
by O
viral O
and O
cellular O
oncogenes O
, O
and O
of O
homologous O
and O
heterologous O
gene O
expression O
. O

Role O
of O
the O
CCAAT O
/ O
enhancer O
binding O
protein O
- O
alpha O
transcription O
factor O
in O
the O
glucocorticoid O
stimulation O
of O
p21waf1 B
/ O
cip1 B
gene O
promoter O
activity O
in O
growth O
- O
arrested O
rat O
hepatoma O
cells O
. O

Treatment O
of O
cells O
for O
10 O
min O
with O
TNF B
- I
alpha I
resulted O
in O
activation O
of O
p44 O
/ O
42 O
MAPK O
, O
p38 B
, O
and O
JNK B
. O

This O
report O
describes O
the O
isolation O
and O
recombinant O
expression O
of O
a O
cDNA O
clone O
encoding O
HER4 O
, O
the O
fourth O
member O
of O
the O
human O
epidermal O
growth O
factor O
receptor O
( O
EGFR B
) O
family O
. O

Sixtieth O
anniversary O
of O
Angiotensin B
. O

Following O
EGF B
or O
NGF B
stimulation O
of O
the O
v O
- O
CrkPC12 O
cells O
, O
the O
v B
- I
Crk I
protein O
itself O
became O
tyrosine O
phosphorylated O
within O
1 O
min O
. O

BCR B
- O
ABL B
expression O
confers O
cross O
- O
resistance O
to O
multiple O
genotoxic O
anticancer O
drugs O
by O
inhibition O
of O
the O
apoptotic O
response O
to O
DNA O
damage O
in O
association O
with O
cell O
cycle O
arrest O
at O
the O
G2 O
- O
M O
restriction O
point O
. O

Deletion O
analysis O
of O
the O
3 O
. O
5kb O
DNA O
fragment O
revealed O
that O
the O
region O
between O
- O
125 O
to O
+ O
1 O
, O
containing O
a O
single O
Sp1 B
binding I
site I
, O
is O
essential O
for O
transcription O
of O
the O
embigin O
gene O
. O

The O
protein B
kinase I
C I
inhibitor O
GF O
- O
109203X O
abolished O
the O
activation O
by O
phorbol O
ester O
and O
inhibited O
the O
effect O
of O
CCK B
by O
78 O
% O
but O
had O
no O
effect O
on O
EGF B
- O
activated O
MAPK B
activity O
. O

Activated O
FGFR3 B
predominantly O
interacts O
with O
GRB2 O
. O
Sos O
in O
complex O
with O
a O
previously O
identified O
90 O
- O
kDa O
protein O
and O
designated O
protein O
80K O
- O
H O
. O

The O
rate O
of O
collagen B
synthesis O
in O
normal O
scar O
was O
approximately O
constant O
between O
6 O
months O
and O
20 O
years O
after O
the O
initial O
wounding O
, O
but O
in O
both O
hypertrophic O
scar O
and O
keloid O
the O
rate O
was O
initially O
approximately O
twice O
that O
in O
normal O
scar O
, O
and O
2 O
- O
3 O
years O
after O
wounding O
it O
fell O
to O
approximately O
the O
same O
level O
as O
in O
normal O
scar O
. O

Mutational O
analysis O
of O
yeast B
CEG1 I
demonstrated O
that O
four O
of O
the O
five O
conserved O
motifs O
are O
essential O
for O
capping B
enzyme I
function O
in O
vivo O
. O

Co O
- O
expression O
of O
PLD1 B
in O
COS O
- O
7 O
cells O
with O
the O
two O
recombinant O
CK2 O
subunits O
, O
alpha O
or O
beta O
, O
suggests O
that O
the O
association O
of O
PLD1 B
with O
the O
kinase O
is O
through O
the O
beta O
subunit O
. O

Our O
objective O
was O
to O
find O
possible O
predictors O
for O
the O
expression O
and O
progression O
of O
LJM O
and O
to O
evaluate O
the O
relationship O
between O
LJM O
and O
other O
long O
- O
term O
complications O
of O
insulin B
- O
dependent O
diabetes O
mellitus O
. O

Human O
recombinant O
erythropoietin O
( O
r B
- I
HuEPO I
, O
EprexR O
) O
was O
administered O
to O
8 O
children O
with O
chronic O
renal O
failure O
and O
high O
transfusion O
requirement O
. O

Northern O
analyses O
further O
confirm O
that O
the O
expression O
of O
endogenous O
alpha O
- O
ENaC O
gene O
in O
salivary O
Pa O
- O
4 O
cells O
is O
suppressed O
by O
an O
ectopic O
HMGI B
- I
C I
overexpression O
. O

Removal O
of O
cyclin O
- O
dependant O
kinases O
( O
cdks B
) O
or O
cdk2 B
from O
these O
extracts O
using O
affinity O
matrices O
severely O
inhibits O
initiation O
of O
S O
phase O
. O

Gel O
mobility O
shift O
analyses O
reveal O
that O
FRTL O
- O
5 O
thyroid O
cell O
nuclear O
extracts O
form O
a O
specific O
protein O
/ O
DNA O
complex O
with O
this O
region O
, O
which O
is O
prevented O
by O
the O
TTF O
- O
1 O
binding O
element O
from O
the O
TG O
promoter O
; O
FRT O
and O
BRL O
cell O
nuclear O
extracts O
do O
not O
have O
TTF B
- I
1 I
and O
do O
not O
form O
this O
complex O
. O

Comparison O
of O
the O
genes O
coding O
for O
mouse O
and O
human O
p36 B
( O
annexin O
II O
) O
and O
mouse O
, O
rat O
and O
human O
p35 B
( O
annexin O
I O
) O
and O
pigeon O
cp35 O
( O
an O
annexin O
I O
- O
related O
protein O
) O
shows O
strong O
genomic O
structural O
conservation O
supporting O
the O
hypothesis O
that O
these O
genes O
had O
a O
common O
ancestor O
. O

Collectively O
, O
these O
studies O
suggest O
that O
the O
major O
EGF B
- O
stimulated O
mitotic O
growth O
pathways O
may O
not O
be O
absolutely O
linked O
to O
the O
stat91 O
signaling O
pathways O
and O
that O
such O
transcription O
complexes O
are O
more O
complex O
than O
previously O
reported O
. O

In O
addition O
, O
we O
show O
that O
expression O
of O
antisense O
mRNA O
for O
p130CAS B
resulted O
in O
reversion O
of O
the O
transformed O
phenotype O
of O
all O
these O
cell O
lines O
. O

The O
amino O
acid O
sequence O
of O
the O
protein O
encoded O
by O
MSK1 B
is O
homologous O
to O
yeast O
cytoplasmic O
lysyl O
- O
tRNA O
synthetase O
and O
to O
the O
product O
of O
the O
herC O
gene O
, O
which O
has O
recently O
been O
suggested O
to O
code O
for O
the O
Escherichia O
coli O
enzyme O
. O

Similar O
to O
the O
D O
, O
B B
/ O
B B
' I
and O
E O
proteins O
, O
the O
F B
and O
G B
proteins I
do O
not O
possess O
any O
of O
the O
known O
RNA O
binding O
motifs O
, O
suggesting O
that O
other O
types O
of O
RNA O
- O
protein O
interactions O
occur O
in O
the O
snRNP O
core O
. O

Blood O
samples O
for O
determination O
of O
fibrinolytic O
activity O
and O
factor B
VIII I
in O
plasma O
were O
obtained O
before O
and O
immediately O
after O
the O
end O
of O
compression O
and O
application O
of O
a O
stocking O
, O
respectively O
. O

This O
interaction O
is O
functional O
as O
it O
leads O
to O
retargeting O
of O
NF B
- I
kappa I
B I
p50 B
from O
the O
nucleus O
to O
the O
cytoplasm O
. O

The O
orf2 O
gene O
product O
is O
a O
protein O
of O
79 O
amino O
acids O
with O
characteristics O
similar O
to O
those O
of O
the O
Tat B
( O
transactivator O
) O
proteins O
of O
the O
ungulate O
lentiviruses O
. O

Rac2 B
, O
a O
member O
of O
the O
Rho B
family I
of O
GTPases B
, O
is O
highly O
expressed O
in O
myeloid O
cells O
and O
is O
a O
regulator O
of O
the O
NADPH O
- O
oxidase O
complex O
. O

In O
vitro O
kinase O
assays O
on O
isolated O
microvilli O
and O
microvillar O
fractions O
enriched O
in O
the O
putative O
signal O
transduction O
particle O
showed O
a O
high O
specific O
activity O
of O
tyrosine B
kinase I
activity O
compared O
to O
that O
of O
membranes O
from O
EGF B
receptor I
- O
overexpressing O
A431 O
cells O
maximally O
activated O
by O
EGF B
. O

In O
the O
studies O
described O
in O
this O
report O
, O
we O
have O
identified O
two O
potential O
Ets B
binding O
sites O
, O
EBS1 B
and O
EBS2 B
, O
which O
are O
conserved O
in O
both O
the O
human O
and O
murine O
interleukin B
- I
2 I
enhancers O
. O

These O
findings O
suggest O
that O
NMDA B
receptor I
blockade O
may O
ameliorate O
the O
dyskinetic O
complications O
of O
long O
- O
term O
levodopa O
therapy O
, O
without O
diminishing O
the O
beneficial O
effects O
on O
parkinsonian O
signs O
. O

This O
study O
demonstrates O
that O
the O
exposure O
to O
sulphur O
mustard O
results O
in O
very O
low O
androgen O
levels O
and O
hypo O
- O
responsiveness O
to O
GnRH B
in O
the O
first O
five O
weeks O
and O
normalization O
by O
the O
twelfth O
week O
after O
injury O
. O

Overexpression O
of O
eIF4E B
transforms O
cells O
, O
and O
mutations O
in O
eIF4E B
arrest O
cells O
in O
G O
, O
in O
cdc33 B
mutants I
. O

Repression O
of O
the O
herpes O
simplex O
virus O
1 O
alpha O
4 O
gene O
by O
its O
gene O
product O
( O
ICP4 B
) O
within O
the O
context O
of O
the O
viral O
genome O
is O
conditioned O
by O
the O
distance O
and O
stereoaxial O
alignment O
of O
the O
ICP4 O
DNA O
binding O
site O
relative O
to O
the O
TATA O
box O
. O

As O
anticipated O
, O
both O
intracellular O
p54 B
- O
SAPKbeta O
activation O
and O
Bcl B
- I
2 I
phosphorylation O
are O
blocked O
by O
co O
- O
transfection O
with O
the O
MAP B
kinase I
specific O
phosphatase O
MKP3 O
/ O
PYST1 O
. O

Relation O
between O
circulating O
immune O
complexes O
and O
serum B
ferritin I
in O
hemosiderosis O
of O
different O
etiologies O

Treatment O
of O
excessive O
bleeding O
after O
cardiopulmonary O
bypass O
was O
based O
on O
an O
algorithm O
using O
point O
- O
of O
- O
care O
testing O
with O
whole O
blood O
prothrombin O
time O
, O
activated O
partial O
thromboplastin B
time O
, O
heparinase O
activated O
clotting O
time O
, O
and O
platelet O
count O
. O

To O
assess O
the O
safety O
of O
the O
angiotensin B
converting I
enzyme I
inhibitor O
enalapril O
a O
multicenter O
, O
open O
, O
randomized O
, O
prazosin O
- O
controlled O
trial O
was O
designed O
comparing O
the O
incidence O
and O
severity O
of O
symptomatic O
hypotension O
on O
the O
first O
day O
of O
treatment O
. O

Glucose O
may O
reduce O
slightly O
the O
pool O
of O
amino O
nitrogen O
available O
for O
albumin B
and O
urea O
synthesis O
by O
diverting O
some O
of O
the O
infused O
amino O
acids O
from O
protein O
synthesis O
by O
the O
liver O
to O
muscle O
. O

Antibodies O
specific O
to O
the O
different O
members O
of O
the O
Jun B
and O
Fos O
family O
of O
transcription O
factors O
show O
that O
, O
in O
gel O
retardation O
assays O
, O
a O
Jun O
- O
like O
factor O
is O
a O
component O
of O
the O
H3 O
. O
2 O
specific O
complex O
. O

Oct B
- I
1 I
is O
a O
ubiquitously O
expressed O
regulatory O
gene O
of O
the O
POU O
domain O
family O
. O

The O
virus O
must O
progress O
past O
the O
immediate O
- O
early O
phase O
and O
express O
an O
early O
gene O
product O
( O
s O
) O
for O
activation O
of O
cyclin B
E I
expression O
. O

This O
is O
a O
consensus O
casein O
kinase O
II O
( O
CKII B
) O
site O
and O
, O
using O
purified O
wild O
- O
type O
and O
mutant O
proteins O
, O
we O
show O
that O
it O
is O
the O
main O
CKII O
site O
in O
the O
body O
of O
the O
N O
- O
terminal O
complex O
- O
forming O
region O
. O

Tubular O
dysfunction O
in O
renal O
lithiasis O
: O
cause O
or O
consequence O
? O
] O
To O
investigate O
whether O
overall O
tubular O
dysfunction O
is O
encountered O
in O
a O
particular O
subgroup O
of O
patients O
with O
urolithiasis O
, O
the O
following O
parameters O
of O
renal O
tubular O
function O
have O
been O
measured O
in O
fasting O
morning O
urine O
in O
124 O
male O
stone O
formers O
: O
excretion O
of O
lysozyme B
and O
gamma B
- I
glutamyl I
transpeptidase I
( O
gamma O
- O
GT O
) O
, O
fractional O
excretion O
( O
FE O
) O
or O
glucose O
, O
insulin B
, O
bicarbonate O
after O
an O
alkali O
load O
, O
and O
theoretical O
phosphate O
threshold O
( O
TmP O
/ O

Interaction O
between O
the O
tobacco O
DNA O
- O
binding O
activity O
CBF B
and O
the O
cyt O
- O
1 O
promoter O
element O
of O
the O
Agrobacterium O
tumefaciens O
T O
- O
DNA O
gene O
T O
- O
CYT O
correlates O
with O
cyt O
- O
1 O
directed O
gene O
expression O
in O
multiple O
tobacco O
tissue O
types O
. O

Extracellular O
regulated O
kinases O
( O
ERK O
) O
1 O
and O
ERK2 B
are O
authentic O
substrates O
for O
the O
dual O
- O
specificity O
protein O
- O
tyrosine O
phosphatase O
VHR O
. O

Truncations O
from O
Hip B
' O
s O
N O
terminus O
resulted O
in O
an O
apparent O
loss O
of O
Hip B
homo O
- O
oligomerization O
, O
but O
these O
mutants O
retained O
association O
with O
hsp70 B
and O
were O
recovered O
in O
receptor O
complexes O
. O

In O
this O
report O
, O
we O
describe O
a O
patient O
with O
renal O
cell O
carcinoma O
who O
experienced O
ventricular O
tachycardia O
while O
undergoing O
treatment O
with O
high O
- O
dose O
bolus O
IL B
- I
2 I
. O

Conversion O
of O
an O
NF B
- I
kappaB I
into O
a O
GABP B
binding O
site O
is O
likely O
to O
have O
occurred O
also O
during O
the O
worldwide O
spread O
of O
HIV O
- O
1 O
, O
as O
we O
noticed O
the O
same O
LTR O
modification O
in O
subtype O
E O
isolates O
from O
Thailand O
. O

The O
increments O
in O
median O
plasma B
secretin I
concentration O
were O
1 O
. O
6 O
, O
3 O
. O
0 O
, O
and O
6 O
. O
4 O
pmol O
x O
1 O
( O
- O
1 O
) O
after O
secretin B
, O
125 O
, O
250 O
and O
500 O
fmol O
x O
kg O
- O
1 O
, O
and O
the O
corresponding O
15 O
- O
min O
bicarbonate O
output O
283 O
, O
442 O
, O
and O
1435 O
micromol O
, O
respectively O
. O

Because O
c B
- I
myb I
encodes O
a O
transcriptional O
activator O
that O
functions O
via O
DNA O
binding O
, O
it O
is O
likely O
that O
c B
- I
myb I
exerts O
its O
biological O
activity O
by O
regulating O
the O
transcription O
of O
genes O
required O
for O
DNA O
synthesis O
and O
cell O
cycle O
progression O
. O

Coexpression O
of O
c B
- I
Rel I
in O
combination O
with O
ATF B
- I
1 I
, O
CREB2 O
, O
or O
ATF B
- I
1 I
/ O
CREB2 O
leads O
to O
synergistic O
transactivation O
of O
a O
CD28RE O
- O
TRE O
reporter O
plasmid O
in O
quiescent O
Jurkat O
T O
- O
cells O
. O

The O
genes O
on O
each O
chromosome O
involved O
in O
this O
translocation O
have O
been O
identified O
as O
the O
transcription O
factor O
- O
encoding O
genes O
PAX3 B
and O
FKHR B
. O

Paradoxically O
, O
loop O
3i O
from O
the O
M1Ach O
- O
muscarinic O
receptor O
also O
maximally O
inhibited O
GnRH B
agonist O
- O
stimulated O
cAMP O
accumulation O
and O
PRL B
release O
by O
40 O
% O
( O
both O
effects O
mediated O
through O
activation O
of O
the O
Gs O
protein O
) O
. O

IGF B
- I
I I
levels O
were O
measured O
in O
the O
CSF O
of O
11 O
children O
with O
autism O
( O
4 O
females O
, O
7 O
males O
; O
mean O
age O
3 O
. O
8 O
years O
, O
SD O
1 O
. O
1 O
) O
using O
a O
sensitive O
radioimmunoassay O
method O
and O
compared O
with O
levels O
in O
11 O
control O
participants O
( O
6 O
females O
, O
5 O
males O
; O
mean O
age O
3 O
. O
8 O
years O
) O
. O

Three O
high O
- O
amylose O
rice O
varieties O
, O
IR42 O
, O
IR36 O
, O
and O
IR62 O
, O
with O
similar O
chemical O
composition O
including O
amylose O
content O
( O
26 O
. O
7 O
- O
27 O
. O
0 O
% O
) O
, O
were O
cooked O
under O
the O
same O
conditions O
and O
tested O
for O
in O
vitro O
digestibility O
as O
well O
as O
blood O
glucose O
and O
insulin B
responses O
in O
healthy O
human O
volunteers O
. O

Using O
beta O
1 O
- O
AR O
- O
luciferase B
reporter O
recombinants O
, O
we O
have O
previously O
determined O
that O
important O
beta O
1 O
- O
AR O
genetic O
elements O
controlling O
expression O
within O
the O
C6 O
glioma O
cell O
line O
are O
contained O
within O
the O
region O
- O
396 O
to O
- O
299 O
, O
relative O
to O
the O
translational O
start O
site O
. O

Here O
we O
show O
that O
expression O
of O
KRAB O
domain O
suppresses O
in O
vivo O
the O
activating O
function O
of O
various O
defined O
activating B
transcription I
factors I
, O
and O
we O
demonstrate O
that O
the O
KRAB O
domain O
specifically O
silences O
the O
activity O
of O
promoters O
whose O
initiation O
is O
dependent O
on O
the O
presence O
of O
a O
TATA O
box O
. O

These O
results O
support O
an O
in O
vivo O
interaction O
between O
Nck B
and O
CKI O
- O
gamma2 O
and O
suggest O
that O
CKI O
- O
gamma2 O
could O
be O
involved O
in O
signaling O
pathways O
downstream O
of O
RTKs B
. O

Phosphorylation O
by O
Cdc28 B
activates O
the O
Cdc20 O
- O
dependent O
activity O
of O
the O
anaphase O
- O
promoting O
complex O
. O

Assays O
of O
APRE O
- O
luciferase B
reporter O
plasmids O
transfected O
into O
HepG2 O
cells O
show O
that O
a O
mutated O
APRE O
that O
binds O
only O
BPi O
functions O
as O
an O
IL B
- I
1 I
alpha I
inducible O
enhancer O
, O
whereas O
a O
mutated O
APRE O
that O
binds O
only O
BPc O
does O
not O
. O

RNA O
unwinding O
in O
U4 B
/ O
U6 B
snRNPs O
requires O
ATP O
hydrolysis O
and O
the O
DEIH O
- O
box O
splicing O
factor O
Brr2 O
. O

It O
also O
showed O
which O
amino O
acid O
residues O
would O
contact O
an O
extended O
TATA O
box O
with O
a O
B O
recognition O
element O
, O
and O
evolutionary O
conservation O
of O
the O
TBP B
- O
TFB O
- O
DNA O
complex O
orientation O
between O
two O
archaeal O
organisms O
with O
widely O
different O
optimal O
temperature O
for O
growth O
( O
37 O
and O
100 O
degrees O
C O
) O
. O

Patients O
with O
Eales O
' O
disease O
, O
chorioretinitis O
, O
central O
serous O
retinopathy O
, O
or O
malignant O
choroidal O
melanoma O
were O
tested O
for O
HLA B
antigen O
deviation O
. O

These O
data O
also O
demonstrate O
that O
insulin B
and O
TPA O
activate O
MBP B
/ O
MAP2 O
kinase O
activity O
by O
de O
novo O
phosphorylation O
of O
threonine O
and O
tyrosine O
residues O
via O
a O
very O
similar O
pathway O
. O

Such O
tetranucleotides O
are O
common O
in O
promoter O
regions O
, O
particularly O
in O
activating O
transcription O
factor O
/ O
cyclic O
AMP O
response O
element O
- O
binding O
protein O
( O
ATF B
/ O
CREB B
) O
and O
E O
- O
box O
motifs O
, O
suggesting O
that O
PIF O
may O
modulate O
the O
transcription O
of O
many O
genes O
. O

The O
dominant O
inhibitory O
biological O
activity O
of O
the O
N O
terminus O
correlated O
with O
its O
ability O
to O
impair O
EGF B
- O
dependent O
activation O
of O
GTP B
- I
Ras I
and O
of O
MAP B
kinase I
, O
as O
well O
with O
the O
ability O
of O
endogenous O
Sos B
to O
form O
a O
stable O
complex O
with O
activated O
EGF O
receptors O
. O

SM B
binds O
RNA O
in O
vitro O
, O
suggesting O
that O
sequence O
- O
or O
structure O
- O
specific O
mRNA O
interactions O
might O
mediate O
SM B
specificity O
. O

Ras B
involvement O
in O
signal O
transduction O
by O
the O
serotonin O
5 O
- O
HT2B O
receptor O
. O

Three O
putative O
ORFs O
have O
significant O
homology O
with O
known O
proteins O
: O
L0968 O
is O
a O
new O
member O
of O
the O
very O
large O
' O
seripauperins O
' O
family O
, O
comprising O
at O
least O
20 O
yeast O
members O
; O
L1313 O
is O
a O
new O
ABC B
transporter I
highly O
homologous O
to O
the O
yeast O
cadmium O
resistance O
protein O
Ycf1p O
and O
to O
the O
human O
multidrug O
resistance O
protein O
hMRP1 O
; O
the O
C O
- O
terminal O
part O
of O
L1325 O
present O
in O
our O
sequence O
is O
very O
homologous O
to O
the O
fruit O
fly O
abdominal O
segment O
formation O
protein O
Pumilio O
. O

Immunofluorescence O
obtained O
using O
antibodies O
against O
alphaI O
SigmaI O
/ O
+ O
+ O
betaI O
SigmaI O
spectrin O
and O
Abl O
tyrosine O
kinase O
but O
not O
against O
alphaII O
/ O
betaII O
spectrin O
colocalized O
with O
the O
overexpressed O
green B
fluorescent I
protein I
- O
SH3 O
- O
binding O
protein O
. O

This O
B O
- O
box O
is O
not O
present O
in O
ETS1 B
, O
ETS2 B
, O
PEA3 B
or O
PU B
. I
1 I
and O
these O
proteins O
were O
unable O
to O
form O
ternary O
complexes O
with O
SRF B
and O
Egrl O
- O
SREs O
or O
c B
- I
fos I
SRE O
. O

Elevated O
systolic O
blood O
pressure O
and O
high O
postglucose O
serum B
insulin I
levels O
showed O
an O
independent O
, O
significant O
association O
with O
left O
ventricular O
mass O
in O
female O
diabetic O
subjects O
. O

Viral O
protein O
U O
( O
Vpu B
) O
is O
a O
protein O
encoded O
by O
human O
immunodeficiency O
virus O
type O
1 O
( O
HIV O
- O
1 O
) O
that O
promotes O
the O
degradation O
of O
the O
virus O
receptor O
, O
CD4 B
, O
and O
enhances O
the O
release O
of O
virus O
particles O
from O
cells O
. O

CSEn O
stimulated O
transcription O
of O
a O
variety O
of O
promoters O
, O
including O
the O
hCS O
, O
human B
growth I
hormone I
, O
thymidine B
kinase I
, O
and O
Rous O
sarcoma O
virus O
promoters O
, O
in O
human O
choriocarcinoma O
cell O
lines O
( O
BeWo O
and O
JEG O
- O
3 O
) O
but O
not O
HeLa O
cells O
or O
rat O
somatolactotrophes O
( O
GC O
) O
. O

Pretreatment O
of O
human O
skin O
with O
tRA O
inhibited O
UV O
induction O
of O
c O
- O
Jun O
protein O
and O
, O
consequently O
, O
AP B
- I
1 I
. O

The O
absolute O
CD4 B
count O
of O
patients O
with O
de O
novo O
IBD O
was O
210 O
- O
700 O
cells O
/ O
ml O
at O
the O
time O
of O
IBD O
. O

Coexpression O
of O
a O
dominant O
negative O
c O
- O
jun O
antagonized O
the O
ras B
- O
dependent O
stimulation O
of O
the O
92 O
- O
kDa O
gelatinase O
B O
promoter O
- O
driven O
CAT O
reporter O
. O

However O
, O
LXRalpha O
inhibited O
binding O
of O
PPARalpha B
/ O
RXRalpha B
heterodimers O
to O
PPREs O
, O
and O
coexpression O
of O
LXRalpha O
in O
mammalian O
cells O
antagonized O
peroxisome O
proliferator O
signaling O
mediated O
by O
PPARalpha B
/ O
RXRalpha B
in O
vivo O
. O

CTDK1 B
and O
CTDK2 B
also O
differ O
in O
their O
protein O
substrate O
specificity O
. O

Engineering O
temperature O
- O
sensitive O
SH3 B
domains I
. O

A O
mean O
value O
for O
HbA1 B
greater O
than O
10 O
% O
was O
associated O
with O
an O
increased O
risk O
of O
progression O
of O
retinopathy O
and O
a O
mean O
value O
less O
than O
8 O
. O
7 O
% O
was O
associated O
with O
a O
diminished O
risk O
. O

NGF B
also O
induced O
a O
synthetic O
promoter O
with O
repeated O
Sp1 B
sites I
linked O
to O
a O
core O
promoter O
, O
and O
a O
plasmid O
regulated O
by O
a O
chimeric O
transactivator O
in O
which O
the O
Gal4 B
DNA I
binding I
domain I
is O
fused O
to O
the O
Sp1 O
transactivation O
domain O
, O
indicating O
that O
this O
transactivation O
domain O
is O
regulated O
by O
NGF B
. O

In O
cotransfection O
assays O
, O
a O
small O
fragment O
of O
Sin B
retaining O
the O
Src B
- O
SH3 B
- O
binding O
site O
and O
one O
tyrosine O
- O
containing O
motif O
induced O
c B
- I
Src I
activation O
as O
measured O
by O
a O
transcriptional O
reporter O
. O

The O
related O
tumor O
suppressor O
, O
p130 B
, O
also O
effects O
this O
function O
. O

p107 B
levels O
increase O
substantially O
as O
cells O
progress O
through O
S O
phase O
. O

p107 B
induction O
of O
E2F B
DNA O
binding O
was O
observed O
primarily O
in O
S O
phase O
cells O
coincident O
with O
the O
increase O
in O
p107 O
protein O
levels O
. O

Further O
, O
cells O
cotransfected O
with O
a O
UF O
promoter O
- O
luciferase B
( O
- O
1935UF O
- O
Luc B
) O
reporter O
gene O
and O
the O
BTEB O
expression O
vector O
had O
2 O
- O
fold O
higher O
Luc B
activity O
than O
those O
cotransfected O
with O
reporter O
gene O
and O
pcDNA O
- O
3 O
. O

In O
agreement O
with O
this O
, O
archaea O
appear O
to O
lack O
eIF5 B
, O
eIF2B O
and O
the O
lysine O
- O
rich O
binding O
domain O
for O
these O
factors O
in O
their O
eIF2beta O
homolog O
. O

Derepression O
of O
RAR B
signaling O
by O
expressing O
a O
dominant O
- O
negative O
corepressor O
resulted O
in O
embryos O
that O
exhibited O
phenotypes O
similar O
to O
those O
treated O
by O
RA O
. O

Thus O
, O
the O
in O
vivo O
function O
of O
Gle2p B
is O
strictly O
coupled O
to O
the O
short O
GLEBS O
within O
Nup116p B
which O
links O
this O
putative O
mRNA O
transport O
factor O
to O
the O
nuclear O
pores O
. O

Regulation O
of O
the O
p21 B
- I
activated I
kinase I
( O
PAK B
) O
by O
a O
human O
Gbeta O
- O
like O
WD O
- O
repeat O
protein O
, O
hPIP1 O
. O

Interestingly O
, O
these O
" O
activation O
- O
defective O
" O
mutants O
segregated O
into O
two O
classes O
: O
1 O
) O
those O
that O
were O
unable O
to O
form O
dimers O
but O
that O
could O
still O
form O
higher O
order O
oligomers O
and O
transform O
cells O
, O
and O
2 O
) O
those O
that O
were O
defective O
for O
PDGF B
- I
R I
binding O
and O
were O
transformation O
- O
incompetent O
. O

We O
have O
shown O
previously O
that O
EGF B
receptor I
activation O
stimulates O
gastrin B
gene O
expression O
through O
a O
GC O
- O
rich O
element O
called O
gERE O
. O

The O
secondary O
end O
points O
included O
creatine B
kinase I
peak O
, O
ventricular O
fibrillation O
/ O
tachycardia O
within O
the O
first O
24 O
hours O
, O
death O
and O
congestive O
heart O
failure O
within O
the O
30 O
- O
day O
follow O
- O
up O
, O
and O
30 O
- O
day O
left O
ventricular O
ejection O
fraction O
. O

This O
demonstrates O
the O
presence O
of O
a O
PKC B
- O
dependent O
pathway O
which O
functions O
independently O
from O
Lck B
in O
MAP B
kinase I
activation O
. O

Cell O
lines O
expressing O
single O
amino O
acid O
substitutions O
of O
the O
carboxyl O
- O
terminal O
asparagine O
of O
CD2 O
are O
incapable O
of O
avidity O
regulation O
by O
TCR B
signaling O
, O
PMA O
treatment O
, O
or O
elevation O
of O
intracellular O
cAMP O
levels O
, O
demonstrating O
that O
each O
of O
these O
stimuli O
utilizes O
a O
common O
structural O
element O
for O
regulating O
CD2 O
avidity O
. O

When O
transfected O
into O
HepG2 O
cells O
, O
which O
lack O
C B
/ I
EBP I
alpha I
, O
the O
mouse O
ob O
promoter O
was O
only O
weakly O
active O
. O

A O
heterologous O
promoter O
construct O
containing O
three O
repeats O
of O
a O
consensus O
Sp1 B
site I
, O
cloned O
upstream O
of O
a O
single O
copy O
of O
the O
ZII B
( O
CREB B
/ O
AP1 B
) O
element O
from O
the O
BZLF1 B
promoter I
linked O
to O
the O
beta B
- I
globin I
TATA O
box O
, O
exhibited O
phorbol O
ester O
inducibility O
. O

We O
also O
show O
that O
psbH B
and O
psbT B
are O
transcribed O
from O
the O
upstream O
psbB O
gene O
promoter O
, O
and O
that O
the O
psbH O
mRNA O
has O
its O
own O
target O
sequence O
for O
Mbb1 O
function O
. O

Consistent O
with O
this O
hypothesis O
, O
stimulation O
of O
A O
( O
2A O
) O
- O
R O
or O
PKA B
enhanced O
nuclear O
aPKC O
activity O
. O

Samples O
( O
1 O
g O
) O
were O
extracted O
with O
0 O
. O
5 O
% O
potassium O
chloride O
( O
KCl O
) O
in O
70 O
% O
methanol O
( O
5 O
ml O
) O
and O
diluted O
subsequently O
to O
give O
two O
- O
fold O
to O
ten O
- O
fold O
step O
- O
wise O
dilutions O
in O
phosphate O
- O
buffered O
saline O
containing O
0 O
. O
05 O
% O
Tween O
20 O
and O
0 O
. O
2 O
% O
bovine B
serum I
albumin I
( O
PBS O
- O
T O
BSA B
) O
. O

Transforming B
growth I
factor I
beta I
activates O
the O
promoter O
of O
cyclin B
- I
dependent I
kinase I
inhibitor O
p15INK4B B
through O
an O
Sp1 O
consensus O
site O
. O

Possible O
or O
definite O
neglect O
or O
abuse O
before O
36 O
months O
of O
age O
was O
correlated O
with O
low O
DBH B
activity O
. O

Methylation O
interference O
analysis O
established O
at O
single O
nucleotide O
resolution O
that O
purified O
recombinant O
Fos B
and O
Jun O
proteins O
bind O
in O
a O
sequence O
- O
specific O
manner O
to O
the O
AP O
- O
1 O
sites O
within O
the O
VDRE O
and O
OC O
box O
. O

These O
include O
urinalysis O
, O
chest O
X O
- O
P O
, O
ECG O
, O
hematological O
examinations O
( O
RBC O
, O
WBC O
, O
Ht O
, O
Hb B
, O
PLT O
and O
ESR O
) O
and O
biochemical O
tests O
( O
AST B
, O
ALT B
, O
ALP B
, O
gamma B
GTP I
, O
LDH B
, O
CPK B
, O
Chol O
, O
T O
- O
Bil O
, O
TP O
, O
Alb O
, O
TG O
, O
BUN O
, O
Cr O
, O
Glu O
, O
Na O
, O
K O
, O
Ca O
, O
P O
and O
CRP B
) O
. O

Mad3 O
and O
Mad4 O
: O
novel O
Max B
- O
interacting O
transcriptional O
repressors O
that O
suppress O
c B
- I
myc I
dependent O
transformation O
and O
are O
expressed O
during O
neural O
and O
epidermal O
differentiation O
. O

Furthermore O
, O
we O
have O
identified O
the O
major O
open O
reading O
frame O
( O
RF4 O
; O
2 O
. O
3 O
kb O
) O
as O
being O
essential O
for O
activation O
, O
and O
we O
have O
shown O
that O
the O
NF B
kappa I
B I
, O
SP1 B
, O
and O
TATA O
box O
motifs O
in O
the O
human O
immunodeficiency O
virus O
LTR O
are O
all O
required O
for O
full O
induction O
of O
the O
promoter O
by O
the O
HHV O
- O
6 O
- O
encoded O
transactivator O
. O

However O
, O
mutations O
of O
the O
C O
- O
rich O
element O
that O
disrupted O
a O
GC O
box O
located O
on O
the O
inverse O
strand O
eliminated O
PMA O
responsiveness O
and O
, O
in O
gel O
mobility O
shift O
assays O
, O
eliminated O
binding O
of O
Sp1 B
. O

TFIIB B
and O
VDR B
can O
also O
interact O
directly O
, O
and O
these O
factors O
synergize O
to O
mediate O
transactivation O
. O

Dual O
signal O
peptides O
mediate O
the O
signal O
recognition O
particle O
/ O
Sec B
- O
independent O
insertion O
of O
a O
thylakoid O
membrane O
polyprotein O
, O
PsbY O
. O

In O
our O
case O
the O
development O
of O
the O
tumor O
at O
the O
posterior O
side O
of O
the O
prostate O
, O
the O
lack O
of O
PSA B
immunoreactivity O
and O
the O
presence O
of O
mucinous O
glands O
, O
sometimes O
" O
endocervical O
- O
like O
" O
, O
could O
suggest O
an O
origin O
from O
embryonic O
mullerian O
remnants O
in O
the O
prostatic O
utricle O
rather O
than O
urogenital O
sinus O
. O

Soluble O
extracts O
from O
FGF B
- O
treated O
as O
compared O
with O
quiescent O
fibroblasts O
exhibited O
up O
to O
3 O
- O
fold O
higher O
kinase O
activity O
towards O
S6 O
in O
exogenously O
added O
rat O
liver O
40S O
ribosomes O
and O
a O
synthetic O
peptide O
, O
RRLSSLRA O
. O

Candidate O
factors O
have O
been O
identified O
by O
the O
observation O
that O
changes O
in O
glucocorticoid O
induction O
parameters O
in O
CV O
- O
1 O
cells O
could O
be O
reproduced O
by O
varying O
the O
cellular O
levels O
of O
coactivators O
[ O
transcriptional O
intermediary O
factor O
2 O
( O
TIF2 O
) O
, O
steroid O
receptor O
coactivator O
1 O
( O
SRC B
- I
1 I
) O
, O
and O
amplified O
in O
breast O
cancer O
1 O
( O
AIB1 O
) O
] O
, O
comodulator O
[ O
CREB B
- I
binding I
protein I
( O
CBP B
) O
] O
, O
or O
corepressor O
[ O
silencing O
mediator O
for O
retinoid O
and O
thyroid O
- O
hormone O
receptors O
( O
SMRT B
) O
] O
without O

concomitant O
increases O
in O
GR B
. O

At O
9 O
months O
postpartum O
, O
serum O
fT4 O
and O
fT3 O
levels O
were O
low O
normal O
( O
8 O
. O
0 O
and O
1 O
. O
7 O
pmol O
/ O
L O
, O
respectively O
) O
, O
but O
TSH B
was O
not O
raised O
( O
0 O
. O
4 O
mU O
/ O
L O
) O
. O

Effect O
of O
TNF B
, O
IL B
- I
1 I
, O
and O
IL B
- I
6 I
on O
the O
proliferation O
of O
human O
Tenon O
' O
s O
capsule O
fibroblasts O
in O
tissue O
culture O
. O

Using O
lacZ B
- O
inducible O
T O
cells O
as O
a O
probe O
, O
we O
screened O
a O
splenic O
cDNA O
library O
in O
transiently O
transfected O
antigen O
- O
presenting O
cells O
( O
APCs O
) O
and O
isolated O
a O
cDNA O
clone O
that O
allowed O
expression O
of O
the O
appropriate O
peptide O
/ O
Kb O
MHC O
complex O
in O
APC O
. O

A O
significant O
reduction O
in O
total O
cellular O
p27 O
protein O
levels O
and O
a O
moderate O
reduction O
in O
p27 O
mRNA O
are O
observed O
, O
but O
no O
changes O
in O
Cdk B
regulatory O
kinases O
and O
phosphatases O
occur O
. O

Genetic O
linkage O
mapping O
of O
the O
CYP11A1 B
gene I
encoding O
the O
cholesterol O
side O
- O
chain O
cleavage O
P450scc B
close O
to O
the O
CYP1A1 O
gene O
and O
D15S204 O
in O
the O
chromosome O
15q22 O
. O
33 O
- O
q23 O
region O
. O

These O
clones O
contain O
most O
of O
the O
exon O
of O
cyclin B
D2 I
except O
exon O
5 O
. O

Plasma O
prolactin B
in O
patients O
with O
colorectal O
cancer O
. O

Reality O
and O
clinical O
application O
of O
immunoglobulin B
preparations O

Recently O
we O
have O
performed O
a O
detailed O
analysis O
of O
specific O
neuronal O
populations O
affected O
by O
the O
mutation O
which O
shed O
new O
light O
on O
the O
role O
of O
Krox B
- I
20 I
in O
the O
segmentation O
and O
on O
the O
physiological O
consequences O
of O
its O
inactivation O
. O

The O
inhibition O
of O
monoamine B
oxidase I
( O
MAO B
) O
by O
tranylcypromine O
was O
studied O
in O
6 O
healthy O
volunteers O
given O
increasing O
doses O
of O
10 O
, O
15 O
, O
20 O
and O
25 O
mg O
/ O
day O
over O
a O
4 O
- O
week O
period O
. O

Using O
probes O
containing O
C B
/ I
EBP I
- I
binding I
sites I
from O
the O
iNOS O
gene O
revealed O
further O
binding O
of O
different O
complexes O
, O
all O
of O
which O
were O
strongly O
inducible O
by O
cAMP O
and O
to O
a O
lower O
extent O
also O
by O
IL B
- I
1beta I
. O

The O
adenovirus O
E1B O
19 O
, O
000 O
- O
molecular O
- O
weight O
( O
19K O
) O
protein O
is O
a O
potent O
inhibitor O
of O
apoptosis O
and O
cooperates O
with O
E1A B
to O
transform O
primary O
rodent O
cells O
. O

Desensitization O
of O
the O
growth B
hormone I
- O
induced O
Janus O
kinase O
2 O
( O
Jak O
2 O
) O
/ O
signal O
transducer O
and O
activator O
of O
transcription O
5 O
( O
Stat5 B
) O
- O
signaling O
pathway O
requires O
protein O
synthesis O
and O
phospholipase O
C O
. O

In O
two O
separate O
studies O
, O
specimens O
of O
saliva O
from O
57 O
individuals O
over O
the O
age O
of O
65 O
years O
( O
mean O
age O
, O
76 O
. O
7 O
years O
) O
and O
37 O
persons O
under O
the O
age O
of O
40 O
years O
( O
mean O
age O
, O
28 O
. O
8 O
years O
) O
were O
examined O
for O
concentrations O
of O
IgA B
as O
functions O
of O
volume O
, O
total O
protein O
, O
and O
electrolyte O
conductivity O
; O
some O
were O
also O
tested O
for O
IgG B
and O
IgM B
content O
. O

E2A B
- O
HLF B
- O
mediated O
cell O
transformation O
requires O
both O
the O
trans O
- O
activation O
domains O
of O
E2A B
and O
the O
leucine O
zipper O
dimerization O
domain O
of O
HLF B
. O

We O
screened O
an O
A O
. O
thaliana O
cDNA O
library O
, O
whose O
inserts O
are O
under O
the O
control O
of O
the O
galactose O
- O
inducible O
GAL10 B
promoter I
, O
for O
cDNAs O
which O
enabled O
YDH8 O
cells O
to O
grow O
at O
the O
restrictive O
temperature O
. O

One O
of O
the O
major O
transcripts O
encodes O
MEQ B
, O
a O
339 O
- O
amino O
- O
acid O
bZIP B
protein I
which O
is O
homologous O
to O
the O
Jun B
/ O
Fos B
family O
of O
transcription O
factors O
. O

It O
is O
concluded O
that O
the O
new O
class O
of O
competitive O
NMDA B
receptor I
antagonists O
, O
exemplified O
by O
CGP O
37849 O
, O
is O
the O
most O
promising O
candidate O
for O
clinical O
trials O
in O
anxiety O
disorders O
. O

Induction O
of O
interferon B
- I
alpha I
( O
IFNalpha O
) O
gene O
expression O
in O
virus O
- O
infected O
cells O
requires O
phosphorylation O
- O
induced O
activation O
of O
the O
transcription O
factors O
IRF3 O
and O
IRF7 O
. O

Mutations O
in O
nifR1 O
( O
ntrC B
) O
and O
nifR4 O
( O
rpoN B
, O
encoding O
sigma54 O
) O
had O
no O
influence O
on O
xdh O
gene O
expression O
. O

Quantitative O
measurement O
of O
antigamma O
globulin O
factors O
( O
rheumatoid B
factors I
) O
using O
laser O
- O
nephelometry O
in O
comparison O
with O
the O
latex O
agglutination O
test O
and O
the O
Waaler O
- O
Rose O
test O

The O
determination O
of O
antithrombin B
III I
( O
AT B
III I
) O
and O
its O
clinical O
significance O

The O
sensitivity O
of O
central O
dopamine O
receptors O
was O
assessed O
with O
the O
growth B
hormone I
response O
to O
apomorphine O
application O
. O

Oral O
basal O
body O
temperature O
( O
BBT O
) O
recordings O
of O
46 O
women O
that O
conceived O
by O
donor O
insemination O
and O
who O
had O
midcycle O
monitoring O
of O
luteinising O
hormone O
( O
LH B
) O
were O
analysed O
to O
establish O
features O
associated O
with O
an O
optimal O
cycle O
. O

Our O
results O
admit O
that O
a O
ribosome O
scanning O
mechanism O
of O
the O
MP B
gene I
expression O
from O
I O
( O
2 O
) O
sgRNA O
operates O
concurrently O
. O

The O
human O
lbc O
oncogene O
product O
is O
a O
guanine B
nucleotide I
exchange I
factor I
that O
specifically O
activates O
the O
Rho O
small O
GTP O
binding O
protein O
, O
thus O
resulting O
in O
biologically O
active O
, O
GTP O
- O
bound O
Rho B
, O
which O
in O
turn O
mediates O
actin B
cytoskeletal O
reorganization O
, O
gene O
transcription O
, O
and O
entry O
into O
the O
mitotic O
S O
phase O
. O

Insulin B
- O
stimulated O
autophosphorylation O
at O
specific O
sites O
in O
the O
tyrosine B
kinase I
domain I
of O
the O
receptor O
' O
s O
beta O
- O
subunit O
is O
correlated O
kinetically O
with O
activation O
of O
kinase O
- O
catalyzed O
phosphorylation O
of O
a O
model O
substrate O
( O
reduced O
and O
carboxyamidomethylated O
lysozyme B
; O
RCAM O
- O
lysozyme O
) O
. O

AST B
activity O
in O
PMNs O
was O
significantly O
low O
, O
approximately O
2 O
% O
of O
that O
observed O
in O
HPLFs O
. O

Specifically O
, O
we O
engineered O
two O
chimeras O
in O
which O
the O
N O
- O
terminal O
lobe O
of O
the O
SH1 O
domain O
of O
c B
- I
Abl I
was O
swapped O
with O
that O
of O
v B
- I
Src I
. O

Highly O
conserved O
regions O
called O
src B
homology I
2 I
and O
3 O
( O
SH2 B
and O
SH3 B
) O
, O
comprising O
amino O
acid O
residues O
88 O
to O
250 O
, O
are O
believed O
to O
modulate O
the O
protein B
- I
tyrosine I
kinase I
activity O
present O
in O
the O
carboxy O
- O
terminal O
halves O
of O
the O
src O
proteins O
. O

Interestingly O
, O
the O
NES O
mutant O
proteins O
appeared O
to O
have O
altered O
interactions O
with O
the O
splicing O
complex O
, O
binding O
more O
tightly O
to O
SC35 B
in O
co O
- O
immunoprecipitation O
assays O
. O

We O
propose O
2 O
separate O
PAI B
- I
1 I
inductory O
pathways O
for O
PMA O
and O
IL B
- I
1alpha I
in O
HepG2 O
, O
both O
involving O
protein B
tyrosine I
kinase I
activation O
; O
the O
serum O
- O
induced O
signaling O
pathway O
may O
( O
partially O
) O
overlap O
with O
the O
PMA O
- O
activated O
protein B
kinase I
C I
/ O
mitogen B
- I
activated I
protein I
kinase I
kinase I
pathway O
, O
leading O
to O
c B
- I
Jun I
homodimer I
binding O
to O
the O
PAI B
- I
1 I
TRE O
. O

Serum O
IgG B
and O
IgA B
level O
were O
decreased O
. O

Therefore O
the O
effect O
of O
GAL11 O
on O
PGK B
transcription O
must O
be O
mediated O
at O
the O
PGK O
UAS O
, O
presumably O
as O
part O
of O
the O
activation O
complex O
. O

Wingless B
/ O
Wnt B
signaling O
directs O
cell O
- O
fate O
choices O
during O
embryonic O
development O
. O

RNase B
protection O
analysis O
reveals O
a O
10 O
- O
fold O
increase O
in O
the O
expression O
of O
SCD2 O
mRNA O
during O
3T3 O
- O
L1 O
preadipocyte O
differentiation O
. O

To O
determine O
whether O
transcription O
of O
orfX O
and O
vfr O
are O
controlled O
by O
the O
same O
mechanisms O
that O
control O
transcription O
of O
the O
region O
of O
the O
divergent O
ORF O
( O
dorf O
) O
and O
of O
crp B
, O
we O
compared O
the O
vfr O
- O
orfX O
and O
crp B
- O
dorf O
intergenic O
regions O
. O

As O
a O
member O
of O
the O
uncoupling O
protein O
family O
, O
UCP2 B
is O
ubiquitously O
expressed O
in O
rodents O
and O
humans O
, O
implicating O
a O
major O
role O
in O
thermogenesis O
. O

Parental O
and O
vector O
- O
transfected O
MCF7 O
cells O
, O
which O
were O
sensitive O
to O
the O
growth O
- O
inhibitory O
effects O
of O
atRA O
, O
exhibited O
atRA O
- O
dependent O
retinoic B
acid I
receptor I
( O
RAR B
) O
transactivation O
and O
transrepression O
of O
12 O
- O
O O
- O
tetradecanoylphorbol O
- O
13 O
- O
acetate O
- O
induced O
AP B
- I
1 I
activity O
. O

99Tcm O
- O
labelled O
albumin B
colloid O
, O
albures O
( O
radius O
250 O
nm O
) O
or O
nanocoll O
( O
radius O
25 O
nm O
) O
, O
or O
both O
were O
used O
as O
test O
substances O
to O
study O
the O
kinetics O
of O
vascular O
clearance O
after O
RES O
stimulation O
. O

Meq B
/ O
c B
- I
Jun I
heterodimers O
bind O
to O
an O
AP1 O
- O
like O
sequence O
in O
the O
meq O
promoter O
region O
with O
an O
affinity O
much O
greater O
than O
that O
of O
Meq B
/ O
Meq B
or O
c B
- I
Jun I
/ O
c B
- I
Jun I
homodimers O
. O

Moreover O
, O
the O
noncoordinate O
effects O
of O
FSK B
on O
PMA O
- O
stimulated O
MKK B
and O
MAPK B
activities O
indicates O
the O
presence O
of O
a O
additional O
distal O
cAMP O
- O
dependent O
inhibitory O
mechanisms O
. O

These O
findings O
indicated O
that O
p35 B
is O
a O
trans O
- O
dominant O
factor O
that O
facilitates O
AcMNPV O
growth O
in O
a O
cell O
line O
- O
specific O
manner O
. O

Nonlethal O
sec71 O
- O
1 O
and O
sec72 O
- O
1 O
mutations O
eliminate O
proteins O
associated O
with O
the O
Sec63p O
- O
BiP B
complex O
from O
S O
. O
cerevisiae O
. O

A O
high O
titer O
of O
anti B
- I
HBc I
, O
thus O
suggested O
to O
be O
an O
indicator O
of O
persistent O
hepatitis O
B O
virus O
infection O
, O
was O
found O
rarely O
in O
seronegative O
patients O
with O
chronic O
hepatitis O
, O
non O
- O
alcoholic O
cirrhosis O
, O
or O
alcoholic O
liver O
diseases O
. O

Eph B
receptors I
and O
their O
membrane O
- O
associated O
ephrin O
ligands O
regulate O
cell O
- O
cell O
interactions O
during O
development O
. O

We O
discuss O
the O
possibility O
that O
DNA O
- O
protein O
interactions O
at O
homologous O
nucleotide O
sequences O
like O
those O
identified O
in O
PII O
are O
part O
of O
a O
regulatory O
gene O
cascade O
that O
participates O
in O
timing O
fla B
gene I
expression O
in O
the O
C O
. O
crescentus O
cell O
cycle O
. O

To O
increase O
the O
number O
of O
circulating O
polymorphonuclear O
neutrophils O
, O
the O
patient O
was O
treated O
with O
recombinant O
granulocyte B
- I
macrophage I
colony I
- I
stimulating I
factor I
( O
GM B
- I
CSF I
) O
at O
a O
dose O
of O
2 O
micrograms O
protein O
/ O
kg O
bodyweight O
s O
. O
c O
. O
/ O
12 O
h O
. O

The O
amino O
acid O
residues O
and O
subdomains O
important O
for O
DNA O
binding O
, O
hormone O
binding O
, O
dimerization O
, O
and O
transactivation O
are O
mostly O
conserved O
among O
all O
VDR B
species O
. O

Transcripts O
appear O
to O
be O
initiated O
from O
an O
upstream O
promoter O
, O
P1 O
, O
located O
in O
front O
of O
the O
tRNA O
( O
met1 O
) O
gene O
and O
from O
three O
internal O
promoters O
: O
P2 O
is O
located O
immediately O
in O
front O
of O
the O
tRNA O
( O
met2 O
) O
gene O
; O
PL10 O
is O
near O
the O
beginning O
of O
the O
L1 B
- O
L10 O
intergenic O
space O
, O
and O
PL12 O
is O
at O
the O
end O
of O
the O
L10 O
gene O
sequence O
. O

In O
both O
liver O
and O
pancreatic O
islet O
, O
glucokinase B
is O
subject O
to O
inhibition O
by O
a O
regulatory O
protein O
( O
GCKR B
) O
. O

Cotransfection O
of O
expression O
plasmids O
encoding O
the O
protein B
kinase I
A I
inhibitor O
, O
or O
an O
inactive O
protein B
kinase I
A I
( O
PKA B
) O
catalytic O
beta O
subunit O
, O
inhibited O
both O
forskolin O
and O
PACAP B
activation O
of O
chromogranin O
A O
transcription O
, O
revealing O
that O
PACAP B
- O
induced O
trans O
- O
activation O
is O
highly O
dependent O
on O
PKA B
. O

GH B
induced O
rapid O
tyrosine O
phosphorylation O
of O
a O
protein O
at O
approximately O
93 O
kDa O
in O
normal O
fibroblasts O
, O
and O
Western O
blotting O
with O
STAT O
- O
specific O
antibodies O
revealed O
STAT5 B
activation O
( O
phosphorylation O
) O
by O
GH O
. O

Furthermore O
, O
CBP B
/ O
p300 B
stimulated O
both O
TGF B
- I
beta I
- O
and O
Smad B
- O
induced O
transcription O
in O
a O
Smad4 B
/ O
DPC4 O
- O
dependent O
fashion O
. O

Sequences O
within O
and O
flanking O
hypersensitive O
sites O
3 O
and O
2 O
of O
the O
beta B
- I
globin I
locus O
control O
region O
required O
for O
synergistic O
versus O
additive O
interaction O
with O
the O
epsilon O
- O
globin O
gene O
promoter O
. O

The O
most O
frequent O
abnormality O
was O
GH B
deficiency O
( O
six O
cases O
) O
, O
followed O
by O
gonadotropin B
( O
four O
cases O
) O
, O
cortisol O
( O
four O
cases O
) O
, O
and O
TSH B
( O
one O
case O
) O
, O
whereas O
four O
patients O
showed O
high O
serum O
PRL O
values O
. O

In O
both O
cell O
types O
, O
insulin B
led O
to O
a O
dose O
- O
dependent O
increase O
in O
the O
association O
of O
tyrosine O
phosphorylated O
IRS O
- O
1 O
with O
the O
SH2 B
domain I
of O
the O
p85 B
regulatory I
subunit I
of O
PI B
- I
3 I
kinase I
, O
and O
also O
increased O
the O
amount O
of O
PI B
kinase I
activity O
detected O
in O
anti O
- O
IRS O
- O
1 O
immunoprecipitates O
. O

The O
Xenopus O
annexin O
II O
heavy O
chain O
lacks O
the O
highly O
conserved O
tyrosine O
at O
position O
23 O
which O
is O
the O
site O
of O
src O
oncogene O
tyrosine B
kinase I
phosphorylation O
in O
the O
murine O
protein O
. O

No O
bafilomycin O
- O
sensitive O
ATPase B
is O
detected O
in O
a O
vacuolar O
fraction O
. O

However O
, O
at O
the O
time O
of O
salvage O
treatment O
, O
the O
mean O
serum B
PSA I
levels O
were O
9 O
. O
1 O
and O
1 O
. O
1 O
ng O
/ O
mL O
for O
the O
salvage O
RP O
and O
salvage O
RT O
groups O
, O
respectively O
( O
P O
= O
0 O
. O
0001 O
) O
. O

The O
implication O
of O
Rac B
and O
Cdc42 B
was O
analyzed O
in O
transient O
transfection O
experiments O
using O
either O
constitutively O
active O
( O
V12 O
) O
or O
dominant O
- O
interfering O
( O
N17 O
) O
mutants O
. O

Alternative O
immune B
globulin I
preparation O
when O
standard O
immune B
serum I
globulin I
is O
not O
available O
. O

GBF1 B
and O
GBF2 O
mRNA O
is O
present O
in O
light O
and O
dark O
grown O
leaves O
as O
well O
as O
in O
roots O
. O

A O
transient O
induction O
of O
both O
c B
- I
fos I
and O
c O
- O
jun O
mRNAs O
by O
TPA O
was O
observed O
in O
both O
cell O
populations O
, O
together O
with O
an O
associated O
suppression O
of O
BSP O
mRNA O
in O
the O
fetal O
rat O
calvarial O
cells O
. O

The O
isomerization O
of O
the O
pre O
- O
existing O
closed O
complex O
to O
an O
open O
promoter O
form O
, O
as O
judged O
by O
the O
local O
denaturation O
of O
promoter O
DNA O
which O
rendered O
sequences O
from O
+ O
5 O
to O
- O
10 O
reactive O
towards O
KMnO4 O
, O
was O
shown O
to O
be O
fully O
dependent O
on O
NifA B
. O

These O
data O
suggest O
that O
overexpression O
of O
MT B
potentiates O
the O
growth O
of O
MCF7 O
cells O
, O
whereas O
downregulation O
of O
MT B
elicits O
antiproliferative O
effects O
. O

Such O
unique O
recognition O
capabilities O
are O
generated O
with O
minimal O
alterations O
in O
the O
CDR3 B
loops O
of O
the O
TCR B
. O

For O
this O
interaction O
, O
the O
C O
- O
terminal O
part O
of O
Sp1 B
and O
the O
N O
terminus O
of O
E2F1 B
, O
a O
domain O
also O
present O
in O
E2F2 B
and O
E2F3 O
but O
absent O
in O
E2F4 O
and O
E2F5 O
, O
were O
essential O
. O

Our O
results O
suggest O
a O
biological O
role O
for O
Elf O
- O
1 O
in O
the O
regulation O
of O
IgH O
gene O
expression O
, O
attribute O
a O
functional O
role O
for O
receptor O
- O
induced O
AP B
- I
1 I
proteins I
in O
B O
lymphocytes O
and O
provide O
evidence O
for O
a O
direct O
link O
between O
IgM O
receptor O
- O
mediated O
signalling O
and O
3 O
' O
enhancer O
activation O
. O

Oncogenic O
activation O
of O
RET B
is O
detected O
in O
human O
papillary O
thyroid O
tumours O
and O
in O
multiple O
endocrine O
neoplasia O
type O
2 O
syndromes O
. O

CD4 B
degradation O
mediated O
by O
Vpu B
does O
not O
require O
the O
ER O
chaperone O
calnexin O
and O
is O
dependent O
on O
an O
intact O
ubiquitin B
- O
conjugating O
system O
. O

Gel O
shift O
and O
southwestern O
experiments O
revealed O
nuclear O
proteins O
of O
43 O
kDa O
and O
30 O
kDa O
in O
GC O
and O
fish O
cells O
, O
respectively O
, O
that O
bind O
specifically O
to O
the O
tGH O
CRE O
, O
suggesting O
the O
involvement O
of O
CRE B
- I
binding I
- I
protein I
/ O
activating O
- O
transcription O
- O
factor O
- O
l O
- O
related O
peptides O
in O
cAMP O
response O
. O

The O
coding O
sequence O
of O
rat O
MEK O
kinase O
1 O
( O
MEKK1 B
) O
has O
been O
determined O
from O
multiple O
, O
independent O
cDNA O
clones O
. O

On O
the O
basis O
of O
experiments O
with O
mutant O
virus O
and O
transfection O
with O
isolated O
genes O
, O
the O
herpes O
simplex O
virus O
immediate O
- O
early O
gene O
product O
ICP4 B
is O
known O
to O
positively O
regulate O
the O
transcription O
of O
viral O
early O
and O
late O
genes O
and O
negatively O
regulate O
expression O
from O
its O
own O
promoter O
. O

The O
POU B
- O
specific O
domain O
of O
Pit B
- I
1 I
is O
essential O
for O
sequence O
- O
specific O
, O
high O
affinity O
DNA O
binding O
and O
DNA O
- O
dependent O
Pit B
- I
1 I
- O
Pit B
- I
1 I
interactions O
. O

These O
results O
suggest O
an O
essential O
role O
of O
the O
binding O
of O
HNF B
- I
4 I
and O
/ O
or O
HNF O
- O
4 O
- O
related O
nuclear O
factors O
to O
the O
6 O
beta O
A O
- O
A O
site O
on O
the O
basal O
transcriptional O
activation O
of O
the O
CYP3A2 O
gene O
in O
liver O
cells O
. O

Using O
the O
yeast O
two O
- O
hybrid O
system O
, O
we O
have O
isolated O
an O
835 O
amino O
acid O
RING O
finger O
( O
C3HC4 O
zinc O
finger O
) O
protein O
, O
TIF1 O
beta O
( O
also O
named O
KAP B
- I
1 I
) O
, O
that O
specifically O
interacts O
with O
the O
KRAB O
domain O
of O
the O
human O
zinc O
finger O
factor O
KOX1 O
/ O
ZNF10 O
. O

Unestablished O
quail O
myoblasts O
were O
infected O
with O
a O
retroviral O
vector O
encoding O
the O
oncogenic O
form O
of O
H B
- I
Ras I
in O
order O
to O
investigate O
the O
mechanism O
by O
which O
this O
oncoprotein O
interferes O
with O
terminal O
differentiation O
. O

VP4 O
differentially O
regulates O
TRAF2 B
signaling O
, O
disengaging O
JNK B
activation O
while O
directing O
NF B
- I
kappa I
B I
to O
effect O
rotavirus O
- O
specific O
cellular O
responses O
. O

Moreover O
, O
we O
show O
that O
GATA B
- I
1 I
and O
Sp1 B
synergize O
from O
a O
distance O
in O
constructs O
designed O
to O
mimic O
the O
architecture O
of O
globin O
locus O
control O
regions O
and O
downstream O
globin O
promoters O
. O

Adhesion O
was O
inhibited O
by O
mAbs O
against O
the O
COOH O
- O
terminus O
and O
central O
cell O
binding O
domains O
of O
fibronectin B
, O
as O
well O
as O
by O
the O
corresponding O
CS1 B
and O
RGD O
peptides O
. O

Activation O
of O
the O
mitogen B
- I
activated I
protein I
kinase I
( O
MAPK B
) O
pathway O
enhances O
long O
- O
range O
transactivation O
by O
the O
beta O
- O
globin O
locus O
control O
region O
( O
LCR O
) O
( O
W O
. O

The O
Ick O
protein B
tyrosine I
kinase I
is O
not O
involved O
in O
antibody O
- O
mediated O
CD4 B
( O
CDR3 O
- O
loop O
) O
signal O
transduction O
that O
inhibits O
HIV O
- O
1 O
transcription O
. O

The O
model O
therefore O
predicts O
that O
1 O
) O
on O
- O
line O
calculation O
of O
airway O
dead O
space O
and O
end O
- O
expired O
lung O
volume O
can O
be O
made O
by O
the O
addition O
of O
an O
oxygen O
sine O
- O
wave O
perturbation O
component O
to O
the O
mean O
FIO2 O
; O
and O
( O
2 O
) O
QS O
/ O
QT O
can O
be O
measured O
from O
the O
resultant O
oxygen O
perturbation O
sine O
- O
wave O
amplitudes O
in O
the O
expired O
gas O
and O
in O
arterial O
and O
mixed O
- O
venous O
blood O
and O
is O
independent O
of O
the O
mean O
blood O
oxygen O
partial O
pressure O
and O
oxyhemoglobin B
saturation O
values O
. O

Fulminant O
hepatic O
failure O
in O
these O
cases O
could O
be O
characterized O
by O
: O
( O
1 O
) O
rapid O
decrease O
in O
serum O
alanine O
transaminase O
( O
ALT B
) O
level O
after O
discontinuation O
of O
ecarazine O
, O
( O
2 O
) O
prolonged O
jaundice O
despite O
discontinuation O
of O
ecarazine O
, O
( O
3 O
) O
high O
incidence O
of O
anti O
- O
nuclear O
antibody O
( O
ANA O
) O
( O
57 O
% O
) O
, O
and O
( O
4 O
) O
histological O
findings O
of O
extensive O
hepatocellular O
necrosis O
ranging O
from O
bridging O
necrosis O
to O
massive O
necrosis O
. O

These O
data O
suggest O
that O
the O
secreted O
, O
truncated O
receptor O
encoded O
by O
the O
2 O
. O
6 O
- O
kb O
c O
- O
erbB O
transcript O
can O
bind O
to O
TGF B
alpha I
and O
may O
play O
an O
important O
growth O
- O
regulatory O
function O
in O
vitro O
. O

Thus O
, O
the O
rates O
of O
a B
- I
factor I
receptor I
endocytosis O
and O
consequent O
vacuolar O
turnover O
depend O
on O
the O
available O
level O
of O
ubiquitin B
in O
the O
cell O
. O

Using O
the O
same O
approach O
we O
have O
shown O
that O
hFIRE O
binds O
the O
stimulatory O
proteins O
Sp1 B
and O
Sp3 B
in O
addition O
to O
CBF B
. O

The O
cyclin B
- I
dependent I
kinase I
Cdk2 B
associates O
with O
cyclins O
A O
, O
D O
, O
and O
E O
and O
has O
been O
implicated O
in O
the O
control O
of O
the O
G1 O
to O
S O
phase O
transition O
in O
mammals O
. O

The O
amino O
- O
terminal O
gag O
- O
encoded O
region O
of O
P140gag O
- O
fps B
contains O
a O
phosphotyrosine O
residue O
in O
addition O
to O
normal O
gag B
phosphorylation O
sites O
. O

The O
activity O
of O
gamma B
- I
glutamyl I
transpeptidase I
in O
the O
serum O
of O
problem O
drinkers O
. O

In O
particular O
, O
lacZ O
transcripts O
synthesised O
this O
way O
are O
highly O
unstable O
and O
yield O
little O
beta B
- I
galactosidase I
. O

All O
three O
SSV O
- O
transformed O
cells O
secreted O
v O
- O
sis O
gene O
product O
( O
p44 B
) O
. O

p44 B
was O
secreted O
but O
remained O
tightly O
associated O
with O
the O
cell O
surface O
. O

To O
determine O
the O
role O
of O
elevated O
FAK B
expression O
in O
facilitating O
epidermal B
growth I
factor I
( O
EGF B
) O
- O
stimulated O
human O
adenocarcinoma O
( O
A549 O
) O
cell O
motility O
, O
antisense O
oligonucleotides O
were O
used O
to O
reduce O
FAK O
protein O
expression O
> O
75 O
% O
. O

To O
further O
study O
the O
role O
of O
tTG B
in O
liver O
disease O
, O
we O
initiated O
investigations O
into O
the O
effect O
of O
a O
proinflammatory O
mediator O
, O
tumor B
necrosis I
factor I
( I
TNF I
) I
- I
alpha I
, O
on O
tTG B
activity O
in O
cultured O
liver O
cells O
. O

Despite O
the O
fact O
that O
biochemical O
estimates O
of O
bone O
turnover O
indicate O
that O
( O
short O
- O
term O
) O
administration O
of O
rhGH O
and O
IGF B
- I
I I
stimulates O
bone O
metabolism O
in O
non O
- O
osteoporotic O
older O
people O
, O
no O
significant O
changes O
have O
been O
observed O
in O
bone O
mineral O
density O
at O
the O
proximal O
femur O
. O

Blood O
pressure O
was O
controlled O
long O
term O
( O
with O
/ O
without O
diuretics O
/ O
beta B
- I
adrenoreceptor I
blocking O
drugs O
) O
in O
sixteen O
out O
of O
nineteen O
patients O
with O
mild O
- O
moderate O
hypertension O
. O

However O
, O
FosB O
- O
L O
and O
FosB O
- O
S O
do O
not O
differ O
in O
all O
trans O
- O
regulatory O
properties O
: O
Trans O
- O
activation O
of O
a O
5x O
TRE O
- O
CAT O
reporter O
construct O
in O
HeLa O
and O
NIH O
- O
3T3 O
cells O
was O
found O
with O
both O
FosB B
forms O
. O

Mutations O
in O
glnB O
, O
nifR1 O
( O
ntrC B
) O
, O
and O
NifR4 O
( O
ntrA O
encoding O
sigma B
54 I
) O
had O
no O
influence O
on O
put O
gene O
expression O
. O

Disruption O
of O
INP53 B
, O
but O
not O
the O
related O
INP51 O
and O
INP52 O
genes O
, O
resulted O
in O
alpha B
- I
factor I
maturation O
defects O
and O
exacerbated O
alpha B
- I
factor I
maturation O
defects O
when O
combined O
with O
chc1 O
- O
521 O
. O

By O
subtractive O
and O
differential O
screening O
, O
we O
have O
cloned O
12 O
of O
these O
sequences O
, O
2 O
of O
which O
were O
c B
- I
fos I
and O
krox B
- I
24 I
. O

Cotransfection O
of O
a O
junB B
stimulated O
the O
basal O
activity O
of O
the O
alpha O
2 O
( O
I O
) O
collagen O
promoter O
93 O
- O
fold O
, O
respectively O
. O

Glutathione B
reductase I
( O
GR B
) O
was O
purified O
from O
the O
cyanobacterium O
Anabaena O
PCC O
7120 O
. O

5 O
' O
- O
Deletion O
of O
the O
Stat O
- O
binding O
sites O
abolished O
all O
promoter O
- O
reporter O
activity O
in O
response O
to O
PRL B
. O

Plasma O
beta O
- O
thromboglobulin O
( O
beta B
- I
TG I
) O
, O
a O
platelet O
- O
specific O
protein O
, O
is O
a O
marker O
of O
intravascular O
platelet O
degranulation O
. O

The O
DNA O
element O
through O
which O
EBNA B
- I
3C I
activates O
the O
LMP O
- O
1 O
promoter O
includes O
a O
Spi O
- O
1 O
/ O
Spi O
- O
B O
binding O
site O
, O
previously O
characterized O
as O
an O
important O
EBNA O
- O
2 O
response O
element O
. O

DP B
- I
1 I
and O
DP O
- O
2 O
encode O
maternally O
stored O
transcripts O
that O
are O
expressed O
during O
early O
development O
. O

Finally O
, O
we O
demonstrate O
that O
animals O
carrying O
a O
snf B
mutation O
that O
converts O
SNF B
from O
a O
bifunctional O
protein O
to O
a O
U1 O
snRNP O
- O
specific O
protein O
are O
viable O
. O

This O
pathway O
has O
been O
reported O
to O
mediate O
heterodimer O
interactions O
with O
the O
proapoptotic O
regulator O
, O
Bad B
. O

Recently O
, O
we O
reported O
that O
SMRT B
also O
directly O
associates O
with O
LAZ3 B
( O
BCL B
- I
6 I
) O
, O
a O
POZ O
/ O
Zn O
finger O
transcriptional O
repressor O
involvedin O
the O
pathogenesis O
of O
non O
- O
Hodgkin O
lymphomas O
. O

Characterization O
of O
a O
cDNA O
encoding O
CNN O
predicts O
a O
novel O
structural O
protein O
with O
three O
leucine O
zipper O
motifs O
and O
several O
coiled O
- O
coil O
domains O
exhibiting O
limited O
homology O
to O
the O
rod O
portion O
of O
myosin B
. O

A O
preformed O
SREBP O
- O
1a O
: O
[ O
32P O
] O
DNA O
complex O
bound O
specifically O
to O
membrane O
- O
immobilized O
GST B
- O
CBP B
fusion O
proteins O
that O
contained O
amino O
- O
terminal O
portions O
of O
CBP B
. O

Previous O
work O
established O
that O
the O
TAL1 O
proteins O
are O
phosphorylated O
exclusively O
on O
serine O
and O
identified O
Ser122 O
as O
a O
substrate O
for O
the O
mitogen B
- I
activated I
protein I
kinase I
ERK B
- I
1 I
. O

When O
cotransfected O
with O
the O
HIV B
LTR I
CAT B
into O
CV O
- O
1 O
cells O
, O
both O
the O
pCD41 O
and O
pGD41 O
clones O
trans O
- O
activated O
the O
HIV B
LTR I
. O

The O
induction O
of O
the O
composite O
H O
- O
PK O
/ O
Tag B
and O
SV O
- O
PK O
/ O
Tag B
transgenes O
by O
a O
carbohydrate O
- O
rich O
diet O
in O
the O
liver O
was O
similar O
to O
that O
of O
the O
endogenous O
L O
- O
PK O
gene O
. O

Exit O
from O
mitosis O
in O
Drosophila O
syncytial O
embryos O
requires O
proteolysis O
and O
cyclin B
degradation O
, O
and O
is O
associated O
with O
localized O
dephosphorylation O
. O

To O
understand O
this O
dramatic O
effect O
, O
we O
examined O
the O
localization O
of O
SR O
proteins O
and O
found O
that O
SC35 B
was O
shifted O
to O
the O
cytoplasm O
in O
sky1Delta O
yeast O
, O
although O
this O
phenomenon O
was O
not O
obvious O
with O
ASF B
/ O
SF2 B
, O
indicating O
that O
nuclear O
import O
of O
SR O
proteins O
may O
be O
differentially O
regulated O
by O
phosphorylation O
. O

On O
the O
contrary O
i O
. O
v O
. O
administration O
of O
calcitonin B
increased O
intrapyloric O
pressure O
via O
vagal O
nerves O
in O
atropinized O
or O
gallaminized O
animals O
. O

We O
conclude O
that O
in O
the O
presence O
of O
fatty O
acids O
in O
the O
medium O
transcription O
of O
SPS19 O
is O
directly O
regulated O
by O
both O
Pip2p O
- O
Oaf1p O
and O
Adr1p B
. O

We O
found O
that O
in O
premature O
infants O
plasminogen B
levels O
are O
low O
; O
thus O
, O
defense O
against O
intra O
- O
alveolar O
fibrin B
deposition O
during O
birth O
trauma O
is O
reduced O
. O

Studies O
on O
the O
reaction O
of O
cytochrome B
c I
with O
corticosteroids O
. O

However O
, O
both O
RAR B
- O
and O
RXR B
- O
specific O
ligands O
increase O
CaSki O
number O
by O
> O
or O
= O
20 O
% O
. O

To O
further O
investigate O
the O
role O
of O
PKR B
in O
transcriptional O
signaling O
, O
we O
expressed O
the O
wild O
type O
human O
PKR O
and O
a O
catalytically O
inactive O
dominant O
negative O
PKR O
mutant O
in O
the O
murine O
pre O
- O
B O
lymphoma O
70Z O
/ O
3 O
cells O
. O

Interestingly O
, O
VDR B
was O
able O
to O
bind O
to O
VDREs O
with O
high O
affinity O
and O
to O
fully O
activate O
transcription O
in O
intact O
yeast O
cells O
in O
the O
presence O
of O
the O
retinoid B
X I
receptor I
( O
RXR B
) O
. O

It O
has O
been O
shown O
that O
renin B
secretion O
is O
stimulated O
by O
endothelin O
, O
a O
recently O
discovered O
peptide O
with O
strong O
vasoconstrictive O
properties O
and O
stimulating O
effects O
on O
renin B
secretion O
. O

No O
significant O
difference O
was O
seen O
found O
between O
the O
two O
groups O
in O
the O
degree O
of O
postoperative O
deterioration O
in O
cardiopulmonary O
function O
or O
in O
interleukin B
- I
6 I
levels O
. O

To O
initiate O
our O
analysis O
of O
factors O
required O
for O
eIF B
- I
2 I
alpha I
expression O
, O
selected O
a O
CAP O
- O
proximal O
element O
shown O
by O
in O
vivo O
methylation O
protection O
analysis O
to O
bind O
a O
potential O
regulatory O
factor O
. O

Furthermore O
, O
addition O
of O
the O
recombinant O
NF O
- O
YA O
subunit O
restores O
NF B
- I
Y I
binding O
. O

Our O
results O
suggest O
that O
Sp1 B
binding I
site I
can O
function O
as O
a O
distinct O
TGF O
- O
beta O
responsive O
element O
for O
TGF B
- I
beta I
mediated O
promoter O
expression O
and O
Sp1 B
per O
se O
can O
mediate O
this O
response O
. O

Effect O
of O
bromocriptine O
and O
metoclopramide O
on O
serum B
prolactin I
levels O
in O
patients O
with O
amyotrophic O
lateral O
sclerosis O
. O

Prolongation O
of O
prothrombin B
time O
was O
not O
due O
to O
depletion O
of O
vitamin O
K O
- O
dependent O
coagulation O
factors O
or O
manifest O
fibrinolysis O
, O
but O
due O
to O
the O
presence O
of O
circulating O
fibrinogen O
fibrinmonomer O
- O
FDP O
complexes O
. O

Mutation O
of O
K14 O
in O
H3 O
, O
which O
serves O
as O
the O
major O
target O
of O
recombinant O
Gcn5p O
acetylation O
in O
vitro O
, O
confers O
a O
strong O
, O
synthetic O
growth O
defect O
in O
gcn5 B
cells O
. O

All O
patients O
whose O
PSA B
levels O
reached O
0 O
. O
1 O
ng O
. O
/ O
ml O
. O

Treatment O
with O
ACE B
inhibitors O
after O
acute O
myocardial O
infarction O

Conversely O
, O
as O
a O
GAL O
- O
4 O
chimera O
, O
the O
isolated O
LAZ3 B
/ O
BCL6 B
BTB B
/ O
POZ O
domain O
appears O
nearly O
as O
efficient O
as O
the O
entire O
protein O
at O
inducing O
transcriptional O
repression O
. O

Overexpression O
of O
either O
Sp1 B
or O
phosphorylated O
CREB O
transactivated O
the O
mCgA O
promoter O
dose O
dependently O
, O
while O
coexpression O
of O
both O
transcription O
factors O
resulted O
in O
an O
additive O
mCgA O
promoter O
response O
. O

mCgA O
- O
92 O
to O
- O
64 O
bp O
, O
comprising O
the O
Sp1 B
/ O
Egr B
- I
1 I
site O
and O
the O
CRE O
motif O
, O
conferred O
gastrin B
responsiveness O
to O
a O
heterologous O
thymidine O
kinase O
promoter O
system O
, O
and O
therefore O
functions O
as O
a O
" O
true O
" O
enhancer O
element O
. O

Together O
with O
the O
up O
- O
regulation O
of O
the O
cAMP O
response O
element O
modulator O
protein O
( O
CREM B
) O
mRNA O
and O
protein O
levels O
demonstrated O
previously O
in O
CREB O
mutant O
mice O
, O
we O
suggest O
that O
the O
up O
- O
regulation O
of O
CREB O
beta O
may O
also O
contribute O
to O
compensation O
within O
the O
CREB B
/ O
ATF B
family O
of O
transcription O
factors O
, O
when O
CREB O
delta O
and O
CREB O
alpha O
are O
absent O
. O

It O
is O
hypothesized O
this O
occurs O
through O
antagonism O
of O
PML B
/ O
RAR B
alpha I
actions O
in O
these O
leukemic O
cells O
. O

13 O
: O
961 O
- O
969 O
, O
1993 O
) O
suggested O
that O
T B
antigen I
could O
mediate O
transcriptional O
activation O
through O
interaction O
with O
the O
TATA B
- I
binding I
protein I
, O
as O
well O
as O
upstream O
bound O
transcription O
factors O
. O

The O
Grb2 B
SH3 O
( O
C O
) O
binding O
region O
of O
Gab1 B
has O
significant O
homology O
to O
a O
region O
of O
the O
adapter O
protein O
SLP O
- O
76 O
. O

A O
phase O
II O
study O
of O
interferon B
- I
alpha I
, O
interleukin B
- I
2 I
and O
5 O
- O
fluorouracil O
in O
advanced O
renal O
carcinoma O
: O
clinical O
data O
and O
laboratory O
evidence O
of O
protease O
activation O
. O

The O
practice O
of O
measuring O
of O
AChE B
levels O
in O
acute O
poisoning O
is O
limited O
. O

The O
authors O
recommend O
in O
cases O
with O
an O
elevated O
transaminase O
serum O
activity O
more O
frequent O
check O
- O
up O
examinations O
to O
avoid O
missing O
of O
a O
relapse O
, O
and O
to O
examine O
repeatedly O
IgM B
anti B
- I
HAV I
as O
in O
protracted O
forms O
of O
hepatitis O
IgM B
anti B
- I
HAV I
may O
persist O
even O
when O
the O
transaminase O
activity O
is O
normal O
. O

The O
strategy O
uses O
RNA B
ligase I
to O
add O
DNA O
oligonucleotide O
priming O
sites O
to O
the O
RNA O
for O
subsequent O
reverse O
transcription O
and O
PCR O
( O
RNA B
ligase I
, O
reverse O
transcription O
- O
PCR O
, O
or O
RL O
/ O
RT O
/ O
PCR O
) O
. O

We O
analyzed O
the O
effects O
of O
light O
on O
tubulin B
mRNA I
abundance O
in O
Arabidopsis O
seedlings O
using O
RNA O
gel O
blot O
hybridizations O
and O
gene O
- O
specific O
probes O
. O

More O
important O
, O
ligand O
- O
activated O
insulin B
and O
IGF O
- O
I O
receptors O
phosphorylate O
SHC B
proteins I
in O
vitro O
, O
indicating O
that O
SHC B
proteins I
could O
be O
direct O
substrates O
for O
insulin B
and O
IGF O
- O
I O
receptors O
. O

This O
chimera O
transduced O
IL B
- I
4 I
- O
specific O
signals O
in O
response O
to O
IL B
- I
2 I
binding O
and O
dramatically O
enhanced O
type O
2 O
responses O
( O
IL B
- I
4 I
, O
IL B
- I
5 I
, O
and O
immunoglobulin B
E I
production O
) O
upon O
in O
vitro O
TCR B
stimulation O
or O
in O
vivo O
antigen O
challenge O
. O

Significantly O
higher O
levels O
of O
vitamin O
C O
and O
catalase B
activity O
were O
found O
in O
vegetarians O
( O
C O
- O
63 O
. O
6 O
and O
86 O
. O
5 O
mumol O
/ O
l O
; O
CAT O
- O
1497 O
and O
1313 O
U O
/ O
ml O
for O
males O
and O
females O
, O
respectively O
) O
when O
compared O
to O
nonvegetarians O
( O
C O
- O
41 O
. O
3 O
and O
54 O
. O
4 O
mumol O
/ O
l O
; O
CAT O
- O
1192 O
and O
1086 O
U O
/ O
ml O
) O
. O

In O
contrast O
, O
no O
change O
in O
the O
level O
of O
either O
p53 B
or O
activation O
of O
mdm2 O
protein O
by O
p53 B
was O
observed O
in O
hamster O
UV61 O
cells O
after O
UV O
exposure O
. O

The O
NF1 O
family O
members O
and O
HNF4 O
interacted O
with O
overlapping O
sequences O
of O
the O
L O
- O
II O
element O
, O
wherein O
the O
5 O
' O
half O
- O
site O
was O
more O
critical O
for O
NF1 B
binding O
, O
and O
the O
3 O
' O
site O
was O
more O
important O
for O
HNF4 O
binding O
. O

RAP B
has O
been O
shown O
to O
be O
a O
useful O
vaccine O
target O
site O
, O
and O
RIP O
and O
inhibitory O
AIPs O
as O
therapeutic O
molecules O
to O
prevent O
and O
suppress O
S O
. O
aureus O
infections O
. O

After O
institution O
of O
insulin B
treatment O
, O
diabetic O
control O
was O
improved O
as O
demonstrated O
by O
decreasing O
levels O
of O
HbA1 B
. O

In O
contrast O
, O
inhibition O
of O
MAPK B
activity O
by O
MAPK O
kinase O
inhibitor O
( O
PD O
98059 O
) O
or O
by O
overexpression O
of O
kinase O
- O
deficient O
MAPKs O
activated O
basal O
and O
GnRH B
- I
A I
- O
stimulated O
GnRHR O
- O
Luc B
activity O
. O

Historically O
, O
Cyps O
were O
first O
identified O
by O
their O
ability O
to O
bind O
the O
immunosuppressive O
agent O
cyclosporin O
A O
( O
CsA O
) O
with O
high O
affinity O
; O
they O
later O
were O
found O
to O
have O
peptidyl B
- I
prolyl I
cis I
- I
trans I
isomerase I
( O
PPIase B
) O
activity O
, O
which O
catalyzes O
the O
folding O
of O
oligopeptides O
at O
proline O
- O
peptide O
bonds O
in O
vitro O
and O
may O
be O
important O
for O
protein O
folding O
in O
vivo O
. O

A O
rare O
tRNA O
- O
Arg O
( O
CCU O
) O
that O
regulates O
Ty1 O
element O
ribosomal O
frameshifting O
is O
essential O
for O
Ty1 B
retrotransposition O
in O
Saccharomyces O
cerevisiae O
. O

Several O
35 O
- O
mm O
slides O
of O
dystrophin O
- O
, O
laminin B
- O
, O
and O
concanavalin B
A I
( O
ConA B
) O
- O
stained O
muscle O
sections O
were O
used O
to O
calculate O
myofiber O
cross O
- O
sectional O
areas O
and O
to O
compare O
different O
techniques O
and O
settings O
of O
an O
image O
capture O
system O
. O

In O
addition O
, O
both O
inhibitors O
blocked O
phosphatidylcholine O
hydrolysis O
and O
protein B
kinase I
C I
translocation O
. O

Laser O
soldering O
with O
exogenous O
fibrinogen B
is O
feasible O
without O
topical O
administration O
of O
additional O
clotting O
agents O
, O
significantly O
improves O
the O
bursting O
strength O
of O
primary O
laser O
welded O
anastomoses O
, O
and O
appears O
to O
result O
from O
urokinase B
- O
resistant O
fibrinogen B
cross O
- O
linking O
. O

We O
describe O
a O
novel O
stat O
- O
related O
factor O
, O
p93 O
, O
that O
is O
found O
in O
EGF B
- O
treated O
A431 O
cell O
extracts O
but O
appears O
to O
be O
absent O
in O
bovine O
fibroblast O
growth O
factor O
( O
bFGF B
) O
, O
IFN B
- I
gamma I
, O
tumor B
necrosis I
factor I
- I
alpha I
( O
TNF B
- I
alpha I
) O
, O
and O
untreated O
cells O
. O

p185c O
- O
neu B
+ O
, O
EGFr B
+ I
( O
M1 O
) O
, O
and O
p185c O
- O
neu B
- O
kinase O
inactive O
, O
EGFr B
+ I
( O
NEN757 O
) O
expressing O
cells O
undergo O
different O
mitotic O
responses O
to O
EGF B
. O

In O
addition O
, O
Fc B
epsilon I
R1 I
cross O
- O
linking O
activates O
PI B
3 I
- I
kinase I
. O

When O
single O
- O
point O
mutation O
was O
introduced O
to O
each O
GC O
box O
, O
EBS O
, O
and O
GT O
box O
in O
PFP9a20 O
, O
at O
least O
3 O
- O
fold O
less O
CAT B
activity O
was O
observed O
in O
CTLL O
- O
R8 O
cells O
. O

Treatment O
with O
H7 O
did O
not O
affect O
IL O
- O
4R O
- O
mediated O
immediate O
signaling O
events O
such O
as O
tyrosine O
phosphorylation O
of O
Jak1 B
, O
Jak3 B
, O
insulin O
receptor O
substrate O
( O
IRS O
) O
- O
1 O
and O
IRS B
- I
2 I
, O
or O
tyrosine O
phosphorylation O
and O
DNA O
binding O
of O
Stat6 B
. O

Transfection O
assays O
using O
the O
first O
600 O
bp O
of O
the O
upstream O
nucleotide O
sequences O
indicated O
that O
a O
region O
from O
- O
75 O
to O
- O
120 O
was O
necessary O
for O
the O
ALDH2 O
gene O
expression O
, O
and O
especially O
NF B
- I
Y I
/ O
CP1 O
binding O
site O
from O
- O
92 O
to O
- O
96 O
( O
CCAAT O
box O
) O
is O
important O
in O
the O
expression O
of O
the O
gene O
. O

This O
distinct O
biochemical O
difference O
between O
STAT5A B
and O
STAT5B B
was O
confirmed O
with O
purified O
activated O
STAT5 O
recombinant O
proteins O
. O

The O
three O
more O
slower O
migrating O
Stat5B B
bands O
observed O
in O
response O
to O
GH B
contain O
phosphorylated O
tyrosyl O
residues O
. O

Specifically O
, O
we O
demonstrate O
that O
this O
25 O
- O
base O
pair O
region O
mediates O
the O
up O
- O
regulatory O
effect O
of O
TGF B
- I
beta I
on O
COL1A2 O
promoter O
activity O
and O
allows O
antagonistic O
activity O
of O
TNF B
- I
alpha I
on O
the O
TGF B
- I
beta I
effect O
. O

Sin4 B
and O
Srb10 B
, O
components O
of O
specific O
RNA O
polymerase O
II O
sub O
- O
complexes O
that O
are O
required O
for O
Ssn6 O
- O
Tup1 O
repression O
activity O
, O
are O
found O
to O
be O
required O
for O
Sfl1 O
repression O
function O
. O

To O
explore O
the O
mechanism O
of O
insulin B
receptor I
phosphorylation O
we O
have O
used O
NIH3T3 O
cells O
transfected O
with O
two O
receptor O
constructs O
: O
one O
encoding O
a O
chimeric O
receptor O
composed O
of O
the O
extracellular O
domain O
of O
the O
human O
EGF O
receptor O
and O
the O
cytosolic O
domain O
of O
the O
human O
insulin O
receptor O
beta O
- O
subunit O
, O
and O
a O
second O
construct O
encoding O
a O
kinase O
- O
defiecient O
human O
insulin O
receptor O
. O

It O
is O
pathogenetically O
proved O
to O
use O
antithrombin B
III I
concentrate O
preparations O
with O
anti O
- O
and O
dysaggregatory O
properties O
, O
fibronectin B
preparations O
, O
trasylol O
or O
its O
analogs O
during O
complex O
preoperative O
preparation O
of O
patients O
. O

Hematopoietic B
progenitor I
kinase I
1 I
( O
HPK1 B
) O
is O
a O
member O
of O
the O
mitogen O
- O
activated O
protein O
kinase O
kinase O
kinase O
kinase O
( O
MAP4K O
) O
family O
and O
an O
upstream O
activator O
of O
the O
c B
- I
Jun I
N I
- I
terminal I
kinase I
( O
JNK B
) O
signaling O
cascade O
. O

We O
have O
used O
the O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
reporter O
gene O
system O
to O
study O
the O
effect O
of O
T B
on O
the O
long O
terminal O
repeats O
( O
LTRs O
) O
of O
a O
large O
family O
of O
human O
endogenous O
retrovirus O
- O
like O
sequences O
, O
RTVL O
- O
H O
. O

Based O
on O
the O
requirement O
for O
CREM B
/ O
ICER B
and O
Rad6B O
proteins O
in O
spermatogenesis O
, O
we O
determined O
expression O
of O
Cdc34 B
, O
Rad6B O
, O
CREM B
/ O
ICER B
isoforms O
, O
and O
the O
Skp1 B
- O
Cullin O
- O
F O
- O
box O
ubiquitin B
protein O
ligase O
subunits O
Cul O
- O
1 O
and O
Cul O
- O
2 O
, O
which O
are O
associated O
with O
Cdc34 B
activity O
during O
murine O
testicular O
development O
. O

Furthermore O
, O
we O
show O
that O
Nck O
- O
2 O
is O
capable O
of O
recognizing O
several O
key O
components O
of O
growth O
factor O
receptor O
kinase O
- O
signaling O
pathways O
including O
EGF O
receptors O
, O
PDGF O
receptor O
- O
beta O
, O
and O
IRS B
- I
1 I
. O

Protein O
sequencing O
, O
electrophoretic O
mobility O
shift O
assay O
, O
and O
immunoblot O
analyses O
identify O
p54 B
and O
p47 O
/ O
48 O
as O
members O
of O
the O
hepatocyte B
nuclear I
factor I
3 I
( O
HNF3 O
[ O
forkhead B
] O
) O
family O
of O
transcription O
factors O
. O

p54 B
belongs O
to O
the O
subfamily O
of O
HNF3 O
beta O
proteins O
, O
while O
p47 O
/ O
48 O
binding O
activity O
includes O
HNF3 O
gamma O
. O

Although O
the O
elevated O
signalling O
is O
eliminated O
by O
deletion O
of O
Ste20p B
( O
or O
components O
downstream O
of O
Ste20p B
) O
, O
the O
growth O
and O
morphological O
abnormalities O
of O
cells O
lacking O
Akr1p O
are O
not O
rescued O
by O
deletion O
of O
any O
of O
the O
known O
pheromone O
response O
pathway O
components O
. O

Fluorescent O
in O
situ O
hybridization O
( O
FISH O
) O
analysis O
showed O
that O
the O
novel O
regions O
involved O
in O
the O
NFKB2 B
rearrangement O
originated O
from O
chromosome O
7q34 O
, O
thus O
implying O
the O
occurrence O
of O
a O
t O
( O
7 O
; O
10 O
) O
( O
q34 O
; O
q24 O
) O
reciprocal O
chromosomal O
translocation O
. O

This O
is O
the O
first O
report O
that O
the O
PH B
domain I
of O
an O
IRS O
protein O
can O
function O
in O
a O
dominant O
negative O
manner O
to O
inhibit O
insulin B
signaling O
. O

SF1 B
/ O
mBBP O
utilizes O
a O
" O
maxi O
- O
K O
homology O
" O
( O
maxi O
- O
KH O
) O
domain O
for O
recognition O
of O
the O
single O
- O
stranded O
BPS O
and O
requires O
a O
cooperative O
interaction O
with O
splicing O
factor O
U2AF65 B
bound O
to O
an O
adjacent O
polypyrimidine O
tract O
( O
PPT O
) O
for O
high O
- O
affinity O
binding O
. O

An O
X O
- O
linked O
zinc B
finger I
gene I
mapping O
to O
Xq21 O
. O
1 O
- O
q21 O
. O
3 O
closely O
related O
to O
ZFX O
and O
ZFY O
: O
possible O
origins O
from O
a O
common O
ancestral O
gene O
. O

In O
addition O
, O
there O
was O
an O
increase O
in O
the O
amount O
of O
p120 O
Ras O
- O
specific O
GTPase B
- I
activating I
protein I
( O
GAP B
) O
and O
GAP B
- O
associated O
p190 O
. O

The O
1 O
. O
3 O
- O
kb O
DNA O
, O
when O
placed O
upstream O
of O
the O
chloramphenicol B
acetyltransferase I
gene I
, O
was O
shown O
to O
be O
functionally O
active O
. O

By O
sequencing O
of O
exonuclease B
III I
deletion O
clones O
an O
open O
reading O
frame O
of O
405 O
nucleotides O
was O
found O
coding O
for O
a O
protein O
of O
135 O
amino O
acids O
with O
a O
molecular O
mass O
of O
15 O
kDa O
. O

Treatment O
of O
steroid O
resistant O
rejection O
following O
renal O
transplantation O
: O
benefits O
and O
risks O
of O
OKT3 B
therapy O
. O

SH3A O
competes O
with O
the O
SH3 B
domains I
of O
Grb2 B
in O
binding O
to O
mSos1 O
, O
and O
the O
intersectin O
- O
mSos1 O
complex O
can O
be O
separated O
from O
Grb2 B
by O
sucrose O
gradient O
centrifugation O
. O

This O
resulted O
in O
a O
shift O
of O
C1 O
/ O
C2 O
, O
so O
that O
the O
effect O
of O
collagen B
was O
more O
pronounced O
( O
maximal O
increase O
of O
C1 O
/ O
C2 O
= O
134 O
% O
) O
than O
ADP O
( O
maximal O
increase O
of O
C1 O
/ O
C2 O
= O
79 O
% O
) O
. O

Xnr3 O
is O
transcriptionally O
activated O
by O
wnt B
signaling O
during O
gastrulation O
in O
the O
Xenopus O
embryo O
. O

The O
sequences O
of O
two O
previously O
known O
tail O
genes O
, O
R B
and O
S O
, O
of O
the O
temperate O
bacteriophage O
P2 O
and O
the O
sequence O
of O
an O
additional O
open O
reading O
frame O
( O
orf O
- O
30 O
) O
located O
between O
S O
and O
V O
, O
were O
determined O
. O

GH B
signals O
by O
interacting O
with O
GH B
receptor I
( O
GHR O
) O
. O

Consistent O
with O
an O
effect O
on O
transcription O
, O
p21 B
was O
localized O
in O
nuclei O
of O
transfected O
cells O
. O

Plasma B
prolactin I
concentrations O
during O
incubation O
, O
25 O
. O
8 O
+ O
/ O
- O
2 O
. O
3 O
ng O
/ O
ml O
, O
decreased O
to O
baseline O
levels O
, O
10 O
. O
8 O
+ O
/ O
- O
1 O
. O
9 O
ng O
/ O
ml O
, O
within O
24 O
hr O
after O
nestbox O
removal O
. O

Genetic O
mutation O
or O
loss O
of O
activin B
/ O
transforming O
growth O
factor O
- O
beta O
( O
TGFbeta O
) O
receptor O
function O
has O
been O
shown O
in O
human O
lymphoid O
, O
breast O
, O
and O
colorectal O
tumors O
as O
well O
as O
Hep2B O
and O
Mv1Lu O
cell O
lines O
. O

Brome O
mosaic O
virus O
polymerase O
- O
like O
protein O
2a O
is O
directed O
to O
the O
endoplasmic O
reticulum O
by O
helicase B
- O
like O
viral O
protein O
1a O
. O

From O
this O
asymmetry O
, O
we O
suggested O
previously O
that O
GCN4 B
interacts O
with O
nonequivalent O
and O
possibly O
overlapping O
half O
- O
sites O
( O
ATGAC O
and O
ATGAG O
) O
that O
have O
different O
affinities O
. O

Furthermore O
the O
aldosterone O
stimulating O
effect O
of O
low O
sodium O
diet O
( O
17 O
children O
) O
, O
severe O
and O
prolonged O
vomiting O
( O
19 O
children O
) O
and O
synthetic O
ACTH B
( O
10 O
children O
) O
has O
been O
studied O
by O
our O
modified O
method O
. O

In O
NIH O
3T3 O
fibroblasts O
the O
high O
affinity O
IL O
- O
2R O
bearing O
a O
deletion O
of O
a O
region O
rich O
in O
acidic O
amino O
acids O
( O
the O
" O
acidic O
" O
region O
) O
in O
the O
IL O
- O
2R O
beta O
- O
chain O
failed O
to O
induce O
the O
tyrosine O
phosphorylation O
of O
MAP B
kinase I
as O
well O
as O
the O
expression O
of O
the O
all O
three O
nuclear O
proto O
- O
oncogenes O
. O

A O
small O
molecule O
ILK B
inhibitor O
suppresses O
the O
phosphorylation O
of O
PKB B
at O
the O
Ser O
- O
473 O
but O
not O
the O
Thr O
- O
308 O
site O
in O
the O
PTEN O
mutant O
cells O
. O

The O
avian O
carcinoma O
virus O
MH2 O
contains O
a O
hybrid O
gene O
delta B
gag I
- O
mht B
with O
a O
contiguous O
open O
reading O
frame O
of O
2682 O
base O
pairs O
as O
well O
as O
v B
- I
myc I
and O
avian O
helper O
virus O
- O
related O
sequences O
. O
delta B
gag I
is O
a O
partial O
retroviral O
core O
protein O
gene O
while O
v O
- O
mht O
and O
v B
- I
myc I
are O
cell O
- O
drived O
sequences O
. O

In O
this O
group O
of O
patients O
, O
the O
mean O
LH B
( O
9 O
. O
3 O
+ O
/ O
- O
5 O
. O
9 O
IU O
/ O
l O
) O
and O
sex B
- I
hormone I
binding I
globulin I
( O
SHBG B
) O
( O
54 O
. O
5 O
+ O
/ O
- O
22 O
. O
9 O
nmol O
/ O
l O
) O
concentrations O
were O
significantly O
greater O
than O
those O
of O
five O
normal O
control O
subjects O
( O
4 O
. O
7 O
+ O
/ O
- O
1 O
. O
11 O
IU O
/ O
l O
and O
26 O
. O
0 O
+ O
/ O
- O
7 O
. O
0 O
nmol O
/ O
l O
respectively O
) O
. O

The O
BCL B
- I
6 I
POZ O
domain O
and O
other O
POZ O
domains O
interact O
with O
the O
co O
- O
repressors O
N B
- I
CoR I
and O
SMRT B
. O

Cytokine O
inducibility O
of O
VCAM1 B
in O
endothelial O
cells O
utilizes O
the O
interaction O
of O
heterodimeric O
p50 B
/ O
p65 B
proteins O
with O
IRF B
- I
1 I
. O

To O
facilitate O
the O
characterization O
of O
NF B
- I
E2 I
functions O
in O
human O
cells O
, O
we O
isolated O
cDNAs O
encoding O
two O
members O
of O
the O
small O
Maf O
family O
, O
MafK O
and O
MafG B
. O

In O
contrast O
to O
the O
restricted O
tissue O
expression O
of O
gonadotropin B
and O
TSH O
receptors O
in O
gonads O
and O
thyroid O
, O
respectively O
, O
LGR4 O
is O
expressed O
in O
diverse O
tissues O
including O
ovary O
, O
testis O
, O
adrenal O
, O
placenta O
, O
thymus O
, O
spinal O
cord O
, O
and O
thyroid O
, O
whereas O
LGR5 O
is O
found O
in O
muscle O
, O
placenta O
, O
spinal O
cord O
, O
and O
brain O
. O

The O
JNK B
/ O
SAPK B
activator O
mixed O
lineage O
kinase O
3 O
( O
MLK3 O
) O
transforms O
NIH O
3T3 O
cells O
in O
a O
MEK B
- O
dependent O
fashion O
. O

In O
contrast O
to O
the O
effect O
on O
DNA O
replication O
, O
the O
L13V O
substitution O
in O
large B
T I
antigen I
did O
not O
prevent O
complex O
formation O
with O
Hsc70 B
and O
the O
Rb B
protein I
. O

We O
report O
here O
that O
AChE B
activity O
tends O
to O
decrease O
in O
individuals O
sampled O
in O
tanks O
at O
a O
salinity O
of O
30 O
per O
thousand O
as O
temperature O
increases O
. O

Three O
RasV12 O
mutants O
( O
S35 O
, O
G37 O
, O
and O
C40 O
) O
which O
differ O
by O
their O
ability O
to O
bind O
to O
Ras O
effectors O
( O
Raf B
, O
Ral O
- O
GEFs O
, O
and O
the O
p110 O
subunit O
of O
PI O
3 O
- O
kinase O
, O
respectively O
) O
were O
able O
to O
induce O
sustained O
NR O
cell O
proliferation O
, O
although O
none O
of O
these O
mutants O
was O
reported O
to O
transform O
NIH O
3T3 O
cells O
. O

A O
significant O
difference O
in O
the O
distribution O
of O
antibodies O
to O
thyroglobulin B
and O
thyroid B
peroxidase I
was O
found O
in O
subgroup O
2 O
. O

Here O
, O
we O
characterize O
TCR B
/ O
CD48 O
and O
TCR B
/ O
CD28 B
costimulation O
in O
T O
cells O
expressing O
Lck B
Src B
homology I
3 I
( O
SH3 B
) O
mutants O
. O

We O
have O
isolated O
two O
H19 O
cDNAs O
( O
AP B
and O
ES O
) O
that O
contain O
this O
ORF4 O
and O
correspond O
to O
incomplete O
copies O
of O
the O
unique O
2 O
. O
3 O
kb O
H19 O
RNA O
. O

The O
related O
adhesion O
focal O
tyrosine O
kinase O
is O
tyrosine O
- O
phosphorylated O
after O
beta1 O
- O
integrin O
stimulation O
in O
B O
cells O
and O
binds O
to O
p130cas B
. O

Analysis O
of O
a O
Het B
- O
mutation O
in O
Anabaena O
sp O
. O
strain O
PCC O
7120 O
implicates O
a O
secondary O
metabolite O
in O
the O
regulation O
of O
heterocyst O
spacing O
. O

Here O
we O
report O
that O
components O
of O
the O
Ras B
/ O
Raf B
/ O
MAPK B
pathway O
are O
constitutively O
activated O
in O
these O
lck B
- O
transformed O
immature O
thymoblasts O
. O

p56 B
( O
lck B
) O
utilizes O
Shc B
and O
Grb2 O
adaptors O
to O
mediate O
activation O
of O
p21 B
( O
ras B
) O
in O
the O
thymoblast O
lines O
by O
promoting O
tyrosine O
phosphorylation O
of O
the O
Shc O
protein O
and O
constitutive O
interaction O
between O
Shc B
and O
Grb2 B
. O

The O
PHO5 O
gene O
is O
activated O
by O
the O
Pho4p O
transcription O
factor O
, O
which O
itself O
is O
negatively O
regulated O
through O
phosphorylation O
by O
the O
products O
of O
PHO80 O
and O
PHO85 B
. O

We O
suggest O
that O
the O
responses O
to O
types O
I O
and O
II O
collagen O
were O
caused O
by O
a O
cross O
- O
reaction O
with O
type B
III I
collagen I
peptides O
. O

The O
5 O
' O
half O
of O
the O
EWS B
gene I
has O
recently O
been O
described O
to O
be O
fused O
to O
the O
3 O
' O
regions O
of O
genes O
encoding O
the O
DNA O
- O
binding O
domain O
of O
several O
transcriptional O
regulators O
, O
including O
ATF1 B
, O
FLI B
- I
1 I
, O
and O
ERG O
, O
in O
several O
human O
tumors O
. O

PDGF B
stimulated O
CDK2 B
activity O
in O
mesangial O
cells O
and O
decreased O
the O
level O
of O
p27 B
( O
kip1 B
) O
cyclin O
kinase O
inhibitor O
protein O
. O

The O
influence O
of O
different O
temperatures O
between O
13 O
degrees O
C O
and O
45 O
degrees O
C O
on O
coagulation O
factors O
in O
vitro O
was O
studied O
by O
measuring O
clotting O
time O
with O
the O
recalcification O
time O
, O
partial O
thromboplastin B
time O
( O
PTT O
) O
, O
and O
thromboplastin B
time O
test O
. O

Thus O
, O
transgene O
expression O
directed O
by O
both O
the O
human O
and O
mouse O
Rb O
promoters O
is O
restricted O
to O
a O
subset O
of O
tissues O
in O
which O
Rb B
is O
normally O
expressed O
during O
embryogenesis O
. O

Thus O
, O
Tax1 B
activates O
CArG O
- O
mediated O
transcription O
without O
mitogenic O
signals O
through O
interaction O
with O
a O
CArG O
- O
binding O
factor O
, O
p67SRF O
. O

The O
transcription O
start O
site O
was O
localized O
224 O
bp O
upstream O
the O
ATG O
codon O
by O
RNase B
protection O
and O
primer O
extension O
mapping O
. O

Rising O
antibody O
titres O
to O
the O
astrovirus O
particles O
were O
demonstrated O
in O
one O
child O
, O
and O
IgM B
was O
also O
demonstrated O
in O
this O
patient O
' O
s O
serum O
. O

Although O
RAD17 O
, O
RAD24 B
and O
MEC3 O
are O
not O
required O
for O
cell O
cycle O
arrest O
when O
S O
phase O
is O
inhibited O
by O
hydroxyurea O
( O
HU O
) O
, O
they O
do O
contribute O
to O
the O
viability O
of O
yeast O
cells O
grown O
in O
the O
presence O
of O
HU O
, O
possibly O
because O
they O
are O
required O
for O
the O
repair O
of O
HU O
- O
induced O
DNA O
damage O
. O

PTP1 O
- O
lacZ B
studies O
indicate O
that O
PTP1 O
is O
spatially O
localized O
to O
prestalk O
and O
anterior O
- O
like O
cell O
types O
. O

When O
translated O
in O
- O
frame O
with O
PKC B
zeta I
, O
a O
stop O
codon O
is O
located O
28 O
amino O
acids O
towards O
the O
N O
- O
terminus O
of O
the O
divergence O
point O
and O
the O
intervening O
sequence O
lacks O
an O
expected O
initiating O
methionine O
. O
psi O
PKC O
zeta O
is O
non O
- O
functional O
in O
terms O
of O
protein O
synthesis O
since O
Western O
blotting O
with O
an O
antibody O
directed O
against O
the O
C O
- O
terminus O
of O
PKC B
zeta I
failed O
to O
reveal O
a O
protein O
smaller O
than O
PKC B
zeta I
, O
and O
synthetic O
psi O
PKC O
zeta O
RNA O
failed O
to O
support O
protein O
synthesis O
in O
a O
translation O
system O
in O
vitro O
. O

Like O
Rev B
- O
Erb B
, O
BD73 O
binds O
as O
a O
monomer O
to O
a O
DNA O
sequence O
which O
consists O
of O
a O
specific O
A O
/ O
T O
- O
rich O
sequence O
upstream O
of O
the O
consensus O
hexameric O
half O
- O
site O
specified O
by O
the O
P O
box O
of O
the O
DNA O
- O
binding O
domain O
. O

In O
contrast O
, O
the O
holo O
- O
dTFIIA O
( O
L O
/ O
S O
) O
binds O
TBP B
with O
high O
affinity O
. O

A O
novel O
serine O
kinase O
activated O
by O
rac1 B
/ O
CDC42Hs B
- O
dependent O
autophosphorylation O
is O
related O
to O
PAK65 O
and O
STE20 O
. O

Overexpression O
of O
SNURF O
in O
cultured O
mammalian O
cells O
enhanced O
not O
only O
androgen O
, O
glucocorticoid O
, O
and O
progesterone B
receptor I
- O
dependent O
transactivation O
but O
also O
basal O
transcription O
from O
steroid O
- O
regulated O
promoters O
. O

The O
human O
protein O
binds O
most O
strongly O
to O
the O
SH3 B
domain I
from O
the O
abl O
proto O
- O
oncogene O
. O

These O
data O
show O
that O
tyrosine O
phosphorylation O
by O
FES B
affects O
the O
interaction O
of O
BCR B
with O
multiple O
signaling O
partners O
and O
suggest O
a O
general O
role O
for O
BCR B
in O
non O
- O
receptor O
protein B
- I
tyrosine I
kinase I
regulation O
and O
signal O
transduction O
. O

In O
addition O
to O
TAK1 B
, O
TGF B
- I
beta I
also O
stimulated O
JNK B
activity O
. O

Foamy O
viruses O
( O
FVs O
) O
express O
the O
Gag O
protein O
as O
a O
precursor O
with O
a O
molecular O
mass O
of O
74 O
kDa O
( O
pr74 O
) O
from O
which O
a O
70 O
- O
kDa O
protein O
( O
p70 B
) O
is O
cleaved O
by O
the O
viral O
protease O
. O

Ectopic O
expression O
of O
cyclin B
D1 I
in O
progestin O
- O
inhibited O
cells O
led O
to O
the O
reappearance O
of O
the O
120 O
- O
kDa O
active O
form O
of O
cyclin B
E I
- O
Cdk2 B
preceding O
the O
resumption O
of O
cell O
cycle O
progression O
. O

Because O
the O
wa O
- O
2 O
mutation O
was O
mapped O
previously O
to O
the O
vicinity O
of O
the O
EGF O
/ O
TGF O
- O
alpha O
receptor O
( O
EGFR B
) O
gene O
on O
mouse O
chromosome O
11 O
, O
we O
hypothesized O
that O
the O
wa O
- O
2 O
phenotype O
might O
result O
from O
a O
defect O
in O
either O
the O
expression O
or O
activity O
of O
EGFR B
, O
or O
both O
. O

INTERVENTIONS O
: O
Postoperative O
follow O
- O
up O
consisted O
of O
serial O
determination O
of O
different O
biochemical O
markers O
( O
CK B
, O
CK B
- I
MB I
, O
cTnI O
) O
, O
ECGs O
, O
and O
echocardiography O
. O

The O
recruitment O
of O
constitutively O
phosphorylated O
p185 O
( O
neu B
) O
and O
the O
activated O
mitogenic O
pathway O
proteins O
to O
this O
membrane O
- O
microfilament O
interaction O
site O
provides O
a O
physical O
model O
for O
integrating O
the O
assembly O
of O
the O
mitogenic O
pathway O
with O
the O
transmission O
of O
growth O
factor O
signal O
to O
the O
cytoskeleton O
. O

Deletion O
of O
the O
region O
from O
amino O
acid O
residues O
2 O
- O
67 O
in O
E1A B
, O
which O
has O
been O
postulated O
to O
interact O
with O
p300 B
/ O
CBP B
, O
also O
abolished O
the O
inhibitory O
effect O
of O
E1A B
, O
whereas O
deletion O
of O
the O
region O
from O
residues O
120 O
to O
140 O
had O
no O
effect O
. O

The O
point O
mutation O
Asp O
- O
316 O
- O
- O
> O
Asn O
in O
the O
C O
- O
terminus O
of O
p38 B
, O
analogous O
to O
the O
ERK2 B
( O
extracellular O
- O
signal O
- O
regulated O
kinase O
2 O
) O
sevenmaker O
mutation O
, O
dramatically O
decreases O
its O
binding O
to O
MKP B
- I
1 I
and O
substantially O
compromises O
its O
stimulatory O
effect O
on O
the O
catalytic O
activity O
of O
this O
phosphatase O
. O

BCR B
- O
ABL B
elicits O
transformation O
of O
both O
fibroblast O
and O
hematopoietic O
cells O
and O
blocks O
apoptosis O
following O
cytokine O
deprivation O
in O
various O
factor O
- O
dependent O
cells O
. O

Expression O
of O
the O
E2 B
protein I
resulted O
in O
rapid O
repression O
of O
HPV O
E6 O
and O
E7 B
expression O
, O
followed O
approximately O
12 O
h O
later O
by O
profound O
inhibition O
of O
cellular O
DNA O
synthesis O
. O

Plasma B
renin I
activity O
in O
end O
- O
stage O
kidney O
disease O
. O

Immunoblotting O
with O
antiphosphotyrosine O
antibody O
showed O
that O
many O
yeast O
proteins O
, O
including O
the O
p34CDC28 O
kinase O
, O
became O
phosphorylated O
at O
tyrosine O
in O
cells O
expressing O
v B
- I
src I
. O

In O
cells O
co O
- O
expressing O
high O
levels O
of O
the O
p38 B
( O
MAPK B
) O
kinase O
( O
MKK3 B
) O
together O
with O
the O
p38 B
( O
MAPK B
) O
, O
a O
significant O
inhibition O
of O
mitogen O
- O
induced O
cyclin B
D1 I
expression O
was O
observed O
. O

As O
regards O
the O
short O
stature O
, O
they O
have O
proved O
that O
the O
syndrome O
is O
related O
to O
low O
levels O
of O
somatomedin B
C I
( O
SmC O
) O
. O

HBO O
had O
marked O
effects O
on O
these O
enzymes O
: O
lung O
SOD O
increased O
( O
guinea O
pigs O
47 O
% O
, O
rats O
88 O
% O
) O
and O
CAT B
and O
GSHPx O
activities O
decreased O
( O
33 O
% O
) O
in O
brain O
and O
lung O
. O

Phylogenetic O
analysis O
of O
yeast O
, O
invertebrate O
, O
and O
multiple O
mammalian O
isoforms O
of O
SNF4 B
shows O
that O
the O
gene O
duplication O
likely O
occurred O
early O
in O
the O
metazoan O
lineage O
, O
as O
the O
protein O
products O
of O
the O
different O
loci O
are O
relatively O
divergent O
. O

The O
structural O
intestinal O
defects O
are O
presumed O
to O
be O
the O
result O
of O
defective O
collagen B
synthesis O
in O
these O
hereditary O
connective O
tissue O
disorders O
. O

Both O
v O
- O
Myb O
and O
c B
- I
Myb I
bind O
specifically O
to O
delta O
E3 O
. O

Serum O
levels O
of O
total O
and O
specific O
immunoglobulin O
E O
( O
IgE B
) O
have O
been O
determined O
by O
radioimmunoassays O
in O
sixty O
- O
nine O
allergic O
subjects O
. O

Hybridization O
was O
detected O
between O
polyadenylated O
H O
chain O
mRNA O
, O
isolated O
from O
the O
majority O
of O
the O
hybridomas O
, O
and O
the O
VH B
probe O
. O

Evaluation O
of O
gamma B
- I
glutamyl I
transpeptidase I
in O
myocardial O
infarction O
. O

Loss O
of O
pRb B
or O
p107 B
binding O
results O
in O
the O
loss O
of O
transforming O
activity O
. O

Peak O
insulin B
response O
to O
glucose O
infusion O
declined O
from O
Groups O
1 O
to O
3 O
( O
51 O
+ O
/ O
- O
14 O
, O
42 O
. O
4 O
+ O
/ O
- O
31 O
, O
20 O
. O
4 O
+ O
/ O
- O
6 O
. O
8 O
microU O
/ O
ml O
, O
respectively O
) O
with O
Group O
3 O
exhibiting O
a O
significantly O
decreased O
mean O
peak O
level O
compared O
to O
the O
other O
groups O
. O

RESULTS O
: O
Here O
, O
we O
report O
the O
identification O
of O
two O
major O
and O
novel O
Shc B
tyrosine O
phosphorylation O
sites O
, O
Y239 O
and O
Y240 O
. O

Dominant O
- O
negative O
upf1 B
mutations O
were O
isolated O
following O
in O
vitro O
mutagenesis O
of O
a O
plasmid O
containing O
the O
UPF1 O
gene O
. O

Papillomavirus O
type O
16 O
oncogenes O
downregulate O
expression O
of O
interferon B
- O
responsive O
genes O
and O
upregulate O
proliferation O
- O
associated O
and O
NF B
- I
kappaB I
- O
responsive O
genes O
in O
cervical O
keratinocytes O
. O

The O
human O
CA11 O
gene O
appears O
to O
be O
located O
between O
the O
secretor O
type O
alpha O
( O
1 O
, O
2 O
) O
- O
fucosyltransferase O
gene O
cluster O
( O
FUT1 B
- O
FUT2 O
- O
FUT2P O
) O
and O
the O
D O
- O
site O
binding O
protein O
gene O
( O
DBP B
) O
on O
chromosome O
19q13 O
. O
3 O
. O

An O
anoerxiant O
, O
mazindol O
suppresses O
food O
intake O
by O
1 O
) O
stimulating O
beta B
- I
adrenergic I
receptors I
, O
2 O
) O
inhibiting O
the O
feeding O
center O
and O
, O
3 O
) O
stimulating O
the O
satiety O
center O
in O
the O
hypothalamus O
. O

The O
fusion O
of O
AML1 B
to O
MDS1 B
is O
in O
frame O
, O
and O
adds O
127 O
codons O
to O
the O
interrupted O
AML1 B
. O

Second O
, O
overexpression O
of O
RIM11 O
can O
suppress O
an O
ime1 B
missense O
mutation O
( O
ime1 O
- O
L321F O
) O
but O
not O
an O
ime1 B
deletion O
. O

This O
50 O
- O
kDa O
protein O
contains O
two O
SH2 B
domains I
and O
an O
inter O
- O
SH2 O
domain O
of O
p85alpha B
, O
but O
the O
SH3 B
and O
bcr O
homology O
domains O
of O
p85alpha B
were O
replaced O
by O
a O
unique O
6 O
- O
amino O
acid O
sequence O
. O

The O
more O
sustained O
effect O
of O
cyclofenil O
on O
prolactin B
secretion O
with O
a O
reduced O
frequency O
of O
relapse O
, O
and O
the O
lower O
oestradiol O
level O
, O
which O
might O
indicate O
a O
reduced O
risk O
of O
thromboembolism O
, O
suggest O
that O
this O
drug O
has O
some O
advantage O
over O
bromocriptine O
in O
the O
inhibition O
of O
postpartum O
lactation O
. O

Northern O
( O
RNA O
) O
blot O
hybridization O
analysis O
with O
the O
p68c B
- I
ets I
- I
1 I
- O
specific O
sequence O
and O
RNase B
protection O
experiments O
showed O
that O
the O
corresponding O
mRNA O
was O
expressed O
in O
normal O
chicken O
spleen O
and O
not O
in O
normal O
chicken O
thymus O
or O
in O
various O
T O
lymphoid O
cell O
lines O
. O

IL B
- I
6 I
was O
detected O
in O
the O
urine O
of O
52 O
% O
of O
children O
with O
pyelonephritis O
compared O
with O
15 O
% O
of O
other O
children O
( O
P O
< O
0 O
. O
001 O
) O
. O

In O
contrast O
to O
p62 B
( O
dok O
) O
, O
DOKL O
lacks O
YxxP O
motifs O
in O
the O
C O
terminus O
and O
does O
not O
bind O
to O
Ras O
GTPase O
- O
activating O
protein O
( O
RasGAP O
) O
upon O
phosphorylation O
. O

These O
observations O
demonstrate O
that O
KSR B
is O
capable O
of O
uncoupling O
the O
MAP B
kinase I
activation O
from O
its O
target O
phosphorylation O
, O
and O
thus O
provide O
a O
novel O
mechanism O
for O
modulating O
the O
Ras B
- O
MAP B
kinase I
signaling O
pathway O
. O

G B
- I
CSF I
( O
10 O
microg O
/ O
kg O
) O
was O
started O
on O
day O
+ O
1 O
and O
all O
patients O
engrafted O
within O
a O
median O
day O
number O
of O
12 O
( O
range O
, O
10 O
- O
22 O
) O
until O
leukocytes O
> O
1 O
. O
0 O
x O
10 O
( O
9 O
) O
/ O
l O
and O
a O
median O
day O
number O
of O
56 O
( O
range O
, O
10 O
- O
180 O
) O
until O
platelets O
> O
20 O
. O
0 O
x O
10 O
( O
9 O
) O
/ O
l O
( O
ie O
platelet O
transfusion O
independence O
) O
. O

A O
higher O
percentage O
of O
children O
with O
cerebral O
malaria O
( O
40 O
per O
cent O
) O
than O
with O
non O
- O
cerebral O
malaria O
( O
29 O
per O
cent O
) O
or O
controls O
( O
20 O
per O
cent O
) O
also O
had O
either O
serum B
ferritin I
< O
100 O
micrograms O
/ O
l O
and O
inflammation O
or O
sTfR O
> O
7 O
. O
3 O
mg O
/ O
l O
or O
both O
. O

During O
the O
burst O
period O
( O
approximately O
5 O
- O
10 O
min O
) O
, O
local O
blood O
H2O2 O
concentrations O
and O
xanthine B
oxidase I
activities O
were O
highly O
correlated O
( O
r O
= O
0 O
. O
999 O
) O
. O

UV O
cross O
- O
linking O
and O
Southwestern O
analysis O
suggested O
that O
KTP1 O
is O
a O
DNA O
- O
binding O
protein O
clearly O
distinct O
from O
AP2 B
, O
and O
this O
protein O
may O
be O
responsible O
for O
the O
basal O
keratinocyte O
- O
specific O
expression O
of O
the O
BPAG1 O
gene O
. O

Here O
we O
demonstrate O
that O
a O
region O
of O
high O
homology O
between O
the O
members O
of O
this O
class O
of O
proteins O
contains O
a O
type O
A O
nucleotide O
binding O
site O
consensus O
sequence O
which O
has O
ATPase B
activity O
and O
is O
sufficient O
to O
bind O
DNA O
containing O
specific O
mismatched O
residues O
. O

S O
- O
phase O
- O
promoting O
cyclin B
- I
dependent I
kinases I
( O
Cdks B
) O
and O
the O
kinase O
Dbf4 B
- O
Cdc7 B
then O
act O
to O
initiate O
replication O
. O

NF B
- I
kappaB I
only O
partially O
mediates O
Epstein B
- I
Barr I
virus I
latent I
membrane I
protein I
1 I
activation O
of O
B O
cells O
. O

Purified O
fER B
exhibited O
a O
distribution O
constant O
( O
KD O
) O
for O
17 O
beta O
- O
estradiol O
of O
0 O
. O
45 O
nM O
. O

Injection O
of O
horseradish B
peroxidase I
( O
HRP O
) O
into O
the O
cerebellar O
flocculus O
of O
the O
rat O
was O
employed O
to O
identify O
neurons O
in O
the O
abducens O
nucleus O
that O
project O
to O
the O
flocculus O
. O

To O
assay O
for O
sequences O
that O
could O
potentially O
regulate O
Xenopus O
proenkephalin O
expression O
, O
we O
transfected O
constructs O
that O
contained O
upstream O
genomic O
sequences O
linked O
to O
the O
CAT B
reporter I
gene I
into O
various O
eukaryotic O
cell O
lines O
. O

This O
suggests O
that O
the O
ratio O
of O
IL B
- I
6 I
to O
IL O
- O
10 O
may O
be O
used O
to O
predict O
the O
injury O
severity O
after O
trauma O
. O

UVB O
- O
induced O
association O
of O
tumor O
necrosis O
factor O
( O
TNF O
) O
receptor O
1 O
/ O
TNF O
receptor O
- O
associated O
factor O
- O
2 O
mediates O
activation O
of O
Rel B
proteins I
. O

Our O
previous O
studies O
demonstrated O
that O
the O
promyelocytic O
leukemia O
gene O
, O
PML B
which O
involved O
in O
the O
15 O
; O
17 O
translocation O
in O
acute O
promyelocytic O
leukemia O
( O
APL O
) O
is O
a O
growth O
and O
transformation O
suppressor O
. O

Our O
data O
define O
Ile O
( O
16 O
) O
, O
Val O
( O
18 O
) O
, O
Val O
( O
31 O
) O
, O
and O
Ile O
( O
33 O
) O
as O
crucial O
for O
protein B
S I
binding O
, O
with O
secondary O
effects O
from O
Leu O
( O
38 O
) O
and O
Val O
( O
39 O
) O
. O

In O
the O
yeast O
two O
- O
hybrid O
assays O
, O
PNRC B
interacted O
with O
the O
orphan O
receptors O
SF1 B
and O
ERRalpha1 B
in O
a O
ligand O
- O
independent O
manner O
. O

Thus O
, O
CR2 O
possesses O
an O
essential O
function O
besides O
pRb B
- O
binding O
. O

Nitroglycerin O
( O
glyceryl O
trinitrate O
) O
as O
a O
monoamine B
oxidase I
inhibitor O
. O

K562 O
erythroleukemia O
cells O
stably O
transfected O
with O
constructs O
containing O
the O
human O
Agamma O
- O
globin O
promoter O
linked O
to O
an O
enhanced O
green O
fluorescent O
protein O
( O
EGFP B
) O
reporter O
, O
with O
or O
without O
HS2 O
, O
were O
analyzed O
for O
EGFP B
expression O
by O
flow O
cytometry O
. O

Gastrin B
stimulates O
transcription O
of O
the O
human O
histidine O
decarboxylase O
( O
HDC O
) O
gene O
through O
binding O
to O
the O
G B
- I
protein I
- O
coupled O
cholecystokinin O
- O
B O
/ O
gastrin B
receptor I
. O

mph1 O
functions O
upstream O
of O
mad2 B
, O
a O
previously O
characterized O
component O
of O
the O
spindle O
checkpoint O
. O

Hepatocyte B
growth I
factor I
( O
HGF B
) O
is O
an O
inducible O
cytokine O
that O
is O
essential O
for O
the O
normal O
growth O
and O
development O
of O
various O
tissues O
, O
such O
as O
the O
liver O
. O

Reduced O
concentrations O
of O
antithrombin B
III I
, O
plasminogen B
, O
( O
free O
) O
protein B
S I
, O
and O
protein B
C I
were O
found O
in O
some O
patients O
but O
were O
not O
associated O
with O
either O
thrombosis O
or O
lupus O
anticoagulant O
. O

Structure O
and O
chromosomal O
localization O
of O
the O
human O
gene O
of O
the O
phosphotyrosyl O
phosphatase O
activator O
( O
PTPA O
) O
of O
protein B
phosphatase I
2A I
. O

The O
unusual O
properties O
of O
TRAC B
activity O
and O
its O
relationship O
, O
if O
any O
, O
with O
the O
enigmatic O
Ku O
protein O
, O
are O
discussed O
. O

When O
expressed O
in O
thymidine B
kinase I
- O
deficient O
L O
cells O
or O
3T3 O
cells O
, O
C B
/ I
EBPalpha I
is O
detected O
in O
a O
protein O
complex O
which O
binds O
to O
the O
E2F O
binding O
sites O
found O
in O
the O
promoters O
of O
the O
genes O
for O
E2F B
- I
1 I
and O
dihydrofolate O
reductase O
( O
DHFR B
) O
. O

Members O
of O
the O
CRE B
- I
binding I
protein I
( O
CREB B
) O
/ O
activating O
transcription O
factor O
transcription O
family O
as O
well O
as O
members O
of O
the O
Jun B
/ O
Fos B
family O
have O
been O
shown O
to O
bind O
to O
this O
sequence O
. O

Csk B
( O
C B
- I
terminal I
Src I
kinase I
) O
is O
a O
protein B
tyrosine I
kinase I
that O
phosphorylates O
Src O
family O
member O
C O
- O
terminal O
tails O
, O
resulting O
in O
downregulation O
of O
Src B
family O
members O
. O

Role O
of O
double O
- O
stranded O
RNA O
- O
dependent O
protein O
kinase O
in O
mediating O
hypersensitivity O
of O
Fanconi O
anemia O
complementation O
group O
C O
cells O
to O
interferon B
gamma I
, O
tumor B
necrosis I
factor I
- I
alpha I
, O
and O
double O
- O
stranded O
RNA O
. O

Reaction O
of O
aromatic O
/ O
heterocyclic O
sulfonamides O
possessing O
free O
amino O
, O
imino O
or O
hydrazino O
moieties O
with O
7 O
- O
chloro O
- O
4 O
- O
chloromethylcoumarin O
afforded O
a O
series O
of O
N O
- O
[ O
( O
7 O
- O
chloro O
- O
4 O
- O
coumarinyl O
) O
- O
methyl O
] O
- O
derivatives O
which O
showed O
effective O
inhibition O
of O
three O
carbonic B
anhydrase I
( O
CA B
) O
isozymes O
. O

It O
is O
noteworthy O
that O
under O
more O
physiological O
conditions O
mimicking O
the O
cellular O
GDP O
/ O
GTP O
ratio O
, O
Raf B
enhances O
the O
GEF B
- O
stimulated O
GDP O
/ O
GTP O
exchange O
on O
Ha B
- I
Ras I
, O
in O
agreement O
with O
the O
sequestration O
of O
Ras O
. O
GTP O
by O
Raf B
. O

When O
O O
- O
2A O
/ O
c B
- I
myc I
cells O
underwent O
terminal O
differentiation O
APprog O
complexes O
were O
lost O
and O
conventional O
AP B
- I
1 I
DNA O
- O
binding O
activity O
became O
evident O
, O
particularly O
in O
astrocytes O
. O

Toward O
this O
end O
, O
we O
used O
two O
cultured O
colon O
cancer O
cell O
lines O
; O
one O
( O
RKO O
) O
has O
a O
transcriptionally O
activated O
u B
- I
PAR I
gene I
, O
and O
the O
other O
( O
GEO O
) O
overexpresses O
the O
receptor O
only O
after O
phorbol O
ester O
treatment O
. O

Site O
- O
directed O
mutagenesis O
of O
the O
conserved O
cysteine O
residue O
( O
tom1C3235A O
) O
in O
the O
hect O
- O
domain O
, O
supposed O
to O
be O
necessary O
for O
thioester O
- O
bond O
formation O
with O
ubiquitin B
, O
abolished O
the O
gene O
function O
. O

The O
two O
yeast O
pheromone O
receptors O
, O
the O
a O
and O
alpha O
- O
factor O
receptors O
, O
share O
many O
functional O
similarities O
: O
both O
G B
protein I
- I
coupled I
receptors I
couple O
to O
the O
same O
downstream O
signal O
transduction O
pathway O
, O
and O
both O
receptors O
undergo O
feedback O
regulation O
involving O
increased O
phosphorylation O
on O
their O
C O
- O
terminal O
domains O
in O
response O
to O
ligand O
challenge O
. O

The O
two O
SH3 B
domains I
are O
separated O
by O
a O
54 O
amino O
acid O
linker O
region O
, O
whose O
length O
is O
highly O
conserved O
in O
xenopus O
, O
chicken O
, O
and O
mamalian O
Crk O
II O
proteins O
. O

This O
complex O
was O
eliminated O
by O
mutation O
of O
either O
half O
- O
site O
, O
and O
it O
was O
supershifted O
by O
antibodies O
against O
chicken B
ovalbumin I
upstream I
promoter I
- I
transcription I
factor I
( O
COUP B
- I
TF I
) O
. O

In O
this O
report O
, O
we O
establish O
that O
the O
heteromeric O
CCAAT O
- O
binding O
factor O
CBF B
is O
the O
major O
component O
of O
the O
C1 O
- O
binding O
factor O
( O
C1F B
) O
in O
human O
cells O
. O

A O
40 O
- O
fold O
stimulation O
of O
chloramphenicol B
acetyltransferase I
activity O
mediated O
by O
four O
tandem O
repeats O
of O
the O
SNE O
could O
be O
induced O
within O
2 O
h O
( O
and O
up O
to O
250 O
- O
fold O
within O
6 O
h O
) O
after O
addition O
of O
TPA O
in O
DNA O
- O
transfected O
U O
- O
937 O
cells O
, O
indicating O
that O
the O
stimulation O
appeared O
likely O
to O
be O
a O
true O
protein B
kinase I
C I
- O
mediated O
signal O
transduction O
event O
rather O
than O
a O
differentiation O
response O
. O

A O
mouse O
brain O
cDNA O
library O
in O
lambdagt11 O
was O
screened O
for O
this O
association O
, O
and O
two O
positive O
clones O
encoding O
tyrosine O
phosphatase O
SH B
- I
PTP2 I
were O
isolated O
. O

Disorganization O
scores O
of O
the O
hypertrophy O
zone O
and O
trabecular O
bone O
were O
low O
, O
approaching O
normal O
( O
P O
< O
0 O
. O
05 O
) O
, O
for O
turkey O
poults O
fed O
on O
diets O
with O
phytase B
supplementation O
, O
and O
tibial O
abnormality O
scores O
were O
linearly O
decreased O
( O
P O
< O
0 O
. O
001 O
) O
as O
nP O
levels O
increased O
( O
zero O
score O
is O
considered O
normal O
) O
. O

Repression O
was O
strictly O
dependent O
on O
the O
presence O
of O
upstream O
Oshox1 B
binding O
sites O
in O
the O
reporter O
gene O
constructs O
and O
a O
function O
of O
the O
N O
- O
terminal O
region O
of O
Oshox1 B
, O
preceding O
the O
homeodomain B
. O

To O
elucidate O
the O
molecular O
mechanism O
by O
which O
the O
Ras B
signaling O
pathway O
activates O
a O
cell O
- O
type O
- O
specific O
gene O
, O
we O
have O
used O
the O
pituitary O
- O
specific O
rat O
prolactin O
( O
rPRL O
) O
promoter O
as O
a O
target O
of O
oncogenic B
Ras I
and O
Raf B
in O
GH4 O
rat O
pituitary O
cells O
. O

HGF B
treatment O
increased O
cyclin B
A I
, O
cyclin O
G1 O
and O
nuclear O
transcriptional O
factor O
( O
NFkappaB B
) O
protein O
expression O
. O

The O
1 O
. O
6 O
- O
kb O
cDNA O
( O
CBF B
- I
A I
) O
encoding O
285 O
amino O
acids O
( O
aa O
) O
was O
obtained O
, O
and O
a O
beta O
- O
galactosidase O
fusion O
protein O
, O
bacterially O
produced O
from O
the O
cDNA O
, O
bound O
to O
DNA O
fragments O
containing O
several O
CArG O
boxes O
. O

Despite O
these O
high O
initial O
rates O
of O
transcription O
, O
of O
all O
the O
promoter O
constructs O
only O
LAT B
- O
LTR O
was O
able O
to O
remain O
transcriptionally O
active O
after O
the O
establishment O
of O
a O
latent O
state O
. O

Effects O
of O
timepidium O
bromide O
( O
TB O
; O
anticholinergic O
agent O
) O
, O
acetylcholine O
( O
ACh O
) O
and O
neostigmine O
( O
Neost O
) O
on O
gastric O
and O
duodenal O
blood O
flow O
distribution O
were O
studied O
by O
the O
use O
of O
131I O
- O
labeled O
macroaggregated O
human O
serum O
albumin O
( O
MAA B
) O
in O
rabbits O
. O

The O
liver O
- O
specific O
sequence O
contains O
unique O
consensus O
sites O
for O
phosphorylation O
by O
cyclic B
AMP I
- I
dependent I
protein I
kinase I
and O
by O
protein B
kinase I
C I
. O

The O
exact O
function O
of O
IP O
- O
30 O
is O
not O
yet O
known O
, O
but O
it O
may O
play O
a O
role O
in O
gamma B
- I
interferon I
mediated O
immune O
reactions O
. O

In O
this O
report O
, O
we O
demonstrate O
that O
FRS2 O
forms O
a O
complex O
with O
the O
N O
- O
terminal O
SH2 O
domain O
of O
the O
protein O
tyrosine O
phosphatase O
Shp2 O
in O
response O
to O
FGF B
stimulation O
. O

These O
results O
establish O
that O
the O
DNA O
fragment O
we O
have O
isolated O
contains O
the O
human O
gp130 O
promoter O
and O
that O
interleukin O
- O
6 O
type O
cytokines O
may O
influence O
the O
activity O
of O
this O
promoter O
via O
activated O
STATs B
. O

When O
targeted O
to O
the O
GAL1 O
promoter O
by O
fusing O
with O
the O
Gal4p O
DNA O
- O
binding O
domain O
, O
Sko1p B
acts O
as O
an O
Ssn6 O
/ O
Tup1p O
- O
dependent O
repressor O
regulated O
by O
osmotic O
stress O
. O

The O
unexpected O
prevalence O
of O
c B
- I
myc I
and O
alpha O
- O
tubulin O
in O
the O
S O
- O
phase O
library O
is O
supported O
by O
Northern O
analysis O
of O
RNA O
from O
phase O
- O
synchronous O
cells O
. O

Growth O
factors O
promote O
cell O
survival O
through O
phosphorylation O
of O
Bad B
, O
resulting O
in O
its O
dissociation O
from O
Bcl B
- I
2 I
and O
Bcl B
- I
x I
( I
L I
) I
and O
its O
association O
with O
14 O
- O
3 O
- O
3tau O
. O

Only O
the O
native O
structure O
of O
phosphorylated O
ERK B
was O
recognized O
by O
VHR O
and O
was O
inactivated O
with O
a O
second O
- O
order O
rate O
constant O
of O
40 O
, O
000 O
M O
- O
1 O
s O
- O
1 O
. O

We O
used O
an O
immobilized O
template O
- O
based O
assay O
to O
examine O
transcription O
termination O
by O
VA1 O
, O
7SL O
, O
and O
Alu O
class O
III O
templates O
and O
the O
role O
of O
transcript O
release O
in O
the O
pol B
III I
terminator O
- O
dependent O
inhibition O
of O
processing O
of O
B1 O
- O
Alu B
transcripts O
. O

Although O
IL B
- I
6 I
can O
activate O
ERK B
- I
1 I
in O
HepG2 O
cells O
, O
STAT3 B
transactivation O
and O
Ser O
( O
727 O
) O
phosphorylation O
were O
not O
reduced O
by O
using O
the O
MAP B
kinase I
/ O
ERK B
kinase I
( O
MEK B
) O
inhibitor O
PD98059 O
or O
by O
overexpression O
of O
dominant O
- O
negative O
Raf B
. O

Joint O
ultrasonography O
demonstrating O
thickening O
of O
synoviae O
and O
tendons O
has O
become O
a O
useful O
non O
- O
invasive O
diagnostic O
tool O
, O
although O
it O
is O
not O
specific O
for O
beta B
2 I
- I
M I
amyloidosis O
, O
and O
results O
depend O
on O
observer O
experience O
. O

Nuclear O
runoff O
assays O
show O
that O
complementation O
by O
HPV16 O
E7 O
restores O
the O
ability O
of O
the O
E1A O
mutants O
to O
stimulate O
early B
gene I
expression O
at O
the O
level O
of O
transcription O
. O

Yet O
IL B
- I
2 I
and O
IFN B
- I
gamma I
production O
are O
independently O
regulated O
, O
as O
demonstrated O
by O
their O
differential O
expression O
in O
certain O
T O
cell O
subsets O
, O
suggesting O
that O
the O
regulatory O
elements O
in O
these O
two O
genes O
must O
differ O
. O

We O
conclude O
that O
a O
0 O
. O
25 O
mg O
dose O
of O
triazolam O
does O
not O
effectively O
counteract O
a O
posture O
- O
induced O
sleep O
disturbance O
, O
but O
induces O
changes O
in O
the O
EEG O
spectra O
which O
are O
typical O
for O
benzodiazepine B
receptor I
agonists O
. O

Functional O
uncoupling O
of O
the O
Janus O
kinase O
3 O
- O
Stat5 B
pathway O
in O
malignant O
growth O
of O
human O
T O
cell O
leukemia O
virus O
type O
1 O
- O
transformed O
human O
T O
cells O
. O

4 O
- O
Hydroxyproline O
assays O
were O
performed O
to O
determine O
collagen B
content O
. O

Although O
IRS O
- O
1 O
, O
- O
2 O
, O
and O
- O
4 O
are O
similar O
in O
overall O
structure O
, O
IRS B
- I
3 I
is O
approximately O
50 O
% O
shorter O
and O
differs O
with O
respect O
to O
sites O
of O
tyrosine O
phosphorylation O
. O

In O
addition O
, O
we O
mapped O
a O
putative O
hnRNP B
A1 I
binding I
site I
in O
U5 B
RNA I
and O
demonstrated O
that O
p40CRS B
( O
hnRNP O
A1 O
) O
binding O
to O
that O
site O
correlates O
with O
CRS B
function O
. O

This O
element O
was O
required O
for O
both O
basal O
and O
activated O
expression O
and O
almost O
certainly O
functions O
as O
a O
TATA B
- I
binding I
protein I
interaction O
site O
. O

In O
HepG2 O
cells O
, O
SREBP O
- O
1c O
mRNA O
and O
precursor O
protein O
levels O
were O
induced O
by O
treatment O
with O
22 O
( O
R O
) O
- O
hydroxycholesterol O
and O
9 O
- O
cis O
- O
retinoic O
acid O
, O
confirming O
that O
endogenous O
LXR O
- O
RXR B
activation O
can O
induce O
endogenous O
SREBP O
- O
1c O
expression O
. O

Four O
of O
15 O
patients O
with O
R2 B
had O
rheumatoid O
arthritis O
and O
in O
two O
of O
these O
four O
cases O
the O
antibody O
was O
of O
the O
IgA B
class O
. O

Vav B
and O
Dbl B
are O
members O
of O
a O
novel O
class O
of O
oncogene O
proteins O
that O
share O
significant O
sequence O
identity O
in O
a O
approximately O
250 O
- O
amino O
- O
acid O
domain O
, O
designated O
the O
Dbl O
homology O
domain O
. O

Serum O
AFP B
is O
a O
useful O
tumor O
marker O
for O
monitoring O
the O
results O
of O
therapy O
. O

Unlike O
LANA1 O
, O
LANA2 B
does O
not O
elicit O
a O
serologic O
response O
from O
patients O
with O
KS O
, O
PEL O
, O
or O
CD O
as O
measured O
by O
Western O
blot O
hybridization O
. O

However O
, O
this O
posttranslational O
modification O
of O
the O
gar2 O
protein O
does O
not O
appear O
to O
be O
essential O
for O
normal O
production O
of O
18S B
rRNA I
. O

Here O
, O
we O
analyzed O
the O
interaction O
of O
CYT B
- I
18 I
with O
a O
small O
RNA O
( O
P4 O
- O
P6 O
RNA O
) O
corresponding O
to O
the O
isolated O
P4 O
- O
P6 O
domain O
of O
the O
N O
. O
crassa O
mitochondrial O
large O
subunit O
ribosomal O
RNA O
intron O
. O

The O
deduced O
amino O
acid O
sequence O
of O
PutR O
( O
154 O
amino O
acid O
residues O
) O
showed O
homology O
to O
the O
small O
regulatory O
proteins O
Lrp B
, O
BkdR O
, O
and O
AsnC O
. O

When O
yeast O
cells O
reach O
a O
critical O
size O
in O
late O
G1 O
they O
simultaneously O
start O
budding O
, O
initiate O
DNA O
synthesis O
, O
and O
activate O
transcription O
of O
a O
set O
of O
genes O
that O
includes O
G1 O
cyclins O
CLN1 B
, O
CLN2 B
, O
and O
many O
DNA O
synthesis O
genes O
. O

Accordingly O
, O
superpeptide O
antigenic O
material O
was O
readily O
detected O
by O
immunoblotting O
cell O
extracts O
and O
enriched O
in O
vacuolar O
preparations O
of O
PrA B
deficient O
mutant O
cells O
. O

Blockade O
of O
T O
cell O
activation O
using O
a O
surface O
- O
linked O
single O
- O
chain O
antibody O
to O
CTLA B
- I
4 I
( O
CD152 O
) O
. O

In O
this O
work O
, O
we O
have O
used O
Xenopus O
oocyte O
maturation O
as O
a O
read O
- O
out O
for O
examining O
the O
ability O
of O
the O
neu B
tyrosine B
kinase I
( O
p185neu O
) O
to O
participate O
with O
the O
epidermal O
growth O
factor O
( O
EGF O
) O
receptor O
in O
a O
common O
signal O
transduction O
pathway O
. O

The O
best O
- O
studied O
neurotrophin O
, O
nerve B
growth I
factor I
( O
NGF B
) O
, O
is O
a O
major O
survival O
factor O
in O
sympathetic O
and O
sensory O
neurons O
and O
promotes O
differentiation O
in O
a O
well O
- O
studied O
model O
system O
, O
PC12 O
cells O
. O

In O
contrast O
, O
MAPK B
activation O
stimulated O
by O
the O
Gq O
- O
coupled O
alpha O
1B O
AR O
or O
M1 O
muscarinic O
cholinergic O
receptor O
is O
unaffected O
by O
expression O
of O
beta O
ARKct O
or O
RasN17 O
expression O
or O
by O
PTK B
inhibitors O
, O
but O
is O
blocked O
by O
expression O
of O
N O
delta O
Raf O
or O
by O
PKC B
depletion O
. O

The O
steady O
- O
state O
levels O
of O
Cdk2 B
, O
Cdk4 B
and O
Cyclin O
A O
proteins O
were O
unaffected O
by O
HPR O
, O
while O
those O
of O
Cyclin B
D1 I
were O
significantly O
reduced O
in O
all O
three O
cell O
lines O
. O

Three O
experiments O
using O
20 O
microM O
2 O
- O
( O
hydroxyamino O
) O
- O
1 O
- O
methyl O
- O
6 O
- O
phenylimidazo O
[ O
4 O
, O
5 O
- O
b O
] O
pyridine O
( O
N O
- O
OH O
- O
PhIP O
) O
were O
performed O
to O
induce O
mutations O
in O
the O
dihydrofolate O
reductase O
( O
DHFR B
) O
gene O
of O
a O
hemizygous O
Chinese O
hamster O
ovary O
( O
CHO O
) O
cell O
line O
( O
UA21 O
) O
. O

Our O
results O
separate O
these O
factors O
into O
four O
regulatory O
classes O
: O
( O
i O
) O
constitutive O
factors O
, O
such O
as O
Oct B
- I
1 I
and O
probably O
Sp1 B
, O
that O
are O
expressed O
in O
thymocytes O
at O
all O
stages O
; O
( O
ii O
) O
inducible O
factors O
, O
such O
as O
NF B
- I
kappa I
B I
and O
complexes O
binding O
to O
the O
region O
of O
a O
CD28 O
response O
element O
, O
that O
can O
be O
activated O
in O
all O
thymocytes O
, O
including O
those O
cells O
( O
CD4 B
+ I
CD8 B
+ I
TcRlow O
) O
that O
can O
undergo O
selection O
; O
( O
iii O
) O
inducible O
factors O
, O
such O
as O
NF B
- I
AT I
and O
AP B
- I
1 I
, O
that O
can O
be O
activated O

in O
mature O
( O
CD4 B
+ I
CD8 B
- I
TcRhigh O
) O
and O
immature O
( O
CD4 B
- I
CD8 B
- I
TcR B
- I
) O
thymocytes O
alike O
but O
not O
in O
the O
transitional O
stages O
when O
the O
cells O
( O
CD4 B
+ I
CD8 B
+ I
TcRlow O
) O
are O
subject O
to O
selection O
; O
and O
( O
iv O
) O
a O
factor O
containing O
CREB B
, O
which O
can O
be O
activated O
in O
thymocytes O
of O
all O
developmental O
stages O
by O
culture O
but O
does O
not O
require O
specific O
induction O
. O

We O
also O
show O
that O
in O
fusions O
with O
the O
DNA O
binding O
domain O
of O
GAL4 B
, O
full O
activity O
requires O
the O
entire O
BHV B
- I
alpha I
TIF I
, O
although O
both O
amino O
and O
carboxyl O
termini O
display O
some O
activity O
on O
their O
own O
. O

Moreover O
, O
antibody O
binding O
to O
the O
same O
two O
determinants O
was O
also O
inhibited O
when O
ZAP B
- I
70 I
or O
the O
SH2 B
domains I
bound O
to O
the O
zeta O
chain O
or O
to O
a O
2pY O
- O
ITAM O
. O

The O
immunoreactive O
antithrombin B
III I
increased O
significantly O
while O
the O
increase O
in O
antithrombin B
III I
activity O
was O
insignificant O
in O
20 O
male O
Caucasian O
Danes O
upon O
3 O
weeks O
supplementation O
of O
the O
diet O
with O
10 O
ml O
daily O
of O
a O
cod O
liver O
oil O
concentrate O
. O

The O
transcriptional O
transactivator O
( O
Tas O
) O
of O
simian O
foamy O
virus O
type O
1 O
strongly O
augments O
gene O
expression O
directed O
by O
both O
the O
promoter O
in O
the O
viral O
long O
terminal O
repeat O
and O
the O
newly O
discovered O
internal O
promoter O
located O
within O
the O
env B
gene I
. O

Mutations O
in O
the O
beta B
- I
galactosidase I
gene I
result O
in O
the O
lysosomal O
storage O
disorders O
GM1 O
- O
gangliosidosis O
and O
Morquio O
B O
syndrome O
. O

The O
IR4 O
ORF O
exhibits O
significant O
homology O
to O
the O
immediate B
- I
early I
gene I
US1 O
( O
ICP22 O
) O
of O
herpes O
simplex O
virus O
type O
1 O
and O
to O
the O
ICP22 O
homologs O
of O
varicella O
- O
zoster O
virus O
( O
ORF63 O
) O
, O
pseudorabies O
virus O
( O
RSp40 O
) O
, O
and O
equine O
herpesvirus O
4 O
( O
ORF4 O
) O
. O

These O
include O
not O
only O
antioxidants O
, O
N O
- O
methyl O
- O
D O
- O
aspartate O
receptor O
antagonists O
, O
inhibitors O
of O
glutamate O
release O
, O
calcium O
channel O
blockers O
, O
polyamine O
antagonists O
, O
and O
nitric B
oxide I
synthase I
inhibitors O
, O
but O
cannabinoids O
, O
aspirin O
, O
melatonin O
, O
and O
vitamin O
B O
- O
12 O
. O

A O
series O
of O
mutations O
were O
constructed O
within O
the O
E2 B
open O
reading O
frame O
which O
delete O
various O
regions O
of O
the O
conserved O
DNA O
binding O
and O
transactivation O
domains O
as O
well O
as O
the O
internal O
hinge O
region O
. O

CrkII O
and O
CrkL B
constitutively O
formed O
complex O
with O
the O
guanine B
nucleotide I
exchange I
factor I
C3G B
, O
in O
unstimulated O
as O
well O
as O
PDGF B
- O
stimulated O
cells O
. O

Further O
studies O
aim O
at O
characterizing O
the O
trans O
- O
acting O
factors O
that O
mediate O
the O
spatial O
and O
temporal O
expression O
of O
Hox B
genes I
in O
the O
developing O
embryo O
. O

As O
to O
the O
side O
effects O
of O
SISO O
, O
cylindruria O
with O
aggravation O
of O
microscopic O
hematuria O
and O
elevations O
of O
GOT O
, O
GPT B
and O
A1 O
- O
P O
were O
observed O
each O
one O
of O
them O
, O
respectively O
. O

Determinants O
of O
recurrent O
ischaemia O
and O
revascularisation O
procedures O
after O
thrombolysis O
with O
recombinant O
tissue B
plasminogen I
activator I
in O
primary O
coronary O
occlusion O
. O

Finally O
, O
transfection O
of O
Grb10 O
genes O
with O
specific O
mutations O
in O
their O
SH2 B
domains I
induces O
apoptosis O
in O
HTC O
- O
IR O
and O
COS O
- O
7 O
cells O
. O

Heterotrimeric O
guanine O
nucleotide O
- O
binding O
proteins O
( O
G B
- I
proteins I
) O
function O
as O
signal O
transducers O
for O
a O
variety O
of O
hormone O
- O
coupled O
enzyme O
and O
ion O
transport O
systems O
in O
eukaryotic O
cells O
. O

In O
the O
HIV B
LTR I
, O
this O
region O
has O
been O
demonstrated O
to O
have O
both O
positive O
and O
negative O
regulatory O
effects O
on O
HIV O
gene O
expression O
. O

Small O
t O
also O
inhibited O
the O
dephosphorylation O
of O
cAMP B
- I
dependent I
protein I
kinase I
( O
PKA B
) O
- O
phosphorylated O
CREB B
in O
rat O
liver O
nuclear O
extracts O
. O

Fos B
/ O
Jun B
bound O
to O
an O
unacetylated O
nucleosome O
with O
only O
a O
4 O
- O
to O
5 O
- O
fold O
reduction O
in O
DNA O
binding O
affinity O
compared O
with O
naked O
DNA O
. O

Electromobility O
shift O
analysis O
using O
oligonucleotides O
encompassing O
the O
proximal O
, O
distal O
, O
and O
BED O
/ O
AP B
- I
1 I
- O
binding O
regions O
failed O
to O
demonstrate O
selective O
transactivation O
after O
CD2 O
signaling O
of O
LPMC O
. O

The O
present O
report O
shows O
that O
a O
cis O
- O
acting O
element O
between O
- O
189 O
and O
- O
175 O
bp O
, O
which O
binds O
thyroid B
transcription I
factor I
- I
1 I
( O
TTF B
- I
1 I
) O
, O
is O
involved O
in O
both O
activities O
. O

Increased O
platelet B
- I
derived I
growth I
factor I
production O
and O
intimal O
thickening O
during O
healing O
of O
Dacron O
grafts O
in O
a O
canine O
model O
. O

Moreover O
, O
we O
show O
that O
ectopic O
expression O
of O
the O
E2A O
protein O
E12 B
in O
this O
macrophage O
line O
results O
in O
the O
induction O
of O
many O
B O
lineage O
genes O
, O
including O
EBF O
, O
IL7Ralpha O
, O
lambda5 O
, O
and O
Rag O
- O
1 O
, O
and O
the O
ability O
to O
induce O
kappa O
light O
chain O
in O
response O
to O
mitogen O
. O

A O
selective O
transcriptional O
induction O
system O
for O
mammalian O
cells O
based O
on O
Gal4 B
- O
estrogen B
receptor I
fusion O
proteins O
. O

Kinase O
renaturation O
tests O
designed O
to O
detect O
reactivated O
protein O
kinases O
after O
electrophoresis O
in O
sodium O
dodecyl O
sulfate O
- O
polyacrylamide O
gels O
revealed O
the O
presence O
of O
a O
60 O
- O
kDa O
kinase O
in O
the O
washed O
immunoprecipitate O
obtained O
from O
liver O
cytosol O
using O
anti O
- O
AHR O
antibody O
( O
IgG B
) O
and O
protein O
A O
/ O
G O
/ O
agarose O
beads O
but O
not O
when O
a O
nonspecific O
IgG B
was O
used O
instead O
of O
anti O
- O
AHR O
antibody O
. O

Immunoblotting O
using O
a O
phosphospecific O
anti O
- O
Src O
( O
416Y O
) O
antibody O
showed O
a O
ceramide O
- O
induced O
increase O
in O
pp60 B
( O
src B
) O
tyrosine O
phosphorylation O
. O

In O
contrast O
, O
dominant O
negative O
Rac O
( O
N17Rac1 O
) O
inhibited O
JNK B
activation O
by O
Galpha12 B
in O
HEK293 O
cells O
as O
well O
as O
three O
other O
cell O
lines O
. O

These O
results O
suggest O
that O
1a B
, O
which O
also O
interacts O
independently O
with O
the O
ER O
and O
viral O
RNA O
, O
is O
a O
key O
organizer O
of O
RNA O
replication O
complex O
assembly O
. O

Expression O
of O
Msx B
- I
1 I
and O
Msx O
- O
2 O
has O
been O
studied O
during O
development O
of O
the O
osteoblast O
phenotype O
, O
but O
the O
role O
of O
Dlx O
in O
this O
context O
and O
in O
the O
regulation O
of O
bone O
- O
expressed O
genes O
is O
unknown O
. O

DESIGN O
: O
Activating O
protein O
- O
1 O
( O
AP B
- I
1 I
) O
and O
Tat B
- O
induced O
transcription O
were O
assessed O
using O
Jun B
and O
hybrid O
Tat B
/ O
Jun B
- O
expression O
plasmids O
and O
reporter O
gene O
constructs O
which O
contained O
AP O
- O
1 O
binding O
sites O
upstream O
of O
the O
rat O
prolactin O
TATAA O
element O
or O
an O
HIV O
- O
1 O
LTR O
construct O
in O
which O
AP O
- O
1 O
binding O
sites O
replaced O
the O
TAR O
element O
. O

Mycobacterium O
tuberculosis O
inhibits O
IFN B
- I
gamma I
transcriptional O
responses O
without O
inhibiting O
activation O
of O
STAT1 B
. O

GH B
stimulated O
the O
activity O
of O
promoter O
fragments O
with O
5 O
' O
- O
ends O
between O
nucleotide O
( O
nt O
) O
- O
2001 O
and O
nt O
- O
653 O
by O
1 O
. O
9 O
- O
to O
2 O
. O
7 O
- O
fold O
. O

We O
have O
recently O
shown O
that O
induced O
expression O
of O
a O
CDK B
target O
site O
- O
deficient O
mutant O
, O
Op18 O
- O
S25A O
, O
S38A O
, O
blocks O
human O
cell O
lines O
during O
G2 O
/ O
M O
transition O
. O

A O
protein O
which O
promotes O
DNA O
strand O
transfer O
between O
linear O
double O
- O
stranded O
M13mp19 O
DNA O
and O
single O
- O
stranded O
viral O
M13mp19 O
DNA O
has O
been O
isolated O
from O
recA B
- I
E O
. O
coli O
. O

The O
serum O
levels O
of O
cortisol O
and O
prolactin B
after O
nasal O
instillation O
of O
a O
suspension O
of O
vaginal O
exudate O
showed O
lower O
values O
than O
in O
control O
conditions O
( O
nasal O
instillation O
of O
saline O
) O
. O

IgE B
antibody I
to O
twelve O
common O
food O
and O
inhalant O
allergens O
was O
measured O
by O
enzyme O
- O
linked O
immunosorbent O
assay O
( O
ELISA O
) O
in O
the O
sera O
of O
thirteen O
atopic O
patients O
with O
one O
or O
more O
allergic O
disorders O
( O
asthma O
occurring O
in O
eleven O
; O
rhinitis O
in O
ten O
; O
eczema O
in O
six O
; O
urticaria O
in O
four O
; O
mouth O
and O
gastro O
- O
intestinal O
symptoms O
in O
six O
) O
, O
of O
twelve O
non O
- O
atopic O
patients O
with O
various O
clinical O
symptoms O
( O
asthma O
in O
four O
; O
rhinitis O
in O
four O
; O
eczema O
in O
one O
; O
urticaria O
in O

Signaling O
through O
mitogen B
- I
activated I
protein I
kinase I
and O
Rac B
/ O
Rho B
does O
not O
duplicate O
the O
effects O
of O
activated O
Ras B
on O
skeletal O
myogenesis O
. O

Internalization O
of O
prolactin O
receptor O
and O
prolactin B
in O
transfected O
cells O
does O
not O
involve O
nuclear O
translocation O
. O

Using O
mammalian O
expression O
vectors O
( O
pRSV O
- O
neo O
and O
pSV2 O
- O
neo O
) O
, O
antisense O
constructs O
for O
perforin B
and O
granzyme O
B O
were O
independently O
electroporated O
into O
YT O
- O
INDY O
, O
a O
human O
non O
- O
MHC B
- O
restricted O
, O
IL B
- I
2 I
- O
independent O
, O
cytotoxic O
lymphocyte O
. O

When O
expressed O
in O
Escherichia O
coli O
, O
SH B
- I
PTP2 I
displays O
tyrosine O
- O
specific O
phosphatase O
activity O
. O

In O
the O
promoters O
of O
many O
immediate B
early I
genes I
, O
including O
c B
- I
fos I
, O
CArG O
DNA O
regulatory O
elements O
mediate O
basal O
constituitive O
expression O
and O
rapid O
and O
transient O
serum O
induction O
. O

The O
biological O
activity O
of O
these O
mutants O
was O
tested O
by O
determining O
their O
capacity O
to O
( O
i O
) O
reconstitute O
RNA B
polymerase I
activity O
in O
vivo O
by O
cotransfection O
with O
proteins O
NP B
, O
PB1 O
, O
and O
PA B
and O
a O
virion O
- O
like O
RNA O
encoding O
the O
cat B
gene O
into O
vaccinia O
virus O
T7 O
- O
infected O
COS O
- O
1 O
cells O
and O
( O
ii O
) O
complete O
with O
the O
wild O
- O
type O
PB2 O
activity O
. O

Western O
blot O
analyses O
reveals O
that O
cJun B
and O
the O
C O
/ O
EBP O
family O
member O
C B
/ I
EBP I
- I
beta I
are O
physiologically O
relevant O
transcription O
factors O
whose O
expression O
corresponds O
with O
mda O
- O
7 O
mRNA O
expression O
. O

In O
isolated O
olfactory O
cilia O
certain O
odorants O
elicit O
a O
rapid O
and O
transient O
cAMP O
response O
, O
terminated O
by O
a O
concerted O
process O
which O
requires O
the O
action O
of O
two O
protein O
kinases O
, O
protein B
kinase I
A I
( O
PKA B
) O
and O
a O
receptor O
- O
specific O
kinase O
( O
GRK3 B
) O
( O
Schleicher O
, O
S O
. O
, O
Boekhoff O
, O
I O
. O

We O
propose O
that O
GCD7 O
and O
GCD2 O
play O
important O
roles O
in O
the O
regulatory O
interaction O
between O
eIF B
- I
2 I
and O
eIF B
- I
2B I
and O
that O
the O
suppressor O
mutations O
we O
isolated O
in O
these O
genes O
decrease O
the O
susceptibility O
of O
eIF B
- I
2B I
to O
the O
inhibitory O
effects O
of O
phosphorylated O
eIF B
- I
2 I
without O
impairing O
the O
essential O
catalytic O
function O
of O
eIF B
- I
2B I
in O
translation O
initiation O
. O

Lack O
of O
changes O
in O
milk O
production O
and O
milk O
composition O
suggest O
that O
acute O
increases O
in O
somatotropin O
with O
concomitant O
increases O
in O
insulin B
are O
not O
sufficient O
to O
stimulate O
synthesis O
of O
milk O
and O
milk O
components O
by O
cows O
during O
established O
lactation O
. O

Iomazenil O
- O
SPECT O
revealed O
a O
highly O
significant O
increase O
in O
the O
benzodiazepine B
receptor I
uptake O
in O
all O
studied O
cortical O
regions O
except O
temporal O
cortices O
. O

Since O
RIP140 B
generally O
down O
- O
regulates O
receptor O
activity O
in O
mammalian O
cells O
and O
specifically O
down O
- O
regulates O
coactivation O
mediated O
by O
SRC B
- I
1 I
, O
we O
propose O
a O
model O
in O
which O
RIP140 B
indirectly O
regulates O
nuclear O
receptor O
AF O
- O
2 O
activity O
by O
competition O
for O
coactivators O
such O
as O
SRC B
- I
1 I
. O

As O
in O
the O
case O
of O
the O
chicken O
homologue O
, O
there O
are O
two O
hPR B
forms O
, O
A O
and O
B O
, O
which O
originate O
from O
translational O
initiation O
at O
AUG2 O
( O
codon O
165 O
) O
and O
AUG1 O
, O
respectively O
. O

In O
cells O
stably O
transfected O
with O
G O
alpha O
i O
- O
2 O
or O
G O
alpha O
i O
- O
3 O
gene O
5 O
' O
- O
flanking O
sequences O
fused O
to O
firefly O
luciferase B
cDNA O
reporter O
, O
temporal O
10 O
- O
15 O
- O
fold O
transcriptional O
activation O
of O
both O
genes O
occurred O
before O
cellular O
polarization O
. O

CONCLUSIONS O
: O
These O
results O
suggest O
that O
histamine O
- O
2 O
receptor O
activation O
mechanisms O
may O
not O
be O
involved O
in O
postoperative O
IL B
- I
6 I
synthesis O
. O

Database O
searches O
revealed O
a O
50 O
- O
63 O
% O
similarity O
and O
34 O
- O
42 O
% O
identity O
with O
several O
families O
of O
serine B
proteases I
, O
in O
particular O
the O
trypsin O
- O
like O
proteases O
, O
members O
of O
the O
glandular O
kallikrein O
family O
( O
including O
prostate B
- I
specific I
antigen I
, O
nerve O
growth O
factor O
gamma O
, O
and O
epidermal O
growth O
factor O
- O
binding O
protein O
) O
and O
the O
activators O
for O
the O
kringle O
family O
proteins O
( O
including O
the O
human O
tissue O
plasminogen O
activator O
and O
human O
hepatocyte O
growth O
factor O
activator O
) O
. O

We O
established O
that O
, O
in O
unstimulated O
lymphocytes O
, O
the O
Src B
homology I
2 I
( O
SH2 B
) O
and O
SH3 O
domain O
- O
containing O
protein O
Grb2 B
and O
the O
p85 B
subunit O
of O
phosphatidylinositol B
3 I
- I
kinase I
, O
associate O
constitutively O
with O
Cbl B
via O
their O
SH3 B
domains I
. O

Zta B
stimulated O
the O
HAT B
activity O
of O
CBP B
that O
had O
been O
partially O
purified O
or O
immunoprecipitated O
from O
mammalian O
cells O
as O
well O
as O
from O
affinity O
- O
purified O
, O
baculovirus O
expressed O
CBP B
. O

Expression O
of O
the O
Hox B
genes I
egl O
- O
5 O
and O
mab O
- O
5 O
is O
reduced O
in O
lin O
- O
49 O
and O
lin O
- O
59 O
mutants O
, O
suggesting O
lin O
- O
49 O
and O
lin O
- O
59 O
regulate O
HOM O
- O
C O
gene O
expression O
in O
C O
. O
elegans O
as O
the O
trx O
- O
G O
genes O
do O
in O
Drosophila O
. O

Interleukin B
- I
1 I
increased O
the O
noradrenaline O
release O
. O

3 O
patients O
with O
acute O
leukaemia O
, O
HLA B
antibodies O
and O
thrombocytopenia O
refractory O
to O
random O
donor O
platelet O
transfusions O
were O
treated O
with O
high O
- O
dose O
i O
. O
v O
. O
immunoglobulin B
. O

Two O
genes O
( O
ptsI O
and O
ptsA O
) O
that O
encode O
homologues O
of O
the O
energy O
coupling O
Enzyme B
I I
of O
the O
phosphoenolpyruvate O
- O
dependent O
sugar O
- O
transporting O
phosphotransferase O
system O
( O
PTS O
) O
have O
previously O
been O
identified O
on O
the O
Escherichia O
coli O
chromosome O
. O

These O
results O
point O
towards O
post O
- O
translational O
steric O
and O
/ O
or O
allosteric O
control O
of O
EKLF B
function O
that O
may O
be O
important O
not O
just O
for O
its O
DNA O
binding O
ability O
, O
but O
also O
for O
its O
potential O
to O
interact O
with O
other O
proteins O
that O
fully O
establish O
the O
correct O
stereospecific O
array O
leading O
to O
efficient O
switching O
of O
beta B
- I
globin I
transcription O
during O
development O
. O

The O
activated O
glucocorticoid B
receptor I
forms O
a O
complex O
with O
Stat5 B
and O
enhances O
Stat5 B
- O
mediated O
transcriptional O
induction O
. O

For O
example O
, O
the O
presence O
of O
two O
related O
genes O
, O
b B
and O
b B
' I
, O
in O
the O
cyanobacterium O
suggests O
that O
its O
ATP O
synthase O
is O
a O
complex O
of O
nine O
polypeptides O
, O
and O
that O
it O
may O
have O
single O
copies O
of O
related O
b B
and O
b O
' O
proteins O
rather O
than O
two O
copies O
of O
identical O
b O
subunits O
as O
found O
in O
the O
E O
. O
coli O
enzyme O
. O
4 O
+ O
off O

Antiserum O
raised O
against O
rat O
liver O
S6 O
kinase O
specifically O
immunoprecipitates O
the O
purified O
32P O
- O
labeled O
H4 O
hepatoma O
insulin O
- O
stimulated O
S6 B
kinase I
. O

CRKL B
, O
an O
SH2 B
- O
SH3 B
- O
SH3 B
adapter O
protein O
, O
is O
one O
of O
the O
major O
tyrosine O
phosphoproteins O
detected O
in O
primary O
leukemic O
neutrophils O
from O
patients O
with O
CML O
. O

In O
contrast O
, O
inactivation O
of O
the O
Sir4p O
- O
interacting O
protein O
Rap1p O
reduces O
partitioning O
by O
a O
LexA B
- O
Sir4p O
fusion O
. O

BACKGROUND O
: O
Murine O
Nramp O
is O
a O
candidate O
for O
the O
macrophage O
resistance O
gene O
Ity O
/ O
Lsh O
/ O
Bcg B
. O

In O
cases O
in O
which O
it O
was O
identified O
, O
insulitis O
affected O
23 O
% O
of O
islets O
containing O
insulin B
, O
but O
affected O
only O
1 O
% O
of O
islets O
which O
were O
insulin B
deficient O
, O
thus O
supporting O
the O
concept O
that O
insulitis O
represents O
an O
immunologically O
mediated O
destruction O
of O
insulin B
secreting O
B O
cells O
. O

To O
investigate O
possible O
roles O
for O
HCP B
during O
late O
erythroid O
differentiation O
, O
effects O
of O
manipulating O
HCP B
expression O
or O
recruitment O
on O
EPO B
- O
induced O
hemoglobinization O
in O
erythroleukemic O
SKT6 O
cells O
have O
been O
investigated O
. O

We O
provided O
evidence O
that O
CaM B
kinase I
II I
played O
a O
role O
in O
regulating O
neurite O
outgrowth O
and O
growth O
cone O
motility O
in O
these O
cells O
, O
and O
that O
the O
autophosphorylation O
is O
essential O
for O
the O
kinase O
to O
sufficiently O
exert O
its O
cellular O
function O
in O
vivo O
[ O
Y O
. O

However O
, O
in O
transient O
transfection O
assays O
, O
a O
truncation O
of O
as O
little O
as O
15 O
Nurr1 O
COOH O
- O
terminal O
amino O
acids O
diminished O
transcriptional O
activation O
of O
B1A O
- O
thymidine B
kinase I
- O
chloramphenicol B
acetyltransferase I
reporter O
. O

Characterization O
of O
human O
activating O
transcription O
factor O
4 O
, O
a O
transcriptional O
activator O
that O
interacts O
with O
multiple O
domains O
of O
cAMP B
- I
responsive I
element I
- I
binding I
protein I
( O
CREB B
) O
- O
binding O
protein O
. O

In O
contrast O
to O
the O
reciprocal O
effects O
of O
Gab1 B
and O
Gab2 B
in O
mediating O
Elk B
- I
1 I
induction O
, O
these O
two O
molecules O
have O
a O
similar O
function O
in O
extracellular B
signal I
- I
regulated I
kinase I
activation O
induced O
by O
either O
oncogenic O
Ras B
or O
growth O
factor O
stimulation O
. O

Chromaffin O
cells O
transfected O
with O
a O
plasmid O
with O
the O
entire O
coding O
sequence O
of O
c O
- O
Rabphilin3a O
inserted O
in O
the O
antisense O
orientation O
inhibited O
secretion O
of O
co O
- O
expressed O
GH B
by O
approximately O
30 O
% O
. O

Having O
demonstrated O
proper O
localization O
of O
GFP B
- O
calmodulin B
in O
budding O
yeast O
, O
we O
examined O
the O
localization O
of O
a O
fusion O
between O
GFP B
and O
calmodulin B
( O
GFP O
- O
Camlp O
) O
in O
fission O
yeast O
, O
where O
calmodulin B
had O
not O
been O
localized O
by O
any O
method O
. O

Sera O
from O
33 O
newborn O
infants O
with O
gestational O
ages O
ranging O
from O
27 O
to O
41 O
weeks O
were O
tested O
by O
radioimmunoassay O
for O
IgG B
antibodies O
to O
surface O
antigens O
of O
group O
B O
streptococci O
( O
GBS O
) O
types O
Ia O
, O
Ib O
, O
II O
and O
III O
. O

Seminal O
prolactin B
levels O
were O
significantly O
elevated O
in O
all O
infertile O
males O
. O

In O
the O
univariate O
models O
of O
either O
fixed O
or O
time O
dependent O
covariates O
, O
many O
variables O
were O
significantly O
associated O
with O
risk O
of O
progression O
to O
AIDS O
( O
T4 O
cell O
count O
, O
T4 O
/ O
T8 O
ratio O
, O
blastogenic O
responses O
to O
phytohemagglutinin B
, O
concanavalin B
A I
, O
and O
pokeweed O
mitogen O
, O
serum B
IgA I
, O
appearance O
of O
p24 O
antigen O
, O
and O
the O
development O
of O
oral O
hairy O
leukoplakia O
, O
thrush O
, O
or O
herpes O
zoster O
) O
. O

Adenovirus O
- O
mediated O
gene O
transfer O
of O
MMAC1 O
/ O
PTEN O
to O
glioblastoma O
cells O
inhibits O
S O
phase O
entry O
by O
the O
recruitment O
of O
p27Kip1 B
into O
cyclin B
E I
/ O
CDK2 B
complexes O
. O

These O
cells O
also O
showed O
an O
increase O
in O
cyclin B
A I
and O
cyclin O
A O
- O
and O
E O
- O
associated O
kinase O
activities O
characteristic O
of O
S O
phase O
induction O
. O

This O
domain O
encompasses O
the O
region O
of O
ARP B
- I
1 I
/ O
COUP B
- I
TFII I
corresponding O
to O
helices O
3 O
to O
12 O
in O
the O
recently O
published O
crystal O
structure O
of O
other O
members O
of O
the O
nuclear O
receptor O
superfamily O
. O

Importantly O
, O
a O
single O
base O
change O
in O
the O
fifth O
position O
of O
the O
c O
- O
fos O
sequence O
( O
GGTCTnnnAGACC O
to O
GGTCA O
/ O
GnnnAGACC O
) O
produced O
an O
element O
that O
bound O
the O
estrogen B
receptor I
and O
conferred O
estrogen O
- O
dependent O
transcriptional O
activation O
of O
a O
reporter O
gene O
. O

Co O
- O
expression O
of O
a O
gag B
- O
TRalpha B
fusion O
protein O
in O
AEV O
- O
transformed O
cells O
and O
addition O
of O
ligand O
derepresses O
CAII O
transcription O
. O

Here O
we O
demonstrate O
that O
the O
T O
cell O
antigen O
receptor O
zeta O
- O
chain O
- O
associated O
ZAP O
- O
70 O
kinase O
and O
T O
cell O
antigen O
receptor O
zeta O
- O
chain O
immunoreceptor O
tyrosine O
- O
based O
activation O
motifs O
are O
essential O
for O
the O
membrane O
recruitment O
of O
SOS B
and O
Vav B
. O

When O
linked O
to O
the O
herpes O
simplex O
thymidine B
kinase I
minimal O
promoter O
, O
this O
fragment O
acts O
as O
an O
enhancing O
element O
in O
Rcho O
but O
not O
GC O
cells O
. O

The O
incidence O
of O
the O
variability O
of O
the O
free O
PSA B
/ O
total O
PSA B
ratio O
on O
the O
early O
diagnosis O
of O
prostate O
cancer O

The O
contribution O
of O
residues O
outside O
the O
Ras O
binding O
domain O
of O
Raf B
( O
RafRBD O
) O
to O
Ras B
- O
Raf B
interaction O
and O
Ras B
- O
dependent O
Raf B
activation O
has O
remained O
unresolved O
. O

To O
obtain O
information O
on O
the O
functional O
role O
of O
the O
Rac1 B
/ O
p38 B
/ O
MAPKAPK O
- O
2 O
pathway O
in O
RA O
signaling O
, O
the O
effects O
of O
pharmacological O
inhibition O
of O
p38 B
on O
RA O
- O
induced O
gene O
transcription O
and O
cell O
differentiation O
were O
determined O
. O

The O
ATF B
/ O
CRE O
site O
is O
also O
essential O
for O
CD4 O
promoter O
activation O
by O
forskolin O
, O
an O
activator O
of O
adenylate B
cyclase I
. O

YLL031c B
is O
an O
essential O
gene O
. O

Incubation O
of O
HeLa O
cell O
cytoplasmic O
extracts O
with O
a O
purified O
recombinant O
glutathione B
S I
- I
transferase I
- O
raf B
fusion O
protein O
in O
the O
presence O
of O
ATP O
released O
active O
NF B
- I
kappa I
B I
that O
could O
be O
detected O
by O
electrophoretic O
gel O
mobility O
shift O
assay O
. O

In O
contrast O
, O
a O
similar O
fusion O
protein O
( O
hGH B
- O
LDLR O
- O
DAF17 O
, O
abbreviated O
HLD O
) O
containing O
a O
fragment O
of O
the O
serine O
/ O
threonine O
- O
rich O
domain O
of O
the O
LDL O
receptor O
( O
LDLR O
) O
in O
place O
of O
the O
DAF O
- O
derived O
serine O
/ O
threonine O
- O
rich O
sequences O
, O
does O
not O
become O
GPI O
anchored O
. O

Thus O
, O
the O
pathway O
to O
Fc O
epsilonRI O
- O
mediated O
MEK B
/ O
ERK B
and O
ERK B
activation O
can O
apparently O
bypass O
Ras B
and O
Raf B
- I
1 I
. O

Ftz B
, O
on O
the O
other O
hand O
, O
influences O
Ftz B
- O
F1 B
activity O
by O
interacting O
with O
its O
AF O
- O
2 O
domain O
in O
a O
manner O
that O
mimics O
a O
nuclear O
receptor O
coactivator O
. O

This O
mechanism O
seems O
to O
be O
involved O
in O
VIP B
- O
induced O
PRL O
gene O
regulation O
. O

Competition O
and O
methylation O
interference O
assays O
showed O
that O
the O
binding O
site O
for O
the O
novel O
factor O
was O
limited O
to O
nucleotides O
in O
the O
3 O
' O
half O
of O
the O
kappa B
B I
site I
. O

These O
properties O
prompted O
us O
to O
investigate O
Ets B
- I
1 I
expression O
in O
32 O
human O
astroglial O
tumors O
of O
WHO O
grades O
I O
- O
IV O
and O
to O
correlate O
the O
data O
with O
the O
expression O
pattern O
of O
VEGF B
, O
Flt O
- O
1 O
, O
and O
KDR O
. O

Mean O
concentration O
of O
insulin B
in O
maternal O
plasma O
across O
all O
sampling O
times O
was O
higher O
in O
ethanol O
treated O
animals O
. O

The O
strongly O
DNA O
binding O
p50 B
subunit I
showed O
only O
very O
weak O
, O
if O
any O
, O
induction O
of O
gene O
expression O
. O

E1A B
+ O
cHa B
- I
ras I
transformed O
rat O
embryo O
fibroblast O
cells O
are O
characterized O
by O
high O
and O
constitutive O
DNA O
binding O
activities O
of O
AP O
- O
1 O
dimers O
with O
significantly O
altered O
composition O
. O

Nuclear O
localization O
of O
this O
SNF2 O
- O
like O
putative O
helicase B
is O
dependent O
on O
a O
nuclear O
localization O
sequence O
located O
in O
the O
NH2 O
- O
terminal O
region O
. O

The O
feasibility O
of O
creating O
CR1 B
/ O
Ig B
chimeras O
makes O
possible O
a O
new O
strategy O
of O
targeting O
complement O
inhibition O
by O
the O
use O
of O
Ig O
fusion O
partners O
having O
particular O
antigenic O
specificities O
. O

Here O
we O
show O
that O
inhibition O
occurs O
with O
a O
NS1 B
- O
Rev B
chimera O
in O
which O
the O
78 O
amino O
- O
terminal O
amino O
acids O
of O
the O
NS1A O
protein O
comprising O
its O
entire O
RNA O
- O
binding O
domain O
is O
deleted O
, O
thereby O
establishing O
that O
this O
carboxyl O
portion O
of O
the O
NS1A O
protein O
can O
function O
as O
an O
independent O
effector O
domain O
. O

The O
non O
- O
major O
histocompatibility O
complex O
( O
MHC B
) O
- O
encoded O
CD1 O
family O
has O
recently O
emerged O
as O
a O
new O
antigen O
- O
presenting O
system O
that O
is O
distinct O
from O
either O
MHC O
class O
I O
or O
class O
II O
molecules O
. O

Removal O
of O
ink4a B
dramatically O
reduces O
the O
lymphoid O
and O
neurological O
defects O
seen O
in O
bmi O
- O
1 O
- O
deficient O
mice O
, O
indicating O
that O
ink4a B
is O
a O
critical O
in O
vivo O
target O
for O
Bmi O
- O
1 O
. O

We O
found O
that O
RXR B
and O
VDR B
transactivated O
selectively O
from O
VDRE O
- O
linked O
templates O
exclusively O
as O
a O
heterodimeric O
complex O
, O
since O
neither O
receptor O
alone O
enhanced O
transcription O
in O
vitro O
. O

Early O
complement O
components O
, O
C1q B
and O
C4 B
, O
and O
IgA B
secretory O
piece O
were O
absent O
. O

Using O
a O
dominant O
negative O
form O
of O
Sp3 B
and O
transcriptional O
activation O
assays O
in O
Schneider O
SL O
- O
2 O
insect O
cells O
, O
it O
was O
confirmed O
that O
ERalpha B
- O
Sp3 B
interactions O
define O
a O
pathway O
for O
E2 B
- O
mediated O
inhibition O
of O
gene O
expression O
, O
and O
this O
represents O
a O
new O
mechanism O
for O
decreased O
gene O
expression O
by O
E2 B
. O

In O
this O
study O
, O
to O
elucidate O
the O
possible O
mechanism O
of O
action O
of O
EM O
, O
we O
examined O
the O
effect O
of O
the O
drug O
on O
the O
expression O
of O
neutrophil O
adhesion O
molecules O
such O
as O
L B
- I
selectin I
and O
Mac O
- O
1 O
. O

In O
this O
study O
, O
we O
verified O
that O
PI B
3 I
- I
kinase I
associates O
with O
the O
CD4 B
: O
p56lck O
complex O
as O
judged O
by O
the O
presence O
of O
PI O
3 O
- O
phosphate O
generated O
from O
anti O
- O
CD4 O
immunoprecipitates O
and O
detected O
by O
high O
- O
pressure O
liquid O
chromatographic O
analysis O
. O

In O
this O
study O
, O
a O
site O
of O
PDGF B
- O
induced O
tyrosine O
phosphorylation O
was O
mapped O
to O
Tyr O
138 O
in O
the O
SH3 B
domain I
; O
Tyr O
138 O
is O
exposed O
on O
the O
SH3 O
peptide O
binding O
surface O
. O

C B
/ I
EBP I
delta I
( O
NFIL O
- O
6 O
beta O
) O
was O
not O
detected O
in O
complexes O
utilizing O
extracts O
from O
the O
IL B
- I
1 I
nonproducing O
T O
cell O
line O
. O

Reduced O
risk O
of O
upper O
gastrointestinal O
ulcer O
complications O
with O
celecoxib O
, O
a O
novel O
COX B
- I
2 I
inhibitor O
. O

Indications O
for O
therapy O
using O
MAO B
inhibitors O

Footprints O
on O
the O
HPV O
18 O
enhancer O
show O
five O
protected O
regions O
with O
homologies O
to O
NF1 B
, O
AP1 B
and O
EFII O
transcription O
factor O
binding O
motifs O
. O

Insulin B
binding O
to O
the O
alpha O
- O
subunit O
of O
its O
receptor O
stimulates O
the O
receptor B
tyrosine I
kinase I
to O
phosphorylate O
the O
beta O
- O
subunit O
and O
several O
endogenous O
protein O
substrates O
, O
including O
pp120 B
/ O
HA4 O
, O
a O
liver O
- O
specific O
plasma O
membrane O
glycoprotein O
of O
M O
( O
r O
) O
20 O
, O
000 O
. O

Motilin B
serum O
levels O
were O
measured O
for O
one O
hour O
. O

We O
have O
analyzed O
herein O
the O
roles O
that O
four O
different O
PIAS O
proteins O
( O
ARIP3 O
/ O
PIASx O
alpha O
, O
Miz1 O
/ O
PIASx O
beta O
, O
GBP O
/ O
PIAS1 O
, O
and O
PIAS3 B
) O
play O
in O
the O
regulation O
of O
steroid O
receptor O
- O
or O
STAT B
- O
mediated O
transcriptional O
activation O
. O

A O
decrease O
was O
also O
found O
of O
the O
levels O
of O
total O
cholesterol O
and O
LDL B
- I
cholesterol I
. O

Previously O
, O
we O
had O
shown O
that O
interleukin B
8 I
( O
IL B
- I
8 I
) O
is O
constitutively O
expressed O
in O
HTLV O
- O
I O
- O
infected O
cells O
and O
in O
cells O
transiently O
expressing O
Tax B
. O

Unlike O
JNK B
activation O
, O
ERK B
activation O
could O
not O
be O
mapped O
to O
specific O
reovirus O
gene O
segments O
, O
suggesting O
that O
ERK B
activation O
and O
JNK B
activation O
are O
triggered O
by O
different O
events O
during O
virus O
- O
host O
cell O
interaction O
. O

B B
and O
C1 O
fusions O
with O
yeast O
GAL4 O
DNA O
- O
binding O
and O
transcriptional O
activation O
domains O
were O
also O
found O
to O
interact O
when O
synthesized O
and O
assayed O
in O
yeast O
. O

In O
addition O
, O
these O
results O
suggest O
that O
the O
interactions O
, O
and O
consequently O
the O
mechanisms O
, O
governing O
transcriptional O
activation O
by O
CTF B
are O
distinct O
from O
those O
mediating O
DNA O
replication O
. O

We O
propose O
that O
optimal O
transcription O
of O
the O
gD O
gene O
depends O
on O
the O
interaction O
of O
ICP4 B
with O
multiple O
binding O
sites O
across O
the O
gene O
and O
cellular O
factors O
that O
recognize O
specific O
sequence O
elements O
in O
the O
promoter O
. O

Recently O
, O
we O
and O
other O
laboratories O
have O
identified O
a O
family O
of O
caveolin O
- O
related O
proteins O
; O
caveolin B
has O
been O
re O
- O
termed O
caveolin O
- O
1 O
. O

Role O
of O
zinc O
- O
finger O
proteins O
Sp1 O
and O
zif268 B
/ O
egr B
- I
1 I
in O
transcriptional O
regulation O
of O
the O
human O
synaptobrevin O
II O
gene O
. O

First O
, O
mutations O
in O
the O
IFNgamma O
- O
activated O
sequence O
( O
GAS B
) O
, O
either O
multimerized O
or O
in O
the O
context O
of O
the O
1 O
. O
7 O
- O
kb O
IRF O
- O
1 O
promoter O
, O
failed O
to O
mediate O
a O
PRL B
response O
, O
showing O
that O
the O
IRF B
- I
1 I
GAS B
is O
a O
target O
of O
PRL B
signaling O
. O

This O
selective O
squelching O
activity O
suggests O
that O
GRIM O
can O
interact O
with O
an O
essential O
component O
of O
the O
RNA B
polymerase I
II I
transcription O
machinery O
. O

A O
360 O
- O
bp O
DNA O
fragment O
located O
over O
500 O
bp O
upstream O
from O
the O
cfl O
transcriptional O
start O
site O
was O
used O
in O
DNase B
I I
protection O
assays O
to O
define O
the O
specific O
bases O
bound O
by O
CorR O
. O

Given O
a O
rapid O
induction O
of O
Egr B
- I
1 I
on O
stimulation O
with O
growth O
factors O
or O
injury O
, O
these O
findings O
may O
represent O
at O
least O
one O
of O
the O
molecular O
mechanisms O
underlying O
phenotypic O
modulation O
of O
smooth O
muscles O
after O
vascular O
injury O
. O

This O
is O
the O
first O
report O
which O
clearly O
proved O
CEA B
synthesis O
in O
the O
cells O
of O
HCC O
. O

By O
screening O
a O
human O
testis O
cDNA O
library O
with O
a O
probe O
containing O
the O
mouse O
PEA3 O
ETS B
domain O
, O
we O
isolated O
a O
2 O
. O
2 O
kb O
clone O
containing O
a O
510 O
AA O
open O
reading O
frame O
. O

These O
findings O
suggest O
that O
IL B
- I
1 I
- O
stimulated O
, O
Rho B
- O
dependent O
cytoskeletal O
reorganization O
may O
cluster O
signaling O
molecules O
in O
specific O
architectures O
that O
are O
necessary O
for O
persistent O
cell O
activation O
in O
chronic O
inflammatory O
disease O
. O

Changes O
in O
testicular O
testosterone O
and O
acid O
and O
alkaline B
phosphatase I
activity O
in O
testis O
and O
accessory O
sex O
organs O
after O
induction O
of O
varicocele O
in O
Noble O
rats O
. O

After O
birth O
, O
there O
was O
a O
significantly O
higher O
increase O
of O
IgA B
and O
IgM O
anti O
- O
M O
. O
leprae O
antibody O
activity O
in O
sera O
taken O
3 O
- O
6 O
months O
after O
birth O
from O
babies O
of O
Group O
1 O
compared O
to O
Group O
2 O
, O
but O
the O
IgA B
and O
IgM B
activity O
in O
sera O
taken O
after O
6 O
months O
of O
age O
showed O
the O
same O
increase O
in O
the O
two O
groups O
. O

The O
relation O
between O
the O
changes O
of O
bone O
density O
and O
the O
level O
of O
blood O
calcium O
, O
blood O
phosphorus O
and O
alkaline B
phosphatase I
( O
AKP O
) O
as O
well O
as O
the O
metabolism O
of O
vitamin O
D O
was O
studied O
. O

trans O
- O
activation O
of O
the O
HIV B
- I
1 I
LTR I
by O
the O
HIV O
- O
1 O
Tat O
and O
HTLV O
- O
I O
Tax O
proteins O
is O
mediated O
by O
different O
cis O
- O
acting O
sequences O
. O

Defective O
concanavalin B
A I
- O
induced O
suppression O
in O
bancroftian O
filariasis O
. O

This O
evaluation O
examines O
several O
analytical O
and O
cost O
parameters O
for O
five O
representative O
assays O
: O
IgG B
, O
IgA B
, O
IgM B
, O
phenytoin O
, O
and O
phenobarbital O
. O

These O
results O
suggest O
that O
UvrA B
is O
involved O
in O
triplet O
repeat O
instability O
in O
cells O
. O

A O
novel O
protein B
kinase I
C I
( O
PKC B
) O
- O
interacting O
protein O
was O
identified O
by O
the O
yeast O
two O
- O
hybrid O
screening O
using O
the O
regulatory O
domain O
of O
PKC O
beta O
I O
as O
a O
bait O
. O

Phosphorylation O
at O
Ser O
( O
670 O
) O
impairs O
the O
ability O
of O
GRK2 B
to O
phosphorylate O
both O
soluble O
and O
membrane O
- O
incorporated O
receptor O
substrates O
and O
dramatically O
attenuates O
Gbetagamma B
- O
mediated O
activation O
of O
this O
enzyme O
. O

METHODS O
: O
CD4 B
cell O
counts O
and O
interview O
data O
were O
recorded O
in O
a O
survey O
of O
136 O
adult O
patients O
attending O
a O
community O
hospital O
- O
based O
HIV O
outpatient O
clinic O
. O

Symptoms O
, O
skin O
- O
prick O
tests O
( O
SPT O
) O
with O
environmental O
allergens O
and O
Pt O
salt O
, O
total O
serum B
IgE I
, O
lung O
function O
, O
and O
bronchial O
hyperresponsiveness O
were O
assessed O
by O
standard O
procedures O
. O

The O
binding O
of O
PTB B
was O
antagonistic O
to O
the O
binding O
of O
U2AF B
to O
the O
enhancer O
- O
located O
pyrimidine O
tract O
. O

VLA O
- O
4 O
integrin O
cross O
- O
linking O
on O
human O
monocytic O
THP O
- O
1 O
cells O
induces O
tissue O
factor O
expression O
by O
a O
mechanism O
involving O
mitogen B
- I
activated I
protein I
kinase I
. O

However O
, O
studies O
using O
the O
A20 O
promoter O
demonstrated O
that O
LMP1 B
transcriptionally O
activates O
the O
A20 O
gene O
through O
cis O
- O
acting O
kappa O
B O
sites O
. O

Southern O
blot O
analysis O
revealed O
that O
CCaMK B
is O
encoded O
by O
a O
single O
gene O
. O

Phenazopyridine O
- O
induced O
hemolytic O
anemia O
in O
a O
patient O
with O
G6PD B
deficiency O
. O

Finally O
, O
we O
demonstrated O
that O
although O
the O
DNA O
- O
binding O
domain O
of O
c B
- I
myb I
is O
required O
for O
both O
the O
differentiation O
block O
and O
the O
shift O
in O
cell O
cycle O
after O
PMA O
treatment O
, O
phosphorylation O
by O
casein O
kinase O
II O
and O
mitogen B
- I
activated I
protein I
kinase I
at O
positions O
11 O
and O
12 O
or O
532 O
of O
c B
- I
myb I
, O
respectively O
, O
are O
not O
. O

The O
activation O
of O
NF B
- I
kappaB I
- O
dependent O
reporter O
gene O
transcription O
by O
E1A B
was O
potently O
suppressed O
upon O
coexpression O
of O
the O
E1B O
19 O
- O
kDa O
protein O
( O
19K O
) O
. O

We O
conclude O
that O
GRF1 B
and O
GRF2 O
can O
form O
homo O
- O
and O
hetero O
- O
oligomers O
via O
their O
DH O
domains O
, O
that O
mutational O
inactivation O
of O
oligomer O
formation O
by O
GRF1 B
is O
associated O
with O
impaired O
biological O
and O
signaling O
activities O
, O
and O
that O
in O
293T O
cells O
GRF1 B
mediates O
at O
least O
two O
pathways O
for O
Raf B
activation O
: O
one O
a O
constitutive O
signal O
that O
is O
mainly O
Ras B
- O
dependent O
, O
and O
one O
an O
ionomycin O
- O
induced O
signal O
that O
cooperates O
with O
the O
constitutive O
signal O
without O
further O
augmenting O
the O
level O
of O
GTP O
- O
Ras O

Influenza O
virus O
- O
induced O
NF O
- O
kappaB O
- O
dependent O
gene O
expression O
is O
mediated O
by O
overexpression O
of O
viral O
proteins O
and O
involves O
oxidative O
radicals O
and O
activation O
of O
IkappaB B
kinase I
. O

These O
observed O
changes O
were O
not O
found O
when O
assessing O
NPY B
level O
in O
plasma O
fluid O
. O

Protein B
kinase I
C I
( O
PKC B
) O
activation O
after O
treatment O
of O
human O
neuroblastoma O
SK O
- O
N O
- O
BE O
( O
2 O
) O
C O
cells O
with O
phorbol O
12 O
- O
myristate O
13 O
- O
acetate O
( O
PMA O
) O
was O
found O
to O
enhance O
transcription O
of O
the O
human O
dopamine O
beta O
- O
hydroxylase O
( O
DBH B
) O
in O
those O
cells O
. O

Bedbug O
( O
Cimex O
lectularius O
) O
samples O
adult O
and O
nymphs O
either O
engorged O
or O
starved O
from O
Central O
Security O
Forces O
sleeping O
wards O
, O
laboratory O
animal O
house O
and O
control O
samples O
from O
laboratory O
reared O
colonies O
were O
ground O
and O
subjected O
to O
ELISA O
test O
of O
hepatitis B
B I
surface I
antigen I
together O
with O
276 O
serum O
samples O
from O
the O
recruits O
slept O
in O
those O
wards O
. O

Synergistic O
induction O
of O
apoptosis O
in O
human O
leukemia O
cells O
( O
U937 O
) O
exposed O
to O
bryostatin O
1 O
and O
the O
proteasome O
inhibitor O
lactacystin O
involves O
dysregulation O
of O
the O
PKC B
/ O
MAPK B
cascade O
. O

The O
role O
of O
haptoglobin B
in O
asphyxia O
mechanism O
( O
II O
) O
- O
- O
Acute O
drowning O
and O
hanging O

Thus O
, O
BCR B
ligation O
initiates O
a O
PI B
3 I
- I
kinase I
/ O
Akt B
/ O
GSK B
- I
3 I
signaling O
pathway O
. O

In O
contrast O
SF B
, O
but O
not O
GM B
- I
CSF I
or O
IL B
- I
3 I
, O
induced O
tyrosine O
phosphorylation O
of O
phospholipase B
C I
- I
gamma I
( O
PLC B
- I
gamma I
) O
. O

The O
temporal O
expression O
of O
CRAlBP O
is O
similar O
to O
IRBP O
while O
bFGF B
is O
not O
expressed O
until O
after O
photoreceptor O
differentiation O
is O
complete O
. O

In O
T O
cells O
these O
two O
signal O
pathways O
are O
critical O
for O
interleukin B
- I
2 I
production O
. O

Replacement O
of O
a O
valine O
( O
V68 O
) O
in O
the O
ETS B
domain O
of O
SAP1a B
by O
aspartic O
acid O
( O
as O
found O
in O
c B
- I
Ets I
- I
1 I
, O
Elk B
- I
1 I
, O
and O
Net O
) O
enhanced O
ternary O
complex O
formation O
by O
more O
than O
60 O
- O
fold O
. O

The O
NF B
- I
kappaB I
/ O
Rel B
transcription O
factors O
participate O
in O
the O
activation O
of O
immune O
system O
regulatory O
genes O
and O
viral B
early I
genes I
including O
the O
human O
immunodeficiency O
virus O
type O
1 O
long O
terminal O
repeat O
. O

Like O
other O
known O
GCD O
genes O
, O
GCD14 O
and O
GCD15 O
are O
therefore O
probably O
required O
for O
general O
translation O
initiation O
in O
addition O
to O
their O
roles O
in O
GCN4 B
- O
specific O
translational O
control O
. O

The O
activity O
of O
plasminogen B
activator I
has O
been O
measured O
in O
tissue O
sections O
with O
the O
aid O
of O
a O
modified O
Todd O
technique O
. O

The O
D443N O
substitution O
is O
an O
activating O
mutation O
that O
increases O
the O
activity O
of O
SCAP B
and O
renders O
it O
resistant O
to O
inhibition O
by O
25 O
- O
hydroxycholesterol O
. O

Central O
( O
heart O
rate O
, O
VE O
, O
VO2 O
) O
or O
local O
( O
muscle O
and O
blood O
lactate O
, O
adenosine O
triphosphate O
, O
creatine B
phosphokinase I
, O
glycogen O
) O
cues O
highlighted O
in O
these O
studies O
demonstrate O
both O
the O
complexity O
of O
effort O
perception O
, O
and O
the O
need O
for O
better O
understanding O
of O
the O
physiological O
components O
upon O
which O
it O
is O
based O
. O

Regulation O
of O
activating O
transcription O
factor O
- O
1 O
and O
the O
cAMP B
response I
element I
- I
binding I
protein I
by O
Ca2 O
+ O
/ O
calmodulin O
- O
dependent O
protein O
kinases O
type O
I O
, O
II O
, O
and O
IV O
. O

Like O
Mdm2 B
, O
MdmX B
is O
able O
to O
bind O
p53 B
and O
inhibit O
p53 B
transactivation O
; O
however O
, O
the O
ability O
of O
MdmX B
to O
degrade O
p53 B
has O
yet O
to O
be O
examined O
. O

Mutant O
p53 O
DNA O
clones O
from O
human O
colon O
carcinomas O
cooperate O
with O
ras B
in O
transforming O
primary O
rat O
cells O
: O
a O
comparison O
of O
the O
" O
hot O
spot O
" O
mutant O
phenotypes O
. O

Although O
paclitaxel O
alone O
failed O
to O
induce O
p38 B
MAPK O
activation O
, O
subsequent O
( O
but O
not O
prior O
) O
exposure O
to O
PD98059 O
induced O
a O
dramatic O
increase O
in O
p38 B
MAPK O
phosphorylation O
. O

The O
promoter O
for O
HMG O
- O
CoA O
synthase O
contains O
two O
binding O
sites O
for O
the O
sterol B
regulatory I
element I
- I
binding I
proteins I
( O
SREBPs B
) O
. O

Characterization O
and O
targeted O
disruption O
of O
murine O
Nup50 O
, O
a O
p27 B
( O
Kip1 B
) O
- O
interacting O
component O
of O
the O
nuclear O
pore O
complex O
. O

p27 B
( O
Kip1 B
) O
is O
a O
member O
of O
the O
Cip O
- O
Kip O
family O
of O
cyclin B
- I
dependent I
kinase I
( O
Cdk B
) O
inhibitors O
that O
binds O
to O
cyclin B
- O
Cdk B
complexes O
and O
inhibits O
their O
catalytic O
activity O
in O
response O
to O
antiproliferative O
stimuli O
. O

p27 B
( O
Kip1 B
) O
is O
regulated O
by O
several O
posttranscriptional O
mechanisms O
, O
including O
subcellular O
localization O
. O

Therefore O
, O
the O
Ogg1 B
protein I
is O
a O
eukaryotic O
DNA B
glycosylase I
/ O
AP O
lyase O
. O

Mutations O
of O
SIN4 B
, O
ROX3 O
, O
SRB8 O
, O
SRB9 O
, O
SRB10 B
, O
SRB11 O
, O
and O
two O
novel O
genes O
, O
NUT1 O
and O
NUT2 O
, O
relieve O
the O
requirement O
of O
Swi4p O
for O
expression O
of O
this O
reporter O
. O

Attenuated O
serum O
cortisol O
responses O
were O
found O
in O
six O
of O
the O
patients O
despite O
a O
normal O
ACTH B
test O
. O

The O
genes O
expressed O
during O
the O
embryonic O
( O
zeta O
) O
or O
fetal O
and O
adult O
stage O
( O
alpha O
2 O
and O
alpha B
1 I
) O
can O
be O
modified O
by O
point O
mutations O
which O
affect O
either O
the O
processing O
- O
translation O
of O
mRNA O
or O
make O
the O
polypeptide O
chains O
extremely O
unstable O
. O

The O
efficiency O
of O
transfections O
was O
normalized O
relative O
to O
the O
net O
amount O
of O
CAT B
plasmid O
actually O
transfected O
into O
recipient O
cells O
, O
determined O
by O
a O
modified O
Southern O
hybridization O
procedure O
. O

In O
the O
present O
study O
we O
found O
that O
CD34 B
downregulation O
during O
hematopoiesis O
occured O
at O
the O
level O
of O
transcriptional O
initiation O
. O

Furthermore O
, O
we O
demonstrate O
that O
in O
myeloid O
and O
B O
cell O
extracts O
, O
PU B
. I
1 I
forms O
a O
novel O
, O
specific O
, O
more O
slowly O
migrating O
complex O
( O
PU O
- O
SF O
) O
when O
binding O
the O
GM B
- I
CSF I
receptor I
alpha I
promoter O
PU B
. I
1 I
site O
. O

Retinoic O
acid O
, O
which O
inhibits O
the O
progression O
of O
certain O
cancers O
, O
repressed O
v B
- I
src I
- O
induced O
MMP O
- O
1 O
transcription O
. O

Reduction O
of O
p53 B
protein I
was O
detected O
after O
1 O
day O
of O
OM O
treatment O
and O
reached O
maximal O
suppression O
of O
10 O
- O
20 O
% O
of O
control O
after O
3 O
days O
in O
H3922 O
and O
40 O
% O
of O
control O
after O
4 O
days O
in O
MCF O
- O
7 O
cells O
. O

Association O
of O
Syk B
protein B
tyrosine I
kinase I
( O
PTK B
) O
with O
LMP2A B
occurs O
at O
the O
two O
tyrosines O
of O
the O
LMP2A O
immunoreceptor O
tyrosine O
- O
based O
activation O
motif O
, O
and O
it O
is O
hypothesized O
that O
Lyn B
PTK B
associates O
with O
the O
YEEA O
amino O
acid O
motif O
at O
LMP2A B
tyrosine O
112 O
( O
Y112 O
) O
. O

Serum O
estriol O
levels O
during O
beta B
- I
receptor I
agonist O
infusion O
in O
the O
third O
trimester O
of O
pregnancy O
. O

In O
this O
study O
, O
we O
investigated O
the O
mechanism O
by O
which O
Tax B
activates O
gene O
expression O
in O
conjunction O
with O
members O
of O
the O
ATF B
/ O
CREB B
family O
. O

Taken O
together O
, O
these O
results O
indicate O
that O
ICSBP B
and O
PU B
. I
1 I
are O
critical O
elements O
for O
IL O
- O
18 O
gene O
expression O
. O

To O
determine O
the O
role O
of O
the O
transmembrane O
region O
of O
HN B
on O
fusion O
- O
promoting O
activity O
, O
mutant O
HN O
proteins O
were O
expressed O
and O
their O
biological O
activities O
examined O
. O

Transient O
transfection O
assays O
indicated O
that O
the O
( O
- O
4551 O
) O
UCP1 O
- O
CAT B
construct O
, O
containing O
the O
5 O
' O
- O
regulatory O
region O
of O
the O
rat O
ucp O
- O
1 O
gene O
, O
was O
activated O
by O
PPARalpha B
co O
- O
transfection O
in O
a O
dose O
- O
dependent O
manner O
and O
this O
activation O
was O
potentiated O
by O
Wy O
14 O
, O
643 O
and O
retinoid O
X O
receptor O
alpha O
. O

MsEPV O
genes O
with O
putative O
functions O
in O
prevention O
and O
repair O
of O
DNA O
damage O
include O
a O
complete O
base O
excision O
repair O
pathway O
( O
uracil B
DNA I
glycosylase I
, O
AP B
endonuclease I
, O
DNA B
polymerase I
beta I
, O
and O
an O
NAD O
+ O
- O
dependent O
DNA O
ligase O
) O
, O
a O
photoreactivation O
repair O
pathway O
( O
cyclobutane O
pyrimidine O
dimer O
photolyase O
) O
, O
a O
LINE O
- O
type O
reverse O
transcriptase O
, O
and O
a O
mutT O
homologue O
. O

The O
biological O
functions O
of O
rat O
surfactant B
protein I
A I
( O
SP B
- I
A I
) O
, O
an O
oligomer O
composed O
of O
18 O
polypeptide O
subunits O
derived O
from O
a O
single O
gene O
, O
are O
dependent O
on O
intact O
disulfide O
bonds O
. O

Coronary O
vasoconstriction O
caused O
by O
endothelin B
- I
1 I
is O
enhanced O
by O
ischemia O
- O
reperfusion O
and O
by O
norepinephrine O
present O
in O
concentrations O
typically O
observed O
after O
neonatal O
cardiopulmonary O
bypass O
. O

Insulin B
- O
secreting O
islet O
- O
cell O
tumours O
of O
the O
pancreas O
. O

We O
have O
previously O
demonstrated O
that O
pyrene O
in O
diesel O
- O
exhaust O
particles O
( O
DEP O
) O
has O
an O
adjuvant O
activity O
on O
immunoglobulin B
E I
( O
IgE B
) O
antibody O
production O
in O
mice O
immunized O
with O
Japanese O
cedar O
pollen O
allergen O
( O
JCPA O
) O
or O
ovalbumin O
( O
OA O
) O
intraperitoneally O
. O

We O
conclude O
that O
transcription O
of O
both O
SCD1 O
and O
SCD2 O
genes O
is O
responsive O
to O
cellular O
sterol O
levels O
and O
to O
the O
levels O
of O
nuclear O
SREBP B
/ O
ADD1 B
and O
that O
transcriptional O
induction O
requires O
three O
spatially O
conserved O
cis O
elements O
, O
that O
bind O
SREBP B
and O
NF B
- I
Y I
. O

Three O
transcriptional O
control O
elements O
within O
300 O
base O
pairs O
of O
the O
5 O
' O
- O
flanking O
region O
of O
the O
rat O
glucagon O
gene O
interact O
with O
regulatory O
cellular O
proteins O
and O
direct O
transcription O
only O
in O
glucagon B
- O
producing O
islet O
cells O
. O

A O
role O
for O
phosphatidylinositol B
3 I
- I
kinase I
in O
the O
regulation O
of O
beta B
1 I
integrin I
activity O
by O
the O
CD2 O
antigen O
. O

Exposure O
of O
raft O
cultures O
to O
activators O
of O
protein B
kinase I
C I
, O
such O
as O
phorbol O
esters O
, O
results O
in O
the O
further O
induction O
of O
late B
gene I
expression O
as O
well O
as O
virion O
assembly O
. O

In O
each O
of O
the O
studied O
HPV O
types O
, O
the O
two O
CDP B
/ O
Cut B
binding O
sites O
of O
PSM O
overlap O
with O
the O
known O
or O
presumed O
binding O
sites O
of O
the O
replication O
initiator O
protein O
E1 O
. O

Hydroxyl O
radical O
footprinting O
of O
DNA O
complexes O
of O
the O
ets B
domain I
of O
PU B
. I
1 I
and O
its O
comparison O
to O
the O
crystal O
structure O
. O

ATF O
is O
formulated O
from O
the O
prothrombin B
time O
( O
PT O
) O
, O
fibrinogen B
transformation O
rate O
( O
FTR O
) O
( O
a O
representation O
of O
thrombin B
activity O
) O
, O
and O
a O
consideration O
of O
the O
fibrinogen B
( O
FBG O
) O
content O
of O
blood O
plasma O
. O

( O
LH B
P O
< O
0 O
. O
05 O
, O
LH B
/ O
FSH B
P O
< O
0 O
. O
01 O
) O
. O

Inhibition O
of O
Raf B
- I
1 I
signaling O
by O
a O
monoclonal O
antibody O
, O
which O
interferes O
with O
Raf B
- I
1 I
activation O
and O
with O
Mek B
substrate O
binding O
. O

The O
classic O
sterol O
regulatory O
cis O
element O
( O
sre O
- O
1 O
) O
in O
the O
LDL O
receptor O
promoter O
mediates O
sterol B
regulatory I
element I
binding I
protein I
( O
SREBP B
) O
- O
binding O
and O
the O
effects O
of O
insulin B
and O
platelet B
derived I
growth I
factor I
( O
PDGF B
) O
. O

This O
is O
probably O
because O
, O
in O
vivo O
, O
some O
bacteria O
( O
perhaps O
dormant O
forms O
) O
are O
not O
entirely O
dependent O
upon O
urease B
for O
survival O
. O

The O
system O
consists O
of O
a O
microcomputer O
and O
six O
laboratory O
analyzers O
: O
a O
blood O
gas O
analyzer O
, O
a O
flame O
photometer O
, O
a O
plasma O
osmotic O
pressure O
meter O
, O
a O
chloride O
ion O
titrator O
, O
a O
blood O
sugar O
analyzer O
, O
and O
a O
hemoglobin B
concentration O
and O
saturation O
meter O
. O

Fusion O
of O
mouse O
CD8 O
+ O
class O
I O
MHC O
- O
restricted O
T O
cells O
with O
the O
BW5147 O
thymoma O
invariably O
yields O
CD8 B
- I
hybridomas O
in O
which O
RNA O
transcribed O
from O
the O
CD8 O
alpha O
( O
Lyt O
- O
2 O
) O
gene O
is O
undetectable O
. O

Peak O
plasma O
ACTH B
responses O
were O
not O
significantly O
different O
between O
control O
and O
patient O
groups O
. O

These O
results O
suggest O
that O
the O
Reg1 B
- O
Glc7 B
phosphatase O
is O
a O
cytoplasmic O
component O
of O
the O
machinery O
responsible O
for O
returning O
Snf1 O
kinase O
activity O
to O
its O
basal O
level O
and O
reestablishing O
glucose O
repression O
. O

The O
majority O
of O
these O
cells O
were O
also O
OKT4 B
positive O
( O
helper O
/ O
inducer O
T O
lymphocytes O
) O
, O
while O
the O
minority O
were O
OKT8 B
positive O
( O
suppressor O
/ O
cytotoxic O
T O
lymphocytes O
) O
. O

The O
IFNAR O
chain O
interacts O
with O
both O
IFN O
- O
alpha O
2 O
and O
IFN B
- I
beta I
, O
as O
demonstrated O
by O
cross O
- O
linking O
. O

These O
three O
phases O
of O
cyclin B
E I
association O
with O
chromatin O
may O
facilitate O
the O
diverse O
activities O
of O
cyclin B
E I
- O
- O
Cdk2 B
in O
initiating O
replication O
, O
blocking O
rereplication O
, O
and O
allowing O
resetting O
of O
origins O
after O
mitosis O
. O

Dermatophagoides O
farinae O
- O
sensitized O
lymphocytes O
in O
asthmatic O
children O
as O
evaluated O
by O
interleukin B
- I
2 I
( O
IL B
- I
2 I
) O
production O
and O
acquisition O
of O
IL B
- I
2 I
responsiveness O

Plasma O
LH O
and O
progesterone O
levels O
after O
single O
or O
multiple O
injections O
of O
synthetic O
LH B
- O
RH O
in O
anoestrous O
ewes O
and O
comparison O
with O
levels O
during O
the O
oestrous O
cycle O
. O

The O
promyelocytic O
leukemia O
protein O
interacts O
with O
Sp1 B
and O
inhibits O
its O
transactivation O
of O
the O
epidermal B
growth I
factor I
receptor I
promoter O
. O

The O
Saccharomyces O
cerevisiae O
targets O
of O
rapamycin O
, O
TOR1 O
and O
TOR2 B
, O
signal O
activation O
of O
cell O
growth O
in O
response O
to O
nutrient O
availability O
. O

The O
Thrombolysis O
in O
Myocardial O
Infarction O
( O
TIMI O
) O
Phase O
II O
Trial O
randomized O
3 O
, O
339 O
patients O
to O
either O
an O
invasive O
( O
INV O
, O
n O
= O
1 O
, O
681 O
) O
or O
a O
conservative O
( O
CON O
, O
n O
= O
1 O
, O
658 O
) O
strategy O
after O
intravenous O
recombinant O
tissue O
- O
type O
plasminogen O
activator O
( O
rt B
- I
PA I
) O
for O
acute O
myocardial O
infarction O
. O

Taken O
together O
, O
these O
data O
suggest O
that O
the O
Smad3 B
/ O
Smad4 B
complex O
has O
at O
least O
two O
separable O
nuclear O
functions O
: O
it O
forms O
a O
rapid O
, O
yet O
transient O
sequence O
- O
specific O
DNA O
binding O
complex O
, O
and O
it O
potentiates O
AP1 B
- O
dependent O
transcriptional O
activation O
. O

When O
phentermine O
was O
mixed O
with O
other O
unlabeled O
reversible O
MAO B
inhibitors O
( O
e O
. O
g O
. O
pseudoephedrine O
, O
ephedrine O
, O
norephedrine O
; O
estradiol O
benzoate O
) O
, O
the O
degree O
of O
MAO B
inhibition O
was O
additive O
. O

4 O
382 O
new O
mothers O
were O
examined O
retrospectively O
with O
the O
enzyme O
- O
linked O
immunosorbent O
assay O
( O
ELISA O
) O
for O
IgG B
activity O
to O
cytomegalovirus O
( O
CMV O
) O
during O
pregnancy O
. O

Alterations O
in O
TCR B
- O
MHC B
contacts O
subsequent O
to O
cross O
- O
recognition O
of O
class O
I O
MHC O
and O
singly O
substituted O
peptide O
variants O
. O

Repeated O
interferon B
- I
beta I
( O
IFN B
- I
beta I
) O
silencer O
B O
motifs O
and O
a O
lysozyme O
silencer O
1 O
motif O
have O
been O
found O
in O
the O
CD95 O
gene O
at O
approximately O
- O
1 O
, O
600 O
and O
- O
1 O
, O
100 O
, O
respectively O
. O

Patients O
with O
the O
chronic O
photosensitivity O
dermatitis O
with O
actinic O
reticuloid O
syndrome O
have O
high O
total O
serum O
IgE B
concentrations O
. O

Tax B
and O
the O
active O
Tax O
mutants O
were O
able O
to O
abrogate O
the O
G1 O
arrest O
and O
apoptosis O
induced O
by O
p53 B
, O
and O
this O
effect O
does O
not O
correlate O
with O
an O
altered O
localization O
of O
nuclear O
p53 O
or O
with O
the O
disruption O
of O
p53 O
- O
DNA O
complexes O
. O

In O
the O
spontaneous O
abortion O
group O
, O
the O
levels O
of O
PAPP B
- I
A I
were O
significantly O
lower O
than O
in O
normal O
pregnancy O
but O
higher O
than O
in O
non O
- O
pregnant O
controls O
. O

In O
cells O
infected O
with O
a O
recombinant O
vaccinia O
virus O
expressing O
HCV O
structural O
proteins O
( O
core B
, O
E1 B
, O
and O
E2 B
) O
, O
DDX3 O
and O
core B
colocalized O
in O
distinct O
spots O
in O
the O
perinuclear O
region O
of O
the O
cytoplasm O
. O

The O
translational O
product O
of O
UL26 B
. I
5 I
is O
infected O
- O
cell O
protein O
35c O
, O
d O
( O
ICP35c O
, O
d O
) O
( O
F O
. O

Due O
to O
significant O
homology O
to O
the O
C O
- O
terminus O
of O
the O
Mutator O
transposase O
this O
alternative O
gene O
product O
was O
named O
Trap B
( O
transposon O
- O
associated O
protein O
) O
. O

Subsequent O
analysis O
revealed O
that O
MyD88 O
possesses O
a O
unique O
modular O
structure O
, O
which O
consists O
of O
an O
N O
- O
terminal O
" O
death O
domain O
, O
" O
similar O
to O
the O
intracellular O
segments O
of O
TNF O
receptor O
1 O
and O
Fas B
, O
and O
a O
C O
- O
terminal O
region O
related O
to O
the O
cytoplasmic O
domains O
of O
the O
Drosophila O
morphogen O
Toll O
and O
vertebrate O
interleukin O
- O
1 O
receptors O
. O

In O
human O
myxoid O
liposarcoma O
, O
a O
chromosomal O
rearrangement O
leads O
to O
fusion O
of O
the O
growth O
- O
arresting O
and O
DNA O
- O
damage O
- O
inducible O
transcription O
factor O
CHOP B
( O
GADD153 B
) O
to O
a O
peptide O
fragment O
encoded O
by O
the O
TLS O
gene O
. O

The O
effects O
of O
dopamine O
and O
of O
dopamine B
D2 I
receptor I
blocker O
haloperidol O
on O
the O
activity O
of O
carotid O
chemoreceptors O
were O
studied O
in O
24 O
anesthetized O
, O
paralyzed O
and O
artificially O
ventilated O
newborn O
kittens O
aged O
0 O
- O
17 O
days O
. O

Plasma B
renin I
activity O
in O
essential O
arterial O
hypertension O
. O

The O
p58 B
( O
PITSLRE O
beta O
1 O
) O
protein O
kinase O
( O
PK O
) O
is O
a O
member O
of O
a O
large O
supergene O
family O
related O
to O
the O
master O
mitotic O
protein O
kinase O
, O
p34cdc2 B
. O

In O
contrast O
, O
NF B
- I
kappa I
B I
activation O
was O
observed O
in O
these O
cells O
after O
PMA O
stimulation O
. O

A O
simple O
procedure O
for O
accurate O
quantitation O
of O
factor B
VIII I
inhibitors O
. O

The O
plants O
were O
then O
brought O
to O
our O
Houston O
laboratory O
where O
they O
were O
measured O
and O
analyzed O
for O
lignin O
and O
protein O
content O
and O
for O
phenylalanine O
ammonia O
- O
lyase O
( O
PAL B
) O
and O
peroxidase B
activities O
. O

Pax B
- I
6 I
constructs O
lacking O
the O
C O
- O
terminal O
activation O
domain O
repressed O
betaB1 O
- O
crystallin O
promoter O
activity O
as O
effectively O
as O
the O
full O
- O
length O
protein O
, O
but O
the O
PD B
alone O
or O
Pax O
- O
6 O
( O
5a O
) O
, O
a O
splice O
variant O
with O
an O
altered O
PD B
affecting O
its O
DNA O
binding O
specificity O
, O
did O
not O
. O

The O
introduction O
of O
FWD1 O
into O
cells O
significantly O
promotes O
ubiquitination O
and O
degradation O
of O
IkappaBalpha B
in O
concert O
with O
IkappaB O
kinases O
, O
resulting O
in O
nuclear O
translocation O
of O
NF B
- I
kappaB I
. O

To O
assess O
the O
effect O
on O
thrombus O
growth O
, O
we O
determined O
the O
accretion O
of O
125I O
- O
labeled O
fibrinogen B
onto O
autologous O
non O
- O
radioactive O
thrombi O
preformed O
in O
the O
jugular O
veins O
of O
rabbits O
. O

Two O
plasmids O
, O
one O
containing O
the O
amino O
terminus O
of O
P O
fused O
to O
the O
DNA O
- O
binding O
domain O
of O
the O
yeast O
transactivator O
, O
GAL4 B
, O
and O
the O
other O
containing O
the O
amino O
terminus O
of O
NP B
fused O
to O
the O
herpesvirus O
transactivator O
, O
VP16 B
, O
were O
transfected O
in O
COS O
- O
1 O
cells O
along O
with O
a O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
reporter O
plasmid O
containing O
GAL4 B
DNA O
- O
binding O
sites O
. O

Biochemical O
experiments O
and O
genome O
sequencing O
have O
shown O
that O
, O
despite O
the O
prokaryotic O
cell O
and O
genome O
organization O
, O
basal O
transcriptional O
elements O
of O
members O
of O
the O
domain O
Archaea O
( O
i O
. O
e O
. O
, O
TATA O
box O
- O
like O
sequences O
, O
RNA B
polymerase I
, O
and O
transcription O
factors O
TBP B
, O
TFIIB B
, O
and O
TFIIS O
) O
are O
of O
the O
eukaryotic O
type O
. O

Humoral O
immunity O
is O
altered O
with O
the O
drop O
in O
IgG B
levels O
. O

We O
report O
on O
a O
case O
of O
a O
43 O
- O
old O
- O
male O
with O
a O
bronchogenic O
cyst O
in O
the O
distal O
esophagus O
, O
which O
was O
misdiagnosed O
as O
a O
malignant O
esophageal O
tumor O
based O
on O
preoperative O
imaging O
and O
high O
levels O
of O
the O
tumor O
markers O
CA B
19 I
- I
9 I
and O
CA B
125 I
. O

The O
expression O
of O
the O
leukocyte O
EL O
- O
246 O
antigen O
was O
regulated O
in O
the O
same O
manner O
as O
L B
- I
selectin I
and O
EL O
- O
246 O
recognized O
anti O
- O
L O
- O
selectin O
mAb O
affinity O
- O
purified O
antigen O
in O
SDS O
/ O
PAGE O
Western O
blot O
analysis O
. O

These O
operons O
encode O
subunits O
of O
photosystems O
I O
( O
psa B
) O
and O
II O
( O
psb O
) O
, O
the O
cytochrome O
bGf O
complex O
( O
pet B
) O
, O
the O
plastid O
NAD O
( O
P O
) O
H O
dehydrogenase O
( O
ndh O
) O
, O
and O
the O
unidentified O
open O
reading O
frame O
ycf9 O
. O

The O
phosphatidylglycerol O
/ O
phosphatidylinositol O
transfer O
protein O
( O
PG O
/ O
PI O
- O
TP O
) O
is O
a O
new O
and O
original O
phospholipid B
transfer I
protein I
( O
PLTP B
) O
isolated O
from O
the O
Deuteromycete O
, O
Aspergillus O
oryzae O
. O

Transcriptional O
modulation O
of O
the O
anti O
- O
apoptotic O
protein O
BCL O
- O
XL O
by O
the O
paired O
box O
transcription O
factors O
PAX3 B
and O
PAX3 B
/ O
FKHR B
. O

Blotting O
analysis O
of O
intestinal O
RNA O
and O
hybridization O
of O
the O
blots O
with O
carboxy O
apoB B
cDNA O
probes O
produced O
a O
single O
15 O
- O
kb O
hybridization O
band O
whereas O
hybridization O
with O
amino O
terminal O
probes O
produced O
two O
hybridization O
bands O
of O
15 O
and O
8 O
kb O
. O

Since O
UmuD O
protein O
is O
proteolytically O
processed O
to O
an O
active O
form O
( O
UmuD B
* I
) O
in O
a O
RecA B
* O
- O
dependent O
fashion O
, O
and O
MucA B
shares O
extensive O
amino O
acid O
homology O
with O
UmuD B
, O
we O
examined O
whether O
MucA B
is O
similarly O
processed O
in O
the O
cell O
, O
using O
antiserum O
against O
a O
LacZ B
' I
- O
' B
MucA I
fusion O
protein O
. O

We O
have O
determined O
the O
molecular O
organization O
and O
transcription O
start O
points O
( O
tsp O
) O
for O
the O
murine O
gene O
( O
TK B
) O
encoding O
thymidine B
kinase I
. O

It O
is O
an O
untested O
argument O
that O
conventional O
beta B
- I
adrenoceptor I
antagonists O
possess O
unwanted O
metabolic O
effects O
that O
may O
counter O
some O
of O
their O
potential O
cardiac O
benefits O
. O

These O
studies O
reveal O
that O
CREM B
, O
a O
tissue O
- O
specific O
factor O
, O
is O
expressed O
and O
regulated O
by O
gonadotropins B
in O
the O
ovary O
, O
that O
the O
predominant O
CREM B
transcripts O
encode O
the O
repressor O
protein O
ICER O
, O
and O
that O
ICER B
is O
capable O
of O
inhibiting O
cAMP O
- O
induced O
expression O
of O
the O
inhibin O
alpha O
- O
subunit O
gene O
. O

Acanthamoeba O
myosin O
I O
heavy O
chain O
kinase O
( O
MIHCK O
) O
phosphorylates O
the O
heavy O
chains O
of O
amoeba O
myosins O
I O
, O
increasing O
their O
actin B
- O
activated O
ATPase B
activities O
. O

Mutation O
of O
the O
HNF3 O
element O
significantly O
reduced O
promoter O
activity O
in O
HepG2 O
cells O
, O
whereas O
this O
element O
in O
isolation O
conferred O
HNF3beta B
responsiveness O
to O
a O
heterologous O
promoter O
. O

The O
findings O
in O
the O
human O
multiple O
myeloma O
cell O
lines O
represent O
the O
first O
examples O
of O
B O
cells O
with O
downregulated O
PU B
. I
1 I
expression O
and O
apparently O
contradict O
observations O
in O
the O
murine O
system O
in O
which O
PU B
. I
1 I
is O
expressed O
and O
active O
in O
plasmacytoma O
cell O
lines O
. O

However O
, O
technical O
advances O
have O
shown O
the O
limitations O
of O
these O
tests O
as O
tests O
for O
IgM B
can O
be O
positive O
because O
of O
residual O
specific O
IgM B
or O
even O
in O
subjects O
free O
of O
acute O
infection O
due O
to O
the O
existence O
of O
natural O
interfering O
IgM B
. O

We O
have O
utilized O
transient O
transfections O
, O
mutation O
analysis O
, O
electromobility O
gel O
- O
shifts O
, O
and O
immunoblot O
analysis O
to O
test O
the O
hypothesis O
that O
expression O
of O
the O
CTalpha O
gene O
is O
controlled O
in O
part O
by O
the O
binding O
of O
three O
trans O
- O
acting O
nuclear O
factors O
, O
Sp1 B
, O
Sp2 O
, O
and O
Sp3 B
. O

AMPK B
is O
a O
heterotrimer O
composed O
of O
a O
catalytic O
subunit O
( O
alpha O
) O
and O
two O
regulatory O
subunits O
( O
beta O
and O
gamma O
) O
. O

Antinuclear O
antibodies O
, O
rheumatoid B
factor I
and O
C B
- I
reactive I
protein I
in O
serum O
of O
normal O
women O
using O
oral O
contraceptives O
. O

Adenovirus O
infection O
of O
hepatoma O
cells O
inhibited O
transcription O
of O
the O
phosphoenolpyruvate B
carboxykinase I
( O
GTP O
) O
( O
EC O
4 O
. O
1 O
. O
1 O
. O
32 O
) O
( O
PEPCK B
) O
gene O
and O
virtually O
eliminated O
transcription O
of O
a O
chimeric O
gene O
which O
contained O
the O
PEPCK O
promoter O
linked O
to O
the O
structural O
gene O
for O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
. O

Expression O
of O
the O
gene O
encoding O
transcription O
factor O
cyclic O
adenosine O
3 O
' O
, O
5 O
' O
- O
monophosphate O
( O
cAMP O
) O
response O
element O
- O
binding O
protein O
( O
CREB B
) O
: O
regulation O
by O
follicle B
- I
stimulating I
hormone I
- O
induced O
cAMP O
signaling O
in O
primary O
rat O
Sertoli O
cells O
. O

High O
and O
pathological O
PAI B
- I
1 I
levels O
before O
and O
after O
the O
VO O
test O
were O
consistent O
with O
a O
defective O
fibrinolytic O
potential O
due O
to O
the O
inhibitory O
effect O
of O
PAI B
- I
1 I
on O
plasminogen B
activation O
. O

During O
hexamethylene O
bisactamide O
( O
HMBA O
) O
- O
induced O
differentiation O
of O
murine O
erythroleukemia O
( O
MEL O
) O
cells O
erythroid O
genes O
are O
transcriptionally O
activated O
while O
c B
- I
myb I
and O
several O
other O
nuclear O
proto O
- O
oncogenes O
are O
down O
- O
regulated O
. O

Choline B
acetyltransferase I
immunohistochemistry O
combined O
with O
the O
retrograde O
transport O
of O
horseradish B
peroxidase I
showed O
that O
the O
reticular O
and O
mediodorsal O
thalamic O
nuclei O
of O
the O
cat O
receive O
an O
important O
input O
from O
cholinergic O
and O
non O
- O
cholinergic O
neurons O
of O
substantia O
innominata O
and O
adjacent O
structures O
in O
the O
basal O
forebrain O
. O

( O
i O
) O
The O
chimeric O
gene O
consisting O
of O
the O
coding O
and O
5 O
' O
nontranslated O
leader O
regions O
of O
the O
TK B
gene I
fused O
to O
portions O
of O
the O
domain O
of O
alpha O
gene O
0 O
extending O
largely O
upstream O
from O
the O
site O
of O
initiation O
of O
transcription O
of O
alpha O
gene O
0 O
was O
regulated O
in O
the O
same O
fashion O
as O
the O
alpha O
4 O
- O
and O
alpha O
27 O
- O
TK O
chimeras O
. O

Nuclear O
proteins O
bound O
the O
cad O
+ O
55 O
/ O
+ O
75 O
element O
in O
a O
cell O
cycle O
- O
dependent O
manner O
in O
electromobility O
shift O
assays O
; O
antibodies O
specific O
to O
USF B
and O
Max B
blocked O
the O
DNA O
- O
binding O
activity O
of O
different O
growth O
- O
regulated O
protein O
- O
DNA O
complexes O
. O

Thus O
, O
an O
unmodified O
threonine O
at O
position O
169 O
in O
Cdc28 B
is O
important O
for O
interaction O
with O
G1 O
cyclins O
. O

Additional O
genetic O
analyses O
described O
herein O
suggest O
that O
Skb1 O
is O
a O
component O
of O
the O
morphology O
control O
branch O
of O
the O
Ras B
signaling O
cascade O
in O
S O
. O
pombe O
and O
that O
it O
positively O
modulates O
Shk1 O
function O
. O

Coexpression O
of O
C B
/ I
EBP I
alpha I
altered O
the O
cell O
specificity O
. O

ET B
- I
1 I
limited O
the O
electrocardiographic O
evidence O
of O
subendocardial O
ischemia O
and O
attenuated O
contractile O
dysfunction O
compared O
with O
mechanical O
stenosis O
at O
the O
same O
coronary O
flows O
, O
even O
though O
lactate O
flux O
was O
similar O
. O

Residues O
that O
affect O
PLCbeta B
and O
adenylyl O
cyclase O
II O
activity O
are O
found O
on O
opposite O
sides O
of O
the O
central O
tunnel O
, O
suggesting O
that O
PLC O
and O
adenylyl B
cyclase I
, O
like O
the O
alpha O
subunit O
, O
make O
many O
contacts O
on O
the O
top O
surface O
. O

The O
ferric O
uptake O
regulation O
( O
fur B
) O
gene O
product O
participates O
in O
regulating O
expression O
of O
the O
manganese O
- O
and O
iron O
- O
containing O
superoxide O
dismutase O
genes O
of O
Escherichia O
coli O
. O

Elements O
of O
the O
hAT O
transposon O
family O
, O
such O
as O
the O
maize O
activator O
( O
Ac B
) O
, O
have O
been O
discovered O
in O
a O
large O
number O
of O
eukaryotic O
species O
. O

We O
found O
both O
the O
v B
- I
Ras I
- O
and O
PC O
- O
PLC O
- O
transformed O
cells O
to O
be O
insensitive O
to O
stimulation O
with O
platelet B
- I
derived I
growth I
factor I
( O
PDGF B
) O
. O

Sequence O
analysis O
of O
the O
catfish O
JH B
- O
CH B
intron O
suggests O
that O
several O
sequences O
are O
present O
which O
appear O
similar O
to O
important O
transcriptional O
regulatory O
elements O
found O
within O
JH B
- O
CH B
introns O
of O
higher O
vertebrates O
. O

TRAF2 B
has O
previously O
been O
demonstrated O
to O
activate O
both O
transcription O
factor O
nuclear B
factor I
kappaB I
( O
NFkappaB B
) O
and O
the O
c B
- I
Jun I
N I
- I
terminal I
kinase I
/ O
stress B
- I
activated I
protein I
kinase I
( O
JNK B
/ O
SAPK B
) O
pathway O
, O
which O
in O
turn O
stimulates O
transcription O
factor O
activating O
protein O
1 O
( O
AP1 B
) O
mainly O
via O
phosphorylation O
of O
the O
c B
- I
Jun I
component O
. O

Human O
alcohol O
dehydrogenase O
( O
ADH B
) O
exists O
as O
a O
heterogeneous O
group O
of O
isozymes O
capable O
of O
oxidizing O
a O
wide O
variety O
of O
aliphatic O
and O
aromatic O
alcohols O
. O

The O
control O
of O
human B
aromatase I
expression O
is O
complex O
in O
that O
several O
promoters O
drive O
aromatase B
expression O
in O
a O
tissue O
- O
specific O
manner O
. O

RXRalpha B
/ O
RARalpha B
heterodimers O
and O
HNF O
- O
4 O
homodimers O
bind O
to O
DR O
- O
1 O
motifs O
on O
elements O
B O
and O
I4 O
, O
respectively O
. O

Evidence O
for O
involvement O
of O
proteins O
HU O
and O
RpoS B
in O
transcription O
of O
the O
osmoresponsive O
proU O
operon O
in O
Escherichia O
coli O
. O

We O
concluded O
that O
RXR B
- I
gamma I
induced O
terminal O
differentiation O
in O
SCC O
lines O
, O
suggesting O
a O
potential O
tumor O
suppressor O
function O
for O
this O
transcription O
factor O
. O

These O
data O
demonstrate O
that O
oleosin B
gene I
transcription O
is O
regulated O
in O
a O
tissue O
- O
specific O
and O
temporally O
regulated O
manner O
and O
clearly O
indicate O
that O
oleosin O
protein O
expression O
is O
co O
- O
ordinated O
primarily O
at O
the O
transcriptional O
level O
. O

Although O
immunoglobulin B
and O
CRP B
concentration O
increased O
, O
anemia O
obviously O
improved O
with O
hemoglobin B
levels O
increasing O
from O
4 O
. O
8 O
g O
/ O
dl O
to O
8 O
. O
5 O
g O
/ O
dl O
without O
any O
side O
effects O
. O

Together O
, O
these O
results O
implicate O
Fal1p B
in O
the O
18S B
rRNA I
maturation O
pathway O
rather O
than O
in O
translation O
initiation O
. O

Screening O
of O
a O
human O
foetal O
brain O
genomic O
DNA O
library O
allowed O
us O
to O
isolate O
an O
EcoRI B
- O
EcoRI B
fragment O
containing O
6 O
kb O
of O
the O
5 O
' O
- O
flanking O
region O
, O
the O
open O
reading O
frame O
and O
4 O
kb O
of O
the O
3 O
' O
- O
flanking O
region O
of O
the O
alpha2C4 O
gene O
. O

The O
rate O
of O
decrease O
of O
PRA O
after O
REM O
onset O
closely O
approximates O
the O
most O
recent O
estimations O
of O
PRA O
half O
- O
life O
, O
which O
suggests O
that O
REM O
onset O
is O
associated O
with O
a O
virtual O
cessation O
in O
renin B
production O
. O

Similarly O
, O
interfering O
with O
MEKK O
, O
which O
lies O
upstream O
of O
JNK1 B
, O
using O
a O
dominant O
negative O
expression O
vector O
reduced O
MMP O
- O
9 O
promoter O
activity O
over O
the O
same O
concentration O
range O
which O
repressed O
the O
AP B
- I
1 I
- O
thymidine B
kinase I
CAT B
reporter O
construct O
. O

There O
was O
no O
difference O
in O
serum O
albumin O
and O
transferrin B
levels O
, O
but O
serum O
prealbumin O
levels O
in O
the O
group O
fed O
early O
were O
more O
desirable O
than O
those O
of O
the O
control O
group O
( O
from O
15 O
. O
8 O
+ O
/ O
- O
2 O
. O
5 O
mg O
/ O
dl O
to O
28 O
. O
9 O
+ O
/ O
- O
3 O
. O
8 O
mg O
/ O
dl O
vs O
from O
18 O
. O
0 O
+ O
/ O
- O
2 O
. O
0 O
mg O
/ O
dl O
to O
25 O
. O
9 O
+ O
/ O
- O
3 O
. O
9 O
mg O
/ O
dl O
) O
. O

This O
constant O
expression O
profile O
, O
coupled O
with O
the O
observation O
that O
over O
- O
expression O
of O
mSin3A O
does O
not O
augment O
the O
anti O
- O
Myc O
activity O
of O
Mxi1 B
- O
SR O
in O
the O
rat O
embryo O
fibroblast O
( O
REF O
) O
transformation O
assay O
, O
suggests O
that O
mSin3A O
is O
not O
a O
limiting O
factor O
in O
the O
regulation O
of O
Myc O
superfamily O
function O
. O

High O
- O
affinity O
binding O
was O
also O
observed O
with O
recombinant O
SH2 O
domains O
from O
v B
- I
src I
and O
v O
- O
fps O
, O
raising O
the O
possibility O
of O
protein O
- O
protein O
interactions O
between O
various O
members O
of O
the O
cytoplasmic O
PTK O
family O
. O

Mutational O
analysis O
of O
the O
putative O
effector O
domain O
of O
the O
GTP O
- O
binding O
Ypt1 O
protein O
in O
yeast O
suggests O
specific O
regulation O
by O
a O
novel O
GAP B
activity O
. O

The O
broad O
range O
protein B
tyrosine I
kinase I
inhibitor O
genistein O
and O
the O
phosphatidylinositol B
3 I
- I
kinase I
inhibitors O
wortmannin O
and O
LY O
294002 O
( O
2 O
- O
( O
4 O
- O
morpholinyl O
) O
- O
8 O
- O
phenyl O
- O
4H O
- O
1 O
- O
benzopyran O
- O
4 O
- O
one O
) O
also O
blocked O
adenosine O
A3 O
receptor O
stimulation O
of O
p42 B
/ O
p44 B
MAPK O
. O

As O
exogenously O
expressed O
PKR B
can O
form O
heterodimers O
with O
endogenous O
PKR O
, O
the O
results O
obtained O
on O
the O
functional O
characterization O
of O
mutant O
forms O
of O
PKR B
have O
been O
taken O
with O
caution O
. O

Orlistat O
is O
a O
specific O
lipase B
inhibitor O
that O
impairs O
fat O
absorption O
, O
thereby O
reducing O
fat O
uptake O
. O

The O
metalloproteinase B
mediating O
Met O
cleavage O
was O
specifically O
inhibited O
by O
the O
tissue O
inhibitor O
of O
metalloproteinases O
( O
TIMP O
) O
- O
3 O
, O
but O
not O
by O
TIMP B
- I
1 I
or O
TIMP O
- O
2 O
. O

It O
is O
also O
conceivable O
that O
elevated O
insulin B
levels O
may O
cause O
hypertriglyceridaemia O
and O
possibly O
other O
abnormalities O
of O
lipid O
metabolism O
. O

Instead O
, O
HBx B
is O
shown O
to O
activate O
the O
cyclin O
A O
promoter O
, O
induce O
cyclin B
A I
- O
cyclin O
- O
dependent O
kinase O
2 O
complexes O
, O
and O
promote O
cycling O
of O
growth O
- O
arrested O
cells O
into O
G1 O
through O
a O
pathway O
involving O
activation O
of O
Src B
tyrosine I
kinases I
. O

Growth B
hormone I
exerts O
its O
effects O
on O
the O
ovarian O
follicular O
cycle O
directly O
or O
by O
local O
production O
of O
insulin O
- O
like O
growth O
factor O
1 O
( O
IGF O
- O
1 O
) O
. O

The O
aim O
of O
this O
study O
was O
to O
evaluate O
the O
impact O
of O
the O
ESRD O
treatment O
modality O
on O
the O
quality O
of O
life O
in O
patients O
with O
Type O
I O
( O
insulin B
- O
dependent O
) O
diabetes O
mellitus O
. O

The O
organelles O
synthesize O
their O
own O
set O
of O
Fe B
/ I
S I
proteins I
, O
and O
they O
initiate O
the O
generation O
of O
extramitochondrial O
Fe O
/ O
S O
proteins O
. O

Most O
significantly O
, O
the O
cyclin B
E I
- O
Cdk2 B
complex O
is O
maximally O
active O
at O
the O
G1 O
/ O
S O
transition O
, O
and O
overexpression O
of O
cyclin B
E I
decreases O
the O
time O
it O
takes O
the O
cell O
to O
complete O
G1 O
and O
enter O
S O
phase O
. O

However O
, O
neither O
SF B
- I
1 I
nor O
NGF O
- O
IB O
alone O
, O
binding O
as O
monomers O
, O
increases O
transcription O
. O

In O
addition O
, O
while O
GCN1 B
is O
required O
in O
vivo O
for O
phosphorylation O
of O
eIF B
- I
2 I
alpha I
by O
GCN2 B
, O
cell O
extracts O
from O
gcn1 O
delta O
strains O
contained O
wild O
- O
type O
levels O
of O
GCN2 B
eIF B
- I
2 I
alpha I
- O
kinase O
activity O
. O

SCOF B
- I
1 I
localized O
to O
the O
nucleus O
but O
did O
not O
bind O
directly O
to O
either O
C O
- O
repeat O
/ O
dehydration O
( O
CRT O
/ O
DRE O
) O
or O
ABA O
responsive O
element O
( O
ABRE O
) O
, O
cis O
- O
acting O
DNA O
regulatory O
elements O
present O
in O
COR O
gene O
promoters O
. O

Although O
no O
detectable O
phenotypes O
are O
associated O
with O
a O
disruption O
allele O
of O
ABP1 B
, O
mutations O
that O
create O
a O
requirement O
for O
this O
protein O
have O
now O
been O
isolated O
in O
the O
previously O
identified O
gene O
SAC6 O
and O
in O
two O
new O
genes O
, O
SLA1 O
and O
SLA2 O
. O

Cross O
- O
talk O
between O
transcription O
factors O
NF B
- I
kappa I
B I
and O
C B
/ I
EBP I
in O
the O
transcriptional O
regulation O
of O
genes O
. O

Furthermore O
, O
CL100 B
suppresses O
the O
[ O
val12 O
] O
ras B
- O
induced O
activation O
of O
MAP B
kinase I
in O
a O
cell O
- O
free O
system O
from O
Xenopus O
oocytes O
. O

The O
Xenopus O
homeobox O
gene O
twin O
mediates O
Wnt B
induction O
of O
goosecoid O
in O
establishment O
of O
Spemann O
' O
s O
organizer O
. O

We O
show O
that O
GCNF B
binds O
to O
one O
of O
the O
two O
DRO O
sequences O
in O
the O
Prm1 O
promoter O
, O
and O
to O
the O
DRO O
sequence O
in O
the O
Prm2 O
promoter O
in O
a O
specific O
manner O
. O

The O
data O
also O
suggest O
that O
gamma O
CACCC O
box O
binding O
factors O
mediate O
LCR O
- O
gamma O
interactions O
which O
normally O
enhance O
gamma B
- I
globin I
and O
suppress O
beta B
- I
globin I
gene I
expression O
in O
fetal O
erythroid O
cells O
. O

Octamer O
recognition O
is O
mediated O
by O
the O
POU B
domain O
, O
a O
conserved O
structural O
motif O
which O
- O
- O
like O
the O
zinc O
finger O
and O
leucine O
zipper O
- O
- O
defines O
a O
family O
of O
related O
transcription O
factors O
. O

The O
major O
promoter O
element O
of O
the O
Xenopus O
laevis O
5S O
RNA O
gene O
is O
located O
within O
the O
transcribed O
region O
of O
the O
gene O
and O
forms O
the O
binding O
site O
for O
the O
transcription O
initiation O
factor O
TFIIIA B
. O

During O
each O
step O
of O
the O
pulse O
infusion O
the O
osteocalcin B
responses O
to O
changes O
in O
CaI O
in O
general O
were O
parallel O
to O
the O
changes O
in O
PTH B
( O
r O
= O
0 O
. O
462 O
; O
P O
= O
0 O
. O
02 O
) O
and O
were O
inversely O
correlated O
to O
CaI O
( O
r O
= O
- O
0 O
. O
562 O
; O
P O
= O
0 O
. O
003 O
) O
. O

Interestingly O
, O
the O
expression O
of O
Id4 O
in O
Sertoli O
cells O
is O
only O
detectable O
after O
stimulation O
with O
FSH B
or O
cAMP O
. O

Furthermore O
, O
it O
is O
also O
established O
that O
serine O
phosphorylation O
of O
STAT5a B
transactivation O
domain O
, O
via O
the O
MAPK B
pathway O
, O
is O
a O
means O
of O
modifying O
GH B
- O
induced O
transcriptional O
activation O
. O

ES O
cells O
in O
which O
the O
gene O
for O
the O
erythroid O
transcription O
factor O
GATA B
- I
1 I
has O
been O
disrupted O
fail O
to O
produce O
mature O
erythroid O
cells O
either O
in O
vivo O
or O
in O
vitro O
. O

It O
is O
concluded O
that O
the O
predominant O
action O
of O
LSD O
on O
the O
female O
copulatory O
response O
is O
not O
mediated O
by O
increased O
dopamine B
receptor I
activity O
but O
that O
the O
LSD O
effect O
might O
be O
modulated O
by O
decreased O
dopaminergic O
activity O
. O

Therefore O
, O
in O
VDR B
- O
mediated O
transcriptional O
activation O
, O
1 O
, O
25 O
( O
OH O
) O
2D3 O
binding O
to O
VDR B
alters O
the O
conformation O
of O
the O
ligand O
binding O
domain O
such O
that O
it O
: O
( O
i O
) O
engages O
in O
strong O
heterodimerization O
with O
RXR B
to O
facilitate O
VDRE O
binding O
, O
( O
ii O
) O
influences O
the O
RXR O
ligand O
binding O
domain O
such O
that O
it O
is O
resistant O
to O
the O
binding O
of O
9 O
- O
cis O
RA O
but O
active O
in O
recruiting O
coactivator O
to O
its O
AF O
- O
2 O
and O
( O
iii O
) O
presents O
the O
AF O
- O
2 O
region O
in O
VDR B
for O
coactivator O
association O
. O

In O
patients O
, O
750 O
mL O
of O
saline O
lowered O
DL O
( O
CO O
) O
( O
- O
8 O
% O
, O
P O
< O
0 O
. O
01 O
versus O
baseline O
) O
, O
D O
( O
M O
) O
( O
- O
10 O
% O
, O
P O
< O
0 O
. O
01 O
versus O
baseline O
) O
, O
aldosterone O
( O
- O
29 O
% O
, O
P O
< O
0 O
. O
01 O
versus O
baseline O
) O
, O
renin B
( O
- O
52 O
% O
, O
P O
< O
0 O
. O
01 O
versus O
baseline O
) O
, O
and O
hematocrit O
( O
- O
6 O
% O
, O
P O
< O
0 O
. O
05 O
versus O
baseline O
) O
and O
increased O
V O
( O
C O
) O
( O
20 O
% O
, O
P O
< O
0 O
. O
01 O
versus O
baseline O
) O
, O
without O
changing O
rap O

The O
5 O
' O
ends O
of O
the O
P B
and O
O O
gene O
mRNAs O
are O
separated O
by O
109 O
nucleotide O
pairs O
in O
the O
DNA O
template O
. O

TGF B
- I
beta1 I
induced O
phosphorylation O
of O
Smad2 B
and O
Smad3 B
in O
Mv1Lu O
mink O
lung O
epithelial O
cells O
. O

There O
is O
little O
supportive O
evidence O
that O
ACE B
inhibitors O
( O
captopril O
or O
enalapril O
) O
are O
teratogenic O
. O

Although O
the O
cDNAs O
of O
HMG B
- I
14 I
and O
HMG O
- O
17 O
do O
not O
cross O
- O
hybridize O
, O
they O
have O
several O
similar O
structural O
features O
: O
the O
open O
reading O
frame O
comprises O
only O
23 O
% O
of O
the O
transcripts O
, O
the O
5 O
' O
- O
untranslated O
region O
is O
extremely O
GC O
rich O
whereas O
the O
3 O
' O
- O
untranslated O
region O
is O
unusually O
long O
and O
AT O
rich O
. O

In O
gel O
mobility O
shift O
assays O
, O
high O
binding O
activities O
of O
ATPC O
- O
2 O
and O
low O
binding O
activities O
of O
CBF B
were O
observed O
with O
nuclear O
extracts O
from O
tissue O
with O
low O
AtpC B
expression O
levels O
, O
and O
the O
opposite O
was O
observed O
with O
extracts O
from O
tissues O
with O
high O
AtpC B
expression O
levels O
. O

Activation O
of O
tyrosine O
kinase O
- O
containing O
receptors O
, O
heterotrimeric B
G I
proteins I
, O
and O
protein B
kinase I
C I
enhanced O
the O
activities O
of O
both O
MEK O
isoforms O
in O
293 O
and O
PC12 O
cells O
. O

Oligomers O
corresponding O
to O
the O
region O
of O
the O
mlc O
- O
1 O
/ O
3 O
enhancer O
, O
which O
encompasses O
this O
conserved O
sequence O
, O
bound O
MEF B
- I
2 I
and O
competed O
for O
its O
binding O
to O
the O
mck O
enhancer O
. O

Similar O
tissue O
- O
specific O
patterns O
are O
observed O
with O
a O
fusion O
between O
the O
caufliflower O
mosaic O
virus O
35S O
RNA O
promotor O
and O
the O
GUS B
gene I
. O

One O
function O
of O
p53 B
is O
in O
regulating O
cell O
cycle O
check O
- O
point O
control O
after O
DNA O
damage O
. O

Apoptosis O
triggered O
through O
Fas B
and O
F O
/ O
F O
was O
inhibited O
by O
coexpression O
of O
CrmA B
and O
p35 B
, O
but O
not O
Bcl O
- O
xL O
. O

We O
found O
a O
prevalence O
of O
eating O
disorders O
of O
5 O
. O
9 O
% O
( O
lifetime O
prevalence O
of O
10 O
% O
) O
, O
irrespective O
of O
gender O
and O
type O
of O
diabetes O
; O
4 O
. O
1 O
% O
of O
the O
whole O
sample O
reported O
intentional O
insulin B
undertreatment O
or O
omission O
. O

These O
results O
are O
discussed O
in O
the O
context O
of O
a O
model O
of O
the O
myogenic O
lineage O
that O
is O
based O
on O
the O
expression O
of O
desmin B
. O

We O
identified O
two O
potential O
phosphorylation O
sites O
at O
serine49 O
and O
serine133 O
, O
both O
of O
which O
seem O
to O
be O
necessary O
for O
Myf B
- I
5 I
activity O
. O

We O
constructed O
a O
series O
of O
chimeric O
genes O
containing O
part O
of O
the O
first O
exon O
and O
increasingly O
longer O
5 O
' O
flanking O
sequences O
of O
the O
ODC O
gene O
fused O
to O
either O
bacterial B
chloramphenicol I
acetyltransferase I
( O
CAT B
) O
or O
luciferase O
reporter O
genes O
. O

This O
latter O
complex O
reacts O
with O
an O
antibody O
to O
serum B
response I
factor I
( O
SRF B
) O
and O
exhibits O
the O
same O
binding O
characteristics O
as O
purified O
SRF B
. O

Akt B
- O
dependent O
antiapoptotic O
action O
of O
insulin B
is O
sensitive O
to O
farnesyltransferase O
inhibitor O
. O

Two O
of O
the O
proteins O
UPRF O
- O
1 O
and O
UPRF O
- O
2 O
( O
which O
is O
apparently O
a O
proteolytic O
degradation O
product O
of O
UPRF O
- O
1 O
) O
bind O
inefficiently O
to O
mutant O
versions O
of O
the O
UPR O
that O
are O
unable O
to O
confer O
responsiveness O
to O
unfolded O
proteins O
to O
the O
( O
CYC1 B
) O
promoter O
. O

Upstream B
stimulatory I
factor I
USF B
is O
a O
human O
transcriptional O
activation O
factor O
, O
which O
uses O
a O
basic O
/ O
helix O
- O
loop O
- O
helix O
/ O
leucin O
zipper O
( O
b O
/ O
HLH O
/ O
Z O
) O
motif O
to O
homodimerize O
and O
recognize O
specific O
sequences O
in O
the O
promoter O
region O
of O
both O
nuclear O
and O
viral O
genes O
transcribed O
by O
RNA B
polymerase I
II I
. O

The O
analysis O
predicted O
that O
progressive O
increases O
in O
serum O
creatinine O
or O
aspartate B
transaminase I
activity O
will O
result O
in O
only O
a O
50 O
% O
reduction O
of O
clearance O
. O

Coimmunoprecipitation O
analysis O
suggests O
that O
these O
residues O
likely O
contribute O
to O
the O
multimerization O
function O
required O
for O
homomeric O
complex O
formation O
or O
heteromeric O
complex O
formation O
with O
p50 B
in O
that O
no O
association O
of O
p65 O
delta O
with O
itself O
or O
with O
p50 B
was O
evident O
. O

A O
yeast O
mitochondrial O
translation O
initiation O
codon O
mutation O
affecting O
the O
gene O
for O
cytochrome O
oxidase O
subunit O
III O
( O
COX3 B
) O
was O
partially O
suppressed O
by O
a O
spontaneous O
nuclear O
mutation O
. O

These O
results O
demonstrate O
that O
GGTase O
- O
I O
inhibitors O
arrest O
cells O
in O
G0 O
/ O
G1 O
and O
induce O
accumulation O
of O
p21WAF O
in O
a O
p53 B
- O
independent O
manner O
and O
that O
FTase O
inhibitors O
can O
interfere O
with O
cell O
cycle O
events O
by O
a O
mechanism O
that O
involves O
neither O
p21WAF O
nor O
p27KIP O
. O

The O
potential O
biological O
significance O
of O
the O
identified O
structural O
motif O
shared O
by O
the O
human O
CCR5 O
, O
CCR3 B
, O
CCR2B O
and O
other O
GPCRs O
is O
discussed O
. O

Since O
1985 O
the O
combination O
of O
chlorambucil O
( O
10 O
mg O
daily O
, O
initially O
for O
six O
weeks O
, O
then O
alternating O
fortnights O
for O
12 O
weeks O
) O
and O
interferon B
- I
alpha I
2b I
( O
Schering O
- O
Plough O
; O
2 O
x O
10 O
( O
6 O
) O
U O
/ O
m2 O
three O
times O
weekly O
by O
subcutaneous O
injection O
for O
18 O
weeks O
) O
has O
been O
compared O
in O
a O
randomised O
trial O
with O
chlorambucil O
alone O
in O
previously O
untreated O
patients O
with O
stage O
III O
or O
IV O
follicular O
lymphoma O
. O

We O
compared O
retrospectively O
the O
efficacy O
of O
granulocyte B
colony I
stimulating I
factor I
( O
G B
- I
CSF I
) O
alone O
with O
chemotherapy O
plus O
G B
- I
CSF I
in O
mobilizing O
CD34 B
- O
positive O
cells O
in O
patients O
with O
malignant O
lymphoma O
. O

We O
now O
show O
that O
purified O
recombinant O
c B
- I
sis I
/ O
PDGF B
can O
induce O
this O
binding O
activity O
which O
we O
have O
termed O
SIF O
, O
for O
sis O
- O
inducible O
factor O
. O

The O
performances O
of O
two O
tests O
, O
the O
ProstAsure O
index O
and O
the O
percent O
free O
PSA B
test O
, O
were O
evaluated O
in O
detecting O
cancer O
. O

The O
protein O
encoded O
by O
the O
NF2 O
gene O
has O
a O
similarity O
to O
ezrin O
, O
radixin O
and O
moesin O
( O
ERM B
) O
proteins O
that O
link O
membrane O
proteins O
to O
the O
cytoskeleton O
. O

In O
the O
healing O
tendons O
, O
the O
rate O
of O
collagen B
synthesis O
decreased O
and O
the O
rate O
of O
noncollagen O
protein O
synthesis O
remained O
unchanged O
. O

FdsR B
purified O
to O
homogeneity O
after O
overexpression O
of O
fdsR B
in O
E O
. O
coli O
is O
a O
130 O
kDa O
homotetramer O
binding O
to O
the O
fds O
control O
region O
located O
between O
the O
fdsR B
and O
fdsG O
genes O
. O

Binding O
of O
ZAP B
- I
70 I
to O
phospho O
- O
TAMs O
is O
notable O
for O
the O
high O
level O
of O
cooperativity O
between O
the O
two O
SH2 B
domains I
, O
which O
individually O
demonstrate O
low O
affinity O
interaction O
with O
the O
ligand O
. O

The O
leader O
peptide O
was O
hypothesized O
to O
inhibit O
ribosome O
release O
at O
the O
tnaC O
stop O
codon O
, O
thereby O
blocking O
Rho B
' O
s O
access O
to O
the O
transcript O
. O

Influence O
of O
huanglian O
used O
in O
combination O
with O
huangqin O
and O
gancao O
on O
the O
erythrocytic O
osmotic O
fragilitas O
of O
experimental O
glucose B
- I
6 I
- I
phosphate I
dehydrogenase I
deficiency O
in O
rats O
] O
OBJECTIVE O
: O
To O
study O
the O
influence O
of O
common O
combination O
of O
Huanglian O
( O
Coptis O
chinensis O
) O
on O
the O
erythrocytic O
osmotic O
fragilitas O
of O
glucose B
- I
6 I
- I
phosphate I
dehydrogenase I
( O
G6PD B
) O
deficiency O
in O
rats O
. O

This O
sequence O
was O
sufficient O
to O
confer O
p53 B
- O
dependent O
activation O
to O
a O
heterologous O
promoter O
and O
p53 B
was O
capable O
of O
binding O
to O
this O
sequence O
as O
assessed O
by O
gel O
shift O
analysis O
. O

Parathyroid B
hormone I
responses O
of O
cyclic O
AMP O
- O
, O
serum O
- O
and O
phorbol O
ester O
- O
responsive O
reporter O
genes O
in O
osteoblast O
- O
like O
UMR O
- O
106 O
cells O
. O

First O
, O
the O
amino O
- O
terminal O
regulatory O
arm O
of O
the O
GDI O
binds O
to O
the O
switch O
I O
and O
II O
domains O
of O
Cdc42 B
leading O
to O
the O
inhibition O
of O
both O
GDP O
dissociation O
and O
GTP O
hydrolysis O
. O

The O
PEP4 B
gene I
was O
isolated O
from O
a O
genomic O
DNA O
library O
by O
complementation O
of O
the O
pep4 O
- O
3 O
mutation O
. O

A O
gene O
with O
a O
high O
degree O
of O
sequence O
identity O
with O
mammalian O
ADP O
- O
ribosylation O
factors O
( O
ARFs B
) O
, O
believed O
to O
be O
important O
in O
vesicular O
transport O
, O
was O
identified O
. O

The O
Tat B
protein I
coded O
by O
human O
immunodeficiency O
virus O
( O
HIV O
) O
is O
a O
strong O
activator O
of O
viral O
gene O
expression O
from O
the O
long O
terminal O
repeat O
( O
LTR O
) O
. O

The O
sections O
were O
stained O
with O
anti O
- O
polymorphonuclear O
leukocyte O
antibody O
, O
the O
endothelial O
marker O
factor B
VIII I
- I
related I
antigen I
, O
and O
with O
hematoxylin O
and O
eosin O
. O

Mapping O
of O
the O
region O
in O
KAP B
- I
1 I
required O
for O
HP1 O
interaction O
showed O
that O
amino O
acid O
substitutions O
which O
abolish O
HP1 O
binding O
in O
vitro O
reduce O
KAP B
- I
1 I
mediated O
repression O
in O
vivo O
. O

Promoter O
activity O
of O
the O
proliferating O
- O
cell O
nuclear O
antigen O
gene O
is O
associated O
with O
inducible O
CRE O
- O
binding O
proteins O
in O
interleukin B
2 I
- O
stimulated O
T O
lymphocytes O
. O

The O
specificity O
of O
the O
transcriptional O
activation O
by O
ISGF3 B
is O
mediated O
by O
specific O
elements O
termed O
IFN O
- O
stimulatory O
response O
element O
( O
ISRE B
) O
located O
in O
the O
promoter O
region O
of O
IFN B
- O
inducible O
genes O
. O

The O
receptor O
for O
CSF B
- I
1 I
, O
c B
- I
Fms I
, O
is O
expressed O
in O
osteoclasts O
, O
possesses O
intrinsic O
tyrosine B
- I
kinase I
activity O
, O
and O
signals O
via O
rapid O
phosphorylation O
of O
selected O
proteins O
. O

3 O
) O
The O
progress O
of O
fibrinolysis O
was O
observed O
by O
serial O
collection O
of O
middle O
ear O
fluid O
in O
the O
same O
side O
ear O
of O
5 O
cases O
out O
of O
17 O
cases O
having O
much O
activity O
for O
fibrin B
degradation O
, O
and O
lowering O
of O
fibrinolytic O
activity O
was O
revealed O
in O
4 O
out O
of O
these O
5 O
cases O
as O
the O
result O
. O

HC O
- O
toxin O
exerts O
a O
potent O
cytostatic O
effect O
on O
plant O
and O
animal O
cells O
by O
inhibiting O
histone B
deacetylase I
. O

